Sentence,class,file
"http://dx.doi.org/10.1016/j.ab.2011.03.03 6 Itoh, T., A. Watabe, A. Toh­E, and Y. Matsui.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1016/S0074 ­7696(08)   61858 ­6 Khmelinskii, A., P.J.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/1   0.1038/nature0925 5 Khmelinskii, A., P.J.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1038/nbt.228 1 Kirchenbauer, M., and D. Liakopoulos.",Non-OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1091/mbc.E12­08­060 2 Korinek, W.S., M.J. Copeland, A. Chaudhuri, and J. Chant.",Non-OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1126/   science.287.5461.225 7 Kosova, B., N. Panté, C. Rollenhagen, and E. Hurt.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/   10.1074/jbc.274.32.2264 6 Li, Y.Y., E. Yeh, T. Hays, and K. Bloom.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1016/0092­8674(95)90528­ 6 Logie, C., and A.F.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10   .1073/pnas.92.13.594 0 Lupu, F., A. Alves, K. Anderson, V. Doye, and E. Lacy.",Non-OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1016/   j.devcel.2008.03.01 1 Maeshima, K., H. Iino, S. Hihara, T. Funakoshi, A. Watanabe, M. Nishimura,  R. Nakatomi, K. Yahata, F. Imamoto, T. Hashikawa, et al.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1038/nsmb.187 8 Makio, T., L.H.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi   .org/10.1083/jcb.20081002 9 Marelli, M., J.D.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/   10.1083/jcb.55.2.43 3 McMillan, J.N., R.A. Sia, E.S.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1091/mbc   .11.9.294 9 Mutvei, A., S. Dihlmann, W. Herth, and E.C.",Non-OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1016/0092­8674(90)90063­ K Neumüller, R.A., and J.A.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
http://dx.doi.org/10.1101/gad.185080 9,Non-OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi   .org/10.1038/emboj.2012.25 6 Wesp, A., L. Hicke, J. Palecek, R. Lombardi, T. Aust, A.L.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1091/mbc.8.11.229 1 Winey, M., D. Yarar, T.H.",Non-OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1073/   pnas.02246289 9 Yang, H.C., A. Palazzo, T.C.",Non-OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1016/   S0960 ­9822(99)80480 ­1 Yewdell, W.T., P. Colombi, T. Makhnevych, and C.P.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi.org/10.1091/mbc.E10­06­055 4 Yin, H., D. Pruyne, T.C.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi   .org/10.1038/3502302 4 Zabel, U., V. Doye, H. Tekotte, R. Wepf, P. Grandi, and E.C.",Non-OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
"http://dx.doi   .org/10.1083/jcb.133.6.114 1 Zhang, L., N.G.",OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
http://dx.doi.org/10.2144/00011245 3,Non-OADS,/arxiv_data1/oa_pdf/20/98/JCB_201305115.PMC3812967.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publica - tion date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1091/mbc.E06-01-006 7 Ihrke, G., E.B.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1083/jcb.123.6.176 1 Jaffe, A.B., N. Kaji, J. Durgan, and A.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1083/jcb.20080712 1 Jou, T.S., and W.J.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1083/ jcb  .142.1.8 5 Kaji, N., A. Muramoto, and K. Mizuno.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1074/jbc.M70864420 0 Kaushik, R., F. Yu, W. Chia, X. Yang, and S. Bahri.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1091/mbc   .E03-04-021 2 Kiyomitsu, T., and I.M.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1038/ncb244 0 Kotak, S., C. Busso, and P. Gönczy.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi   .org/10.1083/jcb.20120316 6 Kunda, P., and B. Baum.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10   .1016/j.tcb.2009.01.00 6 Maddox, A.S., and K. Burridge.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1083/jcb.20020713 0 Martinez-Hernandez, A., and P.S.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1007/BF0160642 5 Masuda-Hirata, M., A. Suzuki, Y. Amano, K. Yamashita, M. Ide, T. Yamanaka,  M. Sakai, M. Imamura, and S. Ohno.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
http://dx.doi.org/10.1111/ j.1365-2443.2009.01315.,Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1038/nrm85 9 Pertz, O., L. Hodgson, R.L.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1038/nature0466 5 Peyre, E., F. Jaouen, M. Saadaoui, L. Haren, A. Merdes, P. Durbec, and X.  Morin.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1083/jcb.20110103 9 Qin, Y., W.H.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1083/jcb.20100209 7 Reinsch, S., and E. Karsenti.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1083/jcb.126.6.150 9 Rodriguez-Fraticelli, A.E., S. Vergarajauregui, D.J.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi   .org/10.1083/jcb.20100204 7 Saadat, I., H. Higashi, C. Obuse, M. Umeda, N. Murata-Kamiya, Y. Saito, H. Lu,  N. Ohnishi, T. Azuma, A. Suzuki, et al.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1038/nature0576 5 Schaar, B.T., K. Kinoshita, and S.K.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1016/S0896-6273(03)00843- 2 Stamatoglou, S.C., C. Enrich, M.M.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"122:171– 177. http://dx.doi.org/10.1242/jcs.01894 5shows the metaphase plate orientation with respect to the lumen in WIF-B9  cells growing in cyst-like structures generated in Matrigel or collagen I, pre - dicting symmetric or asymmetric cell divisions, respectively.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
Online supple - mental material is available at http://www.jcb.org/cgi/content/full/   jcb.201303013/DC1.,Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
Additional data are available in the JCB Data - Viewer at http://dx.doi.org/10.1083/jcb.201303013.dv.,OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1016/0012-1606(86)90095- 3 Böhm, H., V. Brinkmann, M. Drab, A. Henske, and T.V.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1016/S0960-9822(06)00260- 0 Busson, S., D. Dujardin, A. Moreau, J. Dompierre, and J.R. De Mey.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi   .org/10.1016/S0960-9822(98)70208- 8 Chikumi, H., J. Vázquez-Prado, J.M.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1074/jbc   .M20471520 0 Citi, S., P. Pulimeno, and S. Paschoud.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
http://dx.doi.org/10.1111/ j.1749-6632.2012.06506.,Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi   .org/10.1083/jcb.20030810 4 Cohen, D., Y. Tian, and A. Musch.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi   .org/10.1091/mbc.E07-02-009 5 Cohen, D., D. Fernandez, F. Lázaro-Diéguez, and A. Müsch.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi   .org/10.1083/jcb.20100700 2 den Elzen, N., C.V.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1091/mbc.E09-01-002 3 Elbert, M., D. Cohen, and A. Müsch.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1091/ mbc.E06-03-019 3 Fernández-Miñán, A., M.D.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1016/j.devcel.2005.03.01 4 Guo, S., and K.J.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1016/   0092-8674(95)90082- 9 Hao, Y., Q.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1016/j.cub.2010.09.03 2 Heng, Y.W., H.H.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"125:1579– 1590. http://dx.doi.org/10.1242/jcs.09681 8 Herrema, H., D. Czajkowska, D. Théard, J.M.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi   .org/10.1016/j.cub.2004.08.02 1 Tabler, J.M., H. Yamanaka, and J.B. Green.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1242/dev.04983 3 Terry, S.J., C. Zihni, A. Elbediwy, E. Vitiello, I.V.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi   .org/10.1038/ncb215 6 Théry, M., and M. Bornens.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"2:65– 71. http://dx.doi.org/10.2976/1.289566 1 Théry, M., V. Racine, A. Pépin, M. Piel, Y. Chen, J.B. Sibarita, and M. Bornens.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1038/ncb130 7 Théry, M., A. Jiménez-Dalmaroni, V. Racine, M. Bornens, and F. Jülicher.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1038/nature0578 6 Toyoshima, F., and E. Nishida.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"213:407– 411. http://dx.doi.org/10.1002/jcp.2122 7 Toyoshima, F., S. Matsumura, H. Morimoto, M. Mitsushima, and E. Nishida.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.10.01 4 van IJzendoorn, S.C., M.M.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1083/jcb.137.2.34 7 Wakayama, Y., K. Miura, H. Sabe, and N. Mochizuki.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10.1074/jbc.M111.26704 7 Werb, Z., P.M. Tremble, O. Behrendtsen, E. Crowley, and C.H.",Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"http://dx.doi.org/10   .1016/j.yexcr.2004.01.00 5 Zheng, Z., H. Zhu, Q. Wan, J. Liu, Z. Xiao, D.P.",OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
http://dx.doi.org/10.1083/jcb.20091002 1,Non-OADS,/arxiv_data1/oa_pdf/15/f0/JCB_201303013.PMC3812971.pdf
"New findings on  the cellular mechanisms and molecular players of the two  forms of plasticity are uncovering the interplay between  them in individual neurons.Cell biology in neuroscience The interplay between Hebbian and homeostatic  synaptic plasticity Nathalia Vitureira1,2 and Yukiko Goda3 1Departmento de Fisiología, Facultad de Medicina, Universidad de la República, Montevideo 11100, Uruguay 2Institut Pasteur Montevideo, Montevideo 11400, Uruguay 3RIKEN Brain Science Institute, Wako, Saitama 351-0198, Japan © 2013 Vitureira and Goda  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nature0301 0 Ahmad, M., J.S.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/   10.1016/j.neuron.2011.11.02 0 Alvarez, V.A., and B.L.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1146/annurev.neuro.30.051606.09422 2 Andersen, P., S.H.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/266736a 0 Anggono, V ., R.L.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3880-12.201 3 Bacci, A., S. Coco, E. Pravettoni, U. Schenk, S. Armano, C. Frassoni, C. Verderio,  P. De Camilli, and M. Matteoli.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2009.04.02 3 Bats, C., L. Groc, and D. Choquet.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"53:719– 734. http://dx.doi.org/10.1016/j.neuron.2007.01.03 0 Bhattacharyya, S., V .",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nn.224 9 Bi, G., and M. Poo.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/   10.1146/annurev.neuro.24.1.13 9 Bliss, T.V ., and G.L.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1038/361031a 0 Bliss, T.V ., and T. Lomo.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4517-09.201 0 Borgdorff, A.J., and D. Choquet.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nature0078 0 Bortolotto, Z.A., R. Nistico, J.C. More, D.E.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuro.2005.02.00 4 Bourne, J.N., and K.M.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1002/hipo.2076 8 Bozdagi, O., W. Shan, H. Tanaka, D.L.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)00100- 8 Bozdagi, O., X.B.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
http://dx.doi   .org/10.1523/JNEUROSCI.1223-10.201 0is enhanced in parallel.,Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"32:16586– 16596. http://dx.doi.org/10.1523/JNEUROSCI.0965-12.201 2 Granger, A.J., Y. Shi, W. Lu, M. Cerpas, and R.A. Nicoll.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nature1177 5 Han, Y., P.S.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2010.12.01 4 Hardingham, N.R., J.C. Read, A.J.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.3244-09.201 0 Heine, M., L. Groc, R. Frischknecht, J.C. Béïque, B. Lounis, G. Rumbaugh,  R.L.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1126/science.115208 9 Holderith, N., A. Lorincz, G. Katona, B. Rózsa, A. Kulik, M. Watanabe, and Z.  Nusser.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nn.313 7 Holt, M., F. Varoqueaux, K. Wiederhold, S. Takamori, H. Urlaub, D. Fasshauer,  and R. Jahn.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1074/jbc.M51383820 0 Huang, G.Z., H. Ujihara, S. Takahashi, H. Kaba, T. Yagi, and S. Inoue.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1254/jjp.84.17 9 Huang, Y.Y., S.S. Zakharenko, S. Schoch, P.S.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1371/journal.pone.000984 2 Inoue, A., and S. Okabe.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/S0959-4388(03)00077- 1 Jakawich, S.K., H.B.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1016/j.neuron.2010.11.03 4 Jurado, S., V. Biou, and R.C.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nn.261 3 Jurado, S., D. Goswami, Y. Zhang, A.J.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2012.11.02 9 Kaeser, P.S., L. Deng, M. Fan, and T.C.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nn.282 6 Keith, D.J., J.L.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0784-12.201 2 Kennedy, M.J., I.G.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.cell.2010.02.04 2 Kim, J., S.Y.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1073/pnas.080344810 5 Kwon, H.B., Y. Kozorovitskiy, W.J.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nn.325 6 Lawrence, J.J., and C.J.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.tins.2003.09.00 7Brigidi, G.S., and S.X.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10   .1016/j.conb.2010.12.00 4 Burrone, J., M. O’Byrne, and V.N.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nature0124 2 Cajigas, I.J., T. Will, and E.M. Schuman.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/   emboj.2010.17 3 Castillo, P.E., R. Janz, T.C.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/4157 4 Castillo, P.E., S. Schoch, F. Schmitz, T.C.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/415327 a Chen, L., D.M.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/3504603 1 Cingolani, L.A., and Y. Goda.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nrn237 3 Cingolani, L.A., A. Thalhammer, L.M.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2008.04.01 1 Colledge, M., R.A. Dean, G.K. Scott, L.K.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10   .1016/S0896-6273(00)00013- 1 Collingridge, G.L., S. Peineau, J.G.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1038/nrn286 7 Cooper, L.N., and M.F.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"13:798– 810. http://dx.doi.org/10.1038/nrn335 3 Dani, A., B. Huang, J. Bergan, C. Dulac, and X. Zhuang.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nrn289 8 Echegoyen, J., A. Neu, K.D.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1371/journal.pone.000070 0 Ehlers, M.D.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nn101 3 Ehlers, M.D., M. Heine, L. Groc, M.C.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2007.04.01 0 Ehrlich, I., M. Klein, S. Rumpel, and R. Malinow.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/   10.1523/JNEUROSCI.2144-13.201 3 Fourcaudot, E., F. Gambino, Y. Humeau, G. Casassus, H. Shaban, B. Poulain,  and A. Lüthi.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1007/978-3-7091-0932-8_ 7 Futai, K., M.J. Kim, T. Hashikawa, P. Scheiffele, M. Sheng, and Y. Hayashi.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nn183 7 Gainey, M.A., J.R. Hurvitz-Wolff, M.E.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3753-08.200 9 Graf, E.R., V. Valakh, C.M.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"67:239– 252. http://dx.doi.org/10.1016/j.neuron.2010.06.00 7 Park, M., E.C.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1126/science.110202 6 Park, M., J.M.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2006.09.04 0 Patterson, M.A., E.M. Szatmari, and R. Yasuda.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/   j.neuron.2012.07.00 6 Powell, C.M., S. Schoch, L. Monteggia, M. Barrot, M.F.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"42:143– 153. http://dx.doi.org/10.1016/S0896-6273(04)00146- 1 Pozo, K., and Y .",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2010.04.02 8 Rabinowitch, I., and I. Segev.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/   10.1016/j.tins.2008.05.00 5 Sáez, I., and M.J. Friedlander.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2980-09.200 9 Saglietti, L., C. Dequidt, K. Kamieniarz, M.C.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2007.04.01 2 Sanderson, J.L., and M.L.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1177/107385841038474 0 Scanziani, M., R.C.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/380446a 0 Schikorski, T., and C.F.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/415321 a Schuman, E.M., and D.V.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/   10.1126/science.829096 3 Sheng, M., and E. Kim.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"3. http://dx.doi.org/10.1101/cshperspect.a00567 8 Sheng, M., B.L.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/   10.1101/cshperspect.a00577 7 Shi, S., Y .",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/S0092-   8674(01)00321- X Shin, S.M., N. Zhang, J. Hansen, N.Z.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nn.325 9 Shipman, S.L., and R.A. Nicoll.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"76:309– 316. http://dx.doi.org/10.1016/j.neuron.2012.07.02 4 Siegel, G., R. Saba, and G. Schratt.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.gde.2011.04.00 8 Sjöström, P.J., E.A.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1152/physrev.00016.200 7 Stan, A., K.N.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2088-11.201 1 Lee, K.J., I.S.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.0848-12.201 3 Lee, K.J., B.N.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1016/j.neuron.2012.10.03 3 Lee, S.J., Y. Escobedo-Lozoya, E.M. Szatmari, and R. Yasuda.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nature0784 2 Lindskog, M., L. Li, R.D.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1073/pnas.101639910 7 Lisman, J.E., S. Raghavachari, and R.W.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nrn219 1 Lledo, P.M., X. Zhang, T.C.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1126/science.279.5349.39 9 Loebel, A., J.V.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10   .1523/JNEUROSCI.3740-12.201 3 Lu, Y., M. Allen, A.R.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/   sj.emboj.760188 4 Lynch, G.S., T. Dunwiddie, and V. Gribkoff.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/266737a 0 MacGillavry, H.D., Y.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/   10.1016/j.neuron.2013.03.00 9 Makino, H., and R. Malinow.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2009.08.03 5 Man, H.Y.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/   j.conb.2011.01.00 1 Matsuzaki, M., N. Honkura, G.C.R.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nature0261 7 McGeachie, A.B., A.E.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
36:2461– 2469. http://dx.doi.org/10.1111/j.1460-9568.2012.08163.,Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nn.300 4 Müller, M., E.C.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2011.01.02 5 Müller, M., K.S.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .0981-12.201 2 Murthy, V.N., T. Schikorski, C.F.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/S0896-6273(01)00500- 1 Ohno-Shosaku, T., A. Tanimura, Y. Hashimotodani, and M. Kano.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1177/107385841039737 7 Okuda, T., L.M.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/   10.1073/pnas.070233410 4 Opazo, P., S. Labrecque, C.M.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nature0467 1 Südhof, T.C., and J. Rizo.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1101/cshperspect.a00563 7 Suh, Y.H., A. Terashima, R.S.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1038/nn.248 8 Sun, Q., and G.G.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5616-10.201 1 Suzuki, K., Y. Hayashi, S. Nakahara, H. Kumazaki, J. Prox, K. Horiuchi, M.  Zeng, S. Tanimura, Y. Nishiyama, S. Osawa, et al.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2012.10.00 3 Tardin, C., L. Cognet, C. Bats, B. Lounis, and D. Choquet.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1093/emboj/cdg46 3 Tavalin, S.J.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1074/jbc   .M70925320 0 Tavalin, S.J., M. Colledge, J.W.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1016/j.neuron.2005.06.03 7 Tokuoka, H., and Y. Goda.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1073/pnas.080570510 5 Tomita, S., V. Stein, T.J. Stocker, R.A. Nicoll, and D.S.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.neuron.2005.01.00 9 Tsetsenis, T., T.J. Younts, C.Q.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.cell.2008.10.00 8 Turrigiano, G.G., and S.B.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/   S0959-4388(00)00091- X Tyler, W.J., S.P.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1177/107385840223851 1 Urban, N.T., K.I.",Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1016/j.bpj.2011.07.02 7 Vitureira, N., M. Letellier, I.J.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1038/nn.299 5 Xu, W., Y .C.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.1508-12.201 3 Yang, Y., X.B.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi   .org/10.1073/pnas.080297810 5 Yuste, R., and T. Bonhoeffer.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"http://dx.doi.org/10.1146/annurev.neuro.24.1.107 1 Zhao, C., E. Dreosti, and L. Lagnado.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
"31:7492– 7496. http://dx.doi.org/10.1523/JNEUROSCI.6636-10.201 1 Zoghbi, H.Y., and M.F.",OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
http://dx.doi.org/10.1101/   cshperspect.a00988 6,Non-OADS,/arxiv_data1/oa_pdf/22/6a/JCB_201306030.PMC3812972.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201304132/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi   .org/10.1016/j.semcdb.2010.08.00 6Labeling and fractionation of cell wall polysaccharides [14C]Glucose labeling and fractionation of cell wall polysaccharides  were performed essentially as described previously (Cortés et al., 2012).",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi   .org/10.1007/s10482-004-7074- 2 Jordan, S.N., S. Olson, and J.C. Canman.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1016/j.cub.2010   .12.04 0 Katayama, S., D. Hirata, M. Arellano, P. Pérez, and T. Toda.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi   .org/10.1002/yea.97 4 Lee, I.J., V.C.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1002/cm.2105 2 Liu, J., X. Tang, H. Wang, S. Oliferenko, and M.K.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1091/mbc.01-12-058 1 Liu, J., G.D. Fairn, D.F.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1016/j.cub.2011.11.04 0 Lu, P., V.M.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi   .org/10.1083/jcb.20110214 7 Maeda, Y., J. Kashiwazaki, C. Shimoda, and T. Nakamura.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1271/bbb.8057 5 Martín, V., B. García, E. Carnero, A. Durán, and Y. Sánchez.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi   .org/10.1128/EC.2.1.159-169.200 3 Martins, I.M., J.C.G.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1242/jcs.10378 8 Mizuguchi, S., T. Uyama, H. Kitagawa, K.H.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1038/nature0163 5 Moreno, S., A. Klar, and P. Nurse.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1016/0076-6879(91)94059- L Moreno, M.B., A. Durán, and J.C. Ribas.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1002/1097-0061(20000630)16:9<861:: AID-YEA577>3.0.CO;2- 9 Naqvi, N.I., K. Eng, K.L.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1093/emboj/18.4.85 4 Naqvi, N.I., K.C.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10   .1038/3504110 7 Olson, S.K., J.R. Bishop, J.R. Yates, K. Oegema, and J.D.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1083/jcb.20060300 3 Osumi, M., N. Yamada, H. Kobori, A. Taki, N. Naito, M. Baba, and T.  Nagatani.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/   10.2174/13892031079455771 8Balasubramanian, M.K., R. Srinivasan, Y. Huang, and K.H.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10   .1002/cm.2108 2 Bathe, M., and F. Chang.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"18:38– 45. http://dx.doi.org/10.1016/j.tim.2009.10.00 2 Cabib, E., D.H. Roh, M. Schmidt, L.B.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1074/jbc.R00003120 0 Carnahan, R.H., and K.L.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"162:851– 862. http://dx.doi.org/10.1083/jcb.20030501 2 Castro, C., J.C. Ribas, M.H.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1016/0092-8674(94)90406- 5 Cortés, J.C.G., J. Ishiguro, A. Durán, and J.C. Ribas.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1242/jcs.0008 5 Cortés, J.C.G., E. Carnero, J. Ishiguro, Y. Sánchez, A. Durán, and J.C. Ribas.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1242/jcs.0158 5 Cortés, J.C.G., M. Konomi, I.M.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1111/j.1365-2958.2007   .05784. x Cortés, J.C.G., M. Sato, J. Muñoz, M.B.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi   .org/10.1083/jcb.20120201 5 Egel, R. 1984.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi   .org/10.1007/BF0041781 6 Hartland, R.P., C.A.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi   .org/10.1002/yea.32010120 8 Hochstenbach, F., F.M.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10   .1073/pnas.95.16.916 1 Huang, Y., H. Yan, and M.K.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1083/jcb.20080615 1 Humbel, B.M., M. Konomi, T. Takagi, N. Kamasawa, S.A. Ishijima, and  M. Osumi.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10   .1002/yea.69 4 Hwang, H.Y ., S.K.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1038/   nature0163 4 Hynes, R.O., and A. Naba.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
http://dx.doi.org/10.1101/cshperspect.,Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10   .1042/BJ2009182 3 Pollard, T.D.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1016/j.ceb.2009.11.01 0 Proctor, S.A., N. Minc, A. Boudaoud, and F. Chang.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi   .org/10.1016/j.cub.2012.06.04 2 Ribas, J.C., M. Díaz, A. Durán, and P. Pérez.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1002/yea.177 9 Sambrook, J., and D.W. Russell.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/   10.1038/nmeth81 9 Sipiczki, M. 2007.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
7:761– 770. http://dx.doi.org/10.1111/j.1567-1364.2007.00266.,Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1128/JB.182   .6.1693-1701.200 0 Verde, F., J. Mata, and P. Nurse.",Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1083/jcb.131.6.152 9 White, J., and S. Bednarek.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10.1016/   j.cub.2003.08.04 8 Wu, J.Q., J.R. Kuhn, D.R.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi.org/10   .1016/S1534-5807(03)00324- 1 Xu, X., and B.E.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
"http://dx.doi   .org/10.1016/j.cub.2010.12.00 6 Zhang, X., A.V.",OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
69:810– 818. http://dx.doi.org/10.1002/cm.2105 5,Non-OADS,/arxiv_data1/oa_pdf/f3/37/JCB_201304132.PMC3812973.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201304047/DC1.,Non-OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1126/science.108041 8 Aitchison, J.D., and M.P.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1534/   genetics.111.12780 3 Alber, F., S. Dokudovskaya, L.M.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"450:695– 701. http://dx.doi.org/10.1038/nature0640 5a Plan-Apochromat 100×/1.40 NA oil immersion objective lens and a charge coupled device (CCD) camera (AxioCam MRm), controlled by Axio- Vision software (all from Carl Zeiss).",Non-OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/   10.1083/jcb.20081002 9 Mason, D.A., N. Shulga, S. Undavai, E. Ferrando-May, M.F.",Non-OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1016/j   .femsyr.2005.07.00 8 Ptak, C., A.M. Anderson, R.J. Scott, D. Van de Vosse, R.S.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
http://dx.doi   .org/10.1111/j.1600-0854.2009.00978.,Non-OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1016/   S0092-8674(00)80493- 6 Steinberg, G., M. Schuster, U. Theisen, S. Kilaru, A.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1083/jcb.20120108 7Aoki, K., H. Hayashi, K. Furuya, M. Sato, T. Takagi, M. Osumi, A. Kimura,  and H. Niki.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1111/j.1365-2443   .2011.01540. x Bailer, S.M., C. Balduf, and E. Hurt.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1128/MCB.21.23.7944-7955.200 1 Boettcher, B., T.T.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1083/jcb.20111211 7 Chadrin, A., B. Hess, M. San Roman, X. Gatti, B. Lombard, D. Loew, Y. Barral,  B. Palancade, and V. Doye.",Non-OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1083/jcb.20091004 3 Dieppois, G., and F. Stutz.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1242/jcs.05369 4 Estrada, P., J. Kim, J. Coleman, L. Walker, B. Dunn, P. Takizawa, P. Novick,  and S. Ferro-Novick.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"163:1255– 1266. http://dx.doi.org/10.1083/jcb.20030403 0 Fagarasanu, M., A. Fagarasanu, Y.Y.",Non-OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1083/jcb.20050308 3 Fagarasanu, A., M. Fagarasanu, G.A.",Non-OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1016/j   .devcel.2006.04.01 2 Förtsch, J., E. Hummel, M. Krist, and B. Westermann.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/   10.1083/jcb.20101208 8 Gorsch, L.C., T.C.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi   .org/10.1083/jcb.129.4.93 9 Hoelz, A., E.W.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10   .1146/annurev-biochem-060109-15103 0 Ishikawa, K., N.L.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1083/jcb.20021013 9 Itoh, T., A. Toh-E, and Y. Matsui.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1038/sj.emboj.760027 1 Khmelinskii, A., P.J.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/   10.1038/nature0925 5 Kohlwein, S.D., S. Eder, C.S.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10   .1128/MCB.21.1.109-125.200 1 Liu, B., L. Larsson, A. Caballero, X. Hao, D. Oling, J. Grantham, and T. Nyström.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1016/j   .cell.2009.12.03 1 Longtine, M.S., A. McKenzie III, D.J.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2- U Lusk, C.P., T. Makhnevych, M. Marelli, J.D.",Non-OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"159:267– 278. http://dx.doi.org/10.1083/jcb.20020307 9 Makhnevych, T., C.P.",Non-OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
"http://dx.doi.org/10   .1016/S0092-8674(03)00986- 3 Makio, T., L.H.",OADS,/arxiv_data1/oa_pdf/5f/b6/JCB_201304047.PMC3812975.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201307040/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/   10.1074/jbc.M40377720 0 Ness, F., P. Ferreira, B.S.",Non-OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1128/   MCB.22.15.5593-5605.200 2 Ohhashi, Y., K. Ito, B.H.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10   .1038/nchembio.30 6 Patino, M.M., J.J. Liu, J.R. Glover, and S. Lindquist.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1126/science.273.5275.62 2 Paushkin, S.V., V.V.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10   .1371/journal.ppat.100254 7 Sánchez, I., C. Mahlke, and J. Yuan.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"421:373– 379. http://dx.doi.org/10.1038/nature0130 1 Satpute-Krishnan, P., and T.R.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/   10.1038/nature0398 1 Satpute-Krishnan, P., S.X.",Non-OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1371/journal.pbio.005002 4 Serio, T.R., A.G. Cashikar, A.S. Kowal, G.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10   .1126/science.289.5483.131 7 Shorter, J., and S. Lindquist.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1126/science.109800 7 Shorter, J., and S. Lindquist.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"23:425– 438. http://dx.doi.org/10.1016/j.molcel.2006.05.04 2 Silveira, J.R., G.J.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1038/nature0398 9 Taguchi, H., and S. Kawai-Noma.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1038/nature0239 2 Taneja, V., M.L.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1016/j.molcel   .2007.05.02 7 Tessarz, P., A. Mogk, and B. Bukau.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1016/   j.molcel.2008.11.00 3 Tkach, J.M., and J.R. Glover.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1074/jbc.M40078220 0 Tzaban, S., G. Friedlander, O. Schonberger, L. Horonchik, Y. Yedidia, G.  Shaked, R. Gabizon, and A. Taraboulos.",Non-OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1021/bi025958 g Vishveshwara, N., M.E.",Non-OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
http://dx.doi.org/10.1111/j.1365-2958.2009.06836.,Non-OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1074/jbc.M41061120 0 Bagriantsev, S.N., E.O.",Non-OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1091/mbc.E08-01-007 8 Caughey, B., and P.T.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10   .1146/annurev.neuro.26.010302.08114 2 Chernoff, Y.O., S.L.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi   .org/10.1126/science.775437 3 Chiti, F., and C.M.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10   .1146/annurev.biochem.75.101304.12390 1 Conway, K.A., J.D.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1038/331 1 Derkatch, I.L., Y.O.",Non-OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81223- 4 Glover, J.R., and R. Lum.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.2174/   09298660978849008 7 Haass, C., and D.J.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1038/nrm210 1 Kirkitadze, M.D., G. Bitan, and D.B.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi   .org/10.1038/nm123 4 Kryndushkin, D.S., I.M.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1126/science.275.5298.40 2 Lesné, S., M.T.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi   .org/10.1038/nature0453 3 Liebman, S.W., and I.L.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
"http://dx.doi.org/10.1074/   jbc.274.3.118 1 Lum, R., J.M.",OADS,/arxiv_data1/oa_pdf/5a/21/JCB_201307040.PMC3812976.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
1 C and 4 B. Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201304123/DC1.,Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1083/   jcb.119.2.28 7 Knop, M., K. Siegers, G. Pereira, W. Zachariae, B. Winsor, K. Nasmyth, and  E. Schiebel.",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"15(10B):963– 972. http://dx.doi.org/10.1002/(SICI)1097-0061(199907)15:10B<963:: AID-YEA399>3.0.CO;2- W Kurzbauer, R., D. Teis, M.E.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi   .org/10.1038/ncb184 6 Mizushima, N., T. Yoshimori, and Y .",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1038/emboj.2012.15 1 Murakami, K., M. Kimura, J.T.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10   .1073/pnas.94.5.170 9 Nakatogawa, H., K. Suzuki, Y. Kamada, and Y. Ohsumi.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1038/nrm270 8 Noda, N.N., T. Kobayashi, W. Adachi, Y. Fujioka, Y. Ohsumi, and F. Inagaki.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1074/jbc.M112.34825 0 Noda, T., and Y. Ohsumi.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi   .org/10.1074/jbc.273.7.396 3 Noda, T., A. Matsuura, Y. Wada, and Y. Ohsumi.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1006/bbrc.1995.163 6 Obara, K., and Y. Ohsumi.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1091/mbc.E05-09-084 1 Obara, K., T. Sekito, K. Niimi, and Y. Ohsumi.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1074/jbc.M80318020 0 Obita, T., S. Saksena, S. Ghazi-Tabatabai, D.J.",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1074/   jbc.M00467120 0 Rappsilber, J., M. Mann, and Y. Ishihama.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/   10.1038/nprot.2007.26 1 Robinson, J.S., D.J.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1038/nmeth95 3Submitted: 18 April 2013 Accepted: 24 September 2013 References Baba, M., M. Osumi, S.V.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/   10.1083/jcb.139.7.168 7 Backer, J.M.",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1042/BJ2007142 7 Behrends, C., M.E.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi   .org/10.1038/nature0920 4 Bowers, K., and T.H.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1016/j.bbamcr.2005.04.00 4 Brachmann, C.B., A. Davies, G.J.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0061(19980130)14:2<115::AID-YEA204>3.0.CO;2- 2 Breitkreutz, A., H. Choi, J.R. Sharom, L. Boucher, V .",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1126/science.117649 5 Ciccarelli, F.D., C. Proukakis, H. Patel, H. Cross, S. Azam, M.A.",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1016/S0888-7543(03)00011- 9 Harding, T.M., A. Hefner-Gravink, M. Thumm, and D.J.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi   .org/10.1074/jbc.271.30.1762 1 Herman, P.K., J.H.",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1016/0092-8674(91)90650- N Ishihama, A.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1074/mcp.M500061-MCP20 0 Itakura, E., C. Kishi, K. Inoue, and N. Mizushima.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1091/ mbc.E08-01-008 0 Janke, C., M.M.",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1002/yea.114 2 Jones, E.W., G.S.",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.06.01 4 Kieffer, C., J.J. Skalicky, E. Morita, I.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi   .org/10.1016/j.devcel.2008.05.01 4 Kihara, A., T. Noda, N. Ishihara, and Y. Ohsumi.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1083/jcb.152.3.51 9 Kirchhofer, A., J. Helma, K. Schmidthals, C. Frauer, S. Cui, A. Karcher, M.  Pellis, S. Muyldermans, C.S.",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
http://dx.doi.org/10.1038/nsmb.172 7,Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi   .org/10.1126/science.838536 7 Schuck, P. 2000.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1016/S0006-3495(00)76713- 0 Schuck, P., M.A.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1016/S0006-3495(02)75469- 6 Scott, S.V., M. Baba, Y. Ohsumi, and D.J.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1083/jcb.138.1.3 7 Seaman, M.N., E.G.",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1083/jcb.137.1.7 9 Shinoda, K., M. Tomita, and Y. Ishihama.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"26:576– 577. http://dx.doi.org/10.1093/bioinformatics/btp70 0 Söding, J., A. Biegert, and A.N.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1093/nar/gki40 8 Stuchell-Brereton, M.D., J.J. Skalicky, C. Kieffer, M.A.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1038/nature0617 2 Sun, Q., W. Fan, K. Chen, X. Ding, S. Chen, and Q. Zhong.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1093/emboj/20.21.597 1 Suzuki, K., Y .",Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
http://dx.doi.org/10.1111/j.1365-2443.2007.01050.,Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1016/0014-5793(93)80398- E Yasumo, H., N. Masuda, T. Furusawa, T. Tsukamoto, H. Sadano, and T. Osumi.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
"http://dx.doi.org/10.1016/S0167-4781(99)00244- 4 Zhong, Y ., Q.J.",OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
http://dx.doi.org/10.1038/ncb185 4,Non-OADS,/arxiv_data1/oa_pdf/99/5b/JCB_201304123.PMC3812978.pdf
http://dx.doi.org/10.1083/jcb.201303104)  present new evidence that the vesicular ATPase performs  separate acidification and exocytosis roles and pro - pose a mechanism for how these two functions are caus - ally linked.,OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"In contrast, inactivation of  the reversibly associated V1 sector revealed very different effects  than what would be expected from a loss of the proton pump.The vesicular ATPase: A missing link between  acidification and exocytosis Dong Wang and P. Robin Hiesinger Department of Physiology, University of Texas Southwestern Medical Center, Dallas, TX 75390 © 2013 Wang and Hiesinger  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/10.1091/mbc.E11-02-015 5 Strasser, B., J. Iwaszkiewicz, O. Michielin, and A. Mayer.",Non-OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/   10.1242/jcs.0323 4 Ungermann, C., W. Wickner, and Z. Xu.",OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/10.1083/jcb.20100306 2 Yan, Y ., N. Denef, and T. Schüpbach.",OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/10.1016/j.devcel   .2009.07.00 1 Zoncu, R., L. Bar-Peled, A. Efeyan, S. Wang, Y. Sancak, and D.M.",OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
334:678– 683. http://dx.doi.org/10.1126/science.120705 6forms of vesicle release that are differentially regulated.,Non-OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi   .org/10.1083/jcb.20021200 4 Cousin, M.A., and D.G.",OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/10.1046/j.1471- 4159.1997.69051927. x Di Giovanni, J., S. Boudkkazi, S. Mochida, A. Bialowas, N. Samari, C.  Lévêque, F. Youssouf, A. Brechet, C. Iborra, Y .",Non-OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/   10.1016/j.neuron.2010.06.02 4 Ernstrom, G.G., R. Weimer, D.R.",OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/10.1534/genetics.112.13966 7 Forgac, M. 2007.",Non-OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi   .org/10.1038/nrm227 2 Hiesinger, P.R., A. Fayyazuddin, S.Q.",Non-OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi   .org/10.1016/j.cell.2005.03.01 2 Hurtado-Lorenzo, A., M. Skinner, J. El Annan, M. Futai, G.H.",OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/10.1038/ncb134 8 Israël, M., N. Morel, B. Lesbats, S. Birman, and R. Manaranche.",Non-OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/10.1038/nm151 4 Liégeois, S., A. Benedetto, J.M.",Non-OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/10.1083/jcb.20051107 2 Morel, N., J.C. Dedieu, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/10.1242/jcs.0079 1 Peri, F., and C. Nüsslein-Volhard.",OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi.org/10.1016/j.cell.2008.04.03 7 Peters, C., M.J. Bayer, S. Bühler, J.S.",OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
"http://dx.doi   .org/10.1038/3505450 0 Poëa-Guyon, S., M. Raafet Ammar, M. Erard, M. Amar, A.W.",Non-OADS,/arxiv_data1/oa_pdf/8c/e3/JCB_201309130.PMC3812979.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1016/S0960-9822(98)70251- 9 Amthor, H., B. Christ, F. Rashid-Doubell, C.F.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1006/dbio.2001.055 5 Ball, R.W., M. Warren-Paquin, K. Tsurudome, E.H. Liao, F. Elazzouzi, C.  Cavanagh, B.S.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi   .org/10.1016/j.conb.2010.08.01 4 Bodine, S.C., E. Latres, S. Baumhueter, V.K.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1126/science.106587 4 Bogdanovich, S., T.O.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi   .org/10.1038/nature0115 4 Chung, J., C.J.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi   .org/10.1016/0092-8674(92)90643- Q Clever, J.L., Y. Sakai, R.A. Wang, and D.B.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi   .org/10.1152/ajpcell.00388.200 9 Cohen, S., J.J. Brault, S.P.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1083/jcb.20090105 2 Donaldson, C.J., L.S.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1016/0006-291X(92)   91194- U Dworkin, B.R., and S. Dworkin.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1037/0735-7044.104.2.29 8 Dworkin, B.R., and S. Dworkin.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1152/ajpregu.00469.200 3 Fischle, W., F. Dequiedt, M.J. Hendzel, M.G.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1016/S1097-2765(01)   00429- 4 Gregorevic, P., M.J. Blankinship, J.M.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
http://dx.doi.org/10.1038/nm108 5Histology Harvested muscles were placed in Optimal Cutting Temperature cryoprotec - tant (Sakura) and frozen in liquid nitrogen–cooled isopentane.,Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201211134/DC1.,Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1038/387083a 0 Moresi, V., A.H. Williams, E. Meadows, J.M.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10   .1016/j.cell.2010.09.00 4 Musarò, A., K.J.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi   .org/10.1038/2306 0 Nakao, A., M. Afrakhte, A. Morén, T. Nakayama, J.L.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1038/3936 9 Nickel, J., A. Kotzsch, W. Sebald, and T.D.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1016/j.jmb.2005.04.01 5 Ochala, J., A.M. Gustafson, M.L.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"589:2007– 2026. http://dx.doi.org/10.1113/jphysiol.2010.20204 4 Pescatori, M., A. Broccolini, C. Minetti, E. Bertini, C. Bruno, A. D’amico,  C. Bernardini, M. Mirabella, G. Silvestri, V. Giglio, et al.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10   .1096/fj.06-7285co m Potthoff, M.J., H. Wu, M.A.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10   .1172/JCI3196 0 Pourquié, O., C.M.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1016/S0092-8674   (00)81291- X Rafael, J.A., G.A.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1128/MCB.23.20.7230-7242.200 3 Rommel, C., S.C. Bodine, B.A.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1038/   ncb1101-100 9 Ruschke, K., C. Hiepen, J. Becker, and P. Knaus.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1007/s00441-011-1283- 6 Sako, D., A.V.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1074/jbc.M110.11495 9 Sandri, M., C. Sandri, A. Gilbert, C. Skurk, E. Calabria, A. Picard, K. Walsh,  S. Schiaffino, S.H.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1016/   S0092-8674(04)00400- 3 Sartori, R., G. Milan, M. Patron, C. Mammucari, B. Blaauw, R. Abraham, and  M. Sandri.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/ 10.1038/ng.277 2 Shioi, T., J.R. McMullen, O. Tarnavski, K. Converso, M.C.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1161/   01.CIR.0000057979.36322.8 8 Stitt, T.N., D. Drujan, B.A.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10   .1128/MCB.00231-1 2 Gurney, M.E., H. Pu, A.Y.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi   .org/10.1126/science.820925 8 Hayashi, H., S. Abdollah, Y. Qiu, J. Cai, Y.Y.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80303- 7 Heitman, J., N.R.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1126/science.171509 4 Holley, S.A., J.L.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1016/   S0092-8674(00)80134- 8 Ibebunjo, C., J.M.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1038/3935 5 Ishida, W., T. Hamamoto, K. Kusanagi, K. Yagi, M. Kawabata, K. Takehara,  T.K.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1074/jbc.275.9.607 5 Kalista, S., O. Schakman, H. Gilson, P. Lause, B. Demeulder, L. Bertrand,  M. Pende, and J.P. Thissen.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi   .org/10.1210/en.2011-168 7 Kambadur, R., M. Sharma, T.P.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1006/excr.1996.343 2 Langenfeld, E.M., Y. Kong, and J. Langenfeld.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi   .org/10.1158/1541-7786.MCR-05-012 4 Latres, E., A.R.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1074/jbc   .M40751720 0 Lee, S.J.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1371/journal   .pone.000078 9 Lee, S.J., and A.C. McPherron.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi   .org/10.1073/pnas.15127009 8 Lee, S.J., Y.S.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi   .org/10.1210/me.2010-012 7 Massagué, J., J. Seoane, and D. Wotton.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1101/gad.135070 5 Mathews, L.S., W.W. Vale, and C.R.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1126/science.131318 8 McCabe, B.D., G. Marqués, A.P.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
http://dx.doi   .org/10.1016/S0896-6273(03)00426- 4,OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1203/   01.pdr.0000196718.47935.6 e Tang, H., P. Macpherson, M. Marvin, E. Meadows, W.H.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1091/mbc.E08-07-075 9 Townsend, K.L., R. Suzuki, T.L.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi   .org/10.1096/fj.11-19906 7 Trendelenburg, A.U., A. Meyer, D. Rohner, J. Boyle, S. Hatakeyama, and D.J.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1152/ajpcell.00105.200 9 Winbanks, C.E., B. Wang, C. Beyer, P. Koh, L. White, P. Kantharidis, and P.  Gregorevic.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1074/jbc.M110.19262 5 Winbanks, C.E., K.L.",Non-OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1083/jcb.20110909 1 Yamamoto, N., S. Akiyama, T. Katagiri, M. Namiki, T. Kurokawa, and T. Suda.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1006/bbrc.1997.732 5 Zhou, X., J.L.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
"http://dx.doi.org/10.1016/j.cell.2010.07.01 1 Zimmerman, L.B., J.M.",OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
http://dx.doi.org/10.1016/S0092-8674(00)80133- 6,OADS,/arxiv_data1/oa_pdf/da/7e/JCB_201211134.PMC3812980.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"291:583– 590. http://dx.doi.org/10.1007/s00403005045 9 Alblowi, J., R.A. Kayal, M. Siqueira, E. McKenzie, N. Krothapalli, J. McLean,  J. Conn, B. Nikolajczyk, T.A.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"175:1574– 1585. http://dx.doi.org/10.2353/ajpath.2009.09014 8 Ashcroft, G.S., X. Yang, A.B.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1016/S0002-9610(05)80797- 4 Brunet, A., L.B.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1126/science.109463 7 Burgering, B.M., and R.H. Medema.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1189/jlb.120262 9 Calnan, D.R., and A. Brunet.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1038/onc.2008.2 1 Deveci, M., R.R.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
http://dx.doi.org/10.1111/j.1365-2133.2004.06329.,Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1016/S0960-9822(00)00728- 4 Furukawa-Hibi, Y., K. Yoshida-Araki, T. Ohta, K. Ikeda, and N. Motoyama.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1042/0264-6021:349062 9 Gailit, J., M.P.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
http://dx.doi.org/10.1111/1523-1747.,Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1016/j.ccr.2007.08.02 0 Guo, S., and L.A. Dipietro.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1177/002203450935912 5 Hebda, P.A.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi   .org/10.1111/1523-1747.ep1247648 0 Ho, K.K., S.S. Myatt, and E.W.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1038/onc.2008.2 3 Hsieh, H.L., H.H.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"7:88. http://dx.doi.org/10.1186/1742-   2094-7-8 8 Huang, X.Z., J.F.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1007/   s00125-009-1529- y Soneja, A., M. Drews, and T. Malinski.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi   .org/10.1089/ars.2010.340 5 Tothova, Z., R. Kollipara, B.J.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.01.00 3 Tran, H., A. Brunet, J.M.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1126/science.106871 2 Tsuboi, R., C. Sato, C.M.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi   .org/10.1038/nrm219 0 Wenk, J., P. Brenneisen, M. Wlaschek, A. Poswig, K. Briviba, T.D.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10   .1074/jbc.274.36.2586 9 Werner, S., and R. Grose.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.2337/db08-099 7 Zambruno, G., P.C.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1002/jcp.104148011 9 Klass, B.R., A.O.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1136/pgmj.2008.06983 1 Lavker, R.M., S. Miller, C. Wilson, G. Cotsarelis, Z.G.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1111/1523-1747.ep1236255 6 Li, J., J. Chen, and R. Kirsner.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1016/j.clindermatol.2006.09.00 7 Liang, C.C., A.Y.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1038/nprot.2007.3 0 Lund, L.R., K.A.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1038/sj.emboj   .760117 3 Margadant, C., and A. Sonnenberg.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi   .org/10.1038/embor.2009.27 6 Martin, P. 1997.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1126/science.276.5309.7 5 Martin, P., and S.J.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1038/   3500811 5 Myatt, S.S., and E.W.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1038/   nrc222 3 Nishio, E., and Y. Watanabe.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1016/j.cell.2006.12.02 9 Ponugoti, B., G. Dong, and D.T.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"2012:939751. http://dx.doi.org/10.1155/2012/93975 1 Raja, K., K. Sivamani, M.S.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.2741/227 7 Ridley, A.J., M.A.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi   .org/10.1126/science.109205 3 Rodriguez, P.G., F.N.",Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
http://dx.doi.org/10.1111/j.1524-4725.2008.34254.,Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1016/   j.phrs.2008.06.00 4 Sen, C.K., and S. Roy.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi.org/10.1016/j.bbagen.2008.01.00 6 Sengupta, A., J.D.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"http://dx.doi   .org/10.1074/jbc.M110.17924 2 Shigenaga, M.K., C.J.",OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
http://dx.doi.org/10.1056/NEJM19990902341100 6,Non-OADS,/arxiv_data1/oa_pdf/95/df/JCB_201305074.PMC3812981.pdf
"These experiments reveal a novel role  for a Ras superfamily member in catalyzing Cyclin E  turnover during S phase, as well as an unexpected, es - sential role for the Golgi as a ubiquitylation platform for  cell cycle control.Golgi-associated RhoBTB3 targets Cyclin E for  ubiquitylation and promotes cell cycle progression Albert Lu and Suzanne R. Pfeffer Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305 © 2013 Lu and Pfeffer  This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"6:24.  http://dx.doi.org/10.1186/1476-4598-6-2 4 Amrani, Y ., O. Tliba, D. Choubey, C.D.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.cell.2010.11.01 7 Berthold, J., K. Schenková, S. Ramos, Y .",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.yexcr.2008.09.00 5 Berthold, J., K. Schenkova, and F. Rivero.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1128/MCB.00288-1 2 Colanzi, A., C. Suetterlin, and V. Malhotra.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
http://dx.doi.org/10.1038/   nsmb.226 9#1 siRNA were imaged every 3.5 min for 15 h using an inverted micro - scope (Axio Observer Z1; Carl Zeiss) fitted with an LD Plan-Neofluar  20×/0.4 Korr Ph1 Ph2 objective and a CCD camera (AxioCam MRm;  Carl Zeiss) controlled by Axiovision 4.8 software (Carl Zeiss).,OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1002/path.200 5 Krek, W. 2003.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1038/ncb1103-95 0 Lee, H.O., J.M.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10   .1101/gad.182920 9 Lin, D.I., O. Barbash, K.G.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.09.00 7 Litterman, N., Y. Ikeuchi, G. Gallardo, B.C.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1371/journal   .pbio.100106 0 Maerki, S., M.H.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10   .1083/jcb.20090611 7 Malumbres, M., and M. Barbacid.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1038/nrc109 7 Matsumoto, Y., and J.L.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"306:885– 888. http://dx.doi.org/10.1126/science.110354 4 McCusker, D., and D.R.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.ceb.2012.10.00 8 McEvoy, J.D., U. Kossatz, N. Malek, and J.D.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1128/MCB.00720-0 6 Meyer, H.H., Y .",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1093/emboj/cdf57 9 Nacak, T.G., K. Leptien, D. Fellner, H.G.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/   10.1074/jbc.M50907320 0 Ohtsubo, M., A.M. Theodoras, J. Schumacher, J.M.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1136/gutjnl-2012-30209 1 Perez-Torrado, R., D. Yamada, and P.A.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1091/mbc.E10-03-024 3 Petroski, M.D., and R.J. Deshaies.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi   .org/10.1038/nrm154 7 Pfeffer, S., and D. Aivazian.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi   .org/10.1038/nrm150 0 Pintard, L., J.H.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1038/nature0195 9 Potemski, P., R. Kusinska, C. Watala, E. Pluciennik, A.K.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1083/jcb.152.5.94 5 Duensing, S. 2005.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.cellbi   .2005.03.00 5 Duli ć, V., E. Lees, and S.I.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi   .org/10.1126/science.132920 1 Ekholm, S.V ., P. Zickert, S.I.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1128/MCB.21.9.3256-3265.200 1 Enders, G.H.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1186/bcr43 9 Errico, A., K. Deshmukh, Y. Tanaka, A. Pozniakovsky, and T. Hunt.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.advenzreg.2009.12.00 1 Espinosa, E.J., M. Calero, K. Sridevi, and S.R.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.cell.2009.03.04 3 Ferguson, R.L., and J.L.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.cub.2010.03.02 8 Forbes, S., J. Clements, E. Dawson, S. Bamford, T. Webb, A. Dogan, A.  Flanagan, J. Teague, R. Wooster, P.A.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1038/   sj.bjc.660292 8 Furukawa, M., Y.J.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1038/ncb105 6 Gaulin, J.F., A. Fiset, S. Fortier, and R.L.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1074/jbc.275.22.1665 8 Geng, Y., Q. Yu, E. Sicinska, M. Das, J.E.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/   10.1016/S0092-8674(03)00645- 7 Geng, Y., Y.M.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi   .org/10.1016/j.molcel.2006.11.02 9 Hao, B., S. Oehlmann, M.E.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.molcel.2007.02.02 2 Hengst, L., V. Dulic, J.M.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1038/   sj.onc.120861 3 Indraccolo, S., U. Pfeffer, S. Minuzzo, G. Esposito, V. Roni, S. Mandruzzato, N.  Ferrari, L. Anfosso, R. Dell’Eva, D.M.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1146/annurev.cellbio   .21.020604.15072 1 Jorgensen, P., and M. Tyers.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.cub.2004.11.02 7 Keyomarsi, K., S.L.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1056/NEJMoa02115 3 Koepp, D.M., L.K.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi   .org/10.1126/science.106520 3 Koff, A., A. Giordano, D. Desai, K. Yamashita, J.W.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi   .org/10.1126/science.138828 8 Koutsami, M.K., P.K.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10   .1038/nature0231 3 Reddy, J.V., A.S. Burguete, K. Sridevi, I.G.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"7:282– 289. http://dx.doi.org/10.1074/mcp.M700342-MCP20 0 Sahai, E., and C.J.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1038/nrc72 5 Santra, M.K., N. Wajapeyee, and M.R.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1038/nature0801 1 Scaltriti, M., P.J.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1101/gad.13.18.237 5 Siripurapu, V., J. Meth, N. Kobayashi, and M. Hamaguchi.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/   j.jmb.2004.11.04 3 Spruck, C.H., K.A.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/   10.1038/4583 6 Sütterlin, C., P. Hsu, A. Mallabiabarrena, and V. Malhotra.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10   .1016/S0092-8674(02)00720- 1 Tang, D., Y. Xiang, S. De Renzis, J. Rink, G. Zheng, M. Zerial, and Y. Wang.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"2:501. http://dx.doi.org/   10.1038/ncomms150 9 Uchiyama, K., G. Totsukawa, M. Puhka, Y .",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.devcel   .2006.10.01 6 van Drogen, F., O. Sangfelt, A. Malyukova, L. Matskova, E. Yeh, A.R.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.05.02 0 Welcker, M., and B.E.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1038/nrc229 0 Willmarth, N.E., D.G.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1186/bcr90 0 Woo, R.A., and R.Y.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi   .org/10.4161/cc.2.4.46 8 Xu, L., Y. Wei, J. Reboul, P. Vaglio, T.H.",Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi.org/10.1038/nature0198 5 Ye, Y.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"http://dx.doi   .org/10.1016/j.jsb.2006.01.00 5 Zhang, F.L., and P.J.",OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
416:703– 709. http://dx.doi.org/10.1038/416703 a,Non-OADS,/arxiv_data1/oa_pdf/76/e4/JCB_201305158.PMC3812982.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/7a/hks133.PMC3812997.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.Vol.",Non-OADS,/arxiv_data1/oa_pdf/bb/16/kwt137.PMC3813311.pdf
"MATERIALS AND METHODS The Avon Longitudinal Study of Parents and Children (ALSPAC) is a longitudinal, population-based birth cohortstudy that recruited 14,541 pregnant women residing in Avon,United Kingdom, who had expected dates of delivery betweenApril 1, 1991, and December 31, 1992 ( http://www.alspac.",Non-OADS,/arxiv_data1/oa_pdf/bb/16/kwt137.PMC3813311.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
Online supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.201310993/DC1.,Non-OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/ 10.1016/S0896-6273(02)01126-1 Chakrapani, S., P. Sompornpisut, P. Intharathep, B. Roux, and E.  Perozo.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10.1371/journal.pone.0000440 Guipponi, M., C. Tapparel, O. Jousson, N. Scamuffa, C. Mas,  C. Rossier, P. Hutter, P. Meda, R. Lyle, A. Reymond, and S.E.",Non-OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi .org/10.1007/s004390100607 Halaszovich, C.R., D.N.",Non-OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10.1074/jbc .M803543200 Halaszovich, C.R., M.G.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/ 10.1194/jlr.M026021 Hossain, M.I., H. Iwasaki, Y. Okochi, M. Chahine, S. Higashijima,  K. Nagayama, and Y. Okamura.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10.1038/nsmb1320 Kohout, S.C., S.C. Bell, L. Liu, Q. Xu, D.L.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/ 10.1038/nchembio.349 Kumánovics, A., G. Levin, and P. Blount.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10.1096/fj.02-0238hyp Kurokawa, T., S. Takasuga, S. Sakata, S. Yamaguchi, S. Horie, K.J.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"140:481– 493. http://dx.doi.org/10.1085/jgp.201210817Lacroix, J.J., A.J.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10.1016/j.bpj.2011.01.043 Lacroix, J.J., S.A. Pless, L. Maragliano, F.V.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10.1038/nsmb.2289 Long, S.B., X. Tao, E.B.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/ 10.1038/nature06265 Murata, Y., H. Iwasaki, M. Sasaki, K. Inaba, and Y. Okamura.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10.1038/ nature03650 Ratzan, W.J., A.V.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"226:2740– 2746. http://dx.doi.org/10.1002/jcp.22854 Starace, D.M., and F. Bezanilla.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10.1085/jgp.117.5.469 Starace, D.M., and F. Bezanilla.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10.1038/nature02270 Starace, D.M., E. Stefani, and F. Bezanilla.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10.1016/S0896-6273(00) 80422-5 Stefani, E., and F. Bezanilla.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10 .1016/S0076-6879(98)93020-8 Sutton, K.A., M.K.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"29:2147– 2155. http://dx.doi.org/10.1093/molbev/mss083 Taglialatela, M., L. Toro, and E. Stefani.",Non-OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10.1016/ S0006-3495(92)81817-9 Villalba-Galea, C.A.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/ 10.1016/j.cellsig.2012.03.013 Villalba-Galea, C.A.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"3:161. http://dx.doi.org/10.3389/ fphar.2012.00161 Villalba-Galea, C.A., W. Sandtner, D.M.",Non-OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/10 .1073/pnas.0807387105 Villalba-Galea, C.A., F. Miceli, M. Taglialatela, and F. Bezanilla.",Non-OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"http://dx.doi.org/ 10.1085/jgp.200910215 Walker, S.M., C.P.",OADS,/arxiv_data1/oa_pdf/8a/a6/JGP_201310993.PMC3813379.pdf
"Docosahexaenoic acid (DHA), an omega-3 fatty acid  known to be associated with beneficial cardiovascular  effects, was reported to be a potent activator of BK cur- rents in rat coronary artery SMCs and to promote dila- tion of isolated small coronary arteries (Lai et al., 2009; Keeping you healthy: BK channel activation by omega-3 fatty acids Ramon Latorre and Gustavo Contreras Centro Interdisciplinario de Neurociencia de Valparaíso, Facultad de Ciencias, Universidad de Valparaíso,   Valparaíso 2366103, Chile © 2013 Latorre and Contreras  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1016/0896-6273 (92)90160-F Atkinson, N.S., G.A.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10 .1126/science.1857984 Bao, L., and D.H. Cox.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1085/jgp.200509346 Brelidze, T.I., and K.L.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1085/jgp.200509286 Brenner, R., G.J.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10 .1038/35038011 Bukiya, A.N., T. Vaithianathan, L. Toro, and A.M. Dopico.",Non-OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"390:995– 1000. http://dx.doi.org/10.1016/j.bbrc.2009.10.091 Butler, A., S. Tsunoda, D.P.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10 .1126/science.7687074 Chen, X., and R.W.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1085/jgp.201110632 Contreras, G.F., A. Neely, O. Alvarez, C. Gonzalez, and R. Latorre.",Non-OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1074/jbc.M104689200 Dyerberg, J., H.O.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1085/jgp.201110616The finding that DHA is able to activate BK channels in  the absence of  subunits, albeit with about a fivefold  loss in potency, led Hoshi et al.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi .org/10.1016/j.cell.2010.07.041 Orio, P., and R. Latorre.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1038/nrn1992 Serhan, C.N., K. Gotlinger, S. Hong, and M. Arita.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"73:155– 172. http://dx.doi.org/10.1016/j.prostaglandins.2004.03.005 Soler-Llavina, G.J., M. Holmgren, and K.J.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1016/S0896-  6273  (03)00157-0 Sun, X., D. Zhou, P. Zhang, E.G.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/ 10.1152/jn.00700.2006 Thompson, J., and T. Begenisich.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1085/jgp.201110748 Valverde, M.A., P. Rojas, J. Amigo, D. Cosmelli, P. Orio, M.I.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1126/ science.285.5435.1929 Wallner, M., P. Meera, and L. Toro.",Non-OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1085/jgp.200509436 Wang, R.X., Q. Chai, T. Lu, and H.C. Lee.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1093/cvr/cvq411 White, R.E., D.J.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/ 10.1161/01.RES.77.5.936 Wilkens, C.M., and R.W.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1085/jgp.200609579 Wu, R.S., and S.O.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1038/ki.2010.325Gollasch, M., J.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi .org/10.1097/00004872-200205000-00028 Grimm, P.R., and S.C. Sansom.",Non-OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1097/ MNH.0b013e32826fbc7d Ha, T.S., M.S.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1016/ S0006-3495(04)74339-8 Horrigan, F.T.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1085/jgp .201210849 Horrigan, F.T., and R.W.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1085/jgp.20028605 Hoshi, T., Y. Tian, R. Xu, S.H.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi .org/10.1073/pnas.1222003110 Hoshi, T., B. Wissuwa, Y. Tian, N. Tajima, R. Xu, M. Bauer, S.H.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1152/ jn.01352.2005 Lai, L.H., R.X.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1085/jgp.200409067 Lukiw, W.J., J.G.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1111/bph .12211 Martin, G.E., L.M.",Non-OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1074/ jbc.M109.027789 Yan, J., and R.W.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"http://dx.doi.org/10.1038/nature09162Yan, J., and R.W.",OADS,/arxiv_data1/oa_pdf/2b/83/JGP_201311100.PMC3813380.pdf
"Backwards transduction by hair cells Peter G. Barr-Gillespie and Teresa Nicolson Oregon Hearing Research Center and Vollum Institute, Oregon Health & Science University, Portland, OR 97239 © 2013 Barr-Gillespie and Nicolson  This article is distributed under the terms of an Attri- bution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the  publication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10 .1038/nn.2295 Corey, D.P., and A.J.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi .org/10.1038/281675a0 Gillespie, P.G., and U. Müller.",Non-OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1016/j.cell.2009.09.010 Grimsley-Myers, C.M., and P. Chen.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1016/0006-8993(69)90301-1 Hudspeth, A.J.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1038/ng.2007.54 Kawashima, Y., G.S.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1172/JCI60405 Kazmierczak, P., H. Sakaguchi, J. Tokita, E.M. Wilson-Kubalek, R.A.  Milligan, U. Müller, and B. Kachar.",Non-OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1038/nature06091 Keresztes, G., H. Mutai, and S. Heller.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"4:24. http://dx.doi.org/10 .1186/1471-2164-4-24 Kim, K.X., and R. Fettiplace.",Non-OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1085/jgp.201210913 Kim, K.X., M. Beurg, C. Hackney, D.N.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.05.022 Kurima, K., Y. Yang, K. Sorber, and A.J.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1016/ S0888-7543(03)00154-X Labay, V., R.M.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1021/bi1004377 Meyer, J., D.N.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1371/journal.pone.0019183 Assad, J.A., G.M.G.",Non-OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1016/0896-6273(91) 90343-X Bermingham, N.A., B.A.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
http://dx.doi.org/10.1126/science .284.5421.1837,Non-OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1016/ j.cell.2012.06.043 Sobkowicz, H.M., S.M.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
"http://dx.doi.org/10.1007/BF01179815Waguespack, J., F.T.",OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
http://dx.doi.org/10 .1016/j.cell.2012.10.041,OADS,/arxiv_data1/oa_pdf/52/26/JGP_201311111.PMC3813381.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
A wheel plot was made using the Wheel.pl program written by D. Armstrong and R. Zidovetzki (http://rzlab.ucr.edu/scripts/wheel/wheel.cgi).,OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1016/0896-6273(92)90160-F Armstrong, C.M.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1126/stke.2003.188.re10 Bader, C.R., L. Bernheim, and D. Bertrand.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"317:540– 542. http://dx.doi.org/10.1038/317540a0 Becchetti, A., and P. Roncaglia.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1159/000185544 Bruening-Wright, A., W.S.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1038/nn.2313 Catacuzzeno, L., C. Trequattrini, A. Petris, and F. Franciolini.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi .org/10.1038/sj.bjp.0702477 Chen, X., and R.W.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1085/jgp .201110632 Contreras, J.E., and M. Holmgren.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1085/jgp.200509440 Contreras, J.E., D. Srikumar, and M. Holmgren.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1074/ jbc.M710463200 Dai, L., V. Garg, and M.C.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"393:287– 291. http://dx.doi.org/10.1007/BF00581411 Hockerman, G.H., B.D.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1074/jbc.270.38.22119 Hockerman, G.H., B.D.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1074/jbc.272.30.18759 Jiang, Y., A. Lee, J. Chen, M. Cadene, B.T.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1038/417523a Johnson, J.P. Jr., and W.N.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"412:917– 921. http://dx.doi.org/10.1038/35091089 Kameyama, M., M. Kakei, R. Sato, T. Shibasaki, H. Matsuda, and  H. Irisawa.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10 .1038/309354a0 Kitaguchi, T., M. Sukhareva, and K.J.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.do i.org/10.1085/jgp.200409098 Klein, H., L. Garneau, U. Banderali, M. Simoes, L. Parent, and R.  Sauvé.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi .org/10.1002/prot.10104 Krieger, E., K. Joo, J. Lee, J. Lee, S. Raman, J. Thompson, M. Tyka,  D. Baker, and K. Karplus.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1002/prot.22570 Kurokawa, J., S. Adachi-Akahane, and T. Nagao.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1038/302790a0 Levitt, M. 1976.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"104:59– 107. http://dx.doi.org/10.1016/0022-2836(76)90004-8 Li, W., and R.W.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1085/jgp.200409067 Li, W., and R.W.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"128:423– 441. http://dx.doi.org/10.1085/jgp.200609521 Liu, J., and S.A. Siegelbaum.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)00162-8 Liu, Y., M.E.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80106-3 Mitcheson, J.S., J. Chen, M. Lin, C. Culberson, and M.C.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
http://dx.doi.org/ 10.1073/pnas.210244497among voltage-gated K+ channels.,OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1074/jbc.M307411200 DeCoursey, T.E.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1085/jgp.106.4.745 Doyle, D.A., J. Morais Cabral, R.A. Pfuetzner, A. Kuo, J.M.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1126/science.280.5360.69 Dryer, S.E.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1016/0166-2236(94)90093-0 Duan, J.J., J.H.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1111/j.1745-7254.2007.00562.x Egan, T.M., D. Dagan, J. Kupper, and I.B.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1146/annurev.bb.15.060186.001541 Flynn, G.E., and W.N.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1016/S0896-6273(01) 00324-5 Garg, P., and M.C.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"82:795– 802. http://dx.doi.org/10.1124/mol.112.079194 Garg, V., F.B.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"140:307– 324. http://dx.doi.org/10.1085/jgp.201210826 Goldin, A.L.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi .org/10.1016/S0091-679X(08)60293-9 Hackos, D.H., T.H.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1085/jgp.20028569 Hage, T.A., and L. Salkoff.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5088-11 .2012 Haimann, C., and C.R.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"Rep. 13:1133– 1139. http://dx.doi.org/10.1016/0309-1651(89)90027-1 Haimann, C., L. Bernheim, D. Bertrand, and C.R.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1007/BF00376215 Hamill, O.P., A. Marty, E. Neher, B. Sakmann, and F.J. Sigworth.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1007/BF00656997 Harper, A.A., L. Catacuzzeno, C. Trequattrini, A. Petris, and F.  Franciolini.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1007/s002320010041 Hescheler, J., D. Pelzer, G. Trube, and W. Trautwein.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1085/jgp.201110748 Wang, Z., T. Kimitsuki, and A. Noma.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1085/jgp.200609579 Wojtovich, A.P., T.A.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1371/journal.pone.0028287 Yan, Y., Y. Yang, S. Bian, and F.J. Sigworth.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi .org/10.1007/s00232-012-9425-7 Yuan, A., C.M.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1016/S0896-6273 (03)00096-5 Zhainazarov, A.B., and B.W.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1161/01.RES.84.9.989 Zhou, Y., X.M.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1021/bi0348720 Ogielska, E.M., W.N.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1016/S0006-3495(94)80712-X Parfenova, L.V., B.M.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10 .1074/jbc.M603109200 Piela, L., G. Némethy, and H.A.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1007/ BF00388310 Stühmer, W. 1992.",Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"http://dx.doi.org/10.1016/ 0076-6879(92)07021-F Sun, Z.P., M.H.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
"16:141– 149. http://dx.doi.org/10.1016/S0896-6273(00)80031-8 Tamsett, T.J., K.E.",OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
29:5127– 5134. http://dx.doi.org/10.1523/JNEUROSCI.0859-09.2009,Non-OADS,/arxiv_data1/oa_pdf/65/cf/JGP_201311064.PMC3813382.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as   described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
The online supplemental material is available at  http://www.jgp.org/cgi/content/full/jgp.201311061/DC1.,Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi .org/10.1152/ajpcell.00036.2005 Horrigan, F.T., and R.W.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1085/jgp.20028605 Horrigan, F.T., J. Cui, and R.W.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1085/ jgp.114.2.277 Horrigan, F.T., S.H.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1085/jgp.200509262 Horrocks, L.A., and A.A. Farooqui.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1016/j.plefa.2003.12.011 Hoshi, T., A. Pantazis, and R. Olcese.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1152/physiol.00055.2012 Hoshi, T., Y. Tian, R. Xu, S.H.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1152/physiol.00032 .2008 Ichimura, A., A. Hirasawa, O. Poulain-Godefroy, A. Bonnefond, T.  Hara, L. Yengo, I. Kimura, A. Leloire, N. Liu, K. Iida, et al.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1038/ nature10798 Im, D.S.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi .org/10.1016/j.plipres.2012.02.003 Knaus, H.G., K. Folander, M. Garcia-Calvo, M.L.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1016/S0163-7827(00)00017-5 Liu, J.C., S.M.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1038/ajh.2011 .120 Meera, P., M. Wallner, and L. Toro.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1016/S0006-3495(03)70023-X Balendiran, G.K., F. Schnutgen, G. Scapin, T. Borchers, N. Xhong,  K. Lim, R. Godbout, F. Spener, and J.C. Sacchettini.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1529/ biophysj.108.130757 Brasky, T.M., A.K.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"105:1132– 1141. http://dx.doi.org/10.1093/jnci/djt174 Brenner, R., T.J. Jegla, A. Wickenden, Y. Liu, and R.W.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1038/ 35038011 Brohawn, S.G., J. del Mármol, and R. MacKinnon.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10 .1126/science.1213808 Chen, X., and R.W.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1085/jgp .201110632 Clarke, A.L., S. Petrou, J.V.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1152/ajpcell.00035.2002 Drake, S.K., M.A.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1085/jgp.110.2.173 Egea, P.F., A. Mitschler, and D. Moras.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1093/emboj/17.12.3297 Flock, M.R., C.J.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
http://dx.doi.org/10.1002/dmrr.2414,Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1085/jgp.201110748 Uauy, R., and A.D. Dangour.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1301/nr.2006.may.S24-S33 Vaithianathan, T., A. Bukiya, J. Liu, P. Liu, M. Asuncion-Chin, Z.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1085/jgp .200709913 Vecchio, A.J., D.M.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1074/jbc.M110 .119867 Wallner, M., P. Meera, M. Ottolia, G.J.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1093/cvr/cvq411 Wilkens, C.M., and R.W.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1085/jgp.200609579 Wu, Y., Y. Xiong, S. Wang, H. Yi, H. Li, N. Pan, F.T.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1074/ jbc.M109.027789 Yan, Y., W. Jiang, T. Spinetti, A. Tardivel, R. Castillo, C. Bourquin,  G. Guarda, Z. Tian, J. Tschopp, and R. Zhou.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"38:1154– 1163. http://dx.doi.org/10.1016/j.immuni.2013.05.015 Yang, H., J. Shi, G. Zhang, J. Yang, K. Delaloye, and J. Cui.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"15:1152– 1159. http://dx.doi.org/10.1038/nsmb.1507 Yang, J., H. Yang, X.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1085/jgp.201210794 Ye, D., D. Zhang, C. Oltman, K. Dellsperger, H.C. Lee, and M.  VanRollins.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1124/jpet.303.2.768 Yon, J., and M. Fried.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"17:4895. http://dx.doi.org/10.1093/nar/17.12.4895 Zhou, Y., Q.Y.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/ 10.1085/jgp.201010403 Zhou, Y., X.M.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1126/science.1213274 Mozaffarian, D., and J.H.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi .org/10.1016/j.jacc.2011.06.063 Nelson, M.T., and J.M.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi .org/10.1016/j.cell.2010.07.041 Orr, S.K., M.O.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1016/ j.plefa.2012.05.008 Payandeh, J., T. Scheuer, N. Zheng, and W.A.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1038/nature10238 Ramel, A., J.A.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/ 10.1016/j.nut.2009.04.002 Rizos, E.C., E.E.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10 .1001/2012.jama.11374 Roncaglioni, M.C., M. Tombesi, F. Avanzini, S. Barlera, V. Caimi, P.  Longoni, I. Marzona, V. Milani, M.G.",Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1056/ NEJMoa1205409 Saravanan, P., N.C. Davidson, E.B.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1016/S0140-6736(10)60445-X Schopperle, W.M., M.H.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi .org/10.1016/S0896-6273(00)80995-2 Shen, L.R., C.Q.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1194/jlr .M008524 Sun, X., D. Zhou, P .",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
"http://dx.doi.org/10.1152/ jn.00700.2006 Tang, Q.Y., Z. Zhang, X.M.",OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
http://dx.doi.org/10.4161/ chan.4.1.10481,Non-OADS,/arxiv_data1/oa_pdf/65/fd/JGP_201311061.PMC3813383.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as   described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1371/journal.pone.0019183 Assad, J.A., G.M.",Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1016/0896-6273(91)90343-X Bats, C., M. Farrant, and S.G. Cull-Candy.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1016/j.neuropharm.2013.03.037 Beurg, M., M.G.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2188-06.2006 Beurg, M., R. Fettiplace, J.H.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10 .1038/nn.2295 Chatzigeorgiou, M., S. Bang, S.W.",Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10 .1038/nature11845 Coombs, I.D., D. Soto, M. Zonouzi, M. Renzi, C. Shelley, M. Farrant,  and S.G. Cull-Candy.",Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"32:9796– 9804. http://dx.doi.org/10.1523/JNEUROSCI.0345-12.2012 Coste, B., J. Mathur, M. Schmidt, T.J. Earley, S. Ranade, M.J. Petrus,  A.E.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1126/science .1193270 Coste, B., B. Xiao, J.S.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1038/nature10812 Crawford, A.C., M.G.",Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/ 10.1038/nn784 Kurima, K., L.M.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1038/ng842 Lazarczyk, M., C. Pons, J.A.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1084/jem .20071311 Lelli, A., Y. Asai, A.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1152/jn.00136.2009 Marcotti, W., S.M.",Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1113/jphysiol .2005.085951 Marcotti, W., A. Erven, S.L.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1113/jphysiol.2005.095661 Mutai, H., S. Mann, and S. Heller.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/ 10.1016/j.neuroscience.2005.01.046 Ohmori, H. 1985.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1021/ je900320r Peng, A.W., F.T.",Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"2:523. http://dx.doi .org/10.1038/ncomms1533 Pickles, J.O., S.D.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1016/0378-5955(84)90041-8 Rard, J.A., and S.L.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1016/S0896-6273 (03)00721-9 Stauffer, E.A., and J.R. Holt.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1007/s10162-007-0080-0 Fettiplace, R. 2009.",Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi .org/10.1016/0378-5955(86)90222-4 Furness, D.N., Y. Katori, B. Nirmal Kumar, and C.M.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1371/journal.pbio.1001583 Johnson, S.L., M. Beurg, W. Marcotti, and R. Fettiplace.",Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1172/JCI60405 Kazmierczak, P., H. Sakaguchi, J. Tokita, E.M. Wilson-Kubalek, R.A.  Milligan, U. Müller, and B. Kachar.",Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1038/nature06091 Kennedy, H.J., M.G.",Non-OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1085/jgp.201210913 Kindt, K.S., G. Finch, and T. Nicolson.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.05.022 Kros, C.J., A. Rüsch, and G.P.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1098/ rspb.1992.0102 Kros, C.J., W. Marcotti, S.M.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1152/jn.00914 .2007 Steel, K.P., and G.R.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/ 10.1038/288159a0 Vreugde, S., A. Erven, C.J.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"http://dx.doi.org/10.1038/ng848Waguespack, J., F.T.",OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
http://dx.doi.org/10 .1016/j.cell.2012.10.041,OADS,/arxiv_data1/oa_pdf/db/3f/JGP_201311068.PMC3813385.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/ff/rjt082.PMC3813457.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/6d/rjt045.PMC3813458.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/85/rjt038.PMC3813460.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/e3/rjt058.PMC3813461.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/12/rjt051.PMC3813486.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/38/rjt036.PMC3813487.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/f4/rjt044.PMC3813488.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/53/rjt047.PMC3813490.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/2c/rjt071.PMC3813507.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/bb/rjt035.PMC3813509.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/97/rjt060.PMC3813510.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/c8/rjt066.PMC3813514.pdf
"www.landesbioscience.com  Bioengineered  313Bioengineered 4:5, 313–321; Sept ember/October 2013; © 2013 Landes Bioscience ReSeaRch pape R ReSeaRch pape R *Correspondence to: Douwe van Sinderen; Email: d.vansinderen@ucc.ie Submitted: 02/04/13; Revised: 02/27/13; Accepted: 02/28/13http://dx.doi.org/10.4161/bioe.24159Introduction Bifidobacteria are Gram positive, non-motile, non-sporulat - ing, anaerobic rods which possess a high G+C genome con - tent and belong to the phylum Actinobacteria and the family  Bifidobacteriaceae .1,2 Bifidobacteria were first isolated more than  a century ago3 and naturally inhabit the gastrointestinal tract  of humans and other mammals, being particularly abundant in breast-fed infants.",Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Sequence data were obtained  from the Artemis-mediated47 genome annotations of the B. breve   UCC2003 genome.32 Database searches were performed using  non-redundant sequences accessible at the National Centre for  Biotechnology Information internet site (http://www.ncbi.nlm.nih.gov) using Blast.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Antonie Van Leeuwenhoek 2004; 86:205-23; PMID:15539925; http://dx.doi.org/10.1023/B:ANTO.0000047930.11029.ec.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Int J Food Microbiol 2007; 120:2-12; PMID:17629975; http://dx.doi.org/10.1016/j.ijfood - micro.2007.06.011.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Antonie Van Leeuwenhoek 2008; 94:35-50; PMID:18338233; http://dx.doi.org/10.1007/s10482-008-9232-4.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
PLoS One 2012; 7:e36957; PMID:22606315; http://dx.doi.org/10.1371/journal.pone.0036957.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Pr obiotic properties of lactic-acid bac- teria: plenty of scope for fundamental R & D. T rends Biotechnol 1997; 15:270-4; PMID:9237406; http://dx.doi.org/10.1016/S0167-7799(97)01056-1.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Curr Opin Biotechnol 2005; 16:198-203; PMID:15831387; http://dx.doi.org/10.1016/j.copbio.2005.02.008.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Appl Microbiol 2005; 98:1303-15; PMID:15916644; http://dx.doi.org/10.1111/j.1365-2672.2005.02600.x.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Anaerobe 2007; 13:215-9; PMID:17646115; http://dx.doi.org/10.1016/j.anaerobe.2007.05.002.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
T rends Microbiol 2012; 20:467-76; PMID:22902802; http://dx.doi.org/10.1016/j.tim.2012.07.002.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
BMC Biochem 2011; 12:9; PMID:21329502; http://dx.doi.org/10.1186/1471-2091-12-9.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Biotechnol 2012; 158:17-23; PMID:22261174; http://dx.doi.org/10.1016/j.jbiotec.2012.01.002.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Mol Cell Probes 1999; 13:179-82; PMID:10369742; http://dx.doi.org/10.1006/mcpr.1999.0232.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Arch Biochem Biophys 1962; 99:249-53; PMID:13998583; http://dx.doi.org/10.1016/0003-9861(62)90006-1.16.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Bacteriol 2009; 191:5010-2; PMID:19465645; http://dx.doi.org/10.1128/JB.00306-09.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Appl Bacteriol 1985; 59:183-8; PMID:3900022; http://dx.doi.org/10.1111/j.1365-2672.1985.tb03319.x.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Gen Microbiol 1979; 115:233-45; PMID:93615; http://dx.doi.org/10.1099/00221287-115-1-233.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
FEBS Lett 2005; 579:5157-62; PMID:16146629; http://dx.doi.org/10.1016/j.febslet.2005.08.028.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Biol Chem 2010; 285:10353-61; PMID:20145247; http://dx.doi.org/10.1074/jbc.M109.081851.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Nutr Biochem 2006; 17:789-810; PMID:16650752; http://dx.doi.org/10.1016/j.jnutbio.2006.02.009.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Acta Crystallogr Sect F Struct Biol Cryst Commun 2006; 62:153-6; PMID:16511289; http://dx.doi.org/10.1107/S1744309106001229.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Biol Chem 2009; 284:8005-12; PMID:19164287; http://dx.doi.org/10.1074/jbc.M809060200.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Appl Environ Microbiol 2001; 67:1246-52; PMID:11229917; http://dx.doi.org/10.1128/AEM.67.3.1246-1252.2001.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Appl Environ Microbiol 2007; 73:2333-7; PMID:17277221; http://dx.doi.org/10.1128/AEM.01855-06.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Appl Microbiol 2003; 94:138-45; PMID:12492934; http://dx.doi.org/10.1046/j.1365-2672.2003.01814.x.31.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Microbiology 2007; 153:3563-71; PMID:17906153; http://dx.doi.org/10.1099/mic.0.2007/006510-0.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Microb Biotechnol 2011; 4:403-16; PMID:21375716; http://dx.doi.org/10.1111/j.1751-7915.2010.00218.x.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Appl Environ Microbiol 2004; 70:4635-41; PMID:15294796; http://dx.doi.org/10.1128/AEM.70.8.4635-4641.2004.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Appl Microbiol 2009; 106:1315-27; PMID:19187142; http://dx.doi.org/10.1111/j.1365-2672.2008.04098.x.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Microbiology 2011; 157:609-15; PMID:21178166; http://dx.doi.org/10.1099/mic.0.043406-0.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Biotechnol Lett 2012; 35:75-81; PMID:22955678; http://dx.doi.org/10.1007/s10529-012-1044-y.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
N Biotechnol 2009; 26:117-21; PMID:19577017; http://dx.doi.org/10.1016/j.nbt.2009.06.984.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Microbiology 2010; 156:3360-7; PMID:20829293; http://dx.doi.org/10.1099/mic.0.043158-0.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Biotechnol Adv 2011; 29:442-52; PMID:21504787; http://dx.doi.org/10.1016/j.biotechadv.2011.04.002.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Res Microbiol 2002; 153:263-8; PMID:12160316; http://dx.doi.org/10.1016/S0923-2508(02)01319-0.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Ferment Bioeng 1991; 71:194-6; http://dx.doi.org/10.1016/0922-338X(91)90109-T. 46.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Bioinformatics 2000; 16:944-5; PMID:11120685; http://dx.doi.org/10.1093/bioinfor-matics/16.10.944.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Nucleic Acids Res 1997; 25:3389-402; PMID:9254694; http://dx.doi.org/10.1093/nar/25.17.3389.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
FEMS Microbiol Lett 1999; 174:285-94; PMID:10339821; http://dx.doi.org/10.1111/j.1574-6968.1999.tb13581.x.51.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Appl Environ Microbiol 2007; 73:545-53; PMID:17098914; http://dx.doi.org/10.1128/AEM.01496-06.,OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Appl Microbiol Biotechnol 2007; 76:1395-402; PMID:17704917; http://dx.doi.org/10.1007/s00253-007-1115-5.54.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
Microb Biotechnol 2009; 2:321-32; PMID:21261927; http://dx.doi.org/10.1111/j.1751-7915.2008.00071.x.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
J Food Sci 1997; 62:1083-6; http://dx.doi.org/10.1111/j.1365-2621.1997.tb15043.x.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/bbug-4-313.PMC3813531.pdf
"Bioengineered 4:5, 322–331; September/October 2013; © 2013 Landes Bioscience ReSeaRch pape R 322 Bioengineered  Volume 4 Issue 5*Correspondence to: Lucília Domingues; Email: luciliad@deb.uminho.pt Submitted: 01/25/13; Revised: 04/09/13; Accepted: 04/10/13http://dx.doi.org/10.4161/bioe.24653Introduction Because of their natural ability to secrete high amounts of  extracellular proteins, filamentous fungi have been extensively exploited for the production of homologous and heterologous proteins.",Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
T rends Biotechnol 2002; 20:200-6; PMID:11943375; http://dx.doi.org/10.1016/S0167-7799(02)01933-9.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Curr Opin Biotechnol 2003; 14:438-43; PMID:12943855; http://dx.doi.org/10.1016/S0958-1669(03)00099-5.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Antonie Van Leeuwenhoek 1994; 65:245-50; PMID:7847891; http://dx.doi.org/10.1007/BF00871952.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Antonie Van Leeuwenhoek 1994; 65:211-6; PMID:7847888; http://dx.doi.org/10.1007/BF00871949.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Appl Microbiol Biotechnol 1997; 47:1-11; PMID:9035405; http://dx.doi.org/10.1007/s002530050880.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Biosci Biotechnol Biochem 2009; 73:2370-3; PMID:19897917; http://dx.doi.org/10.1271/bbb.90177.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Appl Environ Microbiol 2009; 75:4853-60; PMID:19447952; http://dx.doi.org/10.1128/AEM.00282-09.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Enzyme Microb Technol 1981; 3:153-7; http://dx.doi.org/10.1016/0141-0229(81)90076-4.12.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Mol Gen Genet 1992; 234:332-6; PMID:1508158; http://dx.doi.org/10.1007/BF00283855.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
J Biotechnol 1991; 17:3-9; PMID:1367014; http://dx.doi.org/10.1016/0168-1656(91)90022-N. 16.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Mol Genet Genomics 2001; 265:1112-9; PMID:11523784; http://dx.doi.org/10.1007/s004380100510.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Mutat Res 2006; 602:14-25; PMID:17045307; http://dx.doi.org/10.1016/j.mrfmmm.2006.07.009.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Appl Microbiol Biotechnol 1997; 47:313-6; PMID:9114519; http://dx.doi.org/10.1007/s002530050933.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Appl Microbiol Biotechnol 1994; 41:79-83; http://dx.doi.org/10.1007/BF00166085.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Enzyme Microb Technol 3 1997; 21:25-31; http://dx.doi.org/10.1016/S0141-0229(96)00212-8.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
J Gen Appl Microbiol 2001; 47:181-6; PMID:12483617; http://dx.doi.org/10.2323/jgam.47.181.23.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Appl Microbiol Biotechnol 2006; 69:711-7; PMID:16021486; http://dx.doi.org/10.1007/s00253-005-0013-y.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Bioresour Technol 2007; 98:3464-9; PMID:17223558; http://dx.doi.org/10.1016/j.biortech.2006.11.007.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
J Ind Microbiol Biotechnol 2005; 32:289-94; PMID:15952011; http://dx.doi.org/10.1007/s10295-005-0249-7.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
FEMS Yeast Res 2004; 4:833-40; PMID:15450190; http://dx.doi.org/10.1016/j.femsyr.2004.03.001.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Appl Environ Microbiol 2000; 66:5477-9; PMID:11097931; http://dx.doi.org/10.1128/AEM.66.12.5477-5479.2000.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
FEMS Microbiol Lett 2006; 264:40-7; PMID:17020547; http://dx.doi.org/10.1111/j.1574-6968.2006.00427.x.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Microb Cell Fact 2010; 9:7; PMID:20102600; http://dx.doi.org/10.1186/1475-2859-9-7.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
J Ind Microbiol 1995; 14:523-30; PMID:7662294; http://dx.doi.org/10.1007/BF01573968.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
PLoS One 2010; 5:e14046; PMID:21124977; http://dx.doi.org/10.1371/journal.pone.0014046.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Biotechnol Tech 1994; 8:479-82; http://dx.doi.org/10.1007/BF00222839.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Yeast 1996; 12:259-65; PMID:8904338; http://dx.doi.org/10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C. 51.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Nucleic Acids Res 2002; 30:e23; PMID:11884642; http://dx.doi.org/10.1093/nar/30.6.e23.42.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Appl Microbiol Biotechnol 2006; 70:740-6; PMID:16151800; http://dx.doi.org/10.1007/s00253-005-0122-7.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Mycobiology 2009; 37:267-71; http://dx.doi.org/10.4489/MYCO.2009.37.4.267.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Bioresour Technol 2007; 98:1467-73; PMID:17097876; http://dx.doi.org/10.1016/j.biortech.2006.02.036.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Mol Microbiol 2005; 56:1675-88; PMID:15916615; http://dx.doi.org/10.1111/j.1365-2958.2005.04654.x.35.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Annu Rev  Microbiol 1972; 26:369-88; PMID:4567521; http://dx.doi.org/10.1146/annurev.mi.26.100172.002101.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Appl Microbiol Biotechnol 2010; 87:1437-46; PMID:20422178; http://dx.doi.org/10.1007/s00253-010-2610-7.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Gene 2000; 242:381-91; PMID:10721732; http://dx.doi.org/10.1016/S0378-1119(99)00509-0.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
Mol Biol Cell 2003; 14:4140-54; PMID:12937275; http://dx.doi.org/10.1091/mbc.E03-03-0167.,Non-OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
J Appl Microbiol 2007; 103:468-76; PMID:17650208; http://dx.doi.org/10.1111/j.1365-2672.2006.03264.x.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
J Biosci Bioeng 2009; 108:325-9; PMID:19716523; http://dx.doi.org/10.1016/j.jbiosc.2009.04.021.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
J Appl Microbiol 2005; 98:318-23; PMID:15659186; http://dx.doi.org/10.1111/j.1365-2672.2004.02453.x.,OADS,/arxiv_data1/oa_pdf/82/40/bbug-4-322.PMC3813532.pdf
"Bioengineered 4:5, 332–337; September/October 2013; © 2013 Landes Bioscience ReSeaRch pape R 332 Bioengineered  Volume 4 Issue 5*Correspondence to: Claudio Nicolini; Email: president@fondazioneelba-nicolini.org Submitted: 03/06/13; Revised: 06/03/13; Accepted: 06/04/13http://dx.doi.org/10.4161/bioe.25278Introduction Anodic porous alumina (APA) has attracted considerable atten - tion because of its use as a template to manufacture nanostruc - tures with a hexagonal arrangement of the nanopores as porous  membranes,1 nano ordered arrays2 and nanoparticles3 that have  many applications in commercial electronic fields to detect bio - logical molecules.4,5 APA microarrays may be produced by a well- known two-step process involving anodic oxidation described by Masuda et al.",Non-OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
2007; 1:79-83; http://dx.doi.org/10.1115/1.2360949 18.,Non-OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
J Control Release 2005; 102:123-33; PMID:15653139; http://dx.doi.org/10.1016/j.jcon-rel.2004.09.024 19.,OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Nat Methods 2008; 5:535-8; PMID:18469824; http://dx.doi.org/10.1038/nmeth.1210 22.,OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
J Cell Biochem 2012; 113:1820-32; PMID:22134986; http://dx.doi.org/10.1002/jcb.24013 23.,Non-OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Rev Sci Instrum 2007; 78:013705; PMID:17503926; http://dx.doi.org/10.1063/1.24324109.,Non-OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Adv Drug Deliv Rev 2012; 64:1522-31; PMID:22820526; http://dx.doi.org/10.1016/j.addr.2012.06.015 11.,Non-OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
J Lumin 2007; 126:789-94; http://dx.doi.org/10.1016/j.jlu-min.2006.11.013 13.,OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
J Colloid Interface Sci 2005; 287:664-70; PMID:15925635; http://dx.doi.org/10.1016/j.jcis.2005.02.036 14.,OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Lab Chip 2008; 8:23-33; PMID:18094759; http://dx.doi.org/10.1039/b714128a 15.,OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Biomedical Microdevices 2002; 4:131-9; http://dx.doi.org/10.1023/A:1014639332543.,Non-OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Analyst 2006; 131:705-9; PMID:16732357; http://dx.doi.org/10.1039/b600158kReferences 1.,OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Mater Lett 2006; 60:2331-4; http://dx.doi.org/10.1016/j.matlet.2006.01.001 2.,OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Nano Lett 2004; 4:167-71; http://dx.doi.org/10.1021/nl034835u 3.,OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Biosens Bioelectron 2007; 23:655-60; PMID:17766101; http://dx.doi.org/10.1016/j.bios.2007.07.011 5.,OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Science 1995; 268:1466-8; PMID:17843666; http://dx.doi.org/10.1126/sci-ence.268.5216.1466 7.,OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Advanced Materials 2004; 16:2102-5; http://dx.doi.org/10.1002/adma.200400360 8.,Non-OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
Nanotechnology 2006; 17:795-8; http://dx.doi.org/10.1088/0957-4484/17/3/030,OADS,/arxiv_data1/oa_pdf/fe/ea/bbug-4-332.PMC3813533.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/0d/rjt062.PMC3813551.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/00/rjt032.PMC3813552.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/a1/rjt056.PMC3813553.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/b7/rjt030.PMC3813558.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/49/rjt039.PMC3813587.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/20/rjt072.PMC3813589.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/5c/rjt085.PMC3813590.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/ad/rjt040.PMC3813601.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/80/rjt037.PMC3813620.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/75/rjt057.PMC3813623.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/67/rjt026.PMC3813624.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/4b/rjt087.PMC3813666.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/9a/rjt065.PMC3813678.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/8c/rjt050.PMC3813680.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/f8/rjt083.PMC3813682.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/d1/rjt054.PMC3813689.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/96/rjt067.PMC3813702.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/4b/rjt055.PMC3813704.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/5c/rjt034.PMC3813706.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/ec/rjt076.PMC3813725.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/59/rjt059.PMC3813727.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/a1/rjt031.PMC3813728.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/b0/rjt053.PMC3813746.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/62/rjt052.PMC3813747.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/e8/rjt063.PMC3813751.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/81/rjt046.PMC3813753.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/a4/rjt068.PMC3813768.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/e6/rjt064.PMC3813769.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/13/rjt086.PMC3813775.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/40/rjt041.PMC3813776.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/86/rjt020.PMC3813789.pdf
6. http://www.ovesco.com/products/index.html7.,Non-OADS,/arxiv_data1/oa_pdf/d7/86/rjt020.PMC3813789.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/b6/rjt033.PMC3813790.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/11/rjt042.PMC3813791.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/e7/rjt048.PMC3813796.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/21/rjt049.PMC3813797.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/ac/rjt043.PMC3813824.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3100 | DOI: 10.1038/srep03100 5",Non-OADS,/arxiv_data1/oa_pdf/4c/9f/srep03100.PMC3813927.pdf
"The simulations were performed using the DarwinSupercomputer of the University of Cambridge High Performance Computing Service (http://www.hpc.cam.ac.uk/), provided by Dell Inc. using Strategic Research Infrastructure Funding from the Higher Education Funding Council for England.",OADS,/arxiv_data1/oa_pdf/e9/aa/srep03103.PMC3813928.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 Figure 7 |The probability distributions eq.",Non-OADS,/arxiv_data1/oa_pdf/e9/aa/srep03103.PMC3813928.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3116 | DOI: 10.1038/srep03116 8",Non-OADS,/arxiv_data1/oa_pdf/e5/a7/srep03116.PMC3813929.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Accession codes: The crystal structure of Ca(Ir 4As8)(Fe 2As2)5has been deposited at the Cambridge Crystallographic Data Centre (http://www.ccdc.cam.ac.uk).,OADS,/arxiv_data1/oa_pdf/99/46/srep03101.PMC3813930.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3101 | DOI: 10.1038/srep03101 5",Non-OADS,/arxiv_data1/oa_pdf/99/46/srep03101.PMC3813930.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d6/b0/srep03102.PMC3813933.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3102 | DOI: 10.1038/srep03102 7",Non-OADS,/arxiv_data1/oa_pdf/d6/b0/srep03102.PMC3813933.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3092 | DOI: 10.1038/srep03092 5",Non-OADS,/arxiv_data1/oa_pdf/1f/20/srep03092.PMC3813935.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3096 | DOI: 10.1038/srep03096 5",Non-OADS,/arxiv_data1/oa_pdf/6d/c8/srep03096.PMC3813936.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/06/66/srep03093.PMC3813938.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3093 | DOI: 10.1038/srep03093 9",Non-OADS,/arxiv_data1/oa_pdf/06/66/srep03093.PMC3813938.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/83/a3/srep03099.PMC3813939.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3099 | DOI: 10.1038/srep03099 6",Non-OADS,/arxiv_data1/oa_pdf/83/a3/srep03099.PMC3813939.pdf
"Fluids B 2, 67 (1990) http://dx.doi.org/10.1063/1.859540.",Non-OADS,/arxiv_data1/oa_pdf/61/27/srep03106.PMC3813940.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/61/27/srep03106.PMC3813940.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3106 | DOI: 10.1038/srep03106 6",Non-OADS,/arxiv_data1/oa_pdf/61/27/srep03106.PMC3813940.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e0/0b/srep03109.PMC3813942.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3109 | DOI: 10.1038/srep03109 7",Non-OADS,/arxiv_data1/oa_pdf/e0/0b/srep03109.PMC3813942.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c8/01/srep03095.PMC3813943.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3095 | DOI: 10.1038/srep03095 8",Non-OADS,/arxiv_data1/oa_pdf/c8/01/srep03095.PMC3813943.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6f/4d/srep03105.PMC3813944.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3105 | DOI: 10.1038/srep03105 6",Non-OADS,/arxiv_data1/oa_pdf/6f/4d/srep03105.PMC3813944.pdf
"81 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Evaluation of primary androgen deprivation therapy in  prostate cancer patients using the J-CAPRA risk score Hideyuki Akaza, Shiro Hinotsu1, Michiyuki Usami2, Osamu Ogawa3, Tadaichi Kitamura4, Kazuhiro Suzuki5,  Taiji Tsukamoto6, Seiji Naito7, Mikio Namiki8, Yoshihiko Hirao9, Masaru Murai10 Department of Strategic Investigation on Comprehensive Cancer Network Research Center for Advanced Science and Technology, The University of Tokyo,  Tokyo, Japan 1Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan 2Department of Urology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan 3Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan 4Asoka Hospital, Tokyo, Japan 5Department of Urology, Gunma University Graduate School of Medicine, Gunma, Japan 6Department of Urology, Sapporo Medical University, School of Medicine, Sapporo, Japan 7Department of Urology, Graduate School of Medical Sciences, Kyushu University, Kyushu, Japan 8Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan 9Department of Urology, Nara Medical University, Kashihara, Japan 10International Goodwill Hospital, Yokohama, Japan Purpose:  To determine the influence of maximal androgen blockade (MAB) and non-MAB hormonal therapy with an luteinizing  hormone releasing hormone (LHRH) analog on overall survival of prostate cancer patients in the Japan Study Group of Prostate Cancer  (J-CaP) registry according to risk, as assessed using the novel J-CAPRA risk instrument.",Non-OADS,/arxiv_data1/oa_pdf/94/52/pi_1-2-81-06.PMC3814111.pdf
"Keywords:  Prostate neoplasms, Maximal androgen blockade, Overall survival, Primary androgen deprivation therapy, Risk scoringProstate Int 2013;1(2):81-88 • http://dx.doi.org/10.12954/PI.12016Original Article Corresponding author:  Hideyuki Akaza  Department of Strategic Investigation on Comprehensive Cancer Network Research Center for Advanced Science and Technology, The University of Tokyo,   4-6-1, Komaba, Meguro-ku, Tokyo 1530041, Japan   E-mail: akazah@med.rcast.u-tokyo.ac.jp / Tel: + 81-3-5432-5341 / Fax: +81-3-5432-5343 Submitted: 28 January 2013  / Accepted after revision: 12 May 2013INTRODUCTION Prostate cancer is recognized as a hormone-dependent condi -tion whereby tumour growth is stimulated by endogenous cir - culating androgens.",Non-OADS,/arxiv_data1/oa_pdf/94/52/pi_1-2-81-06.PMC3814111.pdf
Prostate  cancer  hormone  therapy 82PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12016CaP database 59.0% of all patients received MAB therapy and  these regimens were most often administered to patients who  were considered to be at high risk of disease progression [7].,Non-OADS,/arxiv_data1/oa_pdf/94/52/pi_1-2-81-06.PMC3814111.pdf
2 / June 2013 83PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12016had follow-up data for periods ranged from 0 to 9.2 years.,OADS,/arxiv_data1/oa_pdf/94/52/pi_1-2-81-06.PMC3814111.pdf
"Prostate  cancer  hormone  therapy 84PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1201666–75, >75 years of age) found a higher proportion of low- risk patients in the older age category (48%) compared to the  younger two age categories (45% and 31%, respectively).",Non-OADS,/arxiv_data1/oa_pdf/94/52/pi_1-2-81-06.PMC3814111.pdf
2 / June 2013 85PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12016Fig.,OADS,/arxiv_data1/oa_pdf/94/52/pi_1-2-81-06.PMC3814111.pdf
"Prostate  cancer  hormone  therapy 86PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12016DISCUSSION Evidence from RCTs is now accumulating to suggest the  greater benefits of MAB compared with non-MAB hormonal  therapy, particularly in certain subgroups of patients [3-5].",Non-OADS,/arxiv_data1/oa_pdf/94/52/pi_1-2-81-06.PMC3814111.pdf
2 / June 2013 87PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12016of ADT and there is no specific advice at the present time re - lating to MAB therapy.,Non-OADS,/arxiv_data1/oa_pdf/94/52/pi_1-2-81-06.PMC3814111.pdf
Prostate  cancer  hormone  therapy 88PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12016col 2009;27:4306-13.,Non-OADS,/arxiv_data1/oa_pdf/94/52/pi_1-2-81-06.PMC3814111.pdf
"59 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Development of prostate cancer research database with  the clinical data warehouse technology for direct linkage  with electronic medical record system In Young Choi, Seungho Park1, Bumjoon Park1, Byung Ha Chung2, Choung-Soo Kim3, Hyun Moo Lee4,  Seok-Soo Byun5, Ji Youl Lee6 Department of Medical Informatics, The Catholic University of Korea College of Medicine, Seoul, Korea 1Graduate School of Information System, Hanyang University, Seoul, Korea 2Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea 3Department of Urology, Asan Medical Center, Seoul, Korea 4Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 5Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea 6Department of Urology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea Purpose:  In spite of increased prostate cancer patients, little is known about the impact of treatments for prostate cancer patients  and outcome of different treatments based on nationwide data.",Non-OADS,/arxiv_data1/oa_pdf/4a/57/pi_1-2-59-02.PMC3814112.pdf
"Keywords:  Prostate neoplasms, Hospital information systems, Information Storage and Retrieval, Retrospective studiesProstate Int 2013;1(2):59-64 • http://dx.doi.org/10.12954/PI.12015Original Article Corresponding author:  Ji Youl Lee Department of Urology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea   E-mail: uroljy@catholic.ac.kr / Tel: +82-2-2258-6227 / Fax: +82-2-599-7839 Submitted: 20 December 2012  / Accepted after revision: 21 May 2013INTRODUCTION The National Statistics Office in Korea exclaimed that the  prevalence of prostate cancer quadrupled between 2002 and  2008 [1,2].",Non-OADS,/arxiv_data1/oa_pdf/4a/57/pi_1-2-59-02.PMC3814112.pdf
"Prostate  cancer  research  database  for direct  linkage  with  EMR 60PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12015objective was to develop research database system having  easy data access, transparent scientific reproducibility, and  interoperability between multiple centers.",OADS,/arxiv_data1/oa_pdf/4a/57/pi_1-2-59-02.PMC3814112.pdf
"2 / June 2013 61PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12015and recurrence, QoL issues, and many others.",Non-OADS,/arxiv_data1/oa_pdf/4a/57/pi_1-2-59-02.PMC3814112.pdf
"Prostate  cancer  research  database  for direct  linkage  with  EMR 62PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12015intensive and cumbersome, so it usually fails to capture rel - evant data at early times.",Non-OADS,/arxiv_data1/oa_pdf/4a/57/pi_1-2-59-02.PMC3814112.pdf
2 / June 2013 63PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12015ment.,Non-OADS,/arxiv_data1/oa_pdf/4a/57/pi_1-2-59-02.PMC3814112.pdf
Prostate  cancer  research  database  for direct  linkage  with  EMR 64PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12015cancer patients in the future.,Non-OADS,/arxiv_data1/oa_pdf/4a/57/pi_1-2-59-02.PMC3814112.pdf
"69 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Nomogram using transrectal ultrasound-derived infor - mation predicting the detection of high grade prostate  cancer on initial biopsy In Gab Jeong, Ju Hyun Lim, Seung-Sik Hwang1, Sung Cheol Kim, Dalsan You, Jun Hyuk Hong, Hanjong Ahn,  Choung-Soo Kim Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 1Department of Social and Preventive Medicine, Inha University School of Medicine, Incheon, Korea Purpose:  To develop a nomogram using transrectal ultrasound (TRUS)-derived information for predicting high grade (HG) prostate  cancer (PCa) on initial biopsy.",Non-OADS,/arxiv_data1/oa_pdf/1b/f2/pi_1-2-69-04.PMC3814113.pdf
"Keywords:  Prostatic neoplasms, Biopsy, Nomograms, UltrasonographyProstate Int 2013;1(2):69-75 • http://dx.doi.org/10.12954/PI.12008Original Article Corresponding author:  Choung-Soo Kim Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea   E-mail: cskim@amc.seoul.kr / Tel: +82-2-3010-3734 / Fax: +82-2-477-8928 Submitted: 7 December 2012  / Accepted after revision: 9 May 2013INTRODUCTION Prostate cancer (PCa) is the most common nonskin cancer in  men in the United States (US), with an estimated 186,320 new  cases in 2008 [1].",Non-OADS,/arxiv_data1/oa_pdf/1b/f2/pi_1-2-69-04.PMC3814113.pdf
Nomogram  of high  grade  prostate  cancer 70PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.120082.,Non-OADS,/arxiv_data1/oa_pdf/1b/f2/pi_1-2-69-04.PMC3814113.pdf
"2 / June 2013 71PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12008and for predicting HGPCa was 0.78 (95% CI, 0.72 to 0.83).",OADS,/arxiv_data1/oa_pdf/1b/f2/pi_1-2-69-04.PMC3814113.pdf
Nomogram  of high  grade  prostate  cancer 72PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12008DISCUSSION The present report describes a nomogram for predicting HG - PCa using TRUS-derived information in men with intermedi - ate PSA levels.,Non-OADS,/arxiv_data1/oa_pdf/1b/f2/pi_1-2-69-04.PMC3814113.pdf
2 / June 2013 73PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12008for HGPCa.,OADS,/arxiv_data1/oa_pdf/1b/f2/pi_1-2-69-04.PMC3814113.pdf
Nomogram  of high  grade  prostate  cancer 74PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12008tion should be incorporated into nomograms predicting  HGPCa in men with a PSA range of 4.0–9.9 ng/mL.,Non-OADS,/arxiv_data1/oa_pdf/1b/f2/pi_1-2-69-04.PMC3814113.pdf
Avail - able from: http://seer.cancer.gov/statfacts/html/prost.html.,Non-OADS,/arxiv_data1/oa_pdf/1b/f2/pi_1-2-69-04.PMC3814113.pdf
2 / June 2013 75PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12008diation therapy oncology group prostate cancer trials.,Non-OADS,/arxiv_data1/oa_pdf/1b/f2/pi_1-2-69-04.PMC3814113.pdf
"65 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Trends of clinical symptoms and prognosis of   middle-aged prostate cancer patients after instigation of   prostate specific antigen-based population screening Yasuhide Kitagawa, Atsushi Mizokami, Mikio Namiki Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan Purpose:  Due to the low rate of screening for prostate cancer in Japan, the incidence rates of cancer are high.",Non-OADS,/arxiv_data1/oa_pdf/af/78/pi_1-2-65-03.PMC3814114.pdf
"Keywords:  Prostate neoplasms, Clinical symptoms, Prostate-specific antigen screening, PrognosisProstate Int 2013;1(2):65-68 • http://dx.doi.org/10.12954/PI.12017Original Article Corresponding author:  Yasuhide Kitagawa Department of Integrative Cancer Therapy and Urology, Graduate School of Medical Science, Kanazawa University, 920-8640 Takaramachi 13-1, Kanazawa, Japan   E-mail: yasukita@med.kanazawa-u.ac.jp / Tel: +81-76-265-2393 / Fax: +81-76-222-6726 Submitted: 18 March 2013  / Accepted after revision: 7 May 2013INTRODUCTION Prostate cancer is the most common form of cancer among  men in Western countries, and the mortality rate of prostate  cancer was high in the 1990s [1].",Non-OADS,/arxiv_data1/oa_pdf/af/78/pi_1-2-65-03.PMC3814114.pdf
"Symptoms  and prognosis  of middle-aged  prostate  cancer 66PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12017 Clinical staging was determined in accordance with the  unified TNM criteria based on the results of digital rectal ex - amination, transrectal ultrasound, computed tomography,  magnetic resonance imaging (MRI), and bone scan [7].",Non-OADS,/arxiv_data1/oa_pdf/af/78/pi_1-2-65-03.PMC3814114.pdf
"2 / June 2013 67PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12017the prognosis of prostate cancer patients remains controver - sial [8,9].",Non-OADS,/arxiv_data1/oa_pdf/af/78/pi_1-2-65-03.PMC3814114.pdf
Symptoms  and prognosis  of middle-aged  prostate  cancer 68PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12017 We showed that the rate of patients with local disease in the  PSA testing group was higher than those in the symptomatic  groups.,Non-OADS,/arxiv_data1/oa_pdf/af/78/pi_1-2-65-03.PMC3814114.pdf
"47 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Epidemiology of prostate cancer in the Asia-Pacific   region Peter D. Baade1,2,3, Danny R. Youlden1, Susanna M. Cramb1,4, Jeff Dunn1,2,5, Robert A. Gardiner6,7,8 1Cancer Council Queensland, Brisbane, Australia 2Griffith Health Institute, Griffith University, Gold Coast, Australia 3School of Public Health, Queensland University of Technology, Brisbane, Australia 4School of Mathematics, Queensland University of Technology, Brisbane, Australia 5School of Social Science, University of Queensland, Brisbane, Australia 6University of Queensland, Centre for Clinical Research, Royal Brisbane Hospital, Brisbane, Australia 7Department of Urology, Royal Brisbane Hospital, Brisbane, Australia 8Health and Wellness Institute, Edith Cowan University, Perth, Australia The purpose of this paper was to examine and compare available data on incidence, mortality and survival for countries in the Asia- Pacific region.",Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
"Keywords:  Prostate neoplasms, Asia-Pacific, Incidence, Mortality, Prostate specific antigen Prostate Int 2013;1(2):47-58 • http://dx.doi.org/10.12954/PI.12014Review Article Corresponding author:  Peter D. Baade Cancer Council Queensland, PO Box 201, Fortitude Valley QLD 4006, Australia   E-mail: peterbaade@cancerqld.org.au / Tel: +61-7-3634-5317 / Fax: +61-7-3259-8527 Submitted: 20 December 2012  / Accepted after revision: 10 January 2013INTRODUCTION Previous international reviews of prostate cancer epidemiol - ogy have reported high incidence in Western countries, with  lower but typically increasing incidence in less developed  countries [1-3].",Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
"Prostate  cancer  in Asia-Pacific  region 48PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12014der these criteria, Brunei, Malaysia and Fiji were excluded.",Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
2 / June 2013 49PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12014Table 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
"No mortality data China 33,802 4.3 14,297 1.8 0.42 689,397 Upper middle 71 7.3 Local incidence data and national mortality data Micronesia 48 28.2 20 11.2 0.40 266 Lower middle 4.3 National incidence data (Guam) Fiji 41 17.0 32 13.7 0.81 431 Lower middle 66 4.2 National incidence data Papua New Guinea 145 11.7 114 9.7 0.83 3,340 Lower middle 60 2.3 No data (estimated from surrounding countries) Indonesia 9,033 10.6 6,841 8.0 0.75 117,235 Lower middle 67 4.8 No data (estimated from surrounding countries) Philippines 2,491 10.1 1,290 5.3 0.52 45,275 Lower middle 65 3.0 Local incidence data and national mortality data Solomon Islands 10 8.8 9 7.8 0.89 264 Lower middle 65 2.9 No data (estimated from surrounding countries) East Timor 17 7.9 14 6.6 0.84 551 Lower middle 60 2.7 No data (estimated from surrounding countries) Vanuatu 3 5.1 2 3.4 0.67 116 Lower middle 68 3.4 National incidence data Laos 65 4.4 37 2.5 0.57 3,000 Lower middle 65 3.4 No data (estimated from surrounding countries) Viet Nam 1,208 3.2 716 1.9 0.59 42,429 Lower middle 72 5.0 No data (estimated from surrounding countries) Mongolia 16 2.4 10 1.5 0.63 1,317 Lower middle 64 3.5 National incidence data Cambodia 163 5.8 95 3.6 0.62 6,756 Low 60 2.6 Frequency data Myanmar 1,091 5.8 636 3.2 0.55 23,302 Low 62 4.6 No data (estimated from surrounding countries) North Korea 237 2.3 136 1.4 0.61 11,833 Low 65 6.4 No data (estimated from surrounding countries) Polynesia 116 48.1 34 14.1 0.29 338 Unknown 5.1 National incidence data (Samoa, French Polynesia) Chinese Taipei 3,635 20.8 1,116 5.2 0.25 Unknown National incidence data Data from GLOBOCAN [7], United Nations Population Division [8], World DataBank [48], World Bank (income level from: http://data.worldbank.org/income-level/NOC).",Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
"Prostate  cancer  in Asia-Pacific  region 50PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12014100,000 in Australia.",Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
2 / June 2013 51PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12014Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
Prostate  cancer  in Asia-Pacific  region 52PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12014the Solomon Islands [7].,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
2 / June 2013 53PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12014Table 3.,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
Prostate  cancer  in Asia-Pacific  region 54PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12014prostate cancer throughout the Asia-Pacific region (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
"2 / June 2013 55PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12014in New South Wales (Australia) between 1999 and 2007, the  5-year survival ranged from 94% for localised cancers, 86% for  regional cancers and 17% for distant cancers (personal com - munication, Dr XQ Yu, Cancer Council NSW).",Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
"Prostate  cancer  in Asia-Pacific  region 56PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12014rated fat content [25,37,38].",Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
2 / June 2013 57PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12014REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
Available from: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
Available from:  http://www.aihw.gov.au/acim-books/.,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
Available from: http://www3.ha.org.hk/cancereg/statistics.,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
Available  from: http://ganjoho.jp/pro/statistics/en/table_download.,OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
Available from: http://www.med.,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
Available from:  http://ci5.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
Bethesda: National Cancer Institute; c2013  [cited 2012 Jul 11]; Available from: http://surveillance.cancer.,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
"Prostate  cancer  in Asia-Pacific  region 58PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12014namese, Korean, and Japanese ethnicities.",Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
Avail - able from: http://survcan.iarc.fr/survivalchap4.php.,Non-OADS,/arxiv_data1/oa_pdf/b5/e2/pi_1-2-47-01.PMC3814115.pdf
"76 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Simple method for preventing inguinal hernias after   radical retropubic prostatectomy  Hidekazu Koike, Hiroshi Matsui, Yasuyuki Morikawa, Yasuhiro Shibata, Kazuto Ito, Kazuhiro Suzuki Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan Purpose:  Inguinal hernias often occur after radical retropubic prostatectomy (RRP).",Non-OADS,/arxiv_data1/oa_pdf/0f/47/pi_1-2-76-05.PMC3814116.pdf
"Keywords:  Inguinal hernia, Control and prevention, Prostate neoplasms, ProstatectomyProstate Int 2013;1(2):76-80 • http://dx.doi.org/10.12954/PI.12009Original Article Corresponding author:  Hidekazu Koike Department of Urology, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi 371-851 1, Japan   E-mail: hkoike@med.gunma-u.ac.jp / Tel: +81-27-220-8300 / Fax: +81-27-220-8318 Submitted: 7 December 2012  / Accepted after revision: 12 May 2013INTRODUCTION The high incidence of inguinal hernia (IH) after radical ret - ropubic prostatectomy (RRP) has attracted increasing con - cern since the pioneering study by Regan et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/47/pi_1-2-76-05.PMC3814116.pdf
2 / June 2013 77PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12009were then compared between the 2 groups.,OADS,/arxiv_data1/oa_pdf/0f/47/pi_1-2-76-05.PMC3814116.pdf
Prevention  of inguinal  hernias  after  RRP 78PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12009RRP.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/pi_1-2-76-05.PMC3814116.pdf
"2 / June 2013 79PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12009identified the vaginal process of the peritoneum, but did not  use any ligatures.",Non-OADS,/arxiv_data1/oa_pdf/0f/47/pi_1-2-76-05.PMC3814116.pdf
Prevention  of inguinal  hernias  after  RRP 80PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12009tomy.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/pi_1-2-76-05.PMC3814116.pdf
"89 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Clinical courses following acute bacterial prostatitis  Byung Il Yoon, Dong-Seok Han, U-Syn Ha, Seung-Ju Lee, Dong Wan Sohn, Hyun Woo Kim, Chang-Hee Han,   Yong-Hyun Cho Department of Urology, The Catholic University of Korea College of Medicine, Seoul, Korea Purpose:  There are few studies about clinical courses following acute bacterial prostatitis (ABP).",Non-OADS,/arxiv_data1/oa_pdf/7b/e9/pi_1-2-89-07.PMC3814117.pdf
"Keywords:  Acute, Chronic, Bacterial prostatitis, Inflammatory chronic pelvic pain syndrome, ProgressionProstate Int 2013;1(2):89-93 • http://dx.doi.org/10.12954/PI.12013Original Article Corresponding author:  Yong-Hyun Cho Department of Urology, Yeouido St. Mary Hospital, The Catholic University of Korea College of Medicine, 10 63(yuksam)-ro, Yeongdeungpo-gu, Seoul 150-713, Korea   E-mail: cyh0831@catholic.ac.kr / Tel: +82-2-3779-1024 / Fax: +82-2-761-1626 Submitted: 17 December 2012  / Accepted after revision: 15 May 2013INTRODUCTION Acute bacterial prostatitis (ABP) is an uncommon disease that  takes only about 5% of prostatitis [1].",Non-OADS,/arxiv_data1/oa_pdf/7b/e9/pi_1-2-89-07.PMC3814117.pdf
Chronic  infection  from  acute  prostatitis 90PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12013CPPS were confirmed by the prostate massage test (Meares- Stamey four glass test).,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/pi_1-2-89-07.PMC3814117.pdf
2 / June 2013 91PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12013in types or distribution of cultured pathogens (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/7b/e9/pi_1-2-89-07.PMC3814117.pdf
"Chronic  infection  from  acute  prostatitis 92PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12013study, or urethral catheterization can spread inflammation  through lymphatic system or blood circulation system.",Non-OADS,/arxiv_data1/oa_pdf/7b/e9/pi_1-2-89-07.PMC3814117.pdf
"2 / June 2013 93PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12013CPPS was 1.3% and 10.5%, respectively and the progression  rate of CI was 11.8% from ABP treatment.",Non-OADS,/arxiv_data1/oa_pdf/7b/e9/pi_1-2-89-07.PMC3814117.pdf
"125Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 •  eISSN: 2287-903X  PROSTATE  INTERNATIONAL Prostate-specific antigen response rate of sequential  chemotherapy in castration-resistant prostate cancer:  the results of real life practice Geehyun Song, Chunwoo Lee, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim  Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose:  Prostate-specific antigen (PSA) response rate ( > 50% PSA decline in pretreatment PSA following chemotherapy) carries a  significant survival advantage in castration-resistant prostate cancer (CRPC).",Non-OADS,/arxiv_data1/oa_pdf/c5/a5/pi-1-3-125-6.PMC3814118.pdf
"Keywords:  Castration refractory prostate cancer, Chemotherapy, Prostate-specific antigenProstate Int 2013;1(3):125-132 •  http://dx.doi.org/10.12954/PI.13024Original Article Corresponding author: Choung-Soo Kim Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea  E-mail: cskim@amc.seoul, Tel: +82-2-3010-3734, Fax: +82-2-477-8928 Submitted: 28 August 2013  / Accepted after revision: 6 September 2013INTRODUCTION  Prostate cancer is the most common cancer in men in the  United States and the fifth most common cancer in men in  Korea [1].",Non-OADS,/arxiv_data1/oa_pdf/c5/a5/pi-1-3-125-6.PMC3814118.pdf
PSA response rate and castration-resistant prostate cancer 126PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13024that has changed with the emergence of various new agents  that access several different mechanistic disease pathways.,Non-OADS,/arxiv_data1/oa_pdf/c5/a5/pi-1-3-125-6.PMC3814118.pdf
3 / September 2013 127PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13024at the 95% level.,OADS,/arxiv_data1/oa_pdf/c5/a5/pi-1-3-125-6.PMC3814118.pdf
PSA response rate and castration-resistant prostate cancer 128PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1302432.1% at third-line chemotherapy (Fig.,Non-OADS,/arxiv_data1/oa_pdf/c5/a5/pi-1-3-125-6.PMC3814118.pdf
"3 / September 2013 129PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13024dian survival than the mitoxantrone group did (median value,  30 months vs. 21 months vs. 19 months, P= 0.003) (Fig.",OADS,/arxiv_data1/oa_pdf/c5/a5/pi-1-3-125-6.PMC3814118.pdf
PSA response rate and castration-resistant prostate cancer 130PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13024increased according to the PSA response rate (not shown).,Non-OADS,/arxiv_data1/oa_pdf/c5/a5/pi-1-3-125-6.PMC3814118.pdf
"3 / September 2013 131PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13024satisfy the inclusion criteria of the new CPRC definition (cas - trate serum levels of testosterone [testosterone < 50 ng/dL],  antiandrogen withdrawal for at least four weeks for flutamide  and for at least six weeks for bicalutamide) were included in  this study because these patients were treated before the con- cept of CRPC was established.",Non-OADS,/arxiv_data1/oa_pdf/c5/a5/pi-1-3-125-6.PMC3814118.pdf
"117Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 •  eISSN: 2287-903X  PROSTATE  INTERNATIONAL Prospective longitudinal comparative study of   health-related quality of life and treatment satisfaction  in patients treated with hormone therapy, radical   retropubic prostatectomy, and high or low dose rate brachytherapy for prostate cancer Sotaro Miwa, Atsushi Mizokami, Hiroyuki Konaka, Satoru Ueno, Yasuhide Kitagawa, Eitetsu Koh, Mikio Namiki Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan Purpose:  To evaluate the effects of four different prostate cancer treatments on quality of life (QoL) and patient satisfaction.",Non-OADS,/arxiv_data1/oa_pdf/14/14/pi-1-3-117-5.PMC3814119.pdf
"Keywords:  Prostate neoplasms, Quality of life, Treatment satisfaction, Prospective longitudinal comparative studyProstate Int 2013;1(3):117-124 •  http://dx.doi.org/10.12954/PI.13021Original Article Corresponding author: Sotaro Miwa Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Sciences, 920-8640 13-1 Takaramachi, Kanazawa,  Ishikawa, Japan  E-mail: sotaro@oregano.ocn.ne.jp, Tel: +81-76-265-2393, Fax: +81-76-222-6726 Submitted: 5 July 2013  / Accepted after revision: 27 August 2013INTRODUCTION Many treatment options are available for prostate cancer (PCa).",Non-OADS,/arxiv_data1/oa_pdf/14/14/pi-1-3-117-5.PMC3814119.pdf
PCa treatments on HRQoL and satisfaction 118PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13021gen (PSA) are present [2].,Non-OADS,/arxiv_data1/oa_pdf/14/14/pi-1-3-117-5.PMC3814119.pdf
"3 / September 2013 119PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13021 After more than one year had elapsed since the commence- ment of treatment, the patients were sent two questions by  mail with regard to treatment satisfaction.",Non-OADS,/arxiv_data1/oa_pdf/14/14/pi-1-3-117-5.PMC3814119.pdf
PCa treatments on HRQoL and satisfaction 120PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13021Fig.,Non-OADS,/arxiv_data1/oa_pdf/14/14/pi-1-3-117-5.PMC3814119.pdf
"3 / September 2013 121PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13021HT and LDR-BT (HT vs. RRP , HT vs. HDR-BT, HT vs. LDR-BT,  P< 0.001).",OADS,/arxiv_data1/oa_pdf/14/14/pi-1-3-117-5.PMC3814119.pdf
"PCa treatments on HRQoL and satisfaction 122PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13021to the questionnaire at 12 months (pre vs. 3 months, pre vs. 6  months, pre vs. 12 months, P < 0.0001).",Non-OADS,/arxiv_data1/oa_pdf/14/14/pi-1-3-117-5.PMC3814119.pdf
"3 / September 2013 123PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13021 In this study, we evaluated patient satisfaction more than  one year after treatment following QoL evaluations for each  treatment.",Non-OADS,/arxiv_data1/oa_pdf/14/14/pi-1-3-117-5.PMC3814119.pdf
PCa treatments on HRQoL and satisfaction 124PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.130213.,Non-OADS,/arxiv_data1/oa_pdf/14/14/pi-1-3-117-5.PMC3814119.pdf
"102Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 •  eISSN: 2287-903X  PROSTATE  INTERNATIONAL Peripheral zone prostate-specific antigen density:   an effective parameter for prostate cancer prediction in  men receiving 5 α-reductase inhibitors Kyo Chul Koo, Dong Hoon Lee, Seung Hwan Lee, Byung Ha Chung Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Purpose:  To evaluate the predictive performance of various parameters derived from volume-adjusted prostate-specific antigen (PSA)  values in detecting prostate cancer (PCa) and high-grade (Gleason score ≥ 7) PCa according to treatment with a 5α-reductase inhibitor  (5ARI).",Non-OADS,/arxiv_data1/oa_pdf/ca/35/pi-1-3-102-2.PMC3814120.pdf
"Keywords:  Density, Prostate cancer, Prostate-specific antigenProstate Int 2013;1(3):102-108 •  http://dx.doi.org/10.12954/PI.13022Original Article Corresponding author: Byung Ha Chung Department of Urology, Urological Science Institute, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul  135-720, Korea  E-mail: chung646@yuhs.ac, Tel: +82-2-2019-3470, Fax: +82-2-3462-8887 Submitted: 14 August 2013  / Accepted after revision: 8 September 2013INTRODUCTION Prostate cancer (PCa) is the most common solid organ malig- nancy and the second most common cause of cancer-related  death among men in industrialized nations [1].",Non-OADS,/arxiv_data1/oa_pdf/ca/35/pi-1-3-102-2.PMC3814120.pdf
3 / September 2013 103PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13022derwent 12-core to 14-core prostate biopsy.,Non-OADS,/arxiv_data1/oa_pdf/ca/35/pi-1-3-102-2.PMC3814120.pdf
Significance of peripheral zone PSAD 104PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13022(22.3%) and in 280 group B patients (32.1%).,Non-OADS,/arxiv_data1/oa_pdf/ca/35/pi-1-3-102-2.PMC3814120.pdf
3 / September 2013 105PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13022pendent parameter (Table 4).,OADS,/arxiv_data1/oa_pdf/ca/35/pi-1-3-102-2.PMC3814120.pdf
"Significance of peripheral zone PSAD 106PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13022i.e., PSAD and PZPSAD, at a set specificity of 40%, were 85%  and 87%, respectively.",OADS,/arxiv_data1/oa_pdf/ca/35/pi-1-3-102-2.PMC3814120.pdf
"3 / September 2013 107PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13022can affect PSA values, such as benign prostatic enlargement,  may confer additional diagnostic value.",Non-OADS,/arxiv_data1/oa_pdf/ca/35/pi-1-3-102-2.PMC3814120.pdf
Significance of peripheral zone PSAD 108PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13022Int 2012;110 Suppl 1:3-7.,OADS,/arxiv_data1/oa_pdf/ca/35/pi-1-3-102-2.PMC3814120.pdf
"133 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 •  eISSN: 2287-903X  PROSTATE  INTERNATIONALMicrobiological etiology of bacterial prostatitis in general  hospital and primary care clinic in Korea Yong Sun Choi, Kang Sup Kim, Sae Woong Choi, Seol Kim, Woong Jin Bae, Hyuk Jin Cho, Sung-Hoo Hong,   Sae Woong Kim, Tae-Kon Hwang, Ji Youl Lee Department of Urology, The Catholic University of Korea College of Medicine, Seoul, Korea Purpose:  The National Institutes of Health classification of prostatitis reported the proportion of chronic bacterial prostatitis, especially  category II, at 3% to 10%.",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/pi-1-3-133-7.PMC3814121.pdf
"Keywords:  Chronic bacterial prostatitis, Etiology, DiagnosisProstate Int 2013;1(3):133-138 •  http://dx.doi.org/10.12954/PI.13023Original Article Corresponding author: Ji Youl Lee Department of Urology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  E-mail: uroljy@catholic.ac.kr, Tel: +82-2-2258-6227, Fax: +82-2-599-7839 Submitted: 17 August 2013  / Accepted after revision: 26 August 2013INTRODUCTION Prostatitis is a disease diagnosed by clinical symptoms and  signs evident in the microscopy of expressed prostatic secre- tion (EPS), and in the culture of EPS and segmented samples,  according to Meares and Stamey [1,2].",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/pi-1-3-133-7.PMC3814121.pdf
"Bacterial prosatitis in Korea134 PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13023disorder, and possibly considerable psychosocial distress [3].",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/pi-1-3-133-7.PMC3814121.pdf
"3 / September 2013135 PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13023Armonk, NY, USA).",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/pi-1-3-133-7.PMC3814121.pdf
"Bacterial prosatitis in Korea136 PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13023talia  (7%), and T. vaginalis (1%) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/pi-1-3-133-7.PMC3814121.pdf
"3 / September 2013137 PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13023like the results of studies in western countries [15,17-19], PCR  showed that the most common pathogen in the PCC was  U. urealyticum.",Non-OADS,/arxiv_data1/oa_pdf/a4/ae/pi-1-3-133-7.PMC3814121.pdf
Bacterial prosatitis in Korea138 PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13023Jacobsen SJ.,Non-OADS,/arxiv_data1/oa_pdf/a4/ae/pi-1-3-133-7.PMC3814121.pdf
"95Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 •  eISSN: 2287-903X  PROSTATE  INTERNATIONAL The role of radical prostatectomy in high-risk prostate  cancer Byung Ha Chung  Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea  Because of the increase in prostate cancer patients, urologists can detect more clinically localized prostate cancer in patients before  the disease has progressed to advanced stages.",Non-OADS,/arxiv_data1/oa_pdf/cc/7c/pi-1-3-95-1.PMC3814122.pdf
"Keywords:  High-risk prostate cancer, Radical prostatectomy, Radiotherapy, Hormone therapyProstate Int 2013;1(3):95-101 •  http://dx.doi.org/10.12954/PI.13018Review Article Corresponding author: Byung Ha Chung Department of Urology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea   E-mail: chung646@yuhs.ac, Tel: +82-2-2019-3470, Fax: +82-2-3462-8887 Submitted: 28 March 2013  / Accepted after revision: 1 April 2013INTRODUCTION Prostate cancer is the most common cancer among men in  Western countries [1-3].",Non-OADS,/arxiv_data1/oa_pdf/cc/7c/pi-1-3-95-1.PMC3814122.pdf
Chung The role of radical prostatectomy for high-risk prostate cancer  96PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13018article is to define high-risk prostate cancer and to review the  various outcomes after RP .,Non-OADS,/arxiv_data1/oa_pdf/cc/7c/pi-1-3-95-1.PMC3814122.pdf
"3 / September 2013 97PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1301810-year CSS was 89.8% and 84.5%, respectively, in 712 men  with high-risk disease with preoperative PSA over 20 ng/mL.",Non-OADS,/arxiv_data1/oa_pdf/cc/7c/pi-1-3-95-1.PMC3814122.pdf
Chung The role of radical prostatectomy for high-risk prostate cancer  98PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13018deprivation therapy (ADT).,Non-OADS,/arxiv_data1/oa_pdf/cc/7c/pi-1-3-95-1.PMC3814122.pdf
3 / September 2013 99PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13018it is impossible to identify the actual position of RT in these  patients.,Non-OADS,/arxiv_data1/oa_pdf/cc/7c/pi-1-3-95-1.PMC3814122.pdf
Chung The role of radical prostatectomy for high-risk prostate cancer  100PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1301818.,Non-OADS,/arxiv_data1/oa_pdf/cc/7c/pi-1-3-95-1.PMC3814122.pdf
3 / September 2013 101PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1301843.,OADS,/arxiv_data1/oa_pdf/cc/7c/pi-1-3-95-1.PMC3814122.pdf
"113 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 •  eISSN: 2287-903X  PROSTATE  INTERNATIONALChlormadinone acetate is effective for hot flush during  androgen deprivation therapy Hidekazu Koike, Yasuyuki Morikawa, Hiroshi Matsui, Yasuhiro Shibata, Kazuto Ito, Kazuhiro Suzuki Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan Purpose:  To investigate the clinical efficacy of low-dose chlormadinone acetate (CMA) in prostate cancer patients who suffer from  hot flushes that is a major side effect of androgen deprivation therapy.",Non-OADS,/arxiv_data1/oa_pdf/64/01/pi-1-3-113-4.PMC3814123.pdf
"Keywords:  Hormonal antineoplastic agents, Chlormadinone acetate, Hot flashes, Prostate neoplasmsProstate Int 2013;1(3):113-116 •  http://dx.doi.org/10.12954/PI.12010Original Article Corresponding author: Hidekazu Koike Department of Urology, Gunma University Graduate School of Medicine, 3-39-22 Showa-Machi, Maebashi 371-8511, Japan  E-mail: hkoike@med.gunma-u.ac.jp, Tel: +81-27-220-8300, Fax: +81-27-220-8318 Submitted: 9 December 2012  / Accepted after revision: 22 May 2013INTRODUCTION Hot flush is a major side effect of androgen deprivation therapy  for prostate cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/64/01/pi-1-3-113-4.PMC3814123.pdf
CMA is effective for hot flush114 PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12010than 3 months (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/64/01/pi-1-3-113-4.PMC3814123.pdf
3 / September 2013115 PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12010mone therapy for at least 3 months prior to the trial entry.,Non-OADS,/arxiv_data1/oa_pdf/64/01/pi-1-3-113-4.PMC3814123.pdf
CMA is effective for hot flush116 PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12010estrogen in the treatment of hot flushes in men with prostate  cancer.,Non-OADS,/arxiv_data1/oa_pdf/64/01/pi-1-3-113-4.PMC3814123.pdf
"109Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 •  eISSN: 2287-903X  PROSTATE  INTERNATIONAL Serum level of follicle-stimulating hormone is associated  with extraprostatic extension of prostate cancer Hisamitsu Ide, Yuichi Terado1, Kentaro Sakamaki2, Masahiro Inoue, Akiko Nakajima, Yan Lu, Schinichi Hisasue3,  Raizo Yamaguchi, Satoru Muto, Shigeo Horie3 Department of Urology, Teikyo University School of Medicine, Tokyo, Japan 1Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan 2Department of Biostatistics and Epidemiology, Yokohama City University School of Medicine, Yokohama, Japan 3Department of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan Purpose:  To determine whether serum follicle-stimulating hormone (FSH) can be used to predict the aggressiveness of prostate  cancer prior to radical prostatectomy.",Non-OADS,/arxiv_data1/oa_pdf/07/91/pi-1-3-109-3.PMC3814124.pdf
"Keywords:  Prostate neoplasms, FSH, FSH receptorsProstate Int 2013;1(3):109-112 •  http://dx.doi.org/10.12954/PI.13019Original Article Corresponding author: Hisamitsu Ide Department of Urology, Teikyo University School of Medicine, 2-11-1, Kaga, 2chome, Itabashi-ku, Tokyo 173-8605, Japan   E-mail: ihisamit@med.teikyo-u.ac.jp, Tel: +81-3-3964-2497, Fax: +81-3-3964-8934 Submitted: 17 May 2013  / Accepted after revision: 5 August 2013INTRODUCTION In patients with prostate cancer, low testosterone level has  been shown to be associated with advanced tumor stage at  presentation, positive surgical margins, high Gleason score,  and worse overall survival [1-5].",Non-OADS,/arxiv_data1/oa_pdf/07/91/pi-1-3-109-3.PMC3814124.pdf
FSH in prostate cancer 110PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13019the presence of seven transmembrane structures coupled to  G-proteins.,OADS,/arxiv_data1/oa_pdf/07/91/pi-1-3-109-3.PMC3814124.pdf
"3 / September 2013 111PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13019addition, we analyzed each factor associated with tumor size.",OADS,/arxiv_data1/oa_pdf/07/91/pi-1-3-109-3.PMC3814124.pdf
"FSH in prostate cancer 112PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.13019 In conclusion, in this study, we demonstrate that measur - ing serum FSH in prostate cancer patients might provide  clinically relevant information about extraprostatic extension  of tumor.",Non-OADS,/arxiv_data1/oa_pdf/07/91/pi-1-3-109-3.PMC3814124.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6f/9d/3420.PMC3814135.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8f/e9/3278.PMC3814136.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c3/d5/3270.PMC3814137.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/75/b5/3267.PMC3814138.pdf
http://www.hhmi.org/educational-materials   /lab-management/for-early-career-scientists (accessed 16 October 2013).,Non-OADS,/arxiv_data1/oa_pdf/75/b5/3267.PMC3814138.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6e/45/3435.PMC3814139.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e5/3f/3297.PMC3814140.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ed/90/3472.PMC3814141.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/55/6e/3281.PMC3814142.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/91/11/3326.PMC3814143.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/05/de/3285.PMC3814144.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c2/6d/3275.PMC3814145.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/21/54/3292.PMC3814146.pdf
SEPA: Science Education Partnership  Award Available at: http://www.ncrrsepa.org/ (accessed 29 July   2013).,Non-OADS,/arxiv_data1/oa_pdf/21/54/3292.PMC3814146.pdf
Available  at: http://nsfnoyce.org/ (accessed 29 July 2013).,Non-OADS,/arxiv_data1/oa_pdf/21/54/3292.PMC3814146.pdf
"The SPARC Innovator Award recognized the authors  of DORA for “working to challenge the status quo in scholarly com - munication for the benefit of researchers, libraries, universities and  the public.” You can add your support to the DORA movement by  signing the declaration here: http://am.ascb.org/dora/index.php   /sign-the-declaration.",Non-OADS,/arxiv_data1/oa_pdf/d1/f8/3263.PMC3814147.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d1/f8/3263.PMC3814147.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/77/f6/3300.PMC3814148.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/bc/aa/3309.PMC3814149.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7b/86/3449.PMC3814150.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/39/a6/3406.PMC3814151.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/bc/57/3337.PMC3814152.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/59/07/3350.PMC3814153.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/26/35/3358.PMC3814154.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6c/b8/3393.PMC3814155.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/62/13/3381.PMC3814156.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/eb/c7/3369.PMC3814157.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/41/9e/3273.PMC3814158.pdf
https://loop.nigms.nih.gov/index   .php/2010/09/27/measuring-the-scientific-output-and-impact-of-nigms   -grants (accessed 27 September 2013).,Non-OADS,/arxiv_data1/oa_pdf/41/9e/3273.PMC3814158.pdf
https://loop.nigms.nih.gov/index.php/2011/06/02/pro - ductivity-metrics-and-peer-review-scores (accessed 27 September 2013).,OADS,/arxiv_data1/oa_pdf/41/9e/3273.PMC3814158.pdf
https://loop.nigms.nih   .gov/index.php/2011/06/10/productivity-metrics-and-peer-review   -scores-continued (accessed 27 September 2013).,OADS,/arxiv_data1/oa_pdf/41/9e/3273.PMC3814158.pdf
http://scientopia.org/blogs   /drugmonkey/2012/02/14/nigms-data-on-the-timeline-from-ba-to-phd   -to-asst-prof-to-r01 (accessed 27 September 2013).,Non-OADS,/arxiv_data1/oa_pdf/41/9e/3273.PMC3814158.pdf
http://publications.nigms.nih.gov   /loop/20050329.html#1 (accessed 27 September 2013).,OADS,/arxiv_data1/oa_pdf/41/9e/3273.PMC3814158.pdf
https://loop.nigms.nih.gov  (accessed 27 September 2013).,OADS,/arxiv_data1/oa_pdf/41/9e/3273.PMC3814158.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ac/cc/3264.PMC3814159.pdf
"Quantitative validation of three replicates was calculated using the delta–delta threshold cycle relative quantiﬁcation method.Table 2 Summary of experimental tags sequenced in reference A. thaliana and B. rapa genomes Plant species Total reads Mapped reads MapQ /C2110 Total genes Unigenes Reads>0 Reads /C2110 A. thaliana 65,690,858 38,955,652 35,266,802 33,602a21,310 17,240 59.30% 53.69% 63.42%d51.31%d A. hallerib101,509,276 33,613,230 25,431,815 – 23,414 19,260 33.11% 25.05% 69.68%d57.32%d B. rapa 74,175,637 62,343,265 54,037,867 41,173c26,852 21,026 84.05% 72.85% 65.22%d51.07%d aTotal gene number from A. thaliana deposited in the database (http://www.arabidopsis.org/).",OADS,/arxiv_data1/oa_pdf/7d/b4/pct133.PMC3814185.pdf
cTotal gene number from B.rapa deposited in the database (http://brassicadb.org/brad/).,OADS,/arxiv_data1/oa_pdf/7d/b4/pct133.PMC3814185.pdf
Based on the Database Arabidopsis Transcription Factors (DATF: http://datf.cbi.pku.,OADS,/arxiv_data1/oa_pdf/7d/b4/pct133.PMC3814185.pdf
"TFs were assigned by the Database Arabidopsis Transcription Factors (DATF: http://datf.cbi.pku.edu.cn/) for the 12,311 common genes.",Non-OADS,/arxiv_data1/oa_pdf/7d/b4/pct133.PMC3814185.pdf
"Sequence reads with a quality of >Q10 were assembled to reference genome sequences (TAIR10 for Arabidopsis; http://www.arabidopsis.org/, 1902 Plant Cell Physiol.",Non-OADS,/arxiv_data1/oa_pdf/7d/b4/pct133.PMC3814185.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/c1/evt128.PMC3814188.pdf
"Lineages 20c4, VC-21Arc6, CCA-47 (divided in two subgroup -1 and -2), ANT06-05, ASC21, F2apm1A36, and MKCST-A3 were derived from the July 2012 version (v.111) of the Silva Database ( http://www.arb-silva.de/ )a n da r e named according to the clone deﬁnition.",OADS,/arxiv_data1/oa_pdf/8a/c1/evt128.PMC3814188.pdf
Supplementary Material Supplementary table S1 and ﬁgure S1 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/8a/c1/evt128.PMC3814188.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/18/evt129.PMC3814189.pdf
Supplementary Material Supplementary tables S1 andS2a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.oxfordjour- nals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/18/evt129.PMC3814189.pdf
Available from:http://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/1d/18/evt129.PMC3814189.pdf
"Accepted: August 29, 2013 Data deposition: The transcriptome is available at http://lifeserv.bgu.ac.il/wb/dmishmar/pages/supplementary-ﬁles.php ).",OADS,/arxiv_data1/oa_pdf/e4/40/evt131.PMC3814190.pdf
"The transcriptome sequences that were generated were deposited in Short Reads Archive (SRA, http://www.ncbi.nlm.nih.gov/sra ) with the accession #SRP018939.",OADS,/arxiv_data1/oa_pdf/e4/40/evt131.PMC3814190.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/40/evt131.PMC3814190.pdf
"Supplementary table S1 ,Supplementary Material online, sum- marizes all the assembled contigs and Blast hits which areavailable online ( http://lifeserv.bgu.ac.il/wb/dmishmar/pages/ supplementary-ﬁles.php , last accessed September 18, 2013).",OADS,/arxiv_data1/oa_pdf/e4/40/evt131.PMC3814190.pdf
"The schematic tree representing all tested species was de- signed following the taxonomy published in NCBI, which isalso consistent with a recently published phylogenetic study (Vidal and Hedges 2009 )(http://www.ncbi.nlm.nih.gov/ genomes/ORGANELLES/taxtree.cgi?db ¼Mito&taxid ¼2759&First Chameleon Transcriptome GBE Genome Biol.",OADS,/arxiv_data1/oa_pdf/e4/40/evt131.PMC3814190.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/71/evt132.PMC3814191.pdf
Supplementary Material Supplementary ﬁgures S1–S8 andtables S1–S6 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/12/71/evt132.PMC3814191.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/4b/evt134.PMC3814192.pdf
"Ion Transporter Reference Sets and Redundancy Reduction Lists of known families of channels (TC 1.A, n¼37), porters (TC 2.A, n¼96), and pumps (TC 3.A, n¼51) were obtained from TCDB ( http://www.tcdb.org , last accessed October 1, 2013), and all ion transporter families ( n¼78) were sorted out by hand.",OADS,/arxiv_data1/oa_pdf/7c/4b/evt134.PMC3814192.pdf
"These domains were identiﬁed withhmmsearch of the HMMer 3.0 package using the proﬁles Ank (PF00023) and cNMP_binding (PF00027) from Pfam(http://pfam.sanger.ac.uk/ , last accessed October 1, 2013).",OADS,/arxiv_data1/oa_pdf/7c/4b/evt134.PMC3814192.pdf
Available from: http://www.stat.berkeley.edu/~bre iman/Using_random_forests_v4.0.,OADS,/arxiv_data1/oa_pdf/7c/4b/evt134.PMC3814192.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/3a/evt135.PMC3814193.pdf
TheEntransia andRoya organellar fractions were sequenced using 454 GS FLX Titanium technology at the Plate-forme d’Analyses Ge ´nomiques of Laval University ( http://pag.ibis.,OADS,/arxiv_data1/oa_pdf/3b/3a/evt135.PMC3814193.pdf
"2001 ) with the options -f (forward) -p (palindromic) -l (minimum length ¼30 bp) -allmax and then masked on the genome sequence using REPEATMASKER (http://www.repeatmasker.org/ , last accessed September 27, 2013) running under the Crossmatch search engine ( http:// www.phrap.org/ , last accessed September 27, 2013).",OADS,/arxiv_data1/oa_pdf/3b/3a/evt135.PMC3814193.pdf
"Phylogenies based on inversion medians were inferred with GRAPPA 2.0 ( http://www.cs.unm.edu/~moret/ GRAPPA/ , last accessed September 27, 2013) using the algo- rithm of Caprara (2003) and a data set of 55 gene/pseudo- gene positions.",OADS,/arxiv_data1/oa_pdf/3b/3a/evt135.PMC3814193.pdf
Supplementary Material Supplementary table S1 andﬁgures S1–S6 are available at Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/3b/3a/evt135.PMC3814193.pdf
Availablefrom: http://mesquiteproject.org .,Non-OADS,/arxiv_data1/oa_pdf/3b/3a/evt135.PMC3814193.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/3e/evt136.PMC3814194.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/ec/evt137.PMC3814195.pdf
Supplementary Material Supplementary ﬁgures S1–S5 andtables S1–S7 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/90/ec/evt137.PMC3814195.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/bb/evt138.PMC3814196.pdf
This in turn mayconfer varying degrees of ﬁtness in different epidemiologicalsettings.Supplementary Material Supplementary ﬁgures S1–S4 andtables S1–S12 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/bc/bb/evt138.PMC3814196.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/9a/evt139.PMC3814197.pdf
Supplementary Material Supplementary ﬁgures S1–S4 andtable S1 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/26/9a/evt139.PMC3814197.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/4b/evt140.PMC3814198.pdf
We used Velvet 1.0.12 ( Zerbino and Birney 2008 ) and Velvet Optimiser ( http://bioinformatics.net.au/software.,OADS,/arxiv_data1/oa_pdf/a4/4b/evt140.PMC3814198.pdf
"Sequencing Depth Estimation in A. syriaca We removed duplicate sequences from the read pool to elim- inate PCR duplicates that could potentially inﬂate the observed sequencing depth using custom python scripts for paired-endreads and the FASTX-toolkit ( http://codex.cshl.org/labmem- bers/gordon/fastx_toolkit/ , last accessed July 24, 2013) for single-end reads.",OADS,/arxiv_data1/oa_pdf/a4/4b/evt140.PMC3814198.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/48/evt141.PMC3814199.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/3a/evt142.PMC3814200.pdf
Supplementary Material Supplementary ﬁgures S1–S5 andtables S1–S3 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/f6/3a/evt142.PMC3814200.pdf
Computations were performed at the Vital-IT Center for high-performance computing of the SIB Swiss Institute of Bioinformatics ( http://www.vital-it.ch ).,OADS,/arxiv_data1/oa_pdf/f6/3a/evt142.PMC3814200.pdf
"Accepted: September 15, 2013 Data deposition : This project has been deposited in dbSNP at: http://www.ncbi.nlm.nih.gov/SNP/snp_viewBatch.cgi?sbid ¼1058878 .",Non-OADS,/arxiv_data1/oa_pdf/39/eb/evt143.PMC3814201.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/eb/evt143.PMC3814201.pdf
"Genes with no match ( e-value <e/C010) against Arabidopsis (TAIR10), rice (MSU6), Amborella (http://www.amborella.org/ , last accessed October 11, 2013) but with a match either against pines (uni- genes were downloaded from the Plant Genome Database and translated with the getorf program; http://www.",Non-OADS,/arxiv_data1/oa_pdf/39/eb/evt143.PMC3814201.pdf
SNPs have been deposited in dbSNP ( http://www.ncbi.nlm.nih.gov/SNP/snp_viewBatch.,OADS,/arxiv_data1/oa_pdf/39/eb/evt143.PMC3814201.pdf
"It encompassed 27,720 sequences represen tative of distinct transcribed genes.2http://bioinformatics.bc.edu/marthlab/wiki/index.",OADS,/arxiv_data1/oa_pdf/39/eb/evt143.PMC3814201.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/84/evt144.PMC3814202.pdf
"SNPs were selected from theOxford/CTC set ( http://www.well.ox.ac.uk/mouse/INBREDS/ , last accessed October 7, 2013) and scored by the JohnHopkins Center of Inherited Disease Research (CIDR;Baltimore, MD), using the Illumina Golden Gate Bead Array(Illumina, San Diego, CA).",OADS,/arxiv_data1/oa_pdf/af/84/evt144.PMC3814202.pdf
"Genomic Analyses of QTL Regions We identiﬁed the genome coordinates of SNPs ﬂanking theQTL intervals and downloaded the sequence (coding regions, introns, 5 0-UTR, 30-UTR, and 10 kb upstream and downstream of the genes) for these genomic intervals from the University of California Santa Cruz Genome Bioinformatics website(http://genome.ucsc.edu/ [last accessed October 7, 2013]; as- sembly mm9).",OADS,/arxiv_data1/oa_pdf/af/84/evt144.PMC3814202.pdf
All analyses of gene ontology enrichment within sets of genes were conducted with Gostat ( http://gostat.wehi.edu.,OADS,/arxiv_data1/oa_pdf/af/84/evt144.PMC3814202.pdf
"nbcr.net/meme/ , last accessed October 7, 2013) and 2) GREAT to examine the genes potentially regulated by the identiﬁedpolymorphic cis-regulatory regions ( http://bejerano.stanford.",Non-OADS,/arxiv_data1/oa_pdf/af/84/evt144.PMC3814202.pdf
Supplementary Material Supplementary tables S1–S3 andﬁgure S1 are available at Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/af/84/evt144.PMC3814202.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/02/evt145.PMC3814203.pdf
Supplementary Material Supplementary ﬁles S1–S3 andﬁgures S1 andS2are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/22/02/evt145.PMC3814203.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/a2/evt146.PMC3814204.pdf
"Materials and Methods MITE Sequence Retrieval, Clustering, and Alignment MITE sequences were used as input for the Member function of MITE Analysis Kit (MAK) ( http://labs.csb.utoronto.ca/yang/ MAK/ , last accessed October 8, 2013) ( Yang and Hall 2003a ; Janicki et al.",OADS,/arxiv_data1/oa_pdf/4b/a2/evt146.PMC3814204.pdf
"Sequences of the rep- resentative members from the largest 10 clusters were aligned using Muscle at EMBL-EBI ( http://www.ebi.ac.uk/ ,l a s t accessed October 8, 2013).",OADS,/arxiv_data1/oa_pdf/4b/a2/evt146.PMC3814204.pdf
"The alignment was shaded with Boxshade 3.21 ( http://www.ch.embnet.org/software/BOX_ form.html , last accessed October 8, 2013).",Non-OADS,/arxiv_data1/oa_pdf/4b/a2/evt146.PMC3814204.pdf
"A phylogenetic tree of the trans- posases rooted with Mos1 was constructed and visualized with Tree Top of GeneBee with 1,000 boot strap iterations (http://www.genebee.msu.su/services/phtree_reduced.html , last accessed October 8, 2013).",OADS,/arxiv_data1/oa_pdf/4b/a2/evt146.PMC3814204.pdf
Helix turn helix domains were predicted with NPS ( http://npsa-pbil.ibcp.,OADS,/arxiv_data1/oa_pdf/4b/a2/evt146.PMC3814204.pdf
"The A. aegypti TEfam database was available at http://tefam.biochem.vt.edu (last accessed October 8, 2013) ( Nene et al.",OADS,/arxiv_data1/oa_pdf/4b/a2/evt146.PMC3814204.pdf
Supplementary Material Supplementary ﬁle andﬁgure S1 are available at Genome Biology and Evolution online ( http://www.gbe.oxfordjour- nals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/a2/evt146.PMC3814204.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/28/evt147.PMC3814205.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/b0/evt148.PMC3814206.pdf
"The mapped reads were counted with htseq-count 0.5.1p1 using the settings union and stranded- ness ( http://www-huber.embl.de/users/anders/HTSeq/doc/ count.html , last accessed October 18, 2013).",OADS,/arxiv_data1/oa_pdf/9b/b0/evt148.PMC3814206.pdf
"Gene models for each species were constructed using Primate ExonOrthology Database version 2 ( http://giladlab.uchicago.edu/ orthoExon/ , last accessed October 18, 2013).",OADS,/arxiv_data1/oa_pdf/9b/b0/evt148.PMC3814206.pdf
"We also removed genes where the original chro- mosome assignment did not match the Ensembl chromosome assignment and where multiple Ensembl gene IDs were assigned to the same HGNC gene name ( http://www.gene- names.org , last accessed October 18, 2013).",Non-OADS,/arxiv_data1/oa_pdf/9b/b0/evt148.PMC3814206.pdf
"When comparing the chimpanzee and human tran- scriptomes, categorical gene enrichments were calculatedwith the PANTHER tools’ gene expression data analysis feature using the compare gene lists function ( http://www.pantherdb.",OADS,/arxiv_data1/oa_pdf/9b/b0/evt148.PMC3814206.pdf
"Available from: http://ecos.fws.gov/speciesProﬁle/ proﬁle/speciesProﬁle.action?spcode ¼A06C .Wall ME, Bernacki SH, Loboa EG.",OADS,/arxiv_data1/oa_pdf/9b/b0/evt148.PMC3814206.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/a8/evt149.PMC3814207.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/06/evt150.PMC3814208.pdf
"This is an Open Access article distributed under the terms of the Creative Co mmons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/98/evt151.PMC3814209.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/81/djs436.PMC3814220.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, andreproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/e8/gft356.PMC3814229.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseSeptember 2013 |  79  | e50873 | Page 1 of 9Video Article An Orthotopic Murine Model of Human Prostate Cancer Metastasis Janet Pavese1, Irene M. Ogden1, Raymond C. Bergan1,2,3 1Department of Medicine, Northwestern University 2Robert H. Lurie Cancer Center, Northwestern University 3Center for Molecular Innovation and Drug Discovery, Northwestern University Correspondence to: Raymond C. Bergan at r-bergan@northwestern.edu URL: http://www.jove.com/video/50873 DOI: doi:10.3791/50873 Keywords: Medicine, Issue 79, Urogenital System, Male Urogenital Diseases, Surgical Procedures, Operative, Life Sciences (General), Prostate Cancer, Metastasis, Mouse Model, Drug Discovery, Molecular Biology Date Published: 9/18/2013 Citation: Pavese, J., Ogden, I.M., Bergan, R.C.",Non-OADS,/arxiv_data1/oa_pdf/47/ce/jove-79-50873.PMC3814297.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50873/ Introduction Prostate cancer (PCa) is the most commonly diagnosed cancer in men, and the second leading cause of cancer death in the United States1.",Non-OADS,/arxiv_data1/oa_pdf/47/ce/jove-79-50873.PMC3814297.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/fa/gkt718.PMC3814349.pdf
S4TE package is freely available to non-commercial users at http://sate.cirad.fr/.,Non-OADS,/arxiv_data1/oa_pdf/12/fa/gkt718.PMC3814349.pdf
"To run properly, Pfam-scan.pl needs several softwares: the Moose module in CPAN(http://search.cpan.org/ /C24ether/Moose-2.0801/lib/Moose.",OADS,/arxiv_data1/oa_pdf/12/fa/gkt718.PMC3814349.pdf
"pm), hmmer3.0rc2 and the BioPerl-1.6.1.tar.gz package.In addition, Pfam-scan.pl needs motif database Pfam- A.hmm (http://pfam.sanger.ac.uk).",OADS,/arxiv_data1/oa_pdf/12/fa/gkt718.PMC3814349.pdf
"Description of the 13 features used in S4TE to screen a bacterial genome Feature numberFeature name Description References 1 De novo motif search RRRSNTTTTY motif in the /C0300 bp (Supplementary Figure S1)This work, http://meme.sdsc.edu/meme/cgi- bin/meme.cgi 2 Homology Sequence identity to a known effector molecule; Blastp against effector database (e-value = 10/C02)(6,8) 3 Euk-like domains Presence of eukaryotic domain: 58 eukaryotic domainsThis work, Supplementary Table S1 4 Prok-like domains 3617 Domain of Unknown Function (DUF) domains (29), http://pfam.sanger.ac.uk/search/ 5 NLS (nuclear localization signal)Monopartite NLS; [KR]-[KR]-[KR]-[KR]-[KR] and bipartite NLS; K-[KR]-X(6,20)-[KR]-[KR]-X-[KR](30,31) 6 MLS (mitochondrial localization signal)Probability of a sequence containing a mitochondrial targeting peptide ( P>0.95)(32), http://www.bioperl.org/ 7 Prenylation domain CaaX at the C-terminal; ‘C’ represents a cysteine residue, ‘a’ denotes an aliphatic amino acid and ‘X’is one of four amino acids(1,33,34) 8 Secondary structure Probability of a coiled-coil structure for windows of 28 residues through a protein sequence ( P>0.95)(35,36), http://emboss.bioinformatics.nl/cgi- bin/emboss/pepcoil Coiled coils 9 C-ter basicity /C203 [HRK] in the C-terminal 25 amino acids (3,7,22) 10 C-ter charges Charge of C-terminal 25 amino acids /C212; C-ter charge = number of [HRK]-number of [ED]-1 (COO-)(3,7,22) 11 C-ter hydrophobicity Hydropathy of C-terminal 25 amino acids; Hydrophobic residue at the /C03rd or /C04thposition(9,11,37,38) 12 Global hydrophilicity Hydropathy of total protein </C0200 (9,11,37) 13 E-block EEXXE in the C-terminal 30 amino acids (39)Nucleic Acids Research, 2013, Vol.",Non-OADS,/arxiv_data1/oa_pdf/12/fa/gkt718.PMC3814349.pdf
"Databases To analyse a given genome, S4TE needs a genome database with four distinct ﬁles: (i) Genome.nucl con- taining the FASTA genome sequence; (ii) Genome.an ,a csv ﬁle (with; as separator) containing the gene ID; theposition of the ﬁrst nucleotide of coding sequence; the position of the last nucleotide; the sense or antisense status; before use in S4TE, this ﬁle needs to be sorted in ascending order from the ﬁrst nucleotide position; (iii)Genome.prot , a fasta ﬁle containing all the protein sequences of the genome; and (iv) Genome.csv , a ﬁle constructed from Genome.prot with nomprot.pl in the folder /C24/S4TE/DataBases/Genome/Tools/ A database of validated effectors derived from the lit- erature was constructed in a protein sequence ﬁle of ef- fectors ( effector_db.txt ) and formatted by makeblastdb -in effector_db.txt -dbtype prot The database assembling the eukaryotic Pfam domains found in T4Es was constructed from the downloadedoriginal wget ftp://ftp.sanger.ac.uk/pub/ databases/Pfam/releases/Pfam26.0/Pfam-A.",OADS,/arxiv_data1/oa_pdf/12/fa/gkt718.PMC3814349.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/cc/gkt782.PMC3814350.pdf
19. http://variantgps.nci.nih.gov/cgfseq/pages/sequenceSubmit.do?meth od=sequence&regionId=1.,OADS,/arxiv_data1/oa_pdf/e4/cc/gkt782.PMC3814350.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/f4/gkt731.PMC3814351.pdf
"Statistical analysis of data For calculation of the statistical signiﬁcance of obtained results, we used the 2-tailed Fisher’s exact test available online at http://www.langsrud.com/stat/ﬁsher.htm.",OADS,/arxiv_data1/oa_pdf/03/f4/gkt731.PMC3814351.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/f0/gkt702.PMC3814352.pdf
Data access The data reported in this study have been deposited in NCBI’s Gene Expression Omnibus (42) and are accessiblethrough GEO Series accession number GSE43418(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE43418).,OADS,/arxiv_data1/oa_pdf/65/f0/gkt702.PMC3814352.pdf
Source of transcript sequences for assessment of UTR and open reading frame lengths and motif ﬁnding TheDrosophila melanogaster (BDGP5) and Homo sapiens (GRCh37.p6) transcript sequences were downloaded fromEnsembl using BioMart (http://www.ensembl.org/biomart/martview/eea40c9db7c1002506d5c766e8772c08)in August 2012.,OADS,/arxiv_data1/oa_pdf/65/f0/gkt702.PMC3814352.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/36/gkt712.PMC3814353.pdf
"Relationship between CSREs and DNase I hypersensitive and EP300 binding sites DNase I hypersensitive sites (DHSs) peaks in eight of the nine studied cell types (except HepG2) and EP300binding peaks for three cell types (H1 ES, GM12 878and HepG2) were obtained from the UCSC browser (http://genome.ucsc.edu).",OADS,/arxiv_data1/oa_pdf/32/36/gkt712.PMC3814353.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/47/gkt717.PMC3814356.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/41/gkt715.PMC3814357.pdf
"The YEASTRACT website was used for TF analyses (http://www.yeastract.com/) (25,26).",OADS,/arxiv_data1/oa_pdf/77/41/gkt715.PMC3814357.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/81/gkt772.PMC3814358.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/d5/gkt705.PMC3814362.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/b0/gkt607.PMC3814365.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/d8/gkt697.PMC3814366.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/a8/gkt783.PMC3814371.pdf
"Images were col- lected with an electron multiplying charge coupled device camera (Andor iXon X3), and the extension ofthe DNA molecules inside the channels was measuredwith imageJ software (http://rsb.info.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/99/a8/gkt783.PMC3814371.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/27/gkt815.PMC3814375.pdf
"We de-veloped E-TALEN (http://www.e-talen.org), a web-b a s e dt o o lt od e s i g nT A L E N sf o re x p e r i m e n t sof varying scale.",Non-OADS,/arxiv_data1/oa_pdf/20/24/gkt789.PMC3814377.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/24/gkt789.PMC3814377.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/5d/gkt708.PMC3814378.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/c6/gkt722.PMC3814382.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/fa/gkt714.PMC3814385.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/4e/gkt703.PMC3814389.pdf
"Strainswere obtained from the Tetrahymena Stock Center at Cornell University; http://tetrahymena.vet.cornell.edu/)The spo11/C1and dmc1/C1knockout lines were described previously (30,31).",Non-OADS,/arxiv_data1/oa_pdf/9a/4e/gkt703.PMC3814389.pdf
; http://rsb.info.nih.gov/ij/) software.,OADS,/arxiv_data1/oa_pdf/9a/4e/gkt703.PMC3814389.pdf
; http://rsb.info.nih.gov/ij/) software.,OADS,/arxiv_data1/oa_pdf/9a/4e/gkt703.PMC3814389.pdf
"Moreover, the comparison of protein domains using the Feature Architecture ComparisonTool [FACT; http://fact.cibiv.univie.ac.at/index.php;(46)] revealed that Tetrahymena TTHERM_00670390p shares with Yen1 and GEN1 a similar arrangement ofXPGN and XPGI regions.",OADS,/arxiv_data1/oa_pdf/9a/4e/gkt703.PMC3814389.pdf
"@ERSpublications Daily azithromycin is ineffective in improving indices of asthma control and airway inflammation in smokers with asthma http://ow.ly/nQjyn Euan J. Cameron1, Rekha Chaudhuri1, Frances Mair2, Charles McSharry1, Nicola Greenlaw3, Christopher J. Weir3, Lisa Jolly1, Iona Donnelly1, Katie Gallacher2, Deborah Morrison2, Mark Spears1, Tom J. Evans1, Kenneth Anderson4 and Neil C. Thomson1 1Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow,2General Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, Glasgow,3Robertson Centre for Biostatistics, University of Glasgow, Glasgow, and4Respiratory Medicine, Crosshouse Hospital, Kilmarnock, UK.",Non-OADS,/arxiv_data1/oa_pdf/b5/2b/erj-42-05-1412.PMC3814414.pdf
Available from: http://www.tropicalparasitology.,Non-OADS,/arxiv_data1/oa_pdf/2f/d8/ABR-2-61.PMC3814542.pdf
Available from: http://www.biomedcentral.,Non-OADS,/arxiv_data1/oa_pdf/2f/d8/ABR-2-61.PMC3814542.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/38/119019Access this article online Quick Response Code: Website: www.clinicalimagingscience.org DOI: 10.4103/2156-7514.119019,Non-OADS,/arxiv_data1/oa_pdf/15/59/JCIS-3-38.PMC3814545.pdf
Available from: http://www.managedcaremag.com/ archives/0404/0404.biotech.html [Last cited on 2011 Feb 04].,OADS,/arxiv_data1/oa_pdf/c3/6f/ABR-2-62.PMC3814574.pdf
Available from: http://mtnviewfarm.net/drugs‑poisons‑1149.html.,Non-OADS,/arxiv_data1/oa_pdf/c3/6f/ABR-2-62.PMC3814574.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/36/119013,Non-OADS,/arxiv_data1/oa_pdf/86/ee/JCIS-3-36.PMC3814575.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/53/f5/srep03115.PMC3814579.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3115 | DOI: 10.1038/srep03115 7",Non-OADS,/arxiv_data1/oa_pdf/53/f5/srep03115.PMC3814579.pdf
"Globally, it is one of the most important staple crops, both in terms of total production (ranked #1 at 1,685 Milliontonnes) and area planted (#13 at 23.8 Million Ha) (2010 data; http://faostat.fao.org).",Non-OADS,/arxiv_data1/oa_pdf/06/94/srep03107.PMC3814580.pdf
"Although 16S rDNA databases such as the arb-silva (http:www.arb- silva.de/), greengenes (http://greengenes.lbl.gov/cgi-bin/nph-index.",OADS,/arxiv_data1/oa_pdf/06/94/srep03107.PMC3814580.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/06/94/srep03107.PMC3814580.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3107 | DOI: 10.1038/srep03107 7",Non-OADS,/arxiv_data1/oa_pdf/06/94/srep03107.PMC3814580.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/44/srep03120.PMC3814586.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3120 | DOI: 10.1038/srep03120 6",Non-OADS,/arxiv_data1/oa_pdf/57/44/srep03120.PMC3814586.pdf
Available  from: http://www.cdc.gov/tb/statistics/reports/2010/default.htm.,OADS,/arxiv_data1/oa_pdf/de/81/JCIS-3-42.PMC3814615.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/42/119149Address for correspondence:   Dr. Saurabh Karmakar,   Department of Pulmonary Medicine,  Sanjay Gandhi Post Graduate Institute  of Medical Sciences, Lucknow,  Uttar Pradesh, India.",Non-OADS,/arxiv_data1/oa_pdf/de/81/JCIS-3-42.PMC3814615.pdf
"It is assumed that a certain pro- portion of men in all male groups visit FSW or have regularfemale partners (see Appendix, Supplemental Digital Con- tent, http://links.lww.com/QAI/A431).",Non-OADS,/arxiv_data1/oa_pdf/cd/70/qai-63-e142.PMC3814627.pdf
"The equations and further details for the model are given in the Appendix (see Supplemental Digital Content, http://links.lww.com/QAI/A431) and are implemented in Microsoft Excel.",OADS,/arxiv_data1/oa_pdf/cd/70/qai-63-e142.PMC3814627.pdf
"Further details of the data sources are available in the Appendix (see Supplemen- tal Digital Content, http://links.lww.com/QAI/A431).",OADS,/arxiv_data1/oa_pdf/cd/70/qai-63-e142.PMC3814627.pdf
"RESULTS Modeling of the Epidemic Theﬁtted values of the HIV prevalence in 2010 were as follows: 46% in PWID, 55% in FSWs who inject drugs, 3.8% in FSWs who do not inject drugs, 27% in MSM who inject drugs, 3.6% in MSM who do not inject drugs, 1.0% in MCF, and 0.35% in LRW (for Figure of best ﬁtt oH I V trend data, see Figure S3, Supplemental Digital Content, http://links.lww.com/QAI/A431).",Non-OADS,/arxiv_data1/oa_pdf/cd/70/qai-63-e142.PMC3814627.pdf
"Uncertainty Analysis Figure S5 (see Supplemental Dig ital Content, http://links.lww.com/QAI/A431) shows the effects ofJ Acquir Immune Deﬁc Syndr /C15Volume 63, Number 5, August 15, 2013 HIV Treatment as Prevention in Vietnam /C2112013 Lippincott Williams & Wilkins www.jaids.com |e145",Non-OADS,/arxiv_data1/oa_pdf/cd/70/qai-63-e142.PMC3814627.pdf
"(see Figure S5, Supplemental Digital Content, http://links.lww.com/QAI/A431).",Non-OADS,/arxiv_data1/oa_pdf/cd/70/qai-63-e142.PMC3814627.pdf
"Since MCF and LRW are large populations, more HIV tests are required to offer HTC periodically (see Figure S6, Supplemental Digital Content, http://links.lww.com/QAI/A431).",Non-OADS,/arxiv_data1/oa_pdf/cd/70/qai-63-e142.PMC3814627.pdf
"Hanoi, Vietnam: National Committee for AIDS, Drugs and prostitution prevention and control; 2012. http://www.unaids.org/en/dataanalysis/knowyourresponse/ countryprogressreports/2012countries/ce_VN_Narrative_Report.pdf (Accessed on 2 March 2013).",Non-OADS,/arxiv_data1/oa_pdf/cd/70/qai-63-e142.PMC3814627.pdf
"Hanoi, Vietnam: World Health Organization; 2010. http://www.who.int/hiv/pub/idu/wpro_vietnam/en/ Accessed on 2 March 2013.",Non-OADS,/arxiv_data1/oa_pdf/cd/70/qai-63-e142.PMC3814627.pdf
Available at: http://www.unodc.org/documents/eastasiaandpaci ﬁc// 2012/03/drug-detention-centre/JC2310_Joint_Statement6March12FINAL_ En.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/70/qai-63-e142.PMC3814627.pdf
"An experienced librarian in systematic review methods assisted us in developing a search strategy (included in Appendix A, http://links.lww.com/QAD/A370).",Non-OADS,/arxiv_data1/oa_pdf/d7/0e/aids-27-2385.PMC3814629.pdf
"In the 20 studies that met review criteria and are reported in Appendix B, http://links.lww.com/QAD/A370, one other potentially useful tool, The Montreal Cognitive Assessment (MoCA) [48], was highlighted.",Non-OADS,/arxiv_data1/oa_pdf/d7/0e/aids-27-2385.PMC3814629.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/37/119015,Non-OADS,/arxiv_data1/oa_pdf/c9/bd/JCIS-3-37.PMC3814632.pdf
Neh1 contains a CNC- /C2112013 Jaramillo and Zhang This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/52/9e/2179.PMC3814639.pdf
[Keywords : Nrf2; Keap1; chemoprevention; chemoresistance; ARE; oxi- dative stress] 3Corresponding author E-mail dzhang@pharmacy.arizona.edu Article is online at http://www.genesdev.,Non-OADS,/arxiv_data1/oa_pdf/52/9e/2179.PMC3814639.pdf
The success of these studies has led to several phase II clinicaltrials to study SF and broccoli sprouts as chemopreventiveagents (http://www.clinicaltrials.gov).,Non-OADS,/arxiv_data1/oa_pdf/52/9e/2179.PMC3814639.pdf
"As a result, BG-12 (Tecfidera) has been approved by the Food and Drug Administraion for the treatment of MS in March 2013 (http://www.fda.gov).",Non-OADS,/arxiv_data1/oa_pdf/52/9e/2179.PMC3814639.pdf
"Further- more, although primary tumors and circulating tumorcells (CTCs) present EMT features, distant metastasesare generally epithelial in morphology, suggesting that, /C2112013 Tsai and Yang This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).",Non-OADS,/arxiv_data1/oa_pdf/22/51/2192.PMC3814640.pdf
[Keywords : epithelial–mesenchymal transition (EMT); mesenchymal– epithelial transition (MET); carcinoma metastasis; extravasation; intra-vasation; invasion; tumor dormancy] 3Corresponding author E-mail jingyang@ucsd.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.225334.113.,Non-OADS,/arxiv_data1/oa_pdf/22/51/2192.PMC3814640.pdf
This intercellular /C2112013 Matis and Axelrod This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/16/5c/2207.PMC3814641.pdf
[Keywords : Fat; intercellular signaling; planar cell polarity] 1Corresponding author E-mail jaxelrod@stanford.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.228098.113.,Non-OADS,/arxiv_data1/oa_pdf/16/5c/2207.PMC3814641.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/f4/c3/2221.PMC3814642.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as desc ribed at http://creativecommons.org/ licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/f4/c3/2221.PMC3814642.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.227413.113.,Non-OADS,/arxiv_data1/oa_pdf/f4/c3/2221.PMC3814642.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/10/cb/2227.PMC3814643.pdf
"After six months, it is available under a Cre ative Commons License (Attribution- NonCommercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/10/cb/2227.PMC3814643.pdf
Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.224923.113.,Non-OADS,/arxiv_data1/oa_pdf/10/cb/2227.PMC3814643.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Un ported), as described at http:// creativecommons.org/licenses/by-nc/3.0/.10Corresponding author E-mail anil2@mail.med.upenn.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.224659.113.",Non-OADS,/arxiv_data1/oa_pdf/db/78/2233.PMC3814644.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/bc/27/2246.PMC3814645.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.1Corresponding author E-mail xbchen@ucdavis.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.221739.113.",Non-OADS,/arxiv_data1/oa_pdf/bc/27/2246.PMC3814645.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cs hlp.org/site/misc/ terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/c7/ef/2259.PMC3814646.pdf
"After six months, it is available under a Cr eative Commons License (Attribution- NonCommercial 3.0 Unporte d), as described at http://creativecommons.org/ licenses/by-nc/3.0/.3Corresponding author E-mail brownej@mail.med.upenn.edu Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.223180.113.",Non-OADS,/arxiv_data1/oa_pdf/c7/ef/2259.PMC3814646.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/4a/95/2274.PMC3814647.pdf
"After six months, it is available under a Creative Commons License (Attribution- NonCommercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.Present addresses:3Lando and Anastasi, LLP, 1 Main Street, Cambridge, MA 02142, USA.4Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda,MD 20892, USA.",Non-OADS,/arxiv_data1/oa_pdf/4a/95/2274.PMC3814647.pdf
5Corresponding author E-mail david_livingston@dfci.harvard.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.225045.113.,Non-OADS,/arxiv_data1/oa_pdf/4a/95/2274.PMC3814647.pdf
"Results miR-545 suppresses endogenous BRCA1 p220 expression To search for miRNAs that regulate BRCA1 expression, we examined a list of miRNAs that were predicted to target the 39UTR of BRCA1 mRNA in silico (TargetScan, release 4.0; http://www.targetscan.org).",OADS,/arxiv_data1/oa_pdf/4a/95/2274.PMC3814647.pdf
Available	from:	http://www.energyfiend.com/ caffeine‑in‑candy.,Non-OADS,/arxiv_data1/oa_pdf/4c/c8/ABR-2-72.PMC3814650.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3113 | DOI: 10.1038/srep03113 7",Non-OADS,/arxiv_data1/oa_pdf/a7/37/srep03113.PMC3814804.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a9/3f/srep03112.PMC3814814.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3112 | DOI: 10.1038/srep03112 6",Non-OADS,/arxiv_data1/oa_pdf/a9/3f/srep03112.PMC3814814.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3d/09/srep03118.PMC3814829.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3118 | DOI: 10.1038/srep03118 5",Non-OADS,/arxiv_data1/oa_pdf/3d/09/srep03118.PMC3814829.pdf
"In Aparri, Philippines(18u199N, 121 u439E), rainfalls from Oct. 3 to Oct. 13, 2009 (10 days before the sampling of Sample N1) were as high as 265 mm (http://www.weatheronline.co.uk).",OADS,/arxiv_data1/oa_pdf/6b/6e/srep03119.PMC3814847.pdf
"For example, in November 2009,there were rainfalls or snowfalls in 19 days in Bellingshausen Station(62u12’ S, 58 u58’ W) and the total precipitation was about 50 mm in the month (http://www.weatheronline.co.uk).",Non-OADS,/arxiv_data1/oa_pdf/6b/6e/srep03119.PMC3814847.pdf
Global fire maps were obtained by using the Moderate Resolution Imaging Spectroradiometer (MODIS) from NASA satellites (http://lance-modis.eosdis.nasa.,OADS,/arxiv_data1/oa_pdf/6b/6e/srep03119.PMC3814847.pdf
The authors acknowledge the NOAA Air Resources Laboratory(ARL) for making the HYSPLIT transport and dispersion model available on the Internet(http://www.arl.noaa.gov/ready.html).,OADS,/arxiv_data1/oa_pdf/6b/6e/srep03119.PMC3814847.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6b/6e/srep03119.PMC3814847.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3119 | DOI: 10.1038/srep03119 7",Non-OADS,/arxiv_data1/oa_pdf/6b/6e/srep03119.PMC3814847.pdf
Available at: http://www.harpnet.org/doc/london_sepsis_mtg09-07.,Non-OADS,/arxiv_data1/oa_pdf/8d/60/inf-32-S03.PMC3814851.pdf
Available from: http://www.uptodate.com/.,Non-OADS,/arxiv_data1/oa_pdf/7b/c5/ABR-2-68.PMC3814855.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/4b/14/1774.PMC3814878.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.1These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/4b/14/1774.PMC3814878.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.155218.113.",Non-OADS,/arxiv_data1/oa_pdf/4b/14/1774.PMC3814878.pdf
"Of special interest are the GM06990 origin libraries, which derive from an EBV-immortalized lymphoblastoid cell line with an essentially normal karyotype (http://www.genome.gov/ 12513455).",Non-OADS,/arxiv_data1/oa_pdf/4b/14/1774.PMC3814878.pdf
Data access Bubble-seq data from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession no.,OADS,/arxiv_data1/oa_pdf/4b/14/1774.PMC3814878.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b2/29/1789.PMC3814879.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.5These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/b2/29/1789.PMC3814879.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.161265.113.",OADS,/arxiv_data1/oa_pdf/b2/29/1789.PMC3814879.pdf
Data access The deep sequencing raw data from this study have been submitted to theEuropean Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena/) under study accession nos.,OADS,/arxiv_data1/oa_pdf/b2/29/1789.PMC3814879.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e6/24/1810.PMC3814881.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.5These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/e6/24/1810.PMC3814881.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.148916.112.",Non-OADS,/arxiv_data1/oa_pdf/e6/24/1810.PMC3814881.pdf
We downloaded the pairwise alignmentfiles between human and other species from the UCSC database(http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/e6/24/1810.PMC3814881.pdf
CDS conservation estimation We downloaded the CDS alignments of 45 vertebrate genomesfrom the UCSC Genome Bioinformatics site (http://hgdownload.cse.ucsc.edu/downloads.html#human).,OADS,/arxiv_data1/oa_pdf/e6/24/1810.PMC3814881.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/0f/25/1817.PMC3814882.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.8Corresponding author E-mail shm45@cam.ac.ukArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/0f/25/1817.PMC3814882.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.159426.113.",Non-OADS,/arxiv_data1/oa_pdf/0f/25/1817.PMC3814882.pdf
2009) and Picard(http://picard.sourceforge.net).,Non-OADS,/arxiv_data1/oa_pdf/0f/25/1817.PMC3814882.pdf
Data access Whole-genome shotgun sequencing paired-end FASTQ files havebeen submitted to the European Nucleotide Archive (ENA; http://www.ebi.ac.uk/ena/) under accession number ERP002440.,OADS,/arxiv_data1/oa_pdf/0f/25/1817.PMC3814882.pdf
"The following files have been deposited in the Data Dryad repository (http://datadryad.org/resource/doi:10.5061/dryad.dk712): allprocessed VCF files, site-based allele frequency data used for the four-population tests and ABBA BABA analyses, all pairwise F ST values for 100-kb windows, maximum-likelihood trees for each100-kb window for the two four-taxon data sets analyzed (Newick format), data files providing the topology supported by each window, a list of scaffolds and scaffold regions designated asZ-linked, and custom Python and R scripts used for data analyses.",OADS,/arxiv_data1/oa_pdf/0f/25/1817.PMC3814882.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/1f/aa/1829.PMC3814883.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.6These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/1f/aa/1829.PMC3814883.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.157008.113.",Non-OADS,/arxiv_data1/oa_pdf/1f/aa/1829.PMC3814883.pdf
"2013 [source code at http://jcb.rupress.org/ content/202/2/201/suppl/DC1, and the executable file at ftp:// intermtt:MTTinterface@ftp.laas.fr/]).",OADS,/arxiv_data1/oa_pdf/1f/aa/1829.PMC3814883.pdf
"This article, published in Genome Research , is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.5Corresponding authors E-mail Nitin.Baliga@systemsbiology.org E-mail leighj@u.washington.edu Article published online before print.",OADS,/arxiv_data1/oa_pdf/ca/e6/1839.PMC3814884.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.153916.112.",Non-OADS,/arxiv_data1/oa_pdf/ca/e6/1839.PMC3814884.pdf
"The interactive exploration of all biclusters to enable similar discoveries is possible online at thefollowing links: Network portal: http://networks.systemsbiology.net/mmp/ cMonkey Output: http://baliga.syst emsbiology.net/cmonkey/enigma/ mmp/cmonkey_4.8.8_mmp_1661x58_11_Oct_11_16:14:07/Regulation of methanogenesis is distributed across five subnetworks each linked to a different set of biologicalprocesses To find out which biological processes were associated with methanogenesis, we identified biclusters that share three or more genes with the methanogenesis-associated biclusters (Fig.",OADS,/arxiv_data1/oa_pdf/ca/e6/1839.PMC3814884.pdf
"2006) (http://www.SBEAMS.org/microarray), where resultant data was median normalized and subjected to significance of microarray (SAM) and variability and error estimates (VERA) analysis.",OADS,/arxiv_data1/oa_pdf/ca/e6/1839.PMC3814884.pdf
"Data access The microarray data have been deposited in the NCBI Gene Ex- pression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) underaccession numbers GSE42115, GSE42126, GSE42130, GSE42143, GSE42159, GSE42162, GSE42164–GSE42167.",OADS,/arxiv_data1/oa_pdf/ca/e6/1839.PMC3814884.pdf
"The work conducted by ENIGMA-Ecosystems and Networks Integrated with Genes andMolecular Assemblies (http://enigma.lbl.gov), a Scientific FocusArea Program at Lawrence Berkeley National Laboratory, was sup- ported by the Office of Science, Office of Biological and Environ- mental Research, of the U.S. Department of Energy under ContractNo.",OADS,/arxiv_data1/oa_pdf/ca/e6/1839.PMC3814884.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a2/c2/1852.PMC3814885.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.3Corresponding author E-mail fgarrettvieira@gmail.comArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/a2/c2/1852.PMC3814885.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.157388.113.",OADS,/arxiv_data1/oa_pdf/a2/c2/1852.PMC3814885.pdf
"Both are availableat http://cteg.berkeley.edu/ ;nielsen/resources/software/ or, in the case of ngsF, also at https://github.com/fgvieira/ngsF.",OADS,/arxiv_data1/oa_pdf/a2/c2/1852.PMC3814885.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/78/39/1862.PMC3814886.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.9These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/78/39/1862.PMC3814886.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.155697.113.",Non-OADS,/arxiv_data1/oa_pdf/78/39/1862.PMC3814886.pdf
Our approach is freely available in a user-friendly website that allows researchers to easily explore any cell-lineage or tissue of interest (http://nano.princeton.,Non-OADS,/arxiv_data1/oa_pdf/78/39/1862.PMC3814886.pdf
We used high-throughput IHC stainings from the Human Protein Atlas (HPA) (http://www.proteinatlas.org) to systematically validate the podocyte- specific expression of genes identified by nanodissection.,OADS,/arxiv_data1/oa_pdf/78/39/1862.PMC3814886.pdf
"Nanodissection can be performed on user- curated, tissue-specific gene expression compendia via the user- friendly nanodissection web server at http://nano.princeton.edu.",OADS,/arxiv_data1/oa_pdf/78/39/1862.PMC3814886.pdf
"Gene expression data extraction from the GUDMAP and data processing The genome-wide expression data of murine podocytes, mesangial, and endothelial cells were obtained from http://www.gudmap.",OADS,/arxiv_data1/oa_pdf/78/39/1862.PMC3814886.pdf
Data access Normalized gene expression data files of microdissected humankidney biopsies have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/; Edgar et al.2002) under accession number GSE47185.,OADS,/arxiv_data1/oa_pdf/78/39/1862.PMC3814886.pdf
"This article, published in Genome Research ,i s available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.5Corresponding author E-mail pk5@sanger.ac.uk Article published online before print.",Non-OADS,/arxiv_data1/oa_pdf/8b/07/1874.PMC3814887.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.154815.113.",Non-OADS,/arxiv_data1/oa_pdf/8b/07/1874.PMC3814887.pdf
Raw 454 or MiSeq reads were fil- tered for base quality (median >32) using the QUASR program (http://sourceforge.net/projects/ quasr/) (Watson et al.,OADS,/arxiv_data1/oa_pdf/8b/07/1874.PMC3814887.pdf
The network analyses were per- formed using igraph implemented in R (http://igraph.sourceforge.net/index.html).,OADS,/arxiv_data1/oa_pdf/8b/07/1874.PMC3814887.pdf
A phylogenetic tree was fittedusing the unrooted parsimony methods implemented in R (http://cran.r-project.org/web/packages/phangorn/).,OADS,/arxiv_data1/oa_pdf/8b/07/1874.PMC3814887.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/23/e4/1885.PMC3814888.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.8Corresponding author E-mail sorin@wayne.eduArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/23/e4/1885.PMC3814888.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.153551.112.",OADS,/arxiv_data1/oa_pdf/23/e4/1885.PMC3814888.pdf
The experimental verification is labor intensive when applied to hundreds of scaffolds but is /C2112013 Carvalho and Clark This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/00/67/1894.PMC3814889.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/ licenses/by-nc/3.0/.4Corresponding author E-mail bernardo@biologia.ufrj.brArticle published online before print.",Non-OADS,/arxiv_data1/oa_pdf/00/67/1894.PMC3814889.pdf
"Article, supplemental material, and publi- cation date are at http://www.gen ome.org/cgi/doi/10.1101/gr.156034.113.",Non-OADS,/arxiv_data1/oa_pdf/00/67/1894.PMC3814889.pdf
; http://search.cpan.org/ dist/Bit-Vector/) and runs in a single processor.,OADS,/arxiv_data1/oa_pdf/00/67/1894.PMC3814889.pdf
"Comparison of the D. virilis assemblies We used two assemblies, CAF1.2 (available at ftp://ftp.flybase.net/ genomes/Drosophila_virilis/dvir_ r1.2_FB2012_01/fasta/dvir-all- chromosome-r1.2.fasta.gz) and CA (http://goo.gl/qLrG0).",OADS,/arxiv_data1/oa_pdf/00/67/1894.PMC3814889.pdf
Data access The new nucleotide sequences reported in this manuscript havebeen submitted to GenBank (http://www.ncbi.nlm.nih.gov/ genbank/) as Third Party Annotation sequences under the ac-cession numbers TPA: BK008736–BK008744.,Non-OADS,/arxiv_data1/oa_pdf/00/67/1894.PMC3814889.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/97/42/1908.PMC3814890.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.1These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/97/42/1908.PMC3814890.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.157891.113.",Non-OADS,/arxiv_data1/oa_pdf/97/42/1908.PMC3814890.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d5/a1/1916.PMC3814891.pdf
"After six months, it is available under a Creative Commons License (Attribution-NonCommercial3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/ 3.0/.6Present address: Agriculture Research Station Agroscope, Research Group Molecular Diagnostics, Genomics & Bioinformatics, Schloss 1, CH8802 Wa ¨denswil, Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/d5/a1/1916.PMC3814891.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.151035.112.",Non-OADS,/arxiv_data1/oa_pdf/d5/a1/1916.PMC3814891.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ed/44/1928.PMC3814892.pdf
"After six months, it is availableunder a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.5A complete list of consortium authors appears at the end of this manuscript.",Non-OADS,/arxiv_data1/oa_pdf/ed/44/1928.PMC3814892.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.157420.113.",Non-OADS,/arxiv_data1/oa_pdf/ed/44/1928.PMC3814892.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/69/bb/1938.PMC3814893.pdf
"After six months, itis available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.12These authors contributed equally to this paper.",Non-OADS,/arxiv_data1/oa_pdf/69/bb/1938.PMC3814893.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.153692.112.",OADS,/arxiv_data1/oa_pdf/69/bb/1938.PMC3814893.pdf
Data access Raw sequencing data have been deposited in the NCBI Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.gov/sra) under ac-cession number SRA055273.,OADS,/arxiv_data1/oa_pdf/69/bb/1938.PMC3814893.pdf
genereg.net/downloads/danRer 7/ and http://zeprome.genereg.,Non-OADS,/arxiv_data1/oa_pdf/69/bb/1938.PMC3814893.pdf
All tracks can be visualized in the form ofannotated custom tracks in the UCSC Genome Browser using the following URLs: http://zeprome.genereg.net/downloads/danRer7/ Zebrafish_tracks.txt and http://zeprome.genereg.net/downloads/tetNig2/Tetraodon_tracks.txt.,OADS,/arxiv_data1/oa_pdf/69/bb/1938.PMC3814893.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genome.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/12/a1/1951.PMC3814894.pdf
"After six months, it is avail-able under a Creative Commons License (Attribution-NonCommercial 3.0 Unported), as described at http://creativecommons.org/licenses/by-nc/3.0/.Present addresses:12125 East Mall, Vancouver, BC, Canada, V6T 1Z4; 2STEMCELL Technologies Inc., Vancouver, BC, Canada, V5Z 1B3; 3Norwegian University of Life Sciences, 1432 A ˚s, Norway.",Non-OADS,/arxiv_data1/oa_pdf/12/a1/1951.PMC3814894.pdf
The data for all quantifiable proteins can be browsed and searched in an interactive graphical format (http://www.chibi.ubc.ca/faculty/leonard-foster/ foster-lab/data/ under Bee Protein Atlas).Caste-specific differences in honey bee organs T h eq u a n t i t a t i v ea s p e c t so ft h ed a t as e tp r e s e n t e dh e r ec o v e rt w odimensions of bee biology: (1) across dissectible bee organs and (2) across castes.,OADS,/arxiv_data1/oa_pdf/12/a1/1951.PMC3814894.pdf
"In this article we have merely selected a few highlights to discuss, but the vast wealth of data pertaining to other aspects of bee proteins function are available online in a searchable format that includes illustrated caste and organ comparisons for all quantifiable proteins (http://www.chibi.ubc.ca/faculty/ leonard-foster/foster-lab/data/ under Bee Protein Atlas).",Non-OADS,/arxiv_data1/oa_pdf/12/a1/1951.PMC3814894.pdf
The spectra arepublicly available at PeptideAtlas (http://www.peptideatlas.org/ builds/honeybee/).,OADS,/arxiv_data1/oa_pdf/12/a1/1951.PMC3814894.pdf
Interpreted data for all quantifiable proteins c a nb eb r o w s e da n ds e a r c h e di na ni n t e r a c t i v eg r a p h i c a lf o r m a t(http://www.chibi.ubc.ca/faculty/leonard-foster/foster-lab/data/under Bee Protein Atlas).,OADS,/arxiv_data1/oa_pdf/12/a1/1951.PMC3814894.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/7f/tcrm-9-417.PMC3814896.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 417–425Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  417ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S4963 4analysis of the metabolic properties   of maintenance hemodialysis patients   with glucose-added dialysis based on high   performance liquid chromatography   quadrupole time-of-flight mass spectrometry li Cui1 Yu Meng2 Dan Xu2 Yanyan Feng2 gangyi Chen3 Bo hu2 guijuan Feng4 lianghong Yin2 1Xi’xiang People’s hospital affiliated  to guangdong Medical College,   shenzhen, People’s Republic of China;   2nephrology Department of the First  hospital affiliated to Ji’nan University,   guangzhou, People’s Republic of  China; 3First hospital of guangzhou  University of Chinese Medicine,   4assisted Reproductive Centre of  the First hospital affiliated to Ji’nan  University, guangzhou, People’s  Republic of China Correspondence: Yu Meng   nephrology Department, First hospital  Affiliated to Ji’nan University, Guangzhou  510000, People’s Republic of China   email yumeng_dialysis@163.co m;  elajob@126.co mAbstract:  The purpose of this study was to compare the metabolic properties of  maintenance  hemodialysis patients treated with glucose-containing and glucose-free dialysate using   metabonomics.",Non-OADS,/arxiv_data1/oa_pdf/e5/7f/tcrm-9-417.PMC3814896.pdf
The METLIN database was used in this  study ( http://metlin.scripps.edu /metabo_search_alt2.php ).,OADS,/arxiv_data1/oa_pdf/e5/7f/tcrm-9-417.PMC3814896.pdf
"By searching in published literature and the METLIN  Metabolite Database ( http://metlin.scripps.edu /), the possible  metabolite name and its molecular formula were preliminarily  identified ( Table  2).",OADS,/arxiv_data1/oa_pdf/e5/7f/tcrm-9-417.PMC3814896.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/e5/7f/tcrm-9-417.PMC3814896.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/7f/tcrm-9-417.PMC3814896.pdf
"Although the highest rates of EC are seen in Europe and North America, reports from many other countries have shown anincreased incidence of EC http://ganjoho.jp/public/statistics/ backnumber/2011_en.html.",Non-OADS,/arxiv_data1/oa_pdf/5f/73/hyt125.PMC3814898.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/73/hyt125.PMC3814898.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/f5/hyt127.PMC3814899.pdf
"Cancer Statistics in Japan .http://ganjoho.jp/data/professional/statistics/backnumber/2011/ cancer_statistics_2011.pdf (27 April 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e5/f5/hyt127.PMC3814899.pdf
"2013. http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf (26 November 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e5/f5/hyt127.PMC3814899.pdf
"2013. http://www.nccn.org/professiona ls/physician_gls/pdf/rectal.pdf (26 November 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e5/f5/hyt127.PMC3814899.pdf
"National Cancer Institute Common Terminology Criteria for Adverse Events NCI-CTC Version 3.0. http://ctep.cancer.gov/protocolDevelopment/ electronic_application s/docs/ctcaev3.pdf (31 March 2003, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e5/f5/hyt127.PMC3814899.pdf
This is a strategic area for the Italian economy and a site of intensive petroleum extraction2and gas storage (http://unmig.sviluppoeconomico.gov.it/unmig/pozzi/completo.asp).,Non-OADS,/arxiv_data1/oa_pdf/b8/03/srep03114.PMC3814900.pdf
rm.ingv.it) and Rete Accelerometrica Nazionale (http://www.protezionecivile.gov.it/jcms/it/ran.wp).,Non-OADS,/arxiv_data1/oa_pdf/b8/03/srep03114.PMC3814900.pdf
"Geographic location of the 2012 Emilia seismic sequence (Italian Seismological Instrumental and parametric Data-basE, http://iside.rm.ingv.it).",OADS,/arxiv_data1/oa_pdf/b8/03/srep03114.PMC3814900.pdf
The figure was generated by using the Generic Mapping Tools (http://gmt.soest.hawaii.edu/)35.,OADS,/arxiv_data1/oa_pdf/b8/03/srep03114.PMC3814900.pdf
"The topography is based on the ETOPO1 1 Arc-Minute Global Relief Model, http://www.ngdc.noaa.gov/mgg/global/global.html36.",Non-OADS,/arxiv_data1/oa_pdf/b8/03/srep03114.PMC3814900.pdf
"For the events marked by an asterisk, locations are taken from the INGV catalog (http://iside.rm.ingv.it) and focal mechanisms are an average of the all 22 known foc al mechanisms3.",OADS,/arxiv_data1/oa_pdf/b8/03/srep03114.PMC3814900.pdf
The figure was generated by using the Generic Mapping Tools (http://gmt.soest.hawaii.edu/)35.www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3114 | DOI: 10.1038/srep03114 3,OADS,/arxiv_data1/oa_pdf/b8/03/srep03114.PMC3814900.pdf
All the Figures are generated by using the Generic Mapping Tools (http://gmt.soest.,OADS,/arxiv_data1/oa_pdf/b8/03/srep03114.PMC3814900.pdf
"The topography in Figure 1 is based on the ETOPO1 1 Arc-Minute Global Relief Model, http://www.ngdc.noaa.gov/mgg/global/global.html36.",Non-OADS,/arxiv_data1/oa_pdf/b8/03/srep03114.PMC3814900.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b8/03/srep03114.PMC3814900.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3114 | DOI: 10.1038/srep03114 7",Non-OADS,/arxiv_data1/oa_pdf/b8/03/srep03114.PMC3814900.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/39/119021 Received : 05‑08‑2013 Accepted : 03‑09‑2013 Published : 27‑09‑2013 Access this article online Quick Response Code: Website: www.clinicalimagingscience.org DOI: 10.4103/2156-7514.119021,Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JCIS-3-39.PMC3814902.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/40/119134,Non-OADS,/arxiv_data1/oa_pdf/d3/69/JCIS-3-40.PMC3814904.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/41/119139,Non-OADS,/arxiv_data1/oa_pdf/0b/b2/JCIS-3-41.PMC3814905.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Anatomical configuration of the Sylvian fissure and its influence  on outcome after pterional approach for microsurgical aneurysm  clipping Hannah M. Ngando*, Homajoun Maslehaty*, Lutz Schreiber, Klaus Blaeser, Martin Scholz,  Athanasios K. Petridis Department of Neurosurgery, Klinikum Duisburg, Academic T eaching Hospital of University Essen‑Duisburg, Germany E‑mails: Hannah M. Ngando ‑ Hannah.ngando@Sana.de; Homajoun Maslehaty ‑ h.maslehaty@gmx.de; Lutz Schreiber ‑ lutz.schreiber@sana.de;  Klaus Blaeser ‑ klaus.blaeser@sana.de; Martin Scholz ‑ martin.scholz@sana.de, *Athanasios K. Petridis ‑ opticdisc@aol.com *Corresponding author Received: 17 April 13   Accepted: 06 August 13  Published: 30 September 13 Abstract Background:  The sylvian fissure (SF) is the anatomical pathway used in a pterional  approach, which leads to most aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/d7/01/SNI-4-129.PMC3814910.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/129/119073 Copyright: © 2013 Ngando HM.,Non-OADS,/arxiv_data1/oa_pdf/d7/01/SNI-4-129.PMC3814910.pdf
"Surgical Neurology International 2013, 4:129  http://www.surgicalneurologyint.com/content/4/1/129INTRODUCTION The pterional approach to aneurysms of the circle of  Willis is one of the most common approaches in vascular  neurosurgery.",Non-OADS,/arxiv_data1/oa_pdf/d7/01/SNI-4-129.PMC3814910.pdf
"Surgical Neurology International 2013, 4:129  http://www.surgicalneurologyint.com/content/4/1/12916 hours after surgery in retraction related and remote  ischemic lesions.",Non-OADS,/arxiv_data1/oa_pdf/d7/01/SNI-4-129.PMC3814910.pdf
"Surgical Neurology International 2013, 4:129  http://www.surgicalneurologyint.com/content/4/1/129formation was statistically significant higher in group III  there was no statistical difference in the occurrence of  ischemic lesions between the four defined groups.",Non-OADS,/arxiv_data1/oa_pdf/d7/01/SNI-4-129.PMC3814910.pdf
"Surgical Neurology International 2013, 4:129  http://www.surgicalneurologyint.com/content/4/1/129Table 2: Characteristics of brain infarcts in SAH HH 1  and 2 patients Sylvian  Fissure categoryEdema  gradeAneurysm  localisationShape (size)Infarcted  arteryAge GOS I 0 MCA (L) Berry (<1 cm)MCA  perf (L)52 5 I 0 AcomA (R) Berry (<1cm)ACA( R) 71 3 (edema  pre‑surgically) I 2 MCA ( R) Berry (<1cm)MCA ( R) 52 4 I 0 MCA ( R) Berry (<1 cm)MCA perf ( R)73 4 II 2 MCA ( R) Berry (<1cm)MCA ( R) 60 5 II 2 MCA (R) Berry (<1cm)MCA ( L) 55 3 III 0 ICA (R) Berry (<1cm)MCA ( R) 79 1 III 2 MCA (L) Berry (<1cm)ACA, MCA   (R) and (L)52 1 MCA: Medial cerebral artery, ACA: Anterior cerebral artery, ICA: Internal cerebral  artery, AcomA: Anterior communicating artery, PcomA: Posterior communicating  artery, (R): Right, (L): Left, Perf.",Non-OADS,/arxiv_data1/oa_pdf/d7/01/SNI-4-129.PMC3814910.pdf
"Surgical Neurology International 2013, 4:129  http://www.surgicalneurologyint.com/content/4/1/129the age group 50 to <60 years (40/98) ( P < 0.001,  Suppl.",Non-OADS,/arxiv_data1/oa_pdf/d7/01/SNI-4-129.PMC3814910.pdf
"Surgical Neurology International 2013, 4:129  http://www.surgicalneurologyint.com/content/4/1/129bleeding, the remaining patients (67/98) had Fisher 1 and  2 bleeding.",Non-OADS,/arxiv_data1/oa_pdf/d7/01/SNI-4-129.PMC3814910.pdf
"Surgical Neurology International 2013, 4:129  http://www.surgicalneurologyint.com/content/4/1/129CONCLUSION The classification of the SF as proposed by Yasargil  is more than a pure anatomical observation.",Non-OADS,/arxiv_data1/oa_pdf/d7/01/SNI-4-129.PMC3814910.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/87/ndt-9-1655.PMC3814926.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1655–1659Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1655OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5231 7combination treatment with risperidone long- acting injection and psychoeducational approaches  for preventing relapse in schizophrenia Yueren Zhao1–3 Taro Kishi1 Nakao iwata1 Manabu ikeda3,4 1Department of Psychiatry, Fujita  health University school of  Medicine, T oyoake, aichi, Japan;   2Department of Psychiatry,   Okehazama hospital Fujita Kokoro  care center, T oyoake, aichi, Japan;   3Department of Neuropsychiatry,   graduate school of Medical sciences,   Kumamoto University, Kumamoto,   Kumamoto, Japan; 4Department of  Neuropsychiatry, Faculty of life  sciences, Kumamoto University,   Kumamoto, Kumamoto, Japan correspondence: Yueren Zhao   Department of Psychiatry, Fujita health  University school of Medicine, Toyoake,  aichi 470-1192, Japan   Tel +81 562 93 9250   Fax +81 562 93 1831   email zhao@fastmail.j pAbstract:  A recent meta-analysis showed that long-acting injec table (LAI) antipsychotics were  not superior to oral antipsychotics for preventing relapse in patients with  schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/52/87/ndt-9-1655.PMC3814926.pdf
"Overview of original   psychoeducational text Psychoeducation was implemented in all study subjects  using the original psychoeducational text, COMPASS (Japa - nese Original Version: http://bit.ly/COMPASS_J P; English   Version: http://bit.ly/COMPASS_E N), beginning at the time  risperidone LAI treatment was initiated.",Non-OADS,/arxiv_data1/oa_pdf/52/87/ndt-9-1655.PMC3814926.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/52/87/ndt-9-1655.PMC3814926.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/87/ndt-9-1655.PMC3814926.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/da/ijwh-5-689.PMC3814927.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 689–694International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  689ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5078 6Abnormal uterine bleeding as a presenting  symptom is related to multiple uterine  leiomyoma: an ultrasound-based study José Alberto Fonseca- Moutinho1,2 Lígia Silva Barbosa1 Daniel Gonçalves T orres1 Sara Morgado Nunes3 1Faculty of Health Sciences, School of  Medicine, Beira Interior University,  Covilhã, Portugal; 2Child and Women  Department, Cova da Beira Academic  Medical Center, Covilhã, Portugal;  3Polytechnic Institute of Castelo  Branco, Castelo Branco, Portugal Correspondence: José Alberto   Fonseca-Moutinho   Avenida Infante D Henrique   6200-506 Covilhã, Portugal   Tel +351 917 295 400   Fax +351 249 718 430   Email jafmoutinho@fcsaude.ubi.p tPurpose:  To determine the prevalence of uterine leiomyomas, diagnosed by ultrasound, in a  private health care setting located in the central eastern region of Portugal, and to explore the  demographic and clinical factors related to diagnosis and symptomatology.",Non-OADS,/arxiv_data1/oa_pdf/ad/da/ijwh-5-689.PMC3814927.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ad/da/ijwh-5-689.PMC3814927.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/da/ijwh-5-689.PMC3814927.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/21/ijwh-5-729.PMC3814928.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 729–735International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  729OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5220 6Maternal and neonatal risk factors   for early-onset group B streptococcal   disease: a case control study Hanan M al-Kadri1 samira s Bamuhair2 sameera M al Johani3 namsha a al-Buriki1 Hani M Tamim4 1Department of Obstetrics and  gynecology, 2Department of Basic  Medical sciences, 3Microbiology  Division, 4Department of Medical  education, college of Medicine,   King saud Bin abdulaziz University  for Health sciences, King abdulaziz  Medical city, riyadh, Kingdom   of saudi arabia correspondence: Hanan M al-Kadri   King saud Bin abdulaziz University for  Health sciences, college of Medicine,  King abdulaziz Medical city,   PO Box 57374, riyadh 11574,   riyadh, Kingdom of saudi arabia   Tel +966 1252 0088 ext 13611   Fax +966 1252 0088 ext 13128   email halkadri@gmail.co mObjectives:  To identify the prominent maternal and neonatal risk factors associated with  early-onset group B streptococcus (EOGBS) disease in neonates and to determine their impor - tance by comparing them with a control group.",Non-OADS,/arxiv_data1/oa_pdf/ae/21/ijwh-5-729.PMC3814928.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ae/21/ijwh-5-729.PMC3814928.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/21/ijwh-5-729.PMC3814928.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/94/ndt-9-1647.PMC3814929.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1647–1654Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1647OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5168 2cognitive functioning correlates of self-esteem  and health locus of control in schizophrenia chien-shu Wang1 Jo Yung-Wei Wu2 Wei-chung chang3 shu-Ping chuang1 1Department of Psychiatry, Zuoying  Branch of Kaohsiung armed Forces  general hospital, Kaohsiung, Taiwan;   2institute of allied health sciences,   college of Medicine, National cheng  Kung University, Tainan, Taiwan;    3hsin-Jia Psychotherapy clinic, Taitung  county, Taiwan correspondence: shu-Ping chuang   Department of Psychiatry, Zuoying  Branch of Kaohsiung armed   Forces general hospital, No 553,   Jiunshiau rd, Zuoying District,   Kaohsiung 81342, Taiwan   Tel +886 7 587 5938   Fax +886 7 581 8816   email xota51@ngh.c om.twAim:  The study aimed to investigate the relationship among sociodemographic factors,   neurocognitive factors, self-esteem, and health locus of control in patients diagnosed with  schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/e6/94/ndt-9-1647.PMC3814929.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e6/94/ndt-9-1647.PMC3814929.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/94/ndt-9-1647.PMC3814929.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0b/23/ott-6-1527.PMC3814930.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1527–1532OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1527Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5145 2Comparative research on the efficacy of  cyberKnife® and surgical excision for stage i  hepatocellular carcinoma Zhiyong Yuan* lijun Tian* Ping Wang Y ongchun song Yang Dong hongqing Zhuang Department of radiotherapy, Tianjin  Medical University cancer institute  and hospital, national clinical  research center of cancer, Key  laboratory of cancer Prevention and  Therapy, Tianjin, People’s republic   of china *These authors contributed equally to  this work correspondence: Zhiyong Yuan;  hongqing Zhuang   Department of radiotherapy, Tianjin  Medical University cancer institute  and hospital, Tianjin, People’s republic  of china   Tel +86 222 334 1405   Fax +86 222 334 1405   email zhiyong 0524@163.co m;  hongqingzh@163.co mObjective:  To retrospectively analyze and compare the outcomes of patients with  hepatocellular  carcinoma treated with either surgical excision or CyberKnife® from September 2006 to August  2011.",Non-OADS,/arxiv_data1/oa_pdf/0b/23/ott-6-1527.PMC3814930.pdf
Available from: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0b/23/ott-6-1527.PMC3814930.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0b/23/ott-6-1527.PMC3814930.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0b/23/ott-6-1527.PMC3814930.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/11/79/ijwh-5-717.PMC3814931.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 717–728International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  717OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S4978 5comparison of high- versus low-intensity  community health worker intervention   to promote newborn and child health   in northern nigeria sally e Findley1 Omolara T Uwemedimo2 Henry V Doctor1,3 cathy green4 Fatima adamu5 godwin Y afenyadu6 1Department of Population and  Family Health, Mailman school of  Public Health, columbia University,   new Y ork, nY, Usa; 2Pediatric global  Health Program, cohen children’s  Medical centre of new York, Division  of general Pediatrics, new Hyde  Park, nY, Usa; 3Operations research  Unit, Programme for reviving routine  Immunization in northern nigeria- Maternal newborn and child Health  (PrrInn -MncH), abia state House,   abuja, nigeria; 4Health Partners  International, Waterside centre,   lewes, east sussex, United Kingdom;   5social Development and community  engagement Unit, 6Operations  research Unit, P rrInn-MncH  Programme, nassarawa gra , Kano  state, n igeria correspondence: Henry V Doctor   Department of Population and Family  Health, Mailman school of Public Health,  columbia University, 60 Haven avenue,  new York, nY 10032, Usa   email hvd2105@colu mbia.ed uBackground:  In Northern Nigeria, infant mortality rates are two to three times higher than  in the southern states, and, in 2008, a partnership program to improve maternal, newborn, and  child health was established to reduce infant and child mortality in three Northern Nigeria states.",Non-OADS,/arxiv_data1/oa_pdf/11/79/ijwh-5-717.PMC3814931.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/11/79/ijwh-5-717.PMC3814931.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/79/ijwh-5-717.PMC3814931.pdf
"Available from: http://www.unicef.org/publications/files/ SOWC_Spec._Ed._CRC_Main_Report_EN_090409.pd f. Accessed  September 13, 2013.",Non-OADS,/arxiv_data1/oa_pdf/11/79/ijwh-5-717.PMC3814931.pdf
Available from: http://www.population.gov.,OADS,/arxiv_data1/oa_pdf/11/79/ijwh-5-717.PMC3814931.pdf
Available from:  http://www.sure-p.gov.ng /.,Non-OADS,/arxiv_data1/oa_pdf/11/79/ijwh-5-717.PMC3814931.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/da/ott-6-1523.PMC3814932.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1523–1526OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1523Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5055 3Isolated epithelioid trophoblastic tumor of the   vagina: a case report and review of the literature Jing Zhao1 Yang Xiang1 Dachun Zhao2 T ong ren1 Fengzhi Feng1 Xirun Wan1 1Department of Obstetrics   and Gynecology, 2Department   of pathology, peking Union Medical   College Hospital, Chinese academy   of Medical sciences and peking   Union Medical College, Beijing,    people’s republic of China Correspondence: Yang Xiang   Department of Obstetrics and  Gynecology, p eking Union Medical  College Hospital, Chinese academy  of Medical sciences and p eking Union  Medical College, No 1 shuaifuyuan  Wangfujing Dongcheng District, Beijing,   100730, people’s republic of China   Tel +86 10 6915 6287   Fax +86 10 6512 4875   email xiangyang65@gmail.co mAbstract:  An epithelioid trophoblastic tumor (ETT) is a rare trophoblastic tumor originating  from chorionic-type intermediate trophoblasts.",Non-OADS,/arxiv_data1/oa_pdf/82/da/ott-6-1523.PMC3814932.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/82/da/ott-6-1523.PMC3814932.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/da/ott-6-1523.PMC3814932.pdf
"Definitions of clinical signs are provided in Appendix (Supplemental Digital Content 1, http://links.lww.com/InF/B620).",Non-OADS,/arxiv_data1/oa_pdf/18/3e/inf-32-S19.PMC3814935.pdf
The work cannot be changed in any way or used commercially.http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Polymerase chain reaction (PCR) primer sequences and the detailed protocol for RT-PCR are described in SupplementalDigital Content 1, http://links.lww.com/NEN/A510.",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"The stimu- lation of primary cortical neurons by BMP9 and measurement of phosphorylated Smad were performed with modiﬁcations, as previously described (22) (Supplemental Digital Content 1,http://links.lww.com/NEN/A510).",OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Detailed descriptions for each study are in Supplemental Digital Content 1,http://links.lww.com/NEN/A510.",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Detailed protocols for semithin and ultrastructural analyses and immu-nohistochemistry are described in Supplemental Digital Con- tent 1, http://links.lww.com/NEN/A510.",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Detailed methods of nerve conduc tion studies are described in Supplemental Digital Content 1, http://links.lww.com/NEN/A510.",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Protocols are described in Supplemental Digital Content 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"In the next set of experiments, we demonstrated that the NIPA1 transgene is speciﬁcally expressed in brain neu- rons via in situ mRNA hybridization analysis (Supple-mental Digital Content 2, http ://links.lww.com/NEN/A511)and immunohistochemistry (Supplemental Digital Content 3, http://links.lww.com/NEN/A512).",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"In wild-type neurons, a uni-formly low level of NIPA1 signal was observed (Supplemental Digital Content 3A-C, http://links.lww.com/NEN/A512).",OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"In con- trast, there was intense immunoreactivity of NIPA1 in numerousneurons in Thy1.2-hNIPA1 G106RTg rat brains (Supplemental Digital Content 3D-F, http://links.lww.com/NEN/A512).",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Behavioral Characterization of Thy1.2-hNIPA1G106RTg Rats Thy1.2-hNIPA1G106RTg rats show age-dependent pro- gressive gait deﬁcits characterized by poorly coordinatedhindlimb movements, trunk instability, and difﬁculty in initiating locomotion (Supple mental Digital Content 4, http://links.lww.com/NEN/A51 3).",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"The earliest abnormality is detected by the air-lift reﬂex in hindlimbs, characterized by the pronounced adduction, often causing the hindlimbs to cross (26), whereas wild-type rats held their hindlimbsapart with paw external rota tion (Supplemental Digital Content 5A-C, http://links.lww.com/NEN/A514).",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Thy1.2-hNIPA1 G106R Tg rats showed an age-dependent decline in locomotion and pro-gressive hindlimb weakness compared with age-matchedwild-type littermates (Supplemental Digital Content 5D-E, http://links.lww.com/NEN/A514).",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Transgenic rats showed signiﬁcantly slower weight gain (Supplemental DigitalContent 5F, http://links.lww.com/NEN/A514), although they did not develop weight loss until regular stepping was lost.",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Supplemental Digital Content 6, h ttp://links.lww.com/NEN/A515, shows horizontal ladder walking; Supplemental Digital Content 7, http://links.lww.com/NEN/A516, shows inclined grid climbing.",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Central Neurodegeneration in Thy1.2-hNIPA1G106R Tg Rats By 6 weeks of age, there was axonal and dendritic vac- uolar degeneration within the gray matter of anterior horns fromsacral and lumbar spinal cord segments; neuronal cell body in- volvement in the spinal cord and dorsal root ganglia became evident at that time point (Supplemental Digital Content 8,http://links.lww.com/NEN/A517).",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"At theultrastructural level, branched-tubular proﬁles appeared dis- persed within dendritic or axonal extensions, suggesting frag- mentation of smooth endoplasmic reticulum (SupplementalDigital Content 9, http://links.lww.com/NEN/A518).",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"2B); neuronal shrinkage and cell body death with vacuolar degeneration were common (Supplemental Digital Content 10,http://links.lww.com/NEN/A519) .",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Dense accumulations of TV organ- elles were more common in older animals (Supplemental DigitalContent 11A, http://links.lww .com/NEN/A520).",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"In addition, rare axons of intramuscular nerves had clusters of TV structures sequestered by double membranes that pre- sumably were formed by invaginating Schwann cell Yaxon membranous networks (Supplemental Digital Content 11C, http://links.lww.com/NEN/A520 ), as previously described (28).",Non-OADS,/arxiv_data1/oa_pdf/c0/48/nen-72-1016.PMC3814936.pdf
"Sequence Assembly and Quality Control The sequences were assembled with Sequencher 4.10 (Genecodes, Ann Arbor, MI) and then aligned with pre- viously submitted sequences from our laboratory and other reference sequences from the Los Alamos database (http:// hivweb.lanl.gov) using the CLUSTAL X program (available at: http://www.clustal.org/clustal2/).13The sequences were then edited manually using Bioedit 7.09 (available at: www.",OADS,/arxiv_data1/oa_pdf/59/5a/qai-64-16.PMC3814940.pdf
"To exclude experimen- tal contamination, similarities between the polsequences in this study and the sequence database were analyzed by apply- ing Los Alamos HIV Database Web tools (http://www.hiv.",OADS,/arxiv_data1/oa_pdf/59/5a/qai-64-16.PMC3814940.pdf
"Phylogenetic and molecular evolutionary analyses were conducted using MEGA 5.0 (available at: http://www.megasoftware.net/).14J Acquir Immune Deﬁc Syndr /C15Volume 64, Number 1, September 1, 2013 Founding Strains for MSM Epidemic in China /C2112013 Lippincott Williams & Wilkins www.jaids.com |17",OADS,/arxiv_data1/oa_pdf/59/5a/qai-64-16.PMC3814940.pdf
Recombinant forms of virus subtypes were ﬁrst analyzed with the Los Alamos Database RIP online tool (http://hivweb.lanl.,OADS,/arxiv_data1/oa_pdf/59/5a/qai-64-16.PMC3814940.pdf
gov) and then with SimPlot 3.5.1 (available at: http://sray.med.,Non-OADS,/arxiv_data1/oa_pdf/59/5a/qai-64-16.PMC3814940.pdf
"Notably, the polsequence data sets from recently published M SM studies in Beijing,5,23,24Shijiazhuang (capital of Hebei province, near Beijing),9and Zhengzhou (cap- ital of Henan province, near Beijing)10also contain these 3 variants, and the overall trend of their reported prevalence agreed with our ﬁndings (see Table S1, Supplemental Digital Con- tent, http://links.lww.com/QAI/A41 7).",Non-OADS,/arxiv_data1/oa_pdf/59/5a/qai-64-16.PMC3814940.pdf
Maximum clade credibility (MCC) tree representing rooted genealogy of respective HIV-1 clusters identiﬁed among MSM in China The MCC tree was obtained by Bayesian MCMC analysis based on HIV-1 nucleotide sequences (HXB2: 2253–3278 nt) implemented in BEAST v1.6.0 (available at: http://beast.bio.ed.ac.uk/Main_Page).,OADS,/arxiv_data1/oa_pdf/59/5a/qai-64-16.PMC3814940.pdf
"UNGASS, http://data.unaids.org/pub/Report/2010/china_2010_country_progress_ report_en.pdf.",OADS,/arxiv_data1/oa_pdf/59/5a/qai-64-16.PMC3814940.pdf
"Wagner, et al., An assay for the rate of removal of extracellular hydrogen peroxide by cells, Redox Biology 1(1) (2013) 210 –217, http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
"[2] Genevieve E. Romanowicz, et al., Novel device for continuous spatial control and temporal delivery of nitric oxide for in vitro cell culture, Redox Biology 1 (1) (2013) 332 –339, http://dx.doi.org/10.1016/j.redox.2013.06.002 .",OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
"[3] Guang Yang, et al., Heme oxygenase-1 regulates postnatal lung repair after hyperoxia: role of β-catenin/hnRNPK signaling, Redox Biology 1 (1) (2013) 234–243, http://dx.doi.org/10.1016/j.redox.2013.01.013 .",Non-OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
"[4] Matthew J. Randall, et al., Acrolein-induced activation of mitogen-activated protein kinase signaling is mediated by alkylation of thioredoxin reductaseand thioredoxin 1, Redox Biology 1 (1) (2013) 265 –275, http://dx.doi.org/ 10.1016/j.redox.2013.02.001 .",Non-OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
"[5] Donald A. McCarthy, et al., Redox-control of the alarmin, Interleukin-1 α, Redox Biology 1 (1) (2013) 218 –225, http://dx.doi.org/10.1016/j.redox.2013.03.001 .",OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
"[6] B. Kalyanaraman, Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms, Redox Biology 1 (1) (2013) 244 –257, http://dx.doi.org/10.1016/j.redox.2013.01.014 .",Non-OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
"[7] AC Andérica-Romero, et al., Cullin 3 as a novel target in diverse pathologies, Redox Biology 1 (1) (2013) 366 –372, http://dx.doi.org/10.1016/j.redox.2013.",Non-OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
"[8] C. Pereira, et al., The redox interplay between nitrite and nitric oxide: from the gut to the brain, Redox Biology 1 (1) (2013) 276 –284, http://dx.doi.org/ 10.1016/j.redox.2013.04.004 .",OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
"[9] E.H. Heiss, et al., Glucose availability is a decisive factor for Nrf2-mediated gene expression, Redox Biology 1 (1) (2013) 359 –365, http://dx.doi.org/ 10.1016/j.redox.2013.06.001 .",OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
"[10] Yerra V. Ganesh, et al., Potential therapeutic effects of the simultaneous targeting of the Nrf2and NF- κB pathways in diabetic neuropathy, Redox Biology (2013) , http://dx.doi.org/10.1016/j.redox.2013.07.005 .",Non-OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
"Davies, Upregulation of the mitochondrial Lon protease allows adaptation to acute oxidative stress but dysregulation isassociated with chronic stress, disease, and aging, Redox Biology 1 (1) (2013) 258–264, http://dx.doi.org/10.1016/j.redox.2013.01.015 .Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology 2213-2317/$ - see front matter &2013 Published by Elsevier B.V. http://dx.doi.org/10.1016/j.redox.2013.09.001Redox Biology 1 (2013) 446 –447",Non-OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
"[14] M. Grazia Cotticelli, et al., Insights into the role of oxidative stress in the pathology of Friedreich ataxia using peroxidation resistant polyunsaturated fatty acids, Redox Biology 1 (1) (2013) 398 –404, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/d3/d8/main.PMC3814945.pdf
http://dx.doi.org/10.1016/j.nicl.2013.09.003 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/58/98/main.PMC3814947.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.08.036 (Feb 1).,OADS,/arxiv_data1/oa_pdf/58/98/main.PMC3814947.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.01.063 .,OADS,/arxiv_data1/oa_pdf/58/98/main.PMC3814947.pdf
http://dx.doi.org/10.1109/TMI.2006.886812 .,Non-OADS,/arxiv_data1/oa_pdf/58/98/main.PMC3814947.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.03.051 (Jun 15).,OADS,/arxiv_data1/oa_pdf/58/98/main.PMC3814947.pdf
http://dx.doi.org/10.1016/ j.biopsych.2012.12.011 .,OADS,/arxiv_data1/oa_pdf/58/98/main.PMC3814947.pdf
"6 (3), 21–45.http://dx.doi.org/10.1109/MCAS.2006.1688199 .",Non-OADS,/arxiv_data1/oa_pdf/58/98/main.PMC3814947.pdf
http://dx.doi.org/10.1016/j.pnpbp.2012.12.005 .289 E. Zarogianni et al.,OADS,/arxiv_data1/oa_pdf/58/98/main.PMC3814947.pdf
http://dx.doi.org/10.1016/j.nicl.2013.09.002 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/30/c7/main.PMC3814948.pdf
"R-fMRI preprocessing R-fMRI data analyses were carried out by using AFNI software (http://afni.nimh.nih.gov/afni ) and MATLAB programs (The MathWorks Inc., Natick, MA).",OADS,/arxiv_data1/oa_pdf/30/c7/main.PMC3814948.pdf
http://dx.doi.org/10.1016/j.nicl.2013.07.008 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/d7/60/main.PMC3814949.pdf
"http://dx.doi.org/10.1016/j.redox.2013.08.005☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium,provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/30/a6/main.PMC3814950.pdf
http://dx.doi.org/10.1016/j.nicl.2013.08.016 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/f6/25/main.PMC3814952.pdf
Voxel-based morphometry analysis T1 image data was pre-processed and analyzed using the VBM8 tool- box ( http://dbm.neuro.uni-jena.de/vbm.html ) and the SPM8 software package ( http://www.,OADS,/arxiv_data1/oa_pdf/f6/25/main.PMC3814952.pdf
"Cortical thickness and sub-cortical volume analysis Cortical surface reconstruction and volumetric segmentation was performed in an automated manner using the FreeSurfer image analysis suite (version 4.3, http://surfer.nmr.mgh.harvard.edu/ ).",OADS,/arxiv_data1/oa_pdf/f6/25/main.PMC3814952.pdf
"http://dx.doi.org/10.1016/j.redox.2013.08.001☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per- mits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/3b/89/main.PMC3814953.pdf
"http://dx.doi.org/10.1016/j.redox.2013.08.004☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/9f/31/main.PMC3814954.pdf
http://dx.doi.org/10.1016/j.nicl.2013.08.005 Contents lists available at SciVerse ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/19/bb/main.PMC3814955.pdf
"http://dx.doi.org/10.1016/j.redox.2013.08.003Abbreviations: ARE, Antioxidant response element; Nrf2, Nuclear factor erythroid 2-like 2; KO, Knockout; WT, Wild-type; P450, Cytochrome P450; NASH, Nonalco-holic steatohepatitis; NAFLD, Nonalcoholic fatty liver disease; co-IP, Co-immunoprecipitation ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non- commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/47/f6/main.PMC3814957.pdf
http://dx.doi.org/10.1016/j.nicl.2013.08.015 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/ce/7b/main.PMC3814958.pdf
Voxel-based morphometry (VBM) Anatomical MRI data were preprocessed with the VBM8 toolbox (http://dbm.neuro.uni-jena.de/vbm/ ) for SPM8 ( http://www.,OADS,/arxiv_data1/oa_pdf/ce/7b/main.PMC3814958.pdf
"VBM cluster sizes were corrected for non-stationarity using the NS toolbox in SPM5 ( Hayasaka and Nichols, 2003; Worsley et al., 1999 )(http://fmri.wfubmc.edu/cms/ software ).",OADS,/arxiv_data1/oa_pdf/ce/7b/main.PMC3814958.pdf
We performed seed-based functional connectivity analysis using the CONN toolbox in SPM8 ( http://web.mit.edu/swg/software.htm ).,OADS,/arxiv_data1/oa_pdf/ce/7b/main.PMC3814958.pdf
"http://dx.doi.org/10.1016/j.redox.2013.08.006Abbreviations: ARE, antioxidant response elements; CysGly, cysteinylglycine; DMEM, Dulbeccos's Modi ﬁed Eagle Medium; GSH, glutathione; HCys, homocys- teine; Nrf2, nuclear factor erythroid-2-related factor 2; LA, α-lipoic acid; PC, Polygonum cuspidatum ; ROS, reactive oxygen species; SFN, sulforaphane; TBHQ, Tert-butylhydroquinone ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use,distribution, and reproduction in any medium, provided the original author and source are credited.",OADS,/arxiv_data1/oa_pdf/bf/56/main.PMC3814960.pdf
http://dx.doi.org/10.1016/j.nicl.2013.07.013 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/c7/e9/main.PMC3814961.pdf
S1 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c7/e9/main.PMC3814961.pdf
S2 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c7/e9/main.PMC3814961.pdf
S3 can be found online at http://dx.doi.org/10.1016/j.nicl.2013.07.013 .,OADS,/arxiv_data1/oa_pdf/c7/e9/main.PMC3814961.pdf
S4 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c7/e9/main.PMC3814961.pdf
"http://dx.doi.org/10.1016/j.redox.2013.09.004☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/80/47/main.PMC3814963.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/9d/opth-7-2099.PMC3814969.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2099–2105Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2099Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5032 2Proficiency of eye drop instillation in  postoperative cataract patients in ghana Yang liu1 amanda Murdoch2 Ken Bassett3 Shafik Dharamsi4 1Faculty of Land and Food Systems,  University of British Columbia,  Vancouver, BC, Canada; 2Queen’s  School of Medicine, Queen’s  University, Kingston, ON, Canada;  3Departments of Family Practice and  Ophthalmology and Visual Sciences,  University of British Columbia,  Vancouver, BC, Canada; 4Department  of Family Practice, University of  British Columbia, Vancouver, BC,  Canada Correspondence: amanda Murdoch   Queen’s University Undergraduate  Medical Education Office, Undergraduate  Medical Education, Queen’s University,   80 Barrie Street, Kingston, ON,   K7L 3N6, Canada   Tel +1 613 985 7384   email amurdoch@qmed.c aObjective:  The purpose of the study was to evaluate the efficacy of postoperative instruction  on proficiency of eye drop instillation following cataract surgery, and to determine whether such  proficiency correlates with the prevalence and/or duration of irritation and pain experienced  in operated eyes.",Non-OADS,/arxiv_data1/oa_pdf/32/9d/opth-7-2099.PMC3814969.pdf
Available from: http://www.crstoday.,Non-OADS,/arxiv_data1/oa_pdf/32/9d/opth-7-2099.PMC3814969.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/32/9d/opth-7-2099.PMC3814969.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/9d/opth-7-2099.PMC3814969.pdf
Available from: http://www.eipico.com.eg/PRODUCT.,Non-OADS,/arxiv_data1/oa_pdf/32/9d/opth-7-2099.PMC3814969.pdf
http://dx.doi.org/10.1016/j.nicl.2013.09.011 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/31/bb/main.PMC3814972.pdf
"A test of global or overall cognitive function was performed with the Montreal Cognitive Assessment, MoCA ( http://www.mocatest.org/ ).",OADS,/arxiv_data1/oa_pdf/31/bb/main.PMC3814972.pdf
"To investigate evidence of GMV recovery with CR, binary masks of regions of interests (ROIs) were created using the MarsBaR ROI toolbox(http://marsbar.sourceforge.net ) from clusters of voxels that showed389 U.C.",OADS,/arxiv_data1/oa_pdf/31/bb/main.PMC3814972.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial Bringing neurosurgical and neurological care to the world Melvin L. Cheatham Clinical Professor, Department of Neurosurgery, University of California, Los Angeles, California, USA E‑mail: *Melvin L. Cheatham ‑ nurosgn@aol.com   *Corresponding author Received: 22 August 13       Accepted: 22 August 13      Published: 22 October 13 As an online journal, Surgical Neurology focuses upon  being “International” in its circulation and outreach.",Non-OADS,/arxiv_data1/oa_pdf/d0/48/SNI-4-143.PMC3814974.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/143/120221 Copyright: © 2013 Cheatham.,Non-OADS,/arxiv_data1/oa_pdf/d0/48/SNI-4-143.PMC3814974.pdf
"Surgical Neurology International 2013, 4:143  http://www.surgicalneurologyint.com/content/4/1/143amazing story is unfolding in developing countries today  and the words for that story are being written by the huge  number of physicians, nurses, and other humanitarian  assistance workers who are tirelessly at work in places  around the world where there is great need.",Non-OADS,/arxiv_data1/oa_pdf/d0/48/SNI-4-143.PMC3814974.pdf
"Surgical Neurology International 2013, 4:143  http://www.surgicalneurologyint.com/content/4/1/143several cc’s of air through the ventricular tubing into the  right lateral ventricle.",Non-OADS,/arxiv_data1/oa_pdf/d0/48/SNI-4-143.PMC3814974.pdf
"Surgical Neurology International 2013, 4:143  http://www.surgicalneurologyint.com/content/4/1/143medical education.",Non-OADS,/arxiv_data1/oa_pdf/d0/48/SNI-4-143.PMC3814974.pdf
http://dx.doi.org/10.1016/j.nicl.2013.08.017 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/45/bd/main.PMC3814975.pdf
"The software Display was used for manual segmentation ( http://www.bic.mni.mcgill.ca/ServicesSoftware Visualization/HomePage , MNI, Montréal, Canada).",OADS,/arxiv_data1/oa_pdf/45/bd/main.PMC3814975.pdf
"The guidelines for the location and boundaries of CA ﬁelds were obtained using the Mouse Allen Reference Atlas available online at http://www.brain- map.org/ , The Mouse Brain in Stereotaxic Coordinates ( Paxinos and Franklin, 2001 ), and CA pyramidal cell density gradient in a manner similar to published recommendations by Richards et al.",OADS,/arxiv_data1/oa_pdf/45/bd/main.PMC3814975.pdf
Brain structure abbreviations used are from the Mouse Allen Reference Atlas available online at http://www.brain-map.org .296 A. Badhwar et al.,OADS,/arxiv_data1/oa_pdf/45/bd/main.PMC3814975.pdf
"http://dx.doi.org/10.1016/j.redox.2013.08.002Abbreviations: CREB, cAMP-responsive element-binding protein; HIF-1, hypoxia- inducible factor; KEAP1, Kelch-like ECH-associated protein 1; L-NAME, L-NG- nitroarginine methyl ester; MnTBap, manganese [III] tetrakis (4-benzoic acid)porphyrin; NO, nitric oxide; NF κB, nuclear factor kappa B; NOS, nitric oxide synthase; NOX, NADPH oxidase; RNS, reactive nitrogen species; ROS, reactiveoxygen species; Nrf2, nuclear factor erythroid 2-related factor 2; DHE, dihy-droethidium; DAF -2-DA, 4,5-diamino ﬂuorescein diacetate $This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2013.08.002 .,OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"References [1] KA Webster, Hypoxia: life on the Edge, Antioxidants & Redox Signaling 9 (2007) 1303 –1308, http://dx.doi.org/10.1089/ars.2007.1730 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[2] EG Lynn, Z Lu, D Minerbi, MN Sack, The regulation, control, and consequences of mitochondrial oxygen utilization and disposition in the heart and skeletal muscle during hypoxia, Antioxidants & Redox Signaling 9 (2007) 1353 –1362, http://dx.doi.org/10.1089/ars.2007.1700 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[5] G Vangeison, D Carr, HJ Federoff, DA Rempe, The good, the bad, and the cell type-speci ﬁc roles of hypoxia inducible factor-1{alpha} in neurons and astrocytes, J Neurosci 28 (2008) 1988 –1993, http://dx.doi.org/10.1523/jneur- osci.5323-07.2008 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[7] C-H Chen, Y-F Liu, S-D Lee, C-Y Huang, W-C Lee, Y-L Tsai, C-W Hou, Y-S Chan, C-H Kuo, Altitude hypoxia increases glucose uptake in human heart, HighAltitude Medicine & Biology 10 (2009) 83 –86, http://dx.doi.org/10.1089/ ham.2008.1064 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"Heart and Circulatory Physiol- ogy 292 (2007) H101 –108, http://dx.doi.org/10.1152/ajpheart.00699.2006 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[13] M McMahon, K Itoh, M Yamamoto, JD Hayes, KRAP1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven Gene expression, Journal of Biological Chemistry 278 (2003) 21592 –21600, http://dx.doi.org/10.1074/jbc.M300931200 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[14] MO Leonard, NE Kieran, K Howell, MJ Burne, R Varadarajan, S Dhakshinamoorthy, A Porter, C Farrelly, H Rabb, CT Taylor, Reoxygenation- speci ﬁc activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury, The FASEB Journal 20 (2006) 2624 –2626, http://dx.doi.org/10.1096/fj.06-5097fje .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[18] Y Kawai, L Garduño, M Theodore, J Yang, IJ Arinze, Acetylation –deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization, Jour- nal of Biological Chemistry 286 (2011) 7629 –7640, http://dx.doi.org/10.1074/ jbc.M110.208173 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[19] P Nioi, M McMahon, K Itoh, M Yamamoto, JD Hayes, Identi ﬁcation of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H: quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence, Biochemical Journal 374 (2003) 337 –348, http://dx.doi.org/10.1042/ bj20030754 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[21] AM Pickering, RA Linder, H Zhang, HJ Forman, KJA Davies, Nrf2-dependent induction of proteasome and Pa28 αβregulator are required for adaptation to oxidative stress, Journal of Biological Chemistry 287 (2012) 10021 –10031, http://dx.doi.org/10.1074/jbc.M111.277145 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[23] J-M Lee, AY Shih, TH Murphy, JA Johnson, NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increasedconcentrations of intracellular calcium in primary cortical neurons, Journal of Biological Chemistry 278 (2003) 37948 –37956, http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[24] S Dhakshinamoorthy, AG Porter, Nitric oxide-induced transcriptional up- regulation of protective genes by Nrf2 via the antioxidant response elementcounteracts apoptosis of neuroblastoma cells, Journal of Biological Chemistry 279 (2004) 20096 –20107, http://dx.doi.org/10.1074/jbc.M312492200 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[25] CJ Zuurbier, M van Iterson, C Ince, Functional heterogeneity of oxygen supply- consumption ratio in the heart, Cardiovascular Research 44 (1999) 488 –497, http://dx.doi.org/10.1016/s0008-6363(99)00231-x .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[29] MM Grant, VS Barber, HR Grif ﬁths, The presence of ascorbate induces expression of brain derived neurotrophic factor in SH-SY5Y neuroblastoma cells after peroxide insult, which is associated with increased survival, Proteomics 5 (2005) 534 –540, http://dx.doi.org/10.1002/pmic.200300924 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[40] L Chen, P Lizano, X Zhao, X Sui, SK Dhar, Y-T Shen, DE Vatner, SF Vatner, C Depre, Preemptive conditioning of the swine heart by H11 kinase/Hsp22 provides cardiac protection through inducible nitric oxide synthase, American Journal of Physiology: Heart and Circulatory Physiology 300 (2012) H1303 –- H1310, http://dx.doi.org/10.1152/ajpheart.00979.2010 .",Non-OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"[42] R Kohl, J Zhou, B Brune, Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1alpha stabilization, Free Radical Biology & Medicine 40 (2006) 1430 –1442, http://dx.doi.org/10.1016/j.freeradbiomed.2005.12.012 .R.T Kolamunne et al.",OADS,/arxiv_data1/oa_pdf/d6/32/main.PMC3814985.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Indications for valve‑pressure adjustments of gravitational assisted  valves in patients with idiopathic normal pressure hydrocephalus Leonie Gölz, Johannes Lemcke, Ullrich Meier Department of Neurosurgery, Unfallkrankenhaus Berlin, Warener Straße 7, 12686, Berlin, Germany E‑mail: *Leonie Gölz ‑ leonie.goelz@ukb.de; Johannes Lemcke ‑ johannes.lemcke@ukb.de; Ullrich Meier ‑ ullrich.meier@ukb.de   *Corresponding author Received: 22 April 13   Accepted: 01 August 13  Published: 15 October 13 Abstract Background:  Modern ventriculoperitoneal shunts (VPS) are programmable,  which enables clinicians to adjust valve‑pressure according to their patients’  individual needs.",Non-OADS,/arxiv_data1/oa_pdf/49/87/SNI-4-140.PMC3814988.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/140/119879 Copyright: © 2013 Gölz L.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/49/87/SNI-4-140.PMC3814988.pdf
"Surgical Neurology International 2013, 4:140  http://www.surgicalneurologyint.com/content/4/1/140experience headaches and vertigo but an enlargement of  the ventricles in cerebral imaging is mandatory for the  diagnosis iNPH.",Non-OADS,/arxiv_data1/oa_pdf/49/87/SNI-4-140.PMC3814988.pdf
"Surgical Neurology International 2013, 4:140  http://www.surgicalneurologyint.com/content/4/1/140Worsening of symptoms was observed after 21%  of valve‑pressure reductions.",Non-OADS,/arxiv_data1/oa_pdf/49/87/SNI-4-140.PMC3814988.pdf
"Surgical Neurology International 2013, 4:140  http://www.surgicalneurologyint.com/content/4/1/140overdrainage complications since a respectable amount  of cerebrospinal fluid (CSF) can be already lost during  implantation of the shunt.",Non-OADS,/arxiv_data1/oa_pdf/49/87/SNI-4-140.PMC3814988.pdf
"Surgical Neurology International 2013, 4:140  http://www.surgicalneurologyint.com/content/4/1/140between 100 and 70 mmH2O, a phase of aggravation  of symptoms can be observed once more.",Non-OADS,/arxiv_data1/oa_pdf/49/87/SNI-4-140.PMC3814988.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comT echnical Note Minimally invasive one‑level lumbar decompression and fusion  surgery with posterior instrumentation using a combination of  pedicle screw fixation and transpedicular facet screw construct John Hsiang, Keyi Yu1, Y ongxiong He2 Swedish Neuroscience Institute, 550 17th Avenue, Suite 500, Seattle, WA 98122, USA, 1Department of Orthopaedic, Peking Union Medical College Hospital,  1st Shuai Fu Yuan Road, Wang Fu Jing Street, Beijing, China 100730, 2Department of Cervical Spine Surgery, The Second Affiliated Hospital of Inner Mongolia  Medical College, 1, Ying Fang Road, Huimin District, Hohhot, Inner Mongolia, China 010030 E‑mail: *John Hsiang ‑ john.hsiang@swedish.org; Keyi Yu ‑ yukeyi009@gmail.com; Yongxiong He ‑ spinedoctorhyx@gmail.com   *Corresponding author Received: 15 March 13   Accepted: 17 July 13  Published: 26 September 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.119007  Quick Response Code: Abstract Background:  Minimally invasive lumbar spine fusion surgery has gained popularity  in recent years.",Non-OADS,/arxiv_data1/oa_pdf/98/ca/SNI-4-125.PMC3814991.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/125/119007 Copyright: © 2013 Hsiang J.,Non-OADS,/arxiv_data1/oa_pdf/98/ca/SNI-4-125.PMC3814991.pdf
"Surgical Neurology International 2013, 4:125  http://www.surgicalneurologyint.com/content/4/1/125INTRODUCTION In 1968, Dr. Wiltse pioneered a posterior parasagittal  approach to the lumbar spine for surgical treatment of  lumbosacral spondylolisthesis, hence it is now being  known as the Wiltse approach.",Non-OADS,/arxiv_data1/oa_pdf/98/ca/SNI-4-125.PMC3814991.pdf
"Surgical Neurology International 2013, 4:125  http://www.surgicalneurologyint.com/content/4/1/125was then performed through the Kambie’s triangle.",Non-OADS,/arxiv_data1/oa_pdf/98/ca/SNI-4-125.PMC3814991.pdf
"Surgical Neurology International 2013, 4:125  http://www.surgicalneurologyint.com/content/4/1/125shown improvement in their preoperative low back pain  and radicular leg symptoms.",Non-OADS,/arxiv_data1/oa_pdf/98/ca/SNI-4-125.PMC3814991.pdf
"Surgical Neurology International 2013, 4:125  http://www.surgicalneurologyint.com/content/4/1/125of the facet screw.",Non-OADS,/arxiv_data1/oa_pdf/98/ca/SNI-4-125.PMC3814991.pdf
"Surgical Neurology International 2013, 4:125  http://www.surgicalneurologyint.com/content/4/1/125markers after mini‑open lumbar fusion.",Non-OADS,/arxiv_data1/oa_pdf/98/ca/SNI-4-125.PMC3814991.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/a6/ijn-8-4063.PMC3814992.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4063–4076International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4063OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5283 3antibody-conjugated, dual-modal, near-infrared  fluorescent iron oxide nanoparticles   for antiamyloidgenic activity and specific   detection of amyloid- β fibrils hadas skaat1 enav corem-slakmon1 Igor grinberg1 David last2 David goez2 Yael Mardor2,3 shlomo Margel1 1Department of chemistry, Bar-Ilan  Institute of Nanotechnology and  advanced Materials, ramat-gan,   Israel; 2advanced T echnology center,   sheba Medical center, T el-hashomer,   ramat-gan, Israel; 3sackler Faculty   of Medicine, T el-a viv University,    T el-a viv, Israel correspondence: shlomo Margel   Department of chemistry, The Institute  of Nanotechnology and advanced  Materials, Bar-Ilan University,   Max and anna Web st,   ramat-gan 5290002, Israel   Tel +972 3 531 8861   Fax +972 3 635 5208   email s hlomo.margel@mail.biu.ac.i lAbstract:  Amyloid- β (Aβ) peptide is the main fibrillar component of plaque deposits found  in brains affected by Alzheimer’ s disease (AD) and is related to the pathogenesis of AD.",Non-OADS,/arxiv_data1/oa_pdf/a3/a6/ijn-8-4063.PMC3814992.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a3/a6/ijn-8-4063.PMC3814992.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/a6/ijn-8-4063.PMC3814992.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article A study on gingival enlargement and folic acid levels in  phenytoin‑treated epileptic patients: Testing hypotheses Abhishek Singh Nayyar, Mubeen Khan, Vijayalakshmi K. R., G. T .",Non-OADS,/arxiv_data1/oa_pdf/6f/65/SNI-4-133.PMC3814993.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/133/119232 Copyright: © 2013 Nayyar AS.,Non-OADS,/arxiv_data1/oa_pdf/6f/65/SNI-4-133.PMC3814993.pdf
"Surgical Neurology International 2013, 4:133  http://www.surgicalneurologyint.com/content/4/1/133reduction in the quality of life of the affected individual.",Non-OADS,/arxiv_data1/oa_pdf/6f/65/SNI-4-133.PMC3814993.pdf
"Surgical Neurology International 2013, 4:133  http://www.surgicalneurologyint.com/content/4/1/133Controls were assessed only once based on their inclusion  according to age and sex.",Non-OADS,/arxiv_data1/oa_pdf/6f/65/SNI-4-133.PMC3814993.pdf
"Surgical Neurology International 2013, 4:133  http://www.surgicalneurologyint.com/content/4/1/133RESULTS The present study was designed in the Department of Oral  Medicine and Radiology, Government Dental College  and Research Institute, Bangalore during the period of  January‑December 2009 to assess the correlation between  phenytoin‑induced gingival enlargement and serum folate  levels.",Non-OADS,/arxiv_data1/oa_pdf/6f/65/SNI-4-133.PMC3814993.pdf
"Surgical Neurology International 2013, 4:133  http://www.surgicalneurologyint.com/content/4/1/133management of epileptic patients in India.",Non-OADS,/arxiv_data1/oa_pdf/6f/65/SNI-4-133.PMC3814993.pdf
"Surgical Neurology International 2013, 4:133  http://www.surgicalneurologyint.com/content/4/1/133of the indices used to quantify gingival enlargement are  difficult to reproduce because they lack an objective  criteria to differentiate between the degree of horizontal  and vertical overgrowth.",Non-OADS,/arxiv_data1/oa_pdf/6f/65/SNI-4-133.PMC3814993.pdf
"Surgical Neurology International 2013, 4:133  http://www.surgicalneurologyint.com/content/4/1/133Thus, the use of folic acid as an adjuvant to phenytoin  therapy in the prevention of phenytoin‑induced gingival  enlargement calls for further studies in future keeping  in mind the precipitation of epileptic attacks seen in  a significant number of patients on folic acid adjuvant  therapy secondary to fall in the sera levels of phenytoin  due to the propensity of drug interactions between the two.",Non-OADS,/arxiv_data1/oa_pdf/6f/65/SNI-4-133.PMC3814993.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Intracranial bleeding following induction of anesthesia in a patient  undergoing elective surgery for refractory epilepsy Regunath Kandasamy, John Tharakan, Zamzuri Idris, Jafri M. Abdullah Neurosurgical Division, Department of Neurosciences, Hospital Universiti Sains Malaysia, 16150, Kubang Kerian, Kota Bharu, Kelantan, Malaysia E‑mail: *Regunath Kandasamy ‑ kandasamy.regunath@gmail.com; John Tharakan ‑ jtbt7@hotmail.com; Zamzuri Idris ‑ zamzuri@kb.usm.my;  Jafri M ‑ Abdullah.",Non-OADS,/arxiv_data1/oa_pdf/b6/3c/SNI-4-124.PMC3814994.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/124/119006 Copyright: © 2013 Kandasamy R.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/b6/3c/SNI-4-124.PMC3814994.pdf
"Surgical Neurology International 2013, 4:124  http://www.surgicalneurologyint.com/content/4/1/124have not been reported instances of these changes resulting  in intraparenchymal bleeding excepting in patients with  preexisting intracranial vascular pathology like an aneurysm.",Non-OADS,/arxiv_data1/oa_pdf/b6/3c/SNI-4-124.PMC3814994.pdf
"Surgical Neurology International 2013, 4:124  http://www.surgicalneurologyint.com/content/4/1/124Previous accounts of patients developing intracranial  bleeding in literature are present, but are usually in  the setting of regional anesthesia specifically epidural  procedures.",Non-OADS,/arxiv_data1/oa_pdf/b6/3c/SNI-4-124.PMC3814994.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Posterior reversible encephalopathy syndrome in a patient with a  Chiari I malformation David R. Hansberry, Nitin Agarwal, Krystal L. Tomei, Ira M. Goldstein Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA E‑mail:  David R. Hansberry ‑ hansbedr@njms.rutgers.edu; Nitin Agarwal ‑ nitin.agarwal@rutgers.edu; Krystal L. T omei ‑ kltomei@gmail.com;  *Ira M.  Goldstein ‑ goldstir@njms.rutgers.edu   *Corresponding author Received: 18 June 13  Accepted: 07 August 13  Published: 30 September 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.119076  Quick Response Code: Abstract Background:  The authors describe a unique case of a patient who developed  posterior reversible encephalopathy syndrome (PRES) following postoperative  treatment of a Chiari I malformation.",Non-OADS,/arxiv_data1/oa_pdf/7c/bd/SNI-4-130.PMC3814995.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/130/119076 Copyright: © 2013 Hansberry DR.,Non-OADS,/arxiv_data1/oa_pdf/7c/bd/SNI-4-130.PMC3814995.pdf
"Surgical Neurology International 2013, 4:130  http://www.surgicalneurologyint.com/content/4/1/130may expect issues leading to cranial nerve neuropathies;  pseudomeningocele; cerebral spinal fluid (CSF)  leaks; infection; aseptic meningitis; hydrocephalus;  inadequate decompression, causing reobstruction of  flow; and cerebellar ptosis.",Non-OADS,/arxiv_data1/oa_pdf/7c/bd/SNI-4-130.PMC3814995.pdf
"Surgical Neurology International 2013, 4:130  http://www.surgicalneurologyint.com/content/4/1/130seizure activity and CSF cultures were negative.",Non-OADS,/arxiv_data1/oa_pdf/7c/bd/SNI-4-130.PMC3814995.pdf
"Surgical Neurology International 2013, 4:130  http://www.surgicalneurologyint.com/content/4/1/130and treatment of the hypertension is related to improved  symptoms.",Non-OADS,/arxiv_data1/oa_pdf/7c/bd/SNI-4-130.PMC3814995.pdf
"Surgical Neurology International 2013, 4:130  http://www.surgicalneurologyint.com/content/4/1/130CONCLUSION Here, we present an interesting case of a 25‑year‑old  female who developed PRES several days postoperative  from a Chiari decompression who further deteriorated  following the administration of pressors.",Non-OADS,/arxiv_data1/oa_pdf/7c/bd/SNI-4-130.PMC3814995.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/26/119004,Non-OADS,/arxiv_data1/oa_pdf/ec/0a/JPI-4-26.PMC3814996.pdf
"J Pathol Inform 2013, 1:26  http://www.jpathinformatics.org/content/4/1/26INTRODUCTION Lung cancer is the second most common cancer in both  men and women.",Non-OADS,/arxiv_data1/oa_pdf/ec/0a/JPI-4-26.PMC3814996.pdf
"J Pathol Inform 2013, 1:26  http://www.jpathinformatics.org/content/4/1/26of the sample and the base of the holder was gently  moved upward, so the sample was slightly flattened.",Non-OADS,/arxiv_data1/oa_pdf/ec/0a/JPI-4-26.PMC3814996.pdf
"J Pathol Inform 2013, 1:26  http://www.jpathinformatics.org/content/4/1/26alveoli (signal‑void dark areas), along with their septal  walls (bright signal) [Figure 2a and b].",OADS,/arxiv_data1/oa_pdf/ec/0a/JPI-4-26.PMC3814996.pdf
"J Pathol Inform 2013, 1:26  http://www.jpathinformatics.org/content/4/1/26T able 1: Diagnostic performance of FFOCT for lung lesions No.",Non-OADS,/arxiv_data1/oa_pdf/ec/0a/JPI-4-26.PMC3814996.pdf
"J Pathol Inform 2013, 1:26  http://www.jpathinformatics.org/content/4/1/26It is important to note that each tissue type is unique in  the way it will absorb and scatter light.",Non-OADS,/arxiv_data1/oa_pdf/ec/0a/JPI-4-26.PMC3814996.pdf
"J Pathol Inform 2013, 1:26  http://www.jpathinformatics.org/content/4/1/26rates, further evaluation of some more sophisticated  methods for speckle removal seems warranted in the future.",Non-OADS,/arxiv_data1/oa_pdf/ec/0a/JPI-4-26.PMC3814996.pdf
"J Pathol Inform 2013, 1:26  http://www.jpathinformatics.org/content/4/1/26format with small footprint, makes FFOCT an attractive  potential diagnostic tool.",OADS,/arxiv_data1/oa_pdf/ec/0a/JPI-4-26.PMC3814996.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Pediatric traumatic brain injuries treated with decompressive  craniectomy Neil Patel, Michael West, Joanie Wurster, Cassie Tillman Department of  Trauma, St. Mary’s Medical Center/Palm Beach Children’s Hospital, Fl, 33409, USA E‑mail:  Neil Patel ‑ Npatel777@gmail.com; Michael West ‑ Cut2fly@bellsouth.net; *Joanie Wurster ‑ Joan.Wurster@tenethealth.com;   Cassie Tillman ‑ Cassie.Tillman@tenethealth.com   *Corresponding author Received: 21 May 13  Accepted: 02 August 13  Published: 27 September 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.119055  Quick Response Code: Abstract Background:  Traumatic brain injury (TBI) occurs in an estimated 80% of all  pediatric trauma patients and is the leading cause of death and disability in the  pediatric population.",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/128/119055 Copyright: © 2013 Pates N.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
"Surgical Neurology International 2013, 4:128  http://www.surgicalneurologyint.com/content/4/1/128(level 1 evidence).",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
"Surgical Neurology International 2013, 4:128  http://www.surgicalneurologyint.com/content/4/1/128adherent to the skull and thus they are more prone  to subdural hematomas (SDHs) rather than epidural  hematomas (EDHs).",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
"Surgical Neurology International 2013, 4:128  http://www.surgicalneurologyint.com/content/4/1/128diffuse hypoxic/ischemic injury.",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
"Surgical Neurology International 2013, 4:128  http://www.surgicalneurologyint.com/content/4/1/128guidelines from 2012, “decompressive craniectomies with  duraplasty, leaving the bone flap out, may be considered  for pediatric patients with traumatic brain injury who  were showing early signs of neurologic deterioration or  herniation or are developing intracranial hypertension  refractory to medical management during the early stages  of treatment.”[19] According to these guidelines, ICP  monitoring and decompressive craniectomies are listed  as Options (level 3 evidence) not Recommendation (level  2 evidence), and not Guidelines  (level 1 evidence).",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
"Surgical Neurology International 2013, 4:128  http://www.surgicalneurologyint.com/content/4/1/12815 minutes despite sedation 6.",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
"Surgical Neurology International 2013, 4:128  http://www.surgicalneurologyint.com/content/4/1/128Table 1: Pediatric patient summary chart Client  IDAge ISS* MOI* Adm  GCSOpening ICP/ ventriculostomy dateCraniotomy date Craniectomy size and  dateRancho score  on D/S*>6 months  after D/S*  A 11 25 jumping on  bed/hit head  on dresser13 down  to 3Day of admission/ postcraniectomy ICP  2 torrDay of admission  evacuation of acute  epidural hematomaDay of admission Left frontal temporal  parietal craniectomyVIII X B 17 26 fall out of  back of  truck13 Day of admission  Ventriculostomy/ICP  27 torrOne day after  admission  Evacuation of SDHOne day after admission Left frontal temporal  parietal craniectomyVI X C 14 42 MVC with  ejection5 Day of admission  Ventriculostomy inserted  in surgery ICP 21-23 torrDay of admission  Evacuation of SDHDay of admission Left frontal temporal  parietal craniectomyIV VIII D 14 16 fell off a golf  cart3 Day of admission Postcraniectomy ICP 12  torr in surgeryDay of admission  Evacuation of SDHDay of admission Left frontal temporal  parietal craniectomyVI X E 11 20 school bus  accident3 to 6 Day of admission  Ventriculostomy inserted  in surgery ICP>15 torrDay of admission  Evacuation of SDHDay of admission  Bifrontal temporal  Parietal craniectomy VI X F 12 38 pedestrian  vs car11 Day of admission  Ventriculostomy Inserted  in surgery ICP 8 torrDay of admission  Evacuation of SDHDay of admission Left frontal temporal  parietal craniectomyIV X G 15 20 car surfing 6 One day after admission Ventriculostomy inserted  in surgery ICP 8 torrOne day after  admission bifrontal  temporal parietal  craniectomyOne day after admission bifrontal temporal  Parietal craniectomyVIII X *MOI: Mechanism of injury, *ISS: Injury severity score, *D/S: Discharge.",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
"Surgical Neurology International 2013, 4:128  http://www.surgicalneurologyint.com/content/4/1/128Contd...Table 2: Contd... Levels of cognitive functioning Absent short-term memory May cry out or scream out of proportion to stimulus even after its removal May exhibit aggressive or fight behavior Mood may swing from euphoric to hostile with no apparent relationship to environmental events Unable to cooperate with treatment efforts Verbalizations are frequently incoherent and/or inappropriate to activity or environment Level V -Confused, inappropriate nonagitated: Maximal assistance Alert, not agitated but may wander randomly or with a vague intention of going home May become agitated in response to external stimulation, and/or lack of environmental structure Not oriented to person, place, or time Frequent brief periods, nonpurposeful sustained attention Severely impaired recent memory, with confusion of past and present in reaction to ongoing activity Absent goal directed, problem solving, self-monitoring behavior Often demonstrates inappropriate use of objects without external direction May be able to perform previously learned tasks when structured and cues provided Unable to learn new information Able to respond appropriately to simple commands fairly consistently with external structures and cues Responses to simple commands without external structure are random and nonpurposeful in relation to command Able to converse on a social, automatic level for brief periods of time when provided external structure and cues Verbalizations about present events become inappropriate and confabulatory when external structure and cues are not provided Level VI- Confused, appropriate: Moderate assistance Inconsistently oriented to person, time and place Able to attend to highly familiar tasks in nondistracting environment for 30 minutes with moderate redirection Remote memory has more depth and detail than recent memory Vague recognition of some staff Able to use assistive memory aide with maximum assistance Emerging awareness of appropriate response to self, family, and basic needs Moderate assist to problem solve barriers to task completion Supervised for old learning (e.g., self care) Shows carry over for relearned familiar tasks (e.g., self care) Maximum assistance for new learning with little or no carry over Unaware of impairments, disabilities, and safety risks Consistently follows simple directions Verbal expressions are appropriate in highly familiar and structured situations Level VII-Automatic, appropriate: Minimal assistance for daily living skills Consistently oriented to person and place, within highly familiar environments.",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
"Surgical Neurology International 2013, 4:128  http://www.surgicalneurologyint.com/content/4/1/128to facilitate brain swelling and prevent brain compression  and possible herniation.",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
"Surgical Neurology International 2013, 4:128  http://www.surgicalneurologyint.com/content/4/1/128technique can be used as an alternative to maximal  conservative medical therapy instead of a last resort.",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
Brain Injury Association of America (2011) Available from: http://www.biausa.,Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
"Surgical Neurology International 2013, 4:128  http://www.surgicalneurologyint.com/content/4/1/12822.",Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
Available from: http://emedicine.medscape.,Non-OADS,/arxiv_data1/oa_pdf/39/81/SNI-4-128.PMC3815000.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cc/92/dddt-7-1301.PMC3815003.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1301–1313Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1301Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5135 4Bozepinib, a novel small antitumor agent, induces  PKr-mediated apoptosis and synergizes   with iFnα triggering apoptosis, autophagy   and senescence Juan antonio Marchal1,2 esther carrasco1 alberto ramirez1,3 gema Jiménez1,2 carmen Olmedo4 Macarena Peran1,3 ahmad agil5 ana conejo-garcía6 Olga cruz-lópez6 Joaquin María campos6 María Ángel garcía4,7 1Biopathology and regenerative  Medicine institute, centre for  Biomedical research, 2Department  of human anatomy and embryology,   Faculty of Medicine, University of  granada, granada, 3Department of  health sciences, University of Jaén, Jaén,   4experimental surgery research Unit,   Virgen de las nieves University hospital,   granada, 5Department of Pharmacology  and neurosciences institute,   Faculty of Medicine, 6Department of  Pharmaceutical and Organic chemistry,   Faculty of Pharmacy, University of  granada, granada, 7Department  of Oncology, Virgen de las nieves  University hospital, granada, spain correspondence: María Ángel garcía   hospital Universitario Virgen de las  nieves, e-18012 granada, spain   Tel +34 958 249 321   Fax +34 958 246 296   email mangelgarcia@ugr.e s    Juan antonio Marchal   Universidad de granada, e-18100  granada, spain   Tel +34 958 249 321   Fax +34 958 246 296   email jmarchal@ugr.e sAbstract:  Bozepinib [( RS)-2,6-dichloro-9-[1-( p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-  benzoxazepin-3-yl]-9 H-purine] is a potent antitumor compound that is able to induce apoptosis  in breast cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/cc/92/dddt-7-1301.PMC3815003.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/cc/92/dddt-7-1301.PMC3815003.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/92/dddt-7-1301.PMC3815003.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/bd/dhps-5-199.PMC3815004.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug, Healthcare and Patient Safety 2013:5 199–201Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  199Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/DHPS.S5440 2Oral available agents in the treatment of rrMS thierry Aupérin Medical Communications, Global  MS Medical Affairs, Genzyme  Corporation, Cambridge, MA, USA Correspondence: thierry Aupérin   Medical Communications,   Global MS Medical Affairs, Genzyme  Corporation, 500 Kendall Street,  Cambridge, MA, USA   tel +1 617 768 4360   email t hierry.auperin@genzyme.co mDear editor We read with interest the article by Drs Thöne and Ellrichmann entitled “Oral  available  agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits  and culprits” recently published in Drug, Healthcare and Patient Safety.1 The review  provides a valuable overview of a number of new therapeutic options for multiple  sclerosis (MS), with a focus on proposed mechanisms of action and efficacy and safety  profiles of the respective agents.",Non-OADS,/arxiv_data1/oa_pdf/76/bd/dhps-5-199.PMC3815004.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/76/bd/dhps-5-199.PMC3815004.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/bd/dhps-5-199.PMC3815004.pdf
The work cannot be changed in any way or used commercially.http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/e4/6a/nen-72-1000.PMC3815008.pdf
"Silver Spring, MD: US Food and Drug Administration; 16 July 2012. http://www.fda.gov/News- Events/Newsroom/PressAnnouncements/ucm312210.htm.",Non-OADS,/arxiv_data1/oa_pdf/d4/09/cohiv-8-565.PMC3815009.pdf
"Nanomedicine 2013; xx:1-11, http://dx.doi.org/10.1016/j.nano.2013.05.003.",OADS,/arxiv_data1/oa_pdf/d4/09/cohiv-8-565.PMC3815009.pdf
"Bethesda, MD: National Library of Medicine; 2012. http://clinicaltrials.gov/ct2/show/NCT01641809.",Non-OADS,/arxiv_data1/oa_pdf/d4/09/cohiv-8-565.PMC3815009.pdf
"The HIV prevalence data used for ﬁtting the incidence and survival model thus consist of observed number of HIV-positive and number of participants in HIV surveillance stratiﬁed by year of age, by year of surveillance and by sex (see Supplemental Digital Content 1, http://links.lww.com/QAD/A372).",OADS,/arxiv_data1/oa_pdf/25/52/aids-27-2471.PMC3815011.pdf
"Unauthorized reproduction of this article is prohibited.prevalence in older age groups (most pronounced among men) is indicative of lower numbers of HIV surveillance participants in these age groups (see Supplemental Digital Content 1, http://links.lww.com/QAD/A372).This lower sample size is both a reﬂection of smaller numbers of older men living in the DSS (see Fig.",Non-OADS,/arxiv_data1/oa_pdf/25/52/aids-27-2471.PMC3815011.pdf
Stat Commun Infect Dis 2011:3See http://www.degruyter.com/ view/j/scid.2011.3.issue-1/1948-4690.1044/1948- 4690.1044.xml?format=INT .,OADS,/arxiv_data1/oa_pdf/25/52/aids-27-2471.PMC3815011.pdf
"T o estimate the risk of infection for a susceptible individual, the model uses an established mathematical equation that estimates the probability of HIVacquisition (appendix C, http://links.lww.com/QAD/A383), if the individual has a given number of sexual partners from a particular (population) subgroup and a speciﬁed number of sex acts with those partners [9].",Non-OADS,/arxiv_data1/oa_pdf/8a/c8/aids-27-2623.PMC3815012.pdf
"The behavioural and bio- logical parameter tables for the model are provided in Appendix E, http://links.lww.com/QAD/A383.",OADS,/arxiv_data1/oa_pdf/8a/c8/aids-27-2623.PMC3815012.pdf
"Details on high-risk group population estimates and additional calculations are contained in appendix D, http://links.lww.com/QAD/A383, with most of these estimates conserved from the original model.",Non-OADS,/arxiv_data1/oa_pdf/8a/c8/aids-27-2623.PMC3815012.pdf
2010; Available from: http://www.unaids.org/globalreport/Glo- bal_report.htm.,Non-OADS,/arxiv_data1/oa_pdf/8a/c8/aids-27-2623.PMC3815012.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comT echnical Note Intraoperative assessment of spinal vascular flow in the surgery  of spinal intramedullary tumors using indocyanine green  videoangiography Toshihiro Takami, Toru Yamagata, Kentaro Naito, Hironori Arima, Kenji Ohata Department of Neurosurgery, Osaka City University Graduate School of Medicine, Osaka, Japan E‑mail: *T oshihiro Takami ‑ ttakami@med.osaka‑cu.ac.jp; T oru Yamagata ‑ tyamagata@med.osaka‑cu.ac.jp; Kentaro Naito ‑ 7110ken622@med.osaka‑cu.ac.jp;  Hironori Arima ‑ a03ma002@yahoo.co.jp; Kenji Ohata – kohata@med.osaka‑cu.ac.jp   *Corresponding author Received: 14 August 13  Accepted: 19 September 13  Published: 04 October 13 Abstract Background:  The authors demonstrate the utility of indocyanine green  videoangiography (ICG‑VA)  for intraoperative  vascular  flow assessment  in the  surgery of a variety of spinal intramedullary tumors to achieve an additional level  of safety as well as precision with the surgical procedure.",Non-OADS,/arxiv_data1/oa_pdf/e1/e0/SNI-4-135.PMC3815013.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/135/119352 Copyright: © 2013 Takami T.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e1/e0/SNI-4-135.PMC3815013.pdf
"Surgical Neurology International 2013, 4:135  http://www.surgicalneurologyint.com/content/4/1/135relative infrequency and unknown natural history, and  difficulty in standardizing treatment.",Non-OADS,/arxiv_data1/oa_pdf/e1/e0/SNI-4-135.PMC3815013.pdf
"Surgical Neurology International 2013, 4:135  http://www.surgicalneurologyint.com/content/4/1/135at very low power levels under continuous saline irrigation.",Non-OADS,/arxiv_data1/oa_pdf/e1/e0/SNI-4-135.PMC3815013.pdf
"Surgical Neurology International 2013, 4:135  http://www.surgicalneurologyint.com/content/4/1/135dynamics of spinal microvasculature, including the tumor  itself, were well visualized within 10 seconds of intravenous  systemic injection of ICG.",Non-OADS,/arxiv_data1/oa_pdf/e1/e0/SNI-4-135.PMC3815013.pdf
"Surgical Neurology International 2013, 4:135  http://www.surgicalneurologyint.com/content/4/1/135Illustrative case 1 Patient 3: A 42-year -old female was admitted with back  pain, gait disturbance, and moderate dysesthesia of  right upper extremity.",Non-OADS,/arxiv_data1/oa_pdf/e1/e0/SNI-4-135.PMC3815013.pdf
"Surgical Neurology International 2013, 4:135  http://www.surgicalneurologyint.com/content/4/1/135well preserved [Figure 2d and e].",Non-OADS,/arxiv_data1/oa_pdf/e1/e0/SNI-4-135.PMC3815013.pdf
"Surgical Neurology International 2013, 4:135  http://www.surgicalneurologyint.com/content/4/1/135Microvascular flow or anatomical orientation of the  spinal cord needs to be ensured for safe and precise  surgery.",Non-OADS,/arxiv_data1/oa_pdf/e1/e0/SNI-4-135.PMC3815013.pdf
http://dx.doi.org/10.1016/j.nicl.2013.08.011 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/48/9c/main.PMC3815014.pdf
"First, cortical ROIs were identi ﬁed according to indi- vidual anatomical landmarks using FreeSurfer ( http://surfer.nmr.mgh.",OADS,/arxiv_data1/oa_pdf/48/9c/main.PMC3815014.pdf
"DTI data analysis Diffusion data preprocessing and probabilistic tractography were done using the FMRIB Diffusion Toolbox (FDT, http://www.fmrib.ox.",OADS,/arxiv_data1/oa_pdf/48/9c/main.PMC3815014.pdf
Regions of interest are illustrated on the inﬂated surface reconstruction of the ‘fsaverge ’dataset distributed with Freesurfer (https://surfer.nmr.mgh.harvard.edu/fswiki ).,OADS,/arxiv_data1/oa_pdf/48/9c/main.PMC3815014.pdf
"http://dx.doi.org/10.1016/j.redox.2013.09.005☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which per-mits non-commercial use, distribution, and reproduction in any medium, providedthe original author and source are credited.",OADS,/arxiv_data1/oa_pdf/7c/ec/main.PMC3815015.pdf
http://dx.doi.org/10.1089/ars.2012.5167 .,Non-OADS,/arxiv_data1/oa_pdf/7c/ec/main.PMC3815015.pdf
http://dx.doi.org/10.1089/ ars.2012.5147 .,Non-OADS,/arxiv_data1/oa_pdf/7c/ec/main.PMC3815015.pdf
http://dx.doi.org/10.1089/ars.2013.5413 .,Non-OADS,/arxiv_data1/oa_pdf/7c/ec/main.PMC3815015.pdf
http://dx.doi.org/10.1089/ars.2013.5257 .,Non-OADS,/arxiv_data1/oa_pdf/7c/ec/main.PMC3815015.pdf
http://dx.doi.org/10.1089/ars.2013.5576 .,Non-OADS,/arxiv_data1/oa_pdf/7c/ec/main.PMC3815015.pdf
http://dx.doi.org/10.1016/j.nicl.2013.08.013 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/14/42/main.PMC3815016.pdf
"MR image processing Cortical reconstruction and parcellation were performed with the FreeSurfer V4 package (v4.0.2) image analysis suite ( Fischl and Dale, 2000 ), which is documented and freely available for download online (http://surfer.nmr.mgh.harvard.edu/ ).",OADS,/arxiv_data1/oa_pdf/14/42/main.PMC3815016.pdf
http://dx.doi.org/10.1016/j.nicl.2013.09.010 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/54/42/main.PMC3815017.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Bilateral iliopsoas hematoma: Case report and literature review Azam Basheer1, Rajan Jain1,2, Toomas Anton3, Jack Rock1 Departments of 1Neurosurgery, and 2Diagnostic Radiology, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202, 3Neurosurgery, Cleveland Clinic Regional,  6780 Mayfield Road, HCS1‑728 Mayfield Heights, OH 44124, USA E‑mail:  Azam Basheer ‑ abashee1@hfhs.org, Rajan Jain ‑ rajanj@rad.hfh.edu, T oomas Anton ‑ toomas@roadrunner.com, *Jack Rock ‑ jrock1@hfhs.org   *Corresponding author Received: 11 July 2013   Accepted: 23 July 2013  Published: 20 September 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.118561 Quick Response Code: Abstract Background: Clinically significant spontaneous bilateral iliopsoas hematoma is a  rare complication of anticoagulation therapy.",Non-OADS,/arxiv_data1/oa_pdf/cb/19/SNI-4-121.PMC3815018.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/121/118561 Copyright: © 2013 Basheer A.,Non-OADS,/arxiv_data1/oa_pdf/cb/19/SNI-4-121.PMC3815018.pdf
"Surgical Neurology International 2013, 4:121  http://www.surgicalneurologyint.com/content/4/1/121severe pain, muscle dysfunction, and occasionally nerve  palsy with the femoral nerve most commonly affected.",Non-OADS,/arxiv_data1/oa_pdf/cb/19/SNI-4-121.PMC3815018.pdf
"Surgical Neurology International 2013, 4:121  http://www.surgicalneurologyint.com/content/4/1/121muscles are retroperitoneal and may cause sudden severe  back pain that radiates typically to the groin area and  anterolateral thigh.",Non-OADS,/arxiv_data1/oa_pdf/cb/19/SNI-4-121.PMC3815018.pdf
"Surgical Neurology International 2013, 4:121  http://www.surgicalneurologyint.com/content/4/1/121complications.",Non-OADS,/arxiv_data1/oa_pdf/cb/19/SNI-4-121.PMC3815018.pdf
http://dx.doi.org/10.1016/j.nicl.2013.08.008 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/bd/1d/main.PMC3815019.pdf
http://dx.doi.org/10.1016/j.nicl.2013.08.014 Contents lists available at ScienceDirect NeuroImage: Clinical journal homepage: www.elsevier.com/locate/ynicl,Non-OADS,/arxiv_data1/oa_pdf/17/74/main.PMC3815020.pdf
http://dx.doi.org/10.1093/cercor/bht003 (Epub ahead of print).,Non-OADS,/arxiv_data1/oa_pdf/17/74/main.PMC3815020.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comHistorical Review The history of neurosurgery in Bolivia and pediatric neurosurgery  in Santa Cruz de la Sierra Carlos F .",Non-OADS,/arxiv_data1/oa_pdf/52/29/SNI-4-123.PMC3815021.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/123/118937 Copyright: © 2013 Dabdoub CF .,Non-OADS,/arxiv_data1/oa_pdf/52/29/SNI-4-123.PMC3815021.pdf
"Surgical Neurology International 2013, 4:123  http://www.surgicalneurologyint.com/content/4/1/123Neurosurgery in precolumbian culture Skull trepanation The practice of neurosurgery in Bolivia began thousands  of years ago with skull trepanation–one of the oldest  neurosurgical procedures–which was learned in its western  area.",Non-OADS,/arxiv_data1/oa_pdf/52/29/SNI-4-123.PMC3815021.pdf
"Surgical Neurology International 2013, 4:123  http://www.surgicalneurologyint.com/content/4/1/123South America, one in Buenos Aires (Argentina) and the  other in Santiago (Chile).",Non-OADS,/arxiv_data1/oa_pdf/52/29/SNI-4-123.PMC3815021.pdf
"Surgical Neurology International 2013, 4:123  http://www.surgicalneurologyint.com/content/4/1/123School in Brazil with Prof. Mattos Pimenta and at Johns  Hopkins University in the United States with Prof. Earl  Walker, he came to La Paz in 1953.",Non-OADS,/arxiv_data1/oa_pdf/52/29/SNI-4-123.PMC3815021.pdf
"Surgical Neurology International 2013, 4:123  http://www.surgicalneurologyint.com/content/4/1/123economic and industrial capital of this country.",Non-OADS,/arxiv_data1/oa_pdf/52/29/SNI-4-123.PMC3815021.pdf
"Surgical Neurology International 2013, 4:123  http://www.surgicalneurologyint.com/content/4/1/123of the main neurosurgical journals do not offer enough  free articles for young surgeons.",Non-OADS,/arxiv_data1/oa_pdf/52/29/SNI-4-123.PMC3815021.pdf
"Surgical Neurology International 2013, 4:123  http://www.surgicalneurologyint.com/content/4/1/1232.",Non-OADS,/arxiv_data1/oa_pdf/52/29/SNI-4-123.PMC3815021.pdf
Available from:  http://www.undp.org/.,Non-OADS,/arxiv_data1/oa_pdf/52/29/SNI-4-123.PMC3815021.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Regression of cerebellar tonsillar descent and hydrocephalus  after endoscopic third ventriculostomy in a patient with a  quadrigeminal arachnoid cyst Yasuaki Arakawa, Daisuke Kita1, Isamu Ezuka, Yutaka Hayashi1, Jun‑ichiro Hamada1,  Yasuhiko Hayashi1 Department of Neurosurgery, Joetsu General Hospital, Joetsu, Niigata, Japan ‑ 148‑1, Daidoufukuda, Joetsu, 943‑8507, Japan, 1Kanazawa University, Kanazawa,  Ishikawa, Japan ‑ 13‑1, Takara‑machi, Kanazawa, 920‑8641, Japan E‑mail:  YasuakiArakawa ‑ hax  05600@tree.odn.ne.jp; Daisuke Kita ‑ kitad@med.kanazawa‑u.ac.jp; Isamu Ezuka ‑ ezuk2ism9@yahoo.co.jp; Yutaka Hayashi ‑ yuh@ med.kanazawa‑u.ac.jp; Jun‑ichiro Hamada ‑ jhamada@med.kanazawa‑u.ac.jp; *Yasuhiko Hayashi ‑ yahayashi@med.kanazawa‑u.ac.jp   *Corresponding author Received: 21 May 2013   Accepted: 13 August 2013  Published: 15 October 13 Access this article  online Website: www.surgicalneurologyint.",Non-OADS,/arxiv_data1/oa_pdf/1c/0e/SNI-4-142.PMC3815032.pdf
open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/142/119883 Copyright: © 2013 Arakawa Y.,Non-OADS,/arxiv_data1/oa_pdf/1c/0e/SNI-4-142.PMC3815032.pdf
"Surgical Neurology International 2013, 4:142  http://www.surgicalneurologyint.com/content/4/1/142elongation of the cerebellar tonsils results in a portion  of it protruding through the foramen magnum, causing  cerebellar tonsillar herniation, syringomyelia, and  occasionally hydrocephalus.",Non-OADS,/arxiv_data1/oa_pdf/1c/0e/SNI-4-142.PMC3815032.pdf
"Surgical Neurology International 2013, 4:142  http://www.surgicalneurologyint.com/content/4/1/142DISCUSSION The quadrigeminal cistern is a rare location for the origin  of an arachnoid cyst.",Non-OADS,/arxiv_data1/oa_pdf/1c/0e/SNI-4-142.PMC3815032.pdf
"Surgical Neurology International 2013, 4:142  http://www.surgicalneurologyint.com/content/4/1/1425.",Non-OADS,/arxiv_data1/oa_pdf/1c/0e/SNI-4-142.PMC3815032.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Cranioplasty with polymethylmethacrylate prostheses fabricated  by hand using original bone flaps: Technical note and surgical  outcomes Enrique Caro‑Osorio, Rafael De la Garza‑Ramos1, Sergio R. Martínez‑Sánchez,  Félix Olazarán‑Salinas2 Institute of Neurology and Neurosurgery, Hospital Zambrano Hellion, T ec Salud, 1T ecnológico de Monterrey School of Medicine and Health Sciences, 2Dentistry Lab  Olazarán and Associates, Monterrey, Nuevo León, México E‑mail: *Enrique Caro‑Osorio ‑ ecaro@itesm.mx; Rafael De la Garza‑Ramos ‑ rafdelag@gmail.com; Sergio R. Martínez‑Sánchez ‑ sergiorene@itesm.mx;   Félix Olazarán‑Salinas ‑ felixolazaran@gmail.com   *Corresponding author Received: 21 June 13   Accepted: 29 July 13  Published: 08 October 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.119535 Quick Response Code: Abstract Background:  Decompressive craniectomies (DC) mandate future cranioplasties,  accounting for the large array of biomaterials for this purpose.",Non-OADS,/arxiv_data1/oa_pdf/b5/ee/SNI-4-136.PMC3815033.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/136/119535 Copyright: © 2013 Caro-Osoria E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/b5/ee/SNI-4-136.PMC3815033.pdf
"Surgical Neurology International 2013, 4:136  http://www.surgicalneurologyint.com/content/4/1/136INTRODUCTION Cranioplasty is defined as the surgical repair of acquired  defects or congenital deformities of the cranium.",Non-OADS,/arxiv_data1/oa_pdf/b5/ee/SNI-4-136.PMC3815033.pdf
"Surgical Neurology International 2013, 4:136  http://www.surgicalneurologyint.com/content/4/1/136prosthesis, and fixed with Nylon sutures [Figure 2].",Non-OADS,/arxiv_data1/oa_pdf/b5/ee/SNI-4-136.PMC3815033.pdf
"Surgical Neurology International 2013, 4:136  http://www.surgicalneurologyint.com/content/4/1/136titanium; celluloids, PMMA, polyethylene, silicon, and  many others.",Non-OADS,/arxiv_data1/oa_pdf/b5/ee/SNI-4-136.PMC3815033.pdf
"Surgical Neurology International 2013, 4:136  http://www.surgicalneurologyint.com/content/4/1/136techniques depending on whether or not the original  bone flap is available.",Non-OADS,/arxiv_data1/oa_pdf/b5/ee/SNI-4-136.PMC3815033.pdf
"Surgical Neurology International 2013, 4:136  http://www.surgicalneurologyint.com/content/4/1/136reconstruction after decompressive craniectomy:  Prediction of complications  using fuzzy logic.",Non-OADS,/arxiv_data1/oa_pdf/b5/ee/SNI-4-136.PMC3815033.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Intraoperative dynamic assessment of the posterior  communicating artery and its branches by indocyanine green  videoangiography Bora Gürer, Veysel Antar, Ulas Cikla, Andrew Bauer, Mustafa K. Baskaya Departments of Neurological Surgery, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin 53792, USA E‑mail:  Bora Gürer ‑ boragurer@gmail.com; Veysel Antar ‑ veyselantar@hotmail.com; Ulas Cikla ‑ ulas.cikla@yahoo.com; Andrew Bauer ‑ a.bauer@neurosur ‑ gery.wisc.edu; *Mustafa K. Baskaya ‑ m.baskaya@neurosurgery.wisc.edu *Corresponding author Received: 12 June 13   Accepted: 28 August 13   Published: 25 September 13 Abstract Background:  True hemodynamic assessment of the posterior communicating  artery (PComA) by preoperative angiography in terms of its perforators and  configuration (adult  vs. fetal vs. transitional)  can be challenging  in the surgical  treatment  of aneurysms  involving  the PComA,  posterior  cerebral  artery, and basilar  artery.",Non-OADS,/arxiv_data1/oa_pdf/c1/77/SNI-4-122.PMC3815034.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/122/118936 Copyright: © 2013.,Non-OADS,/arxiv_data1/oa_pdf/c1/77/SNI-4-122.PMC3815034.pdf
"Surgical Neurology International 2013, 4:122  http://www.surgicalneurologyint.com/content/4/1/122avoid injury to the anterior thalamoperforating arteries  arising from the PComA.",Non-OADS,/arxiv_data1/oa_pdf/c1/77/SNI-4-122.PMC3815034.pdf
"Surgical Neurology International 2013, 4:122  http://www.surgicalneurologyint.com/content/4/1/122amenable to safe coiling due to its broad neck involving  the P1 posterior thalamoperforating artery.",Non-OADS,/arxiv_data1/oa_pdf/c1/77/SNI-4-122.PMC3815034.pdf
"Surgical Neurology International 2013, 4:122  http://www.surgicalneurologyint.com/content/4/1/122DSA, microvascular Doppler ultrasonography, and  ICG‑VA.",Non-OADS,/arxiv_data1/oa_pdf/c1/77/SNI-4-122.PMC3815034.pdf
"Incident AIDS-deﬁning illness The proportion of women who reported an incident ADI at 10 years was 21.3, 13.9, and 16.6% for black, white, and other women, respectively (see Supplemental Digital Content 1, Figure of Cumulative Incidence of Incident AIDS-Deﬁning Illness, http://links.lww.com/QAD/ A386).",OADS,/arxiv_data1/oa_pdf/39/6a/aids-27-2413.PMC3815041.pdf
"With drug users excluded, there was again no association of race with non- AIDS death (aHR for African American race 1.32, 95% CI 0.65, 2.66; P¼0.43) and little change in the association of other predictors with AIDS deaths (see Supplemental Digital Content 2, Supplemental Table 1, http://links.lww.com/QAD/A386 Predictors of AIDS Death with Illicit Drug Users Excluded and Supple- mental Digital Content 3, http://links.lww.com/QAD/ A386, Supplemental Table 2, http://links.lww.com/ QAD/A386 Predictors of Non-AIDS Death with Illicit Drug Users Excluded).",Non-OADS,/arxiv_data1/oa_pdf/39/6a/aids-27-2413.PMC3815041.pdf
http://aidsinfo.nih.,Non-OADS,/arxiv_data1/oa_pdf/39/6a/aids-27-2413.PMC3815041.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/25/119003 Stuart M. Brown.,Non-OADS,/arxiv_data1/oa_pdf/28/bd/JPI-4-25.PMC3815042.pdf
"J Pathol Inform 2013, 1:25  http://www.jpathinformatics.org/content/4/1/25helpful for the annotation and interpretation of this class  of sequence variants.",OADS,/arxiv_data1/oa_pdf/28/bd/JPI-4-25.PMC3815042.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Contralateral delayed epidural hematoma following intracerebral  hematoma surgery Volodymyr O. Solomiichuk, Konstantin I. Drizhdov Neurosurgical Department, Yalta City Hospital, Yalta, Crimea, Ukraine E‑mail: *Volodymyr O. Solomiichuk ‑ solomiichuk@gmail.com; Konstantin I. Drizhdov ‑ yaltaneurozav@bigmir.net   *Corresponding author Received: 31 May 13   Accepted: 29 August 13   Published: 03 October 13 Abstract Background: Delayed epidural hematoma (EDH) is an uncommon finding in  patients after intracranial hematomas evacuation.",Non-OADS,/arxiv_data1/oa_pdf/1f/2d/SNI-4-134.PMC3815043.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/134/119234 Copyright: © 2013.,Non-OADS,/arxiv_data1/oa_pdf/1f/2d/SNI-4-134.PMC3815043.pdf
"Surgical Neurology International 2013, 4:134  http://www.surgicalneurologyint.com/content/4/1/134CASE REPORT A 28‑year‑old right‑handed male with trauma signs  on his head (a wound in his occipital region, nasal  hemoliquorrhea, right‑sided otohemoliquorrhea) was  admitted to Yalta City Hospital after he felt down while  riding a skateboard.",Non-OADS,/arxiv_data1/oa_pdf/1f/2d/SNI-4-134.PMC3815043.pdf
"Surgical Neurology International 2013, 4:134  http://www.surgicalneurologyint.com/content/4/1/134Figure 3: CT scan in a day after the EDH evacuation Figure 4:  CT scan shows sinking skin flap at the 19th day after  decompressive craniectomy Figure 5: CT scan at the 76th day in the hospital Figure 6: Bone defects (left side) before cranioplasty Figure 7: Bone defects (right side) before cranioplasty  Figure 8: CT scan in a month after the cranioplasty At the 32nd day in the hospital, he was transferred from the  intensive care unit (ICU) into the neurosurgical department.",Non-OADS,/arxiv_data1/oa_pdf/1f/2d/SNI-4-134.PMC3815043.pdf
"Surgical Neurology International 2013, 4:134  http://www.surgicalneurologyint.com/content/4/1/134left‑sided spastic hemiparesis, anosognosia, right‑sided  convergent strabismus.",Non-OADS,/arxiv_data1/oa_pdf/1f/2d/SNI-4-134.PMC3815043.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Trigeminocardiac reflex in neurosurgical practice: Report of two  new cases Abbas Amirjamshidi, Kazem Abbasioun1, Farhad Etezadi2, Seyed Babak Ghasemi1 Departments of Neurosurgery, Sina Hospital, Emam Ave., 1Arad Hospital, Somaye Ave., 2Anesthesiology, Sina Hospital, Emam Ave., T ehran, Iran E‑mail: *Abbas Amirjamshidi ‑ abamirjamshidi@yahoo.com; Kazem Abbasioun ‑ dr.abbassioun@gmail.com; Farhad Etezadi ‑ etezadi@tums.ac.ir;  Seyed Babak Ghasemi ‑ babak.ghassemi@gmail.com   *Corresponding author Received: 23 May 13   Accepted: 13 August 13  Published: 27 September 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.119053 Quick Response Code: Abstract Background:  Systemic hypotension, cardiac dysrhythmia especially bradycardia,  apnea, and gastric hypermotility occurring presumably after stimulation of any of  the sensory branches of trigeminal nerve are coined as trigeminocardiac reflex  (TCR).",Non-OADS,/arxiv_data1/oa_pdf/39/1a/SNI-4-126.PMC3815044.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/126/119053 Copyright: © 2013 Amirjamshidi A.,Non-OADS,/arxiv_data1/oa_pdf/39/1a/SNI-4-126.PMC3815044.pdf
"Surgical Neurology International 2013, 4:126  http://www.surgicalneurologyint.com/content/4/1/126INTRODUCTION The trigeminocardiac reflex (TCR) is a well‑recognized  entity even though not a fully explained phenomenon,  consisting of arterial hypotension, bradycardia, apnea,  and gastric hypermotility.",Non-OADS,/arxiv_data1/oa_pdf/39/1a/SNI-4-126.PMC3815044.pdf
"Surgical Neurology International 2013, 4:126  http://www.surgicalneurologyint.com/content/4/1/126Lastly, she could not tolerate the vacuum drain and we  had to attach it to the bag without negative pressure.",Non-OADS,/arxiv_data1/oa_pdf/39/1a/SNI-4-126.PMC3815044.pdf
"Surgical Neurology International 2013, 4:126  http://www.surgicalneurologyint.com/content/4/1/126smoothly and gently.",Non-OADS,/arxiv_data1/oa_pdf/39/1a/SNI-4-126.PMC3815044.pdf
"Surgical Neurology International 2013, 4:126  http://www.surgicalneurologyint.com/content/4/1/126elevation in a patient undergoing craniotomy.",Non-OADS,/arxiv_data1/oa_pdf/39/1a/SNI-4-126.PMC3815044.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/24/119002,Non-OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
"J Pathol Inform 2013, 1:24  http://www.jpathinformatics.org/content/4/1/24INTRODUCTION Telepathology (remote pathological diagnosis system using  IT equipment) was first implemented in the early 1980s,[1]  and quickly spread around the world.",Non-OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
"J Pathol Inform 2013, 1:24  http://www.jpathinformatics.org/content/4/1/24The latter reached upload and download maximum  speeds of 2 and 10 Mbps, respectively.",OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
"J Pathol Inform 2013, 1:24  http://www.jpathinformatics.org/content/4/1/24Remote Image Diagnosis The cases used in our experiments are illustrated in  Tables 1 and 2.",Non-OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
"J Pathol Inform 2013, 1:24  http://www.jpathinformatics.org/content/4/1/24RESULTS Communication Network Communication Quality We used standard network testing tools (ping and  Iperf) to evaluate communication quality using the  WINDS.",OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
"J Pathol Inform 2013, 1:24  http://www.jpathinformatics.org/content/4/1/24T able 3: RTT measured with ping Sender→Receiver Minimum Mean Maximum Year 1 2010.1.27 1 hop Uchimaru →Yahaba 740.471 781.413 819.152 Yahaba→Uchimaru 740.807 779.588 818.951 Year 2 2011.6.30 1 hop Iwate→T okyo 746.813 786.608 825.848 T okyo→Iwate 756.958 794.970 836.155 Iwate→Okinawa 746.982 785.855 824.997 Okinawa→Iwate 775.997 811.766 854.027 2 hop T okyo→Okinawa 1576.921 1604.343 1625.646 Okinawa→T okyo 1535.765 1572.741 1614.639 ping: A network administration utility to test host reachability and measure RTT.",OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
"J Pathol Inform 2013, 1:24  http://www.jpathinformatics.org/content/4/1/24Operability of Remote Medical Equipment W arpVision Real‑time Video System (Year 1) For diagnosis to be made, remote microscopy requires  manipulability of the field of vision, zoom, and focus.",Non-OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
"J Pathol Inform 2013, 1:24  http://www.jpathinformatics.org/content/4/1/24Figure 5: Thyroid tissue specimen.",Non-OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
"J Pathol Inform 2013, 1:24  http://www.jpathinformatics.org/content/4/1/2411, 2011.",Non-OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
"J Pathol Inform 2013, 1:24  http://www.jpathinformatics.org/content/4/1/24pathological diagnosis with real‑time video and for  viewing and manipulating still‑image virtual slides  for conferencing and consultation.",Non-OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
"J Pathol Inform 2013, 1:24  http://www.jpathinformatics.org/content/4/1/24ACKNOWLEDGMENTS We would like to thank Ms. Kasumi Suzuki for managing the  project finances, and the many staff members who helped  with this new project at Iwate Medical University, IUHW Mita  Hospital and the University of the Ryukyus.",Non-OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
Available from: http://www.jaxa.jp/projects/sat/winds/index_e.html [Last  accessed on 2013 Jun 20].,OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
Available from: http://www.sapc.jaxa.jp/ antidisaster/20110311report_e/311report0_e.pdf [Last accessed on  2013 Jun 20].,OADS,/arxiv_data1/oa_pdf/c5/98/JPI-4-24.PMC3815045.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Primary human chorionic gonadotropin secreting germinoma  of the corpus callosum Foo Song Chuan Aaron, Chong Q. Q.",Non-OADS,/arxiv_data1/oa_pdf/e9/0e/SNI-4-137.PMC3815051.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/137/119537 Copyright: © 2013 Aaron FSC.,Non-OADS,/arxiv_data1/oa_pdf/e9/0e/SNI-4-137.PMC3815051.pdf
"Surgical Neurology International 2013, 4:137  http://www.surgicalneurologyint.com/content/4/1/137CASE REPORT History A 15-year -old Malay boy with no significant past medical  history was referred to our institution with a 2-month  history of intermittent fever, recurrent headaches,  vomiting, significant weight loss, and deterioration in  school performance.",Non-OADS,/arxiv_data1/oa_pdf/e9/0e/SNI-4-137.PMC3815051.pdf
"Surgical Neurology International 2013, 4:137  http://www.surgicalneurologyint.com/content/4/1/1371837.01 IU/L to less than 2.0 IU/L.",Non-OADS,/arxiv_data1/oa_pdf/e9/0e/SNI-4-137.PMC3815051.pdf
"Surgical Neurology International 2013, 4:137  http://www.surgicalneurologyint.com/content/4/1/137for IDIG treated with intensive platinum-based  chemotherapy combined with CSI (median dose 30.0 Gy;  range 21.0-36.0 Gy) and focal boosts to both primary  and secondary lesions (median dose 30.6 Gy; range  30.6-55.0 Gy) with minimal long-term side effects.",Non-OADS,/arxiv_data1/oa_pdf/e9/0e/SNI-4-137.PMC3815051.pdf
"Surgical Neurology International 2013, 4:137  http://www.surgicalneurologyint.com/content/4/1/1379.",Non-OADS,/arxiv_data1/oa_pdf/e9/0e/SNI-4-137.PMC3815051.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial The Crisis in the lack of skilled workers worldwide: Its meaning  for healthcare worldwide Edward E. Gordon President, Imperial Consulting Corporation; Chicago, IL, USA E-mails: *Edward E. Gordon - imperialcorp@juno.com   *Corresponding author Received: 23 August 13   Accepted: 23 August 13  Published: 10 October 13 EDITOR’S NOTE I have asked Ed Gordon who is an expert on the  Workforce Issues worldwide to comment on his new  book on this subject.",Non-OADS,/arxiv_data1/oa_pdf/47/d8/SNI-4-138.PMC3815077.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/138/119729 Copyright: © 2013 Gordon EE.,Non-OADS,/arxiv_data1/oa_pdf/47/d8/SNI-4-138.PMC3815077.pdf
"Surgical Neurology International 2013, 4:138  http://www.surgicalneurologyint.com/content/4/1/138were not part of the U.S. labor market.",Non-OADS,/arxiv_data1/oa_pdf/47/d8/SNI-4-138.PMC3815077.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/27/119005 Access this article online Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.119005 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
"J Pathol Inform 2013, 1:27  http://www.jpathinformatics.org/content/4/1/27their format is too small.",Non-OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
"J Pathol Inform 2013, 1:27  http://www.jpathinformatics.org/content/4/1/27OpenSlide on these platforms.",OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
"J Pathol Inform 2013, 1:27  http://www.jpathinformatics.org/content/4/1/27Calls for error handling and version control are shown  in Table 5.",OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
"J Pathol Inform 2013, 1:27  http://www.jpathinformatics.org/content/4/1/27of a slide; OpenSlide currently does not support such  slides due to API limitations.",OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
"J Pathol Inform 2013, 1:27  http://www.jpathinformatics.org/content/4/1/27the roles of OpenSlide and the OpenDiamond platform  highlighted.",OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
"J Pathol Inform 2013, 1:27  http://www.jpathinformatics.org/content/4/1/27slides.",Non-OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://confluence.cci.emory.edu:  8090/display/PAIS/DICOM+WG26 [Last accessed on 2013 Aug 26].,OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://loci.wisc.edu/software/bio‑formats [Last  accessed on 2013 Aug 26].,OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://www.gtk.org/[Last  accessed on 2013 Aug 26].,Non-OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://www.ijg.org/[Last accessed on 2013 Aug 26].,Non-OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://www.openjpeg.,Non-OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://www.xmlsoft.org/[Last  accessed on 2013 Aug 26].,OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://www.cairographics.org/ [Last accessed on 2013 Aug 26].,Non-OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://openslide.org/ [Last accessed on 2013 Aug 26].,OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from:  http://partners.adobe.com/public/developer/en/tiff/TIFF6.pdf [Last accessed  on 2013 Aug 26].,OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://www.aperio.com/documents/api/Aperio_ Digital_Slides_and_Third‑party_data_interchange.pdf.,OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://www.vips.ecs.soton.ac.uk/ [Last accessed on 2013 Aug 26].,Non-OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
"J Pathol Inform 2013, 1:27  http://www.jpathinformatics.org/content/4/1/2723.",Non-OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from:  http://rsbweb.nih.gov/ij/[Last accessed on 2013 Aug 26].,OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://slidetutor.upmc.edu/ [Last accessed on 2013 Aug 26].,Non-OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
Available from: http://www.scvp.net/acr/ [Last accessed on 2013 Aug 26].,Non-OADS,/arxiv_data1/oa_pdf/7e/33/JPI-4-27.PMC3815078.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Undifferentiated uterine sarcoma metastatic to the brain Douglas L Stofko Department of Neurosurgery, Philadelphia College of Osteopathic Medicine, Philadelphia, PA 19131, USA E‑mail: *Douglas L Stofko ‑ douglas.stofko@gmail.com   *Corresponding author Received: 30 April 13  Accepted: 01 August 13  Published: 27 September 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.119054  Quick Response Code: Abstract Background:  Undifferentiated uterine sarcoma  (UUS) is a rare tumor with an  aggressive growth pattern.",Non-OADS,/arxiv_data1/oa_pdf/f3/3e/SNI-4-127.PMC3815079.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/127/119054 Copyright: © 2013 Stofko DL.,Non-OADS,/arxiv_data1/oa_pdf/f3/3e/SNI-4-127.PMC3815079.pdf
"Surgical Neurology International 2013, 4:127  http://www.surgicalneurologyint.com/content/4/1/127local recurrence, and distant metastases.",Non-OADS,/arxiv_data1/oa_pdf/f3/3e/SNI-4-127.PMC3815079.pdf
"Surgical Neurology International 2013, 4:127  http://www.surgicalneurologyint.com/content/4/1/127DISCUSSION Uterine sarcomas are uncommon neoplasms,  compromising only 1% of all gynecological malignancies,  with an aggressive clinical course and poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/f3/3e/SNI-4-127.PMC3815079.pdf
"Surgical Neurology International 2013, 4:127  http://www.surgicalneurologyint.com/content/4/1/127ACKNOWLEDGMENTS William Rafferty, M.D REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/f3/3e/SNI-4-127.PMC3815079.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Endoglin (CD105) is a more appropriate marker than CD31 for  detecting microvessels in carotid artery plaques Ryu Fukumitsu, Yasushi Takagi, Kazumichi Y oshida, Susumu Miyamoto Department of Neurosurgery, Kyoto University School of Medicine, Kyoto, Japan E‑mail:  Ryu Fukumitsu ‑ ryuf@kuhp.kyoto‑u.ac.jp; *Yasushi Takagi ‑ ytakagi@kuhp.kyoto‑u.ac.jp; Kazumichi Yoshida ‑ kazuy@kuhp.kyoto‑u.ac.jp;  Susumu Miyamoto ‑ miy@kuhp.kyoto‑u.ac.jp   *Corresponding author Received: 26 June 2013   Accepted: 18 August 2013   Published: 30 September 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.119081  Quick Response Code: Abstract Background:  Microvascular proliferation is a major risk factor for plaque  vulnerability in patients with carotid stenosis.",Non-OADS,/arxiv_data1/oa_pdf/d3/0e/SNI-4-132.PMC3815080.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/132/119081 Copyright: © 2013 Fukumitsu R.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d3/0e/SNI-4-132.PMC3815080.pdf
"Surgical Neurology International 2013, 4:132  http://www.surgicalneurologyint.com/content/4/1/132MATERIALS AND METHODS Patient population Between November 2009 and March 2011, we performed  13 carotid endarterectomy operations in 12 patients at  Fukui Red Cross Hospital.",Non-OADS,/arxiv_data1/oa_pdf/d3/0e/SNI-4-132.PMC3815080.pdf
"Surgical Neurology International 2013, 4:132  http://www.surgicalneurologyint.com/content/4/1/132more microvessels were stained with CD105, although  the difference was not significant.",Non-OADS,/arxiv_data1/oa_pdf/d3/0e/SNI-4-132.PMC3815080.pdf
"Surgical Neurology International 2013, 4:132  http://www.surgicalneurologyint.com/content/4/1/132overexpressed in vascular endothelial tissues undergoing  angiogenesis.",Non-OADS,/arxiv_data1/oa_pdf/d3/0e/SNI-4-132.PMC3815080.pdf
"Surgical Neurology International 2013, 4:132  http://www.surgicalneurologyint.com/content/4/1/132REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/d3/0e/SNI-4-132.PMC3815080.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Giant cell angiofibroma of the scalp: A  benign rare neoplasm with  bone destruction Muhammad Z. Arifin1,2, Firman P .",Non-OADS,/arxiv_data1/oa_pdf/5a/da/SNI-4-131.PMC3815085.pdf
from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/131/119079 Copyright: © 2013 Arifin MZ.,Non-OADS,/arxiv_data1/oa_pdf/5a/da/SNI-4-131.PMC3815085.pdf
"Surgical Neurology International 2013, 4:131  http://www.surgicalneurologyint.com/content/4/1/131in size, soft, and without any tenderness [Figure 1a].",Non-OADS,/arxiv_data1/oa_pdf/5a/da/SNI-4-131.PMC3815085.pdf
"Surgical Neurology International 2013, 4:131  http://www.surgicalneurologyint.com/content/4/1/131round‑ to spindle‑shaped cells, collagenous or myxoid  stroma with focal sclerotic areas, medium‑sized to small  thick‑walled vessels, and multinucleated giant stromal  cells often lining the angiectoid spaces.",Non-OADS,/arxiv_data1/oa_pdf/5a/da/SNI-4-131.PMC3815085.pdf
"Surgical Neurology International 2013, 4:131  http://www.surgicalneurologyint.com/content/4/1/131Clinicopathologic and immunohisto chemical analysis of a series in favor of  a unifying concept.",Non-OADS,/arxiv_data1/oa_pdf/5a/da/SNI-4-131.PMC3815085.pdf
All libraries were deep sequenced and sequences analysed using IMGT/HighV-QUEST software (http://imgt.org/HighV-QUEST/index.,OADS,/arxiv_data1/oa_pdf/16/36/aids-27-2529.PMC3815086.pdf
"Unauthorized reproduction of this article is prohibited.scFv library construction (Table S1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/16/36/aids-27-2529.PMC3815086.pdf
"The cDNA was used as a template to amplify heavy chain variable regions and kappa/lambda light chains by PCR using high-ﬁdelity DNA polymerase and primers annealing to FR1s and FR4s of human antibody heavy chain variable regions and primers annealing to FR1s and constant regions of human antibody light chains (Table S2, http://links.lww.com/ QAD/A401).",OADS,/arxiv_data1/oa_pdf/16/36/aids-27-2529.PMC3815086.pdf
Trim sequences (/C21290 nt) were analysed using IMGT/HighV-QUEST software (http://imgt.org/HighV-QUEST/index.action).,OADS,/arxiv_data1/oa_pdf/16/36/aids-27-2529.PMC3815086.pdf
"Results Construction of large combinatorial DNA and cDNA antibody libraries We prepared the gDNAs from the PBMCs of 300 uninfected healthy donors and ampliﬁed the heavy chain variable regions and kappa and lambda light chain variable regions by semi-nested PCR using pooled gDNA as a template and a set of primers that annealed to the leader sequence or framework 1 (FR1) or FR4 of each heavy chain or kappa and lambda light chain gene family (Table S1, http://links.lww.com/QAD/A401).",OADS,/arxiv_data1/oa_pdf/16/36/aids-27-2529.PMC3815086.pdf
"More diverse heavy chain V-gene lineage usage in the genomic DNA libraries than in the cDNA libraries We ampliﬁed the scFvs from the gDNA libraries and the Fds and light chains from the cDNA libraries using primers that annealed to the pComb3X vector or to the constant regions of heavy or light chains (CH1 and CL, respectively) (Table S1 and S2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/16/36/aids-27-2529.PMC3815086.pdf
Available at: http://apps.who.int/iris/bitstream/10665/ 85321/1/9789241505727_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/62/af/qai-64-134.PMC3815087.pdf
Available at: http://www.msfaccess.org/content/putting-hiv-treatment-test.,Non-OADS,/arxiv_data1/oa_pdf/62/af/qai-64-134.PMC3815087.pdf
Available at: http://www.unitaid.eu/images/marke tdynamics/publications/UNITAIDHIV_ Diagnostics_Landscape-2nd_edition.pdf.,Non-OADS,/arxiv_data1/oa_pdf/62/af/qai-64-134.PMC3815087.pdf
The work cannot be changed in any way or used commercially.http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/06/90/nen-72-1062.PMC3815088.pdf
"Gallyas silver method or the AT100 antibody speciﬁc for a late phospho-form of tau (40) appeared in the entorhinal cortex onlystarting at 6 weeks pi (Figure, S upplemental Digital Content 1, http://links.lww.com/NEN/A524).",Non-OADS,/arxiv_data1/oa_pdf/06/90/nen-72-1062.PMC3815088.pdf
"Labeling of the dentate gyrus with the nerve terminal marker synaptophysin showed that, at6 weeks after pathologic human tau expression, the synapticdensity was reduced in the lateral perforant pathway terminal ﬁeld in the OML and the molecular layer shrank (Figure, Sup- plemental Digital Content 2, http://links.lww.com/NEN/A525);this is an established response to perforant pathway partial deaf- ferentation (43 Y45).",Non-OADS,/arxiv_data1/oa_pdf/06/90/nen-72-1062.PMC3815088.pdf
"4; Figure, Sup-plemental Digital Content 2, http://links.lww.com/NEN/A525).",Non-OADS,/arxiv_data1/oa_pdf/06/90/nen-72-1062.PMC3815088.pdf
"The tau-driven death of perforant pathway neurons precedes Gallyas-positive neuroﬁbrillary tangles and phos- phorylation of the AT100 and PHF1 epitopes that are latemarkers for tau aggregation (Figure, Supplemental DigitalContent 2, http://links.lww.com/NEN/A525) (53), thus adding to evidence that tau neurotoxicity is separable from tangle formation (54 Y56).",Non-OADS,/arxiv_data1/oa_pdf/06/90/nen-72-1062.PMC3815088.pdf
"The model inputs and structure contain notable differences (Table 1, with more detail included in Supplemental Digital Content 1, http://links.lww.- com/QAD/A377).",Non-OADS,/arxiv_data1/oa_pdf/f2/93/aids-27-2637.PMC3815090.pdf
"More details on the model input s are included as Supplemental Digital Content 1, http://links.lww.com/QAD/A377.",Non-OADS,/arxiv_data1/oa_pdf/f2/93/aids-27-2637.PMC3815090.pdf
"New York: UNICEF, the World Health Organization, the World Bank, and the United Nations Popula- tion Division; 2012, http://www.childinfo.org/ﬁles/Child_ Mortality_Report_2012.pdf (Accessed 6 June 2013) .",Non-OADS,/arxiv_data1/oa_pdf/f2/93/aids-27-2637.PMC3815090.pdf
Pretoria: Government of South Africa; 2005. http://www.parliament.gov.za/content/millennium %20development%20goals%20country%20report%202005.,Non-OADS,/arxiv_data1/oa_pdf/f2/93/aids-27-2637.PMC3815090.pdf
"Cape Town: South African Medical Research Council; 2012, http://www.mrc.ac.za/bod/RapidMor tality2011.pdf (Accessed 22 May 2013) .",Non-OADS,/arxiv_data1/oa_pdf/f2/93/aids-27-2637.PMC3815090.pdf
"Cape Town: South African Medical Research Council, National Department of Health of South Africa, and PEPFAR/US Centers for Disease Control and Prevention; 2012, http://www.doh.gov.za/docs/ reports/2012/pmtcteffectiveness.pdf (Accessed 6 June 2013) .",Non-OADS,/arxiv_data1/oa_pdf/f2/93/aids-27-2637.PMC3815090.pdf
Available at: http://www.plosone.org/article/info%3Adoi%2F10.1371% 2Fjournal.pone.0002891.,Non-OADS,/arxiv_data1/oa_pdf/d6/53/qai-63-0647.PMC3815091.pdf
Available at: http://www.plosone.,Non-OADS,/arxiv_data1/oa_pdf/d6/53/qai-63-0647.PMC3815091.pdf
Available a t: http://www.biomedcen- tral.com/1471-2334/11/244.,Non-OADS,/arxiv_data1/oa_pdf/d6/53/qai-63-0647.PMC3815091.pdf
Available at: http://www.harpnet.org/doc/london_sepsis_mtg09-07.pdf.,Non-OADS,/arxiv_data1/oa_pdf/14/33/inf-32-S26.PMC3815092.pdf
Available at: http://www.who.int/maternal_child_adolescent/docu- ments/ImCI_chartbooklet/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/inf-32-S46.PMC3815093.pdf
Available at: http://www.everywomaneverychild.org/component/content/article/1-about/316-injectable-antibiotics-for-newborn-sepsis–product-   profile.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/inf-32-S46.PMC3815093.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial EDITOR’S NOTE Most people, physicians included, do not have the time to understand the socio‑economic and political events that  are happening daily.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/139/119730 Copyright: © 2013 Ausman JI.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139their expenses.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139For those with restricted time, I suggest that you read  the ABSTRACT first, then the outline of the contents of  the paper to get a broad view of the subject, and finally  Section 24 beginning with “What you should conclude  from this Information” to the end.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139PART I: THE SOCIO-ECONOMIC-POLITICAL- SCENE-WHAT YOU NEED TO KNOW 1.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139Printing currency to remain competitive in the world  economy as has been done in the USA and Europe and  other countries only causes a currency war that is bad for  all.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139throughout the rest of this decade and beyond, and debt  will spiral ever higher…By 2025 revenue will be able to  finance only interest payments [on the debt] Medicare,  Medicaid and Social Security.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/1395.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139Even the passage of Obamacare violated the  constitutional process in Congress according to a  paper written by Faria.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139b.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139the government scandals and corruption of the present  administration.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139gasoline costs impact the working poor more than others,  driving many of these people to obtain food stamps and  government assistance programs.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139own currencies[17,22,42] and not US dollars.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139under a central controlling philosophy by a self‑selected  few, who believe they know more than others and should  decide the course of human life.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139b.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139with this huge self‑centered consumption and welfare  state we have created.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139US needs workers, who can think critically and possess  intellectual curiosity…The jobs and skills mismatch is not  simply escalating in the United States but also across the  globe as well…Six out of every ten applicants for basic  tech jobs do not qualify because they lack a basic liberal  arts education in reading, writing, math, and science… For the remainder of this decade business competition  for this scarce talent will be unprecedented…only ten  percent of Chinese engineering graduates meet the global  professional standards of major American and European  firms…[In India] talent growth is constricted because  academic quality is so poor in many of India’s higher  educational institutions…[In India] 75% of the technical  graduates and 85% of the general college education  graduates were considered unemployable…Although  the United States invests more in its schools than any  other nation, the results of its general education system  largely range from mediocre to downright dismal…the  percentage of Americans who are well educated is below  average compared to other rich nations…Only 7 percent  of US students scored at the advanced level in math, in  contrast to 48% of eighth graders in Singapore and 47%  of South Koreans, the two best performing nations…In  reading and math the number of low achieving American  children exceeds the total combined number of similar  students in Germany, France, the United Kingdom,  T urkey and Japan…[In the USA] one million students  drop out of school every year…”[47] Gordon describes a solution to this skill‑education crisis  that is being utilized worldwide.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139Oklahoman by Elmer T .",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139and unemployment do not fit with what the public sees  and hears and are manipulated by the government.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/13921st century by molecular and genetic changes, (13) the  introduction of Artificial Intelligence providing creative  powers beyond what can be conceived today, (14) the  production of food for all, and (15) the challenge of  meeting other civilizations that probability must exist in  yet undiscovered planets.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139replacements, angioplasty, bypass surgery and cataract  operations …Astoundingly, doctors will be paid less to  treat a senior than to treat someone on Medicaid, and  only about one‑third of what a doctor will be paid to  treat a patient with private insurance.”[78] These policies exist in many European countries with  Socialized Medicine.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139or companies has given SNI or me any compensation for  this endorsement.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.nerdwallet.com/blog/credit-card-data/ average-credit-card-debt-household.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.people-press.org/2013/08/08/ amid-criticism-support-for -medias-watchdog-role-stands-out.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Kitco;	7/1/13	 Available from: http://www.kitco.com/ind/Aden/2013-07-01-DEFLATION-P ULLING-MORE-THAN-INFLATION.html.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.wallstreetdaily.com/2013/05/06/unemployment- rate-jobs-market.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://sovereign-investor.com/2013/04/18/ obama-has-a-new-401k-yours.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.thedailybell.com/29116/ Bill-Bonner -What-TARP-Boss-Neil-Barofsky-T old-Me-Yesterday-Should-Sh ock-Y ou.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from:  http://www.bls.gov/news.release/empsit.t15.htm.,OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available  from: http://blog.heritage.org/2009/02/12/true-cost-of-stimulus-327-trillion.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available  from: http://www.wnd.com/2013/01/heres-the-real-unemployment-rate.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://news.investors.com/print/ibd-editorials/072413- 664997-doctors-rather -quit-than-practice-under -obamacare.aspx (60% will  retire earlier than planned).,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.moneynews.com/Economy/ retail-sales -economic-growth/2013/07/15/id/515025?s  = alandpromo_ code = 142B2-1.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Emanuel R. Y ou Never Want a Serious Crisis to go to Waste… Available from:  http://www.youtube.com/watch?v = 1yeA_kHHLow.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.haciendapub.com/articles/ america-guns-and-freedom-part-i-recapitulation-liberty.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://haciendapublishing.com/articles/political- spectrum-part-ii-%E2%80%94-center-democracy-or-constitutional-republic.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.people-press.org/2013/07/26/ few-see-adequate-limits-on-nsa-surveillance-program.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Did Justice Department support anti-Zimmerman protests after  Martin shooting Available from: http://www.foxnews.com/politics/2013/07/10/ did‑justice‑department‑support‑anti‑zimmerman‑protests‑after‑trayvon‑sho oting/#ixzz2aMec9kMB.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.washingtonpost.com/blogs/wonkblog/ wp/2013/07/24/obamas-speech-on-the-economy.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/13951.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.mauldineconomics.com/ outsidethebox/is- the-government- lying- to-us-about- inflation- yes.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.washingtonpost.com/blogs/ fact-checker/post/romneys-claims-of-misspent-stimulus-money/2012/07/26/ gJQAIjOHBX_blog.html.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://blog.heritage.org/2013/05/27/the-irs-obamacare-and -you-part-i-the-taxes.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.reuters.com/article/2013/05/15/ us-italy-gdp-idUSBRE94E0D820130515.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.slate.com/articles/news_and_politics/map_of_ the_week/2013/04/food_stamp_recipients_by_county_an_interactive_tool_ showing_local_snap_data.html.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.forbes.com/sites/trulia/2013/02/12/ jobs-arent-leaving-california-for -texas-but-people-are.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://townhall.com/columnists/ donaldlambro/2013/06/05/a -darkening -cloud -of-scandals -engulfs -obama -ad ministration-n1612919/page/full.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.bloomberg.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.law.harvard.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://news.investors.com/economy/050313- 654656-uneven-job-gains-still-lack-momentum.htm.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available	from:	http://finance.yahoo.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available	 from: http://www.chaostan.com/values.html.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available  from: http://www.wfs.org/futurist/2013-issues-futurist/march-april-2013-vol- 47-no-2/how-innovation-could-save-planet.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from:  http://www.ntu.org/tax-basics/who-pays-income-taxes.html.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.moneynews.com/StreetTalk/ WSJ-Moore-Cities-Detroit/2013/07/23/id/516643.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.moneynews.com/Outbrain/ billionaires -dump -economist -stock/2012/08/29/id/450265?PROMO_ CODE = FE8A-1.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://sovereign-investor.com/2013/08/02/ civil-unrest-coming-to-america.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://sovereign-investor.com/2013/05/21/ protect-yourself-from-the-fed.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://sovereign-investor.com/2013/08/01/ no-one -saw-this -coming/?utm_source = feedburnerandutm_ medium = feedandutm_campaign = Feed%3A + sovereign-investor+(The +  Sovereign + Investor).,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://moneymorning.com/ob-article/ schiff-us-will-win-currency-war.php.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://blog.heritage.org/2013/05/27/ the-facts-about-food-stamps-everyone-should-hear.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://fullcomment.nationalpost.com/2011/01/22/,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Surgical Neurology International 2013, 4:139  http://www.surgicalneurologyint.com/content/4/1/139lawrence-solomon-china’s-fall.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available	from:	http://www.gopusa.co	 m/ commentary/2013/02/05/sowell-prophets-and-losses/?subscriber = 1.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available  from: http://news.investors.com/ibd-editorials-perspective/021513-644751- banker -says-government-not-market-caused -crisis.html.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available  from: http://news.goldseek.com/GoldSeek/1374156000.php; and http://sprott.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"The Daily  Crux, 8/5/13 Available from: http://www.thedailycrux.com/Post/42858/ porter -stansberry-the-end-of-america-has-arrived.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.thedailybeast.com/articles/2011/01/26/ states-most-likely-to-go-bankrupt.html.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.physiciansweekly.com/ physician-survey-salary-hours.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from:  http://news.investors.com/ibd-editorials/071012-617686-doctor-discontent- with-obamacare-known-long-ago.htm.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available	from:	http://www.fiscalcommission.gov/ sites/fiscalcommission.gov/files/documents/TheMomentofTruth12_1_2010.,OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available  from: http://www.hschange.com/CONTENT/851/851.pdf.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.nytimes.com/2011/01/21/business/ economy/21bankruptcy.html?pagewanted = all.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.moneynews.com/Economy/ Dimon-US-economy-Fed/2013/07/12/id/514804.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.moneynews.com/Economy/ economy-recovery-data-Fed/2013/07/23/id/516471?s = alandpromo_ code = 1442D-1.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://www.moneynews.com/RobertWiedemer/China- growth-Morgan-Stanley-Bear -Stearns/2013/07/12/id/514787.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://en.wikipedia.org/wiki/ Friedrich_Hayek Wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: https://en.wikipedia.org/wiki/Gold_standard.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://en.wikipedia.org/ wiki/Gross_national_product.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available	from:	https://en.wikipedia.org/wiki/Inflation.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available	from:	https://en.wikipedia.org/ wiki/Keynesian_economics.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://en.wikipedia.org/wiki/ Vladimir_Lenin.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available	from:	http://en.wikipedia.org/wiki/ Medical_tourism.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available	from:	http://en.wikipedia.org/wiki/ Ponzi_scheme.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available	from:	http://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
Available from: http://en.wikipedia.org/wiki/Republic.,Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-4-139.PMC3815094.pdf
"Data analyses were conducted using STATA version 12 (Stata Corporation, College Station, T exas, USA) and R version 2.15.0 (http://CRAN.R-project.org).Demographic variables, method to determine EDI, and baseline characteristics were summarized by HIV-1 subtype.",OADS,/arxiv_data1/oa_pdf/e2/0a/aids-27-2775.PMC3815107.pdf
"(See Table, Supplemental Digital Content, http://links.lww.com/QAD/A402, which shows the population characteristics for all 615 enrolled volunteers.)",Non-OADS,/arxiv_data1/oa_pdf/e2/0a/aids-27-2775.PMC3815107.pdf
"(See Table, Supplemental Digital Content 1, http://links.lww.com/QAD/A402, which shows the Cox proportional hazards models for participants in East Africa only.)",Non-OADS,/arxiv_data1/oa_pdf/e2/0a/aids-27-2775.PMC3815107.pdf
"(See Table, Supplemental Digital Content 2, http://links.lww.com/QAD/A402, which shows the Cox proportional hazards models among study participants from discordant couples.)",Non-OADS,/arxiv_data1/oa_pdf/e2/0a/aids-27-2775.PMC3815107.pdf
"Adjusted analyses combining non-MSM and MSM (see Table, Supplemental Digital Content 3, http://links.lww.com/QAD/A402, which shows Cox proportional hazards models comparing all men to women) showed no difference in immunologic pro- gression between males and women but indicated faster virologic and clinical progression for males.2778 AIDS 2013, Vol 27 No 17",Non-OADS,/arxiv_data1/oa_pdf/e2/0a/aids-27-2775.PMC3815107.pdf
"(See Table, Supplemental Digital Content 4, http://links.lww.com/QAD/A402, which shows the distribution of HLA types identiﬁed in the study by infecting HIV-1 subtypes.",Non-OADS,/arxiv_data1/oa_pdf/e2/0a/aids-27-2775.PMC3815107.pdf
"(See table, Supplementary Digital Content 5, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/e2/0a/aids-27-2775.PMC3815107.pdf
"(See Table, Supplemental Digital Content 6, http://links.lww.com/ QAD/A402, which shows median CD4þcell counts at month 3 among participants in East Africa by sex and infecting subtype.)",Non-OADS,/arxiv_data1/oa_pdf/e2/0a/aids-27-2775.PMC3815107.pdf
"Meetings in the UK Postgraduate Course in Radiopharmacy Date: 10–13 December 2013 Venue: St Thomas’ Hospital, King’s College London Contact: teachingadmin-imaging@ kcl.ac.uk UK Radiopharmacy Workshop Date: 17 January 2014 Venue: The Beeches Conference Centre, Bournville, Birmingham Website: www.ukrg.org.uk 3rdAnnual SPECT/CT Imaging Sympo- sium: Current status and future direction of SPECT/CT imagingDate: 24 February 2014 Venue: British Institute of Radiology, London Website: www.bnms.org.uk BNMS Spring Meeting Date: 11–14 May 2014 Venue: International Centre, Harrogate Website: www.bnms.org.ukInternational meetings Imaging Infections and Inflammation Date: 12–14 December 2013 Venue: Rome, Italy Contact: alberto.signore@ uniroma1.it 3rdT ubingen PET/MR Workshop Date: 17–21 February 2014 Venue: T ubingen, Germany Website: www.pet-mr-tuebingen.de NuklearMedizin 2014 Date: 26–29 March 2014 Venue: Hannover, Germany Contact: office@nuklearmedizin.de ESRR14: 17th European Symposium on Radiopharmacy and Radiopharmaceuti- cals Date: 24–27 April 2014 Venue: Pamplona, Spain Website: http://esrr14.eanm.org Society of Nuclear Medicine and Molecu- lar Imaging Annual Meeting Date: 7–11 June 2014 Venue: St Louis, Missouri Website: www.snmmi.org/am2014 Gordon Research Conference: Metals in Medicine Date: 22–27 June 2014 Venue: Proctor Academy, Andover, New Hampshire Website: www.grc.org 11thCongress of World Federation of Nuclear Medicine and Biology Date: 27–31 August 2014 Venue: Cancun, Mexico Website: www.wfnmb.org EANM14: Annual congress of the Euro- pean Association of Nuclear Medicine Date: 18–22 October 2014 Venue: Goteberg, Sweden Website: www.eanm.org An ongoing list of events can be found on the BNMS website at www.bnms.org.uk .",Non-OADS,/arxiv_data1/oa_pdf/56/80/mnm-34-1240.PMC3815115.pdf
"1 (Supplemental digital content 1, http://links.lww.com/NMC/A16 ).Fig.",Non-OADS,/arxiv_data1/oa_pdf/8d/e6/mnm-34-1166.PMC3815117.pdf
"Available at: http://www.drugs.com [Accessed 25 August 2013].10 Luxen A, Guillaume M, Melega WP, Pike VW, Solin O, Wagner R. Production of 6-[18F]fluoro- L-DOPA and its metabolism in vivo: critical review.",Non-OADS,/arxiv_data1/oa_pdf/d9/fb/mnm-34-1141.PMC3815120.pdf
Available at: http://ec.europa.eu/energy/ nuclear/radiation_protection/doc/publication/097_en.pdf [Accessed 10 July 2013].,Non-OADS,/arxiv_data1/oa_pdf/ae/5a/mnm-34-1208.PMC3815145.pdf
Method for estimating effective dose equivalent from external radiation sources using two dosimeters.Available at: http://www.nrc.gov .,Non-OADS,/arxiv_data1/oa_pdf/ae/5a/mnm-34-1208.PMC3815145.pdf
"3 Du Bruyn C. SA boosts isotope production after Canadian reactor shuts down, 2009; Available at: http://www.engineeringnews.co.za/article/ sa-boosts-medical-isotope-production-after canadian-reactor-shutdown-2009-07-03 [Accessed 18 March 2013].",Non-OADS,/arxiv_data1/oa_pdf/0a/99/mnm-34-1233.PMC3815205.pdf
"4 Atchar R, Guerin B. U.S. still vulnerable to isotope shortage, 2011; Available at:http://www.rsna.org/NewsDetail [Accessed 21 April 2013].",Non-OADS,/arxiv_data1/oa_pdf/0a/99/mnm-34-1233.PMC3815205.pdf
"For the replication dataset, we used 481 patient DNA samples from the NINDS Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/ninds).",OADS,/arxiv_data1/oa_pdf/fe/17/ahg0077-0351.PMC3815478.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:301-314 Regulation of Muscle Pyruvate Dehydrogenase  Complex in Insulin Resistance: Effects of Exercise   and Dichloroacetate Dumitru Constantin-Teodosiu School of Life Sciences, University of Nottingham Medical School, Nottingham, UK Since the mitochondrial pyruvate dehydrogenase complex (PDC) controls the rate of carbohydrate oxidation, impairment of PDC  activity mediated by high-fat intake has been advocated as a causative factor for the skeletal muscle insulin resistance, metabolic  syndrome, and the onset of type 2 diabetes (T2D).",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
Pyruvate can either be reduced to  lactate or oxidised by pyruvate dehydrogenase complex (PDC)  in mitochondria to produce acetyl-CoA according to the fol - lowing irreversible reaction: pyruvate+coenzyme A (CoASH)+   nicotinamide adenine dinucleotide (NAD+)→ acetyl-CoA+  Review Pathophysiology http://dx.doi.org/10.4093/dmj.2013.37.5.301 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
302Constantin-Teodosiu D Diabetes Metab J 2013;37:301-314 http://e-dmj.orgnicotinamide adenine dinucleotide hydrogen (NADH)+CO 2.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
303Carbohydrate utilisation during exercise Diabetes Metab J 2013;37:301-314 http://e-dmj.orgoverexpressed [8].,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
"304Constantin-Teodosiu D Diabetes Metab J 2013;37:301-314 http://e-dmj.orgsuggest that following a standard mixed-meal (55% to 60%  CHO, 30% to 35% fat, and 10% to 15% protein) the exercise  mediated muscle acetyl-CoA and NADH accumulation do not  inhibit the transformation/activation of PDC to PDCa.",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
"305Carbohydrate utilisation during exercise Diabetes Metab J 2013;37:301-314 http://e-dmj.orgother similar rodent inflammatory model it was observed that  concomitant with the up-regulation of skeletal muscle PDK4, there was also a down-regulation of the muscle Ca2+-depen - dent PDC phosphatase (PDP1) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
"306Constantin-Teodosiu D Diabetes Metab J 2013;37:301-314 http://e-dmj.org In T2D and starvation, states which are well associated with  high circulating FFA levels, PDP1 level in heart and presum - ably skeletal muscle is lower than in control [34].",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
"307Carbohydrate utilisation during exercise Diabetes Metab J 2013;37:301-314 http://e-dmj.orgbeen linked to lower blood glucose levels, it seems therefore  appropriate to suggest that any PPAR- δ mediated blood glu - cose lowering effect will be unlikely to be attributable to an in - crease in PDC-mediated oxidative glucose disposal as this  route would be inhibited following PPAR- δ mediated inhibi - tion of PDCa.",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
"308Constantin-Teodosiu D Diabetes Metab J 2013;37:301-314 http://e-dmj.orgcleus [48,49], and FOXO1 can bind directly to the promoter  region of the PDK4 gene [48], it is reasonable to suggest that  FOXO factors could also play an important role in promoting  the up-regulation of PDK4 mRNA in response to increased  FFA availability.",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
"309Carbohydrate utilisation during exercise Diabetes Metab J 2013;37:301-314 http://e-dmj.orgDCA increases CHO oxidation, reduces muscle lactate accu - mulation simultaneously.",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
"310Constantin-Teodosiu D Diabetes Metab J 2013;37:301-314 http://e-dmj.orgthe condition of Chuvash polycythemia (CP), which is an au - tosomal recessive disorder with an endemic prevalence in the  region of Chuvashia in the central European part of Russia.",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
311Carbohydrate utilisation during exercise Diabetes Metab J 2013;37:301-314 http://e-dmj.orgfollowing several days of high-fat dietary intake can also fully  activate muscle PDC and restore oxidative glucose use during  exercise.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
312Constantin-Teodosiu D Diabetes Metab J 2013;37:301-314 http://e-dmj.orgol 1987;63:440-2.,Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
"313Carbohydrate utilisation during exercise Diabetes Metab J 2013;37:301-314 http://e-dmj.orgKW , Y eaman SJ.",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
"314Constantin-Teodosiu D Diabetes Metab J 2013;37:301-314 http://e-dmj.orgmon MC, Huang J, Simcox JA, Y oon D, Prchal JT, Gordeuk  VR.",Non-OADS,/arxiv_data1/oa_pdf/2e/bf/dmj-37-301.PMC3816130.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:315-325 SIRT1 in Type 2 Diabetes: Mechanisms and  Therapeutic Potential Munehiro Kitada, Daisuke Koya Division of Diabetology and Endocrinology, Kanazawa Medical University, Kahoku, Japan The prevalence of type 2 diabetes mellitus (T2DM) has been increasing worldwide.",Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
Review Pathophysiology http://dx.doi.org/10.4093/dmj.2013.37.5.315 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
"Diabetes Metab J 2013;37:315-325 http://e-dmj.orgThus, CR has a variety of beneficial effects with respect to lifes - pan extension and delays the onset of age-related diseases,  such as cardiovascular diseases, neurodegenerative disorders,  and diabetes.",Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
317SIRT1 and type 2 diabetes Diabetes Metab J 2013;37:315-325 http://e-dmj.orgsis and function and is regulated by an acetylation/deacety - lation reaction.,Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
"Diabetes Metab J 2013;37:315-325 http://e-dmj.orgβ-Cells in SIRT1-deficient mice, however, produce less ATP in  response to glucose than do normal mice.",Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
319SIRT1 and type 2 diabetes Diabetes Metab J 2013;37:315-325 http://e-dmj.orgtribute to the regulation of inflammation in monocytes/mac - rophages and adipose tissue in humans [8].,Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
Diabetes Metab J 2013;37:315-325 http://e-dmj.orgPGC-1α expression and activation.,Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
321SIRT1 and type 2 diabetes Diabetes Metab J 2013;37:315-325 http://e-dmj.org Dyslipidemia often coincides with T2DM.,Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
"Diabetes Metab J 2013;37:315-325 http://e-dmj.orgsitivity, triglyceride levels, energy expenditure, hepatic lipid  accumulation, and the activation of the AMPK/SIRT1 path - way in skeletal muscle.",Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
323SIRT1 and type 2 diabetes Diabetes Metab J 2013;37:315-325 http://e-dmj.org3.,Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
Diabetes Metab J 2013;37:315-325 http://e-dmj.org25.,Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
325SIRT1 and type 2 diabetes Diabetes Metab J 2013;37:315-325 http://e-dmj.orgtion.,Non-OADS,/arxiv_data1/oa_pdf/fe/56/dmj-37-315.PMC3816131.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/b9/dmj-37-326.PMC3816132.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:326-332 Refocusing Peroxisome Proliferator Activated  Receptor-α: A New Insight for Therapeutic Roles in  Diabetes Hannah Seok, Bong Soo Cha Division of Endocrinology and Metabolism, Department of Internal Medicine, Y onsei University College of Medicine, Seoul, Korea Although glucose-lowering treatment shows some risk lowering effects in cardiovascular diseases, risks of macrovascular and  microvascular complications have still remained, and development of new therapeutic strategies is needed.",Non-OADS,/arxiv_data1/oa_pdf/5b/b9/dmj-37-326.PMC3816132.pdf
Ligand-binding do -Review Pathophysiology http://dx.doi.org/10.4093/dmj.2013.37.5.326 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/5b/b9/dmj-37-326.PMC3816132.pdf
327Metabolic role of PPAR-α in type 2 diabetes Diabetes Metab J 2013;37:326-332 http://e-dmj.orgmains determine how specific pharmacologic and endogenous  nuclear receptor ligands bind to and modulate receptor activity.,Non-OADS,/arxiv_data1/oa_pdf/5b/b9/dmj-37-326.PMC3816132.pdf
"Diabetes Metab J 2013;37:326-332 http://e-dmj.org(HR, 1.19; 95% CI, 0.90 to 1.57).",Non-OADS,/arxiv_data1/oa_pdf/5b/b9/dmj-37-326.PMC3816132.pdf
"329Metabolic role of PPAR-α in type 2 diabetes Diabetes Metab J 2013;37:326-332 http://e-dmj.orgOther PPAR- α agonist such as gemfibrozil and bezafibrate also  showed reno-protective effect in diabetic nephropathy [48,49].",Non-OADS,/arxiv_data1/oa_pdf/5b/b9/dmj-37-326.PMC3816132.pdf
Diabetes Metab J 2013;37:326-332 http://e-dmj.orgported.,Non-OADS,/arxiv_data1/oa_pdf/5b/b9/dmj-37-326.PMC3816132.pdf
331Metabolic role of PPAR-α in type 2 diabetes Diabetes Metab J 2013;37:326-332 http://e-dmj.orgMed 2012;125:126-33.,Non-OADS,/arxiv_data1/oa_pdf/5b/b9/dmj-37-326.PMC3816132.pdf
Diabetes Metab J 2013;37:326-332 http://e-dmj.org43.,Non-OADS,/arxiv_data1/oa_pdf/5b/b9/dmj-37-326.PMC3816132.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/4b/dmj-37-333.PMC3816133.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:333-339 The Interplay between Autophagy and Aging Jong-Ok Pyo, Seung-Min Y oo, Y ong-Keun Jung Bio-MAX Institute, Seoul National University School of Biological Sciences, Seoul, Korea Numerous studies have established a link between autophagy and aging; however, the relationship has not been clearly defined.",Non-OADS,/arxiv_data1/oa_pdf/3a/4b/dmj-37-333.PMC3816133.pdf
"Mice  with a knockout of atg5, an essential gene for membrane elon - gation in autophagy, are normal at birth but show severe nutri -Review Pathophysiology http://dx.doi.org/10.4093/dmj.2013.37.5.333 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/3a/4b/dmj-37-333.PMC3816133.pdf
Diabetes Metab J 2013;37:333-339 http://e-dmj.orgent and energy insufficiency within 10 hours after birth and  have significantly shorter survival times than wild-type mice  under starvation conditions [6].,Non-OADS,/arxiv_data1/oa_pdf/3a/4b/dmj-37-333.PMC3816133.pdf
335Autophagy and aging  Diabetes Metab J 2013;37:333-339 http://e-dmj.orged direct evidence that overexpression of Atg5 in mice acti - vates autophagy and significantly extends lifespan.,Non-OADS,/arxiv_data1/oa_pdf/3a/4b/dmj-37-333.PMC3816133.pdf
"Diabetes Metab J 2013;37:333-339 http://e-dmj.orgalso critical for lifespan extension by CR, indicating a strong  correlation between CR and autophagy.",Non-OADS,/arxiv_data1/oa_pdf/3a/4b/dmj-37-333.PMC3816133.pdf
"337Autophagy and aging  Diabetes Metab J 2013;37:333-339 http://e-dmj.orgM, Madeo F, Tavernarakis N, Kroemer G. Caloric restriction  and resveratrol promote longevity through the Sirtuin-1-de - pendent induction of autophagy.",Non-OADS,/arxiv_data1/oa_pdf/3a/4b/dmj-37-333.PMC3816133.pdf
Diabetes Metab J 2013;37:333-339 http://e-dmj.orgerated aging phenotypes accompanied by altered protein qual - ity control.,Non-OADS,/arxiv_data1/oa_pdf/3a/4b/dmj-37-333.PMC3816133.pdf
339Autophagy and aging  Diabetes Metab J 2013;37:333-339 http://e-dmj.orgLevine B. Autophagy genes protect against Salmonella ty - phimurium infection and mediate insulin signaling-regulated  pathogen resistance.,Non-OADS,/arxiv_data1/oa_pdf/3a/4b/dmj-37-333.PMC3816133.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/dd/dmj-37-340.PMC3816134.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:340-342 Diagnosing Diabetes with Hemoglobin A1c: Current  Debates and Considerations for Anemic Patients Tae Hyuk Kim1, Sung Hee Choi1,2 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul,  2Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea Corresponding author: Sung Hee Choi Department of Internal Medicine, Seoul National University Bundang  Hospital, Seoul National University College of Medicine, 82 Gumi-ro   173beon-gil, Bundang-gu, Seongnam 463-707, Korea E-mail: drshchoi@snu.ac.krOver the past few decades hemoglobin A1c (HbA1c) has be - come a targeted measurement in the management of diabetes  mellitus (DM).",Non-OADS,/arxiv_data1/oa_pdf/58/dd/dmj-37-340.PMC3816134.pdf
A study in the Unit - ed States comparing the diagnostic rates showed that a HbA1c  of 6.5% categorized the fewest individual as having diabetes Editorial Epidemiology http://dx.doi.org/10.4093/dmj.2013.37.5.340 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/58/dd/dmj-37-340.PMC3816134.pdf
341HbA1c in patients with anemia Diabetes Metab J 2013;37:340-342 http://e-dmj.org(5.2%) than did either the fasting plasma glucose (7.1%) or the  2-hour plasma glucose (15.4%) [14].,Non-OADS,/arxiv_data1/oa_pdf/58/dd/dmj-37-340.PMC3816134.pdf
Diabetes Metab J 2013;37:340-342 http://e-dmj.orgdiagnostic criteria for diabetes.,Non-OADS,/arxiv_data1/oa_pdf/58/dd/dmj-37-340.PMC3816134.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/a0/dmj-37-343.PMC3816135.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:343-348 Hemoglobin A1c May Be an Inadequate Diagnostic  Tool for Diabetes Mellitus in Anemic Subjects Jung Il Son1, Sang Y oul Rhee1,2, Jeong-taek Woo1,2, Jin Kyung Hwang1, Sang Ouk Chin1,2, Suk Chon1,2, Seungjoon Oh1,2,  Sung Woon Kim1,2, Y oung Seol Kim1,2 1Department of Endocrinology and Metabolism, 2Research Institute of Endocrinology, Kyung Hee University School of Medicine, Seoul, Korea Background:  Recently, a hemoglobin A1c (HbA1c) level of 6.5% has been determined to be a criterion for diabetes mellitus  (DM), and it is a widely used marker for the diagnosis of DM.",Non-OADS,/arxiv_data1/oa_pdf/26/a0/dmj-37-343.PMC3816135.pdf
The pathogene -Original Article Epidemiology http://dx.doi.org/10.4093/dmj.2013.37.5.343 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/26/a0/dmj-37-343.PMC3816135.pdf
Diabetes Metab J 2013;37:343-348 http://e-dmj.orgsis of anemia varies depending on the cause and the influence  on HbA1c is also variable.,Non-OADS,/arxiv_data1/oa_pdf/26/a0/dmj-37-343.PMC3816135.pdf
345HbA1c for DM diagnosis in anemia Diabetes Metab J 2013;37:343-348 http://e-dmj.orgvariables which were not normally distributed were analyzed by  the Mann-Whitney U test.,Non-OADS,/arxiv_data1/oa_pdf/26/a0/dmj-37-343.PMC3816135.pdf
Diabetes Metab J 2013;37:343-348 http://e-dmj.orgHbA1c levels in the anemic group (5.9%±0.8% vs. 5.7%±0.4%;  P=0.051).,Non-OADS,/arxiv_data1/oa_pdf/26/a0/dmj-37-343.PMC3816135.pdf
347HbA1c for DM diagnosis in anemia Diabetes Metab J 2013;37:343-348 http://e-dmj.orgNutrition Examination Survey (NHANES) population data for  8 years revealed that iron deficiency was associated with shifts  in HbA1c distribution from less than 5.5% to more than 5.5%  in nondiabetic women.,Non-OADS,/arxiv_data1/oa_pdf/26/a0/dmj-37-343.PMC3816135.pdf
Diabetes Metab J 2013;37:343-348 http://e-dmj.orgdeficiency.,Non-OADS,/arxiv_data1/oa_pdf/26/a0/dmj-37-343.PMC3816135.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:349-357 Prevalence of Diabetes and Prediabetes according to  Fasting Plasma Glucose and HbA1c Ja Y oung Jeon1, Seung-Hyun Ko2, Hyuk-Sang Kwon2, Nan Hee Kim3, Jae Hyeon Kim4, Chul Sik Kim5, Kee-Ho Song6, Jong Chul  Won7, Soo Lim8, Sung Hee Choi8, Myoung-jin Jang9, Yuna Kim9, Kyungwon Oh9, Dae Jung Kim1, Bong-Yun Cha2, on behalf of  the Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association 1Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon,  2Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, 3Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, 4Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  5Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of    Medicine, Anyang,  6Department of Internal Medicine, Konkuk University School of Medicine, Seoul, 7Department of Internal Medicine, Mitochondrial Research Group, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul,  8Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, 9Division of Health and Nutrition Survey, Korea Centers for Disease Control and Prevention, Cheongwon, Korea Background:  Due to the inconvenience of performing oral glucose tolerance tests and day to day variability in glucose level, gly - cated hemoglobin (HbA1c) has been recommended by the American Diabetes Association as a method to diagnose diabetes.",Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
"23, 2013; Accepted: Aug. 27, 2013Original Article Epidemiology http://dx.doi.org/10.4093/dmj.2013.37.5.349 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
Diabetes Metab J 2013;37:349-357 http://e-dmj.orgINTRODUCTION The prevalence of type 2 diabetes has tremendously increased  worldwide and in Korea [1-3].,Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
"351Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c Diabetes Metab J 2013;37:349-357 http://e-dmj.org7600 (Hitachi, Tokyo, Japan).",Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
Diabetes Metab J 2013;37:349-357 http://e-dmj.orgHbA1c ≥6.5% and FPG <126 mg/dL were older and had a  lower eGFR ( P<0.05).,Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
353Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c Diabetes Metab J 2013;37:349-357 http://e-dmj.orgdiagnosed with diabetes when using HbA1c criteria.,Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
Diabetes Metab J 2013;37:349-357 http://e-dmj.orgproportion of participants with HbA1c ≥6.5% and FPG <126  mg/dl was larger than that of participants with HbA1c <6.5%  and FPG ≥126 mg/dL among subjects with undiagnosed dia - betes [10].,Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
355Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c Diabetes Metab J 2013;37:349-357 http://e-dmj.orgold of 6.5% was appropriate to detect diabetic retinopathy in  Korean patients [26].,Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
Diabetes Metab J 2013;37:349-357 http://e-dmj.org10.,Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
DOI:  http://dx.doi.org/10.1007/s00592-013-0452-3.,Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
357Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c Diabetes Metab J 2013;37:349-357 http://e-dmj.org1997;94:4789-90.,Non-OADS,/arxiv_data1/oa_pdf/83/69/dmj-37-349.PMC3816136.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/51/dmj-37-358.PMC3816137.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:358-364 Effect of Treadmill Exercise on Interleukin-15  Expression and Glucose Tolerance in Zucker Diabetic  Fatty Rats Hee-Jae Kim1, Jae Y oung Park2, Seung Lyul Oh1, Y ong-An Kim1, Byunghun So1, Je Kyung Seong3, Wook Song1,4 1Health and Exercise Science Laboratory, The Institute of Sports Science, Seoul National University, Seoul, 2Department of Sport, Kyungil University College of Arts and Sports, Gyeongsan,  3Department of Anatomy and Cell Biology, Research Institute for Veterinary Science, Seoul National University College of Veterinary Medicine, Seoul, 4Institute on Aging, Seoul National University College of Medicine, Seoul, Korea Background:  Interleukin-15 (IL-15), a well-known myokine, is highly expressed in skeletal muscle and is involved in muscle-fat  crosstalk.",Non-OADS,/arxiv_data1/oa_pdf/e2/51/dmj-37-358.PMC3816137.pdf
The ac - tion of IL-15 stimulates muscle-specific myosin heavy chain Original Article Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2013.37.5.358 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/e2/51/dmj-37-358.PMC3816137.pdf
"359Effect of treadmill exercise on IL-15  Diabetes Metab J 2013;37:358-364 http://e-dmj.orgaccumulation by differentiated myocytes and muscle fibers in  culture, suggesting a role in skeletal muscle fiber growth in  vivo [4].",Non-OADS,/arxiv_data1/oa_pdf/e2/51/dmj-37-358.PMC3816137.pdf
"Diabetes Metab J 2013;37:358-364 http://e-dmj.orgtized by Zoletil 50 (intraperitoneal injection, 10 mg/kg; Vibac  Laboratories, Carros, France) and sacrificed.",Non-OADS,/arxiv_data1/oa_pdf/e2/51/dmj-37-358.PMC3816137.pdf
361Effect of treadmill exercise on IL-15  Diabetes Metab J 2013;37:358-364 http://e-dmj.org IPGTT was performed on every weekend to verify the im - provement of glucose tolerance.,Non-OADS,/arxiv_data1/oa_pdf/e2/51/dmj-37-358.PMC3816137.pdf
Diabetes Metab J 2013;37:358-364 http://e-dmj.orgly changed in trained diabetic rats.,Non-OADS,/arxiv_data1/oa_pdf/e2/51/dmj-37-358.PMC3816137.pdf
363Effect of treadmill exercise on IL-15  Diabetes Metab J 2013;37:358-364 http://e-dmj.orgabetes have been reported [30].,Non-OADS,/arxiv_data1/oa_pdf/e2/51/dmj-37-358.PMC3816137.pdf
Diabetes Metab J 2013;37:358-364 http://e-dmj.org513(Pt 3):889-94.,Non-OADS,/arxiv_data1/oa_pdf/e2/51/dmj-37-358.PMC3816137.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:365-374 Risk Factors for the Progression of Intima-Media  Thickness of Carotid Arteries: A 2-Y ear Follow-Up  Study in Patients with Newly Diagnosed Type 2  Diabetes Sang Ouk Chin1, Jin Kyung Hwang1, Sang Y oul Rhee1, Suk Chon1, Y ou-Cheol Hwang1, Seungjoon Oh1, Kyu Jeung Ahn1,   Ho Y eon Chung1, Jeong-taek Woo1, Sung-Woon Kim1, Y oung Seol Kim1, Ja-Heon Kang2, In-Kyung Jeong1 1Department of Endocrinology and Metabolism, 2Department of Ophthalmology, Kyung Hee University School of Medicine, Seoul, Korea  Background:  Intima-media thickness (IMT) of the carotid arteries is known to have a positive correlation with the risk of car - diovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
Original Article Complications http://dx.doi.org/10.4093/dmj.2013.37.5.365 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
"Diabetes Metab J 2013;37:365-374 http://e-dmj.orgThe disequilibrium between increases in toxic metabolites (e.g.,  advanced glycation end-products, protein kinase C activation,  and oxidative stress) and decreases in protective endogenous  factors (e.g., insulin, vascular endothelial growth factor, plate - let-derived growth factors, and adiponectin) may play a role in  the development of diabetic complications [2], which raises the  likelihood of cardiovascular disease (CVD), such as myocardial  infarction and stroke [3].",Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
"367Progression of intima-media thickness Diabetes Metab J 2013;37:365-374 http://e-dmj.orgdefined using the following criteria established by the National  Cholesterol Education Program Adult Treatment Panel III:  triglyceride (TG) ≥150 mg/dL, low density lipoprotein choles - terol (LDL-C) ≥100 mg/dL or high density lipoprotein choles - terol (HDL-C) ≤40 mg/dL in males and ≤50 mg/dL in fe - males [17].",Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
"Calculated risks of the United Kingdom Prospective  Diabetes Study risk engine Risk for coronary heart disease (CHD) was estimated by sub - stituting risk factors such as age, gender, race, current smoking  status, glycated hemoglobin (HbA1c), SBP , total cholesterol,  HDL-C, and presence or absence of atrial fibrillation into the  United Kingdom Prospective Diabetes Study (UKPDS) risk  engine calculator, which was provided by the Diabetes Trials  Units: The Oxford Centre for Diabetes, Endocrinology and  Metabolism (http://www.dtu.ox.ac.uk/riskengine) [22-24].",Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
Diabetes Metab J 2013;37:365-374 http://e-dmj.orggression of carotid IMT included those whose left mean carot - id IMT at the 2-year follow-up examination had decreased by  more than 0.01 mm or had remained unchanged.,Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
"369Progression of intima-media thickness Diabetes Metab J 2013;37:365-374 http://e-dmj.orgwere compared with those in the progression group, the LDL- C level at the 2-year follow-up was significantly higher in males  of the progression group than in the nonprogression group  (79.79±24.6 mg/dL vs. 99.9±34.6 mg/dL; P=0.007) (Table 4,  Fig.",Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
"aP<0.05, bBased upon the UKPDS risk engine calculator (http://www.dtu.ox.ac.uk/riskengine).",OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
"Diabetes Metab J 2013;37:365-374 http://e-dmj.orglevels, and blood pressure after the diagnosis of T2DM were  more important than the baseline levels of these variables in  preventing the progression of atherosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
"aP<0.05, bBased upon the UKPDS risk engine calculator (http://www.dtu.ox.ac.uk/riskengine).",OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
371Progression of intima-media thickness Diabetes Metab J 2013;37:365-374 http://e-dmj.orgcommon to encounter patients with well-controlled DM but  also concurrent aggravation of carotid IMT.,Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
"aP<0.05, bBased upon the UKPDS risk engine calculator (http://www.dtu.ox.ac.uk/riskengine).",OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
Diabetes Metab J 2013;37:365-374 http://e-dmj.org(99.9±34.6 mg/dL vs. 79.8±24.6 mg/dL; P=0.007) (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
373Progression of intima-media thickness Diabetes Metab J 2013;37:365-374 http://e-dmj.orgrosis.,Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
"Diabetes Metab J 2013;37:365-374 http://e-dmj.orgBek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S,  Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krish - naiah S, Mayurasakorn K, O’Hare JP , Orchard TJ, Porta M,  Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM,  Varma R, Wang JJ, Wang N, West S, Xu L, Y asuda M, Zhang X,  Mitchell P , Wong TY; Meta-Analysis for Eye Disease (META- EYE) Study Group.",Non-OADS,/arxiv_data1/oa_pdf/f9/0a/dmj-37-365.PMC3816138.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:375-384 Ruboxistaurin for the Treatment of Diabetic Peripheral  Neuropathy: A Systematic Review of Randomized  Clinical Trials  Dipika Bansal1, Y ogesh Badhan1, Kapil Gudala1, Fabrizio Schifano2 1Clinical Research Unit, Department of Pharmacy Practice, National Institute of Pharmaceutical and Education Research, Mohali, India,  2Clinical Pharmacology and Therapeutics, University of Hertfordshire, Hertfordshire, UK  Background:  Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
Original Article Complications http://dx.doi.org/10.4093/dmj.2013.37.5.375 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
Diabetes Metab J 2013;37:375-384 http://e-dmj.orgSymptoms may go unnoticed for a long period.,Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
We also  searched electronic registers of ongoing trials such as the Cur - rent Controlled Trials register (http://www.controlled-trials.,OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
We also searched  (http://www.clinicaltrials.gov/) and found two registered clini - cal trials with clinical trial registry number NCT00044408 and  NCT00044395; full published studies regarding these trials  could not be retrieved.,OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
377Ruboxistaurin and diabetic neuropathy  Diabetes Metab J 2013;37:375-384 http://e-dmj.orgwere divided alphabetically by first author and each citation  was assessed for inclusion independently by two review au - thors.,Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
Diabetes Metab J 2013;37:375-384 http://e-dmj.org[22] in which information regarding randomization and blind - ing was not reported (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
379Ruboxistaurin and diabetic neuropathy  Diabetes Metab J 2013;37:375-384 http://e-dmj.orgin VDT was the outcome measure seen in one study by Vinik  et al.,Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
Diabetes Metab J 2013;37:375-384 http://e-dmj.org32 mg/day ( P=0.012) and 64 mg/day ( P=0.026) as compared  with placebo group.,Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
381Ruboxistaurin and diabetic neuropathy  Diabetes Metab J 2013;37:375-384 http://e-dmj.orgstudies recruiting a total of 80 participants.,Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
"Diabetes Metab J 2013;37:375-384 http://e-dmj.orgbetic retinopathy are QT prolongation, creatinine phospoki - nase elevation.",Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
383Ruboxistaurin and diabetic neuropathy  Diabetes Metab J 2013;37:375-384 http://e-dmj.orgstudies is too small to come to firm conclusion.,Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
Diabetes Metab J 2013;37:375-384 http://e-dmj.org16.,Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
Avail - able from: http://www.ema.europa.eu/docs/en_GB/docu - ment_library/Application_withdrawal_assessment_re - port/2010/01/WC500068826.pdf (updated 2007 May 24).,Non-OADS,/arxiv_data1/oa_pdf/41/05/dmj-37-375.PMC3816139.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/88/dmj-37-385.PMC3816140.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:385-390 Predicting Mortality of Critically Ill Patients by Blood  Glucose Levels Byung Sam Park, Ji Sung Y oon, Jun Sung Moon, Kyu Chang Won, Hyoung Woo Lee Department of Internal Medicine, Y eungnam University College of Medicine, Daegu, Korea Background:  The aim of this study is to observe the outcome of critically ill patients in relation to blood glucose level at admis - sion and to determine the optimal range of blood glucose at admission predicting lower hospital mortality among critically ill  patients.",Non-OADS,/arxiv_data1/oa_pdf/f9/88/dmj-37-385.PMC3816140.pdf
"Moreover, sys -Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2013.37.5.385 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/f9/88/dmj-37-385.PMC3816140.pdf
"Diabetes Metab J 2013;37:385-390 http://e-dmj.orgtematic reviews and meta-analyses have derived different con - clusions [17,18].",Non-OADS,/arxiv_data1/oa_pdf/f9/88/dmj-37-385.PMC3816140.pdf
"387Predicting mortality by blood glucose at admission Diabetes Metab J 2013;37:385-390 http://e-dmj.orgmonk, NY , USA) with 5% significance level ( P<0.05).",Non-OADS,/arxiv_data1/oa_pdf/f9/88/dmj-37-385.PMC3816140.pdf
"Diabetes Metab J 2013;37:385-390 http://e-dmj.orgDISCUSSION Hyperglycemia is associated with increased mortality and  poor outcome in hospitalized patients, even those who have  not previously had diabetes.",Non-OADS,/arxiv_data1/oa_pdf/f9/88/dmj-37-385.PMC3816140.pdf
389Predicting mortality by blood glucose at admission Diabetes Metab J 2013;37:385-390 http://e-dmj.orgCONFLICTS OF INTEREST  No potential conflict of interest relevant to this article was re - ported.,Non-OADS,/arxiv_data1/oa_pdf/f9/88/dmj-37-385.PMC3816140.pdf
Diabetes Metab J 2013;37:385-390 http://e-dmj.org19.,Non-OADS,/arxiv_data1/oa_pdf/f9/88/dmj-37-385.PMC3816140.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/dmj-37-391.PMC3816141.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:391-392 Diabetic Retinopathy and Endothelial Dysfunction in  Patients with Type 2 Diabetes Mellitus ( Diabetes Metab  J 2013;37:262-9) Seok Man Son Department of Internal Medicine, Pusan National University School of Medicine, Y angsan, Korea Corresponding author: Seok Man Son Department of Internal Medicine, Pusan National University School of  Medicine, and Diabetes Center and Endocrine Clinic, Pusan National  University Y angsan Hospital, 20 Geumo-ro, Y angsan 626-787, Korea E-mail: sonsm@pusan.ac.krThe mechanisms underlying the association of type 2 diabetes  mellitus (T2DM) with vascular dysfunction are complex.",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/dmj-37-391.PMC3816141.pdf
"However, no pro - spective or population-based data have demonstrated the rela - tionship between elevated concentrations of these molecules  and the progression of DR or incidence of ME, or whether  these associations remain significant while controlling for Letter http://dx.doi.org/10.4093/dmj.2013.37.5.391 pISSN 2233-6079 · eISSN 2233-6087",OADS,/arxiv_data1/oa_pdf/d0/6d/dmj-37-391.PMC3816141.pdf
"Diabetes Metab J 2013;37:391-392 http://e-dmj.orgHbAlc level, blood pressure, and signs of diabetic nephropa - thy in T2DM.",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/dmj-37-391.PMC3816141.pdf
"DIABETES  & METABOLISM JOURNAL This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/23/dmj-37-393.PMC3816142.pdf
"Copyright © 2013 Korean Diabetes Association http://e-dmj.orgDiabetes Metab J 2013;37:393-394 Diabetic Retinopathy and Endothelial Dysfunction in  Patients with Type 2 Diabetes Mellitus ( Diabetes Metab J   2013;37:262-9) Jae-Seung Yun, Yu-Bae Ahn Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of Medicine,  Suwon, Korea Corresponding author: Yu-Bae Ahn Division of Endocrinology and Metabolism, Department of Internal  Medicine, St. Vincent’s Hospital, The Catholic University of Korea College of  Medicine, 93 Jungbu-daero, Paldal-gu, Suwon 442-723, Korea E-mail: ybahn@catholic.ac.kr We sincerely appreciate the interests and comments on our  study, “Diabetic retinopathy and endothelial dysfunction in pa - tients with type 2 diabetes mellitus” which was published in Di- abetes & Metabolism Journal  2013;37:262-9.",Non-OADS,/arxiv_data1/oa_pdf/29/23/dmj-37-393.PMC3816142.pdf
"Increased urinary albumin excretion, endothelial  dysfunction, and chronic low-grade inflammation in type 2  diabetes: progressive, interrelated, and independently associat -Response http://dx.doi.org/10.4093/dmj.2013.37.5.393 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/29/23/dmj-37-393.PMC3816142.pdf
Diabetes Metab J 2013;37:393-394 http://e-dmj.orged with risk of death.,Non-OADS,/arxiv_data1/oa_pdf/29/23/dmj-37-393.PMC3816142.pdf
"Right ven -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2013 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2013.21.3.103 REVIEW J Cardiovasc Ultrasound  2013;21(3):103-112 Anatomic Variants Mimicking Pathology on  Echocardiography: Differential Diagnosis Mi-Jeong Kim, MD and Hae Ok Jung, MD Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea,  Seoul, Korea Differentiation of normal from abnormal findings is critical in echocardiography.",Non-OADS,/arxiv_data1/oa_pdf/10/a0/jcu-21-103.PMC3816159.pdf
"•	Received: August 23, 2013  •	Revised: September 17, 2013  •	Accepted: September 17, 2013    •	Address for Correspondence: Hae Ok Jung, Division of Cardiology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea,   222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea     T el: +82-2-2258-6033, Fax: +82-2-591-1506, E-mail: hojheart@catholic.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Fig.",Non-OADS,/arxiv_data1/oa_pdf/10/a0/jcu-21-103.PMC3816159.pdf
"In a study of eight patients with SCMP , myocardial  scintigraphy with 123I-metaiodobenzylguanidine showed evi -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2013 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2013.21.3.113 EDITORIAL COMMENT J Cardiovasc Ultrasound  2013;21(3):113-115 Variable Morphology of Stress-Induced  Cardiomyopathy Dong Ryeol Ryu, MD Division of Cardiology, Department of Internal Medicine, Kangwon National University Hospital, Chuncheon, Korea • Editorials published in the Journal of Cardiovascular Ultrasound do not necessarily represent the views of JCU or the Korean Society of Echocardiography.",Non-OADS,/arxiv_data1/oa_pdf/1a/02/jcu-21-113.PMC3816160.pdf
"• Received: September 3, 2013  • Revised: September 9, 2013  • Accepted: September 9, 2013    • Address for Correspondence: Dong Ryeol Ryu, Division of Cardiology, Department of Internal Medicine, Kangwon National University Hospital,   156 Baengnyeong-ro, Chuncheon 200-722, Korea     T el: +82-33-258-9439, Fax: +82-33-258-9495, E-mail: rdr0203@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.REFER TO THE PAGE 116-122",Non-OADS,/arxiv_data1/oa_pdf/1a/02/jcu-21-113.PMC3816160.pdf
"The diagnosis of SCM  was established by fulfillment of the following criteria: 1)  presence of preceding stressors; 2) demonstration of apical or  non-apical ballooning and compensatory hypercontractility of  not involved segments by echocardiography; 3) new develop -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2013 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2013.21.3.116 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2013;21(3):116-122 Different Characteristics between Patients  with Apical and Non-Apical Subtypes   of Stress-Induced Cardiomyopathy Sun Hwa Lee, MD, Won Ho Kim, MD, Sang Rok Lee, MD, Kyung Suk Rhee, MD,   Jei Keon Chae, MD and Jae Ki Ko, MD Division of Cardiology, Department of Internal Medicine, Chonbuk National University Medical School & Hospital,  Jeonju, Korea Background:  Stress-induced cardiomyopathy (SCM) is characterized by apical ballooning on echocardiography, but some of  SCM patients show non-apical involvement and their characteristics are not well defined.",Non-OADS,/arxiv_data1/oa_pdf/77/74/jcu-21-116.PMC3816161.pdf
"•	Received: May 9, 2013  •	Revised: August 11, 2013  •	Accepted: August 12, 2013    •	Address for Correspondence: Sun Hwa Lee, Division of Cardiology, Department of Internal Medicine, Chonbuk National University Medical School, 20 Geonji-ro,    Deokjin-gu, Jeonju 561-712, Korea     T el: +82-63-250-2572, Fax: +82-63-250-1680, E-mail: shleemd@jbnu.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/74/jcu-21-116.PMC3816161.pdf
"In patients with native valve IE, anticoagulation is typically pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2013 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2013.21.3.123 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2013;21(3):123-129 Prediction of Hemorrhagic Transformation  Following Embolic Stroke in Patients   with Prosthetic Valve Endocarditis In-Jeong Cho, MD1*, Jin-Sun Kim, MD2*, Hyuk-Jae Chang, MD, PhD1,3,  Yong-Jin Kim, MD, PhD4, Sang-Chol Lee, MD, PhD5, Jung-Hyun Choi, MD, PhD6,  Sanghoon Shin, MD1, Chi Young Shim, MD, PhD1, Geu-Ru Hong, MD, PhD1,  Jong-Won Ha, MD, PhD1,3 and Namsik Chung, MD, PhD1 1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei  University Health System, Seoul, Korea 2Division of Cardiology, Bundang CHA Medical Center, CHA University, Seongnam, Korea 3Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea 4Division of Cardiology, Seoul National University College of Medicine, Seoul, Korea 5Division of Cardiology, Sungkyunkwan University School of Medicine, Seoul, Korea 6Division of Cardiology, Pusan National University Hospital, Busan, Korea Background:  Hemorrhagic transformation (HT) of stroke is a disastrous complication in patients with infective endocarditis  (IE).",Non-OADS,/arxiv_data1/oa_pdf/c7/da/jcu-21-123.PMC3816162.pdf
"•	Received: March 14, 2013  •	Revised: June 23, 2013  •	Accepted: August 12, 2013    •	Address for Correspondence: Hyuk-Jae Chang, Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine,   50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea    T el: +82-2-2228-8454, Fax: +82-2-393-2041, E-mail: hjchang@yuhs.ac •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/da/jcu-21-123.PMC3816162.pdf
"The  pathophysiology of these catastrophic events involves impaired endothelial function and increase inflammation and coagulation  activity.1)2) Endogenous nitric oxide (NO) production, which  mediated endothelial dependent vasodilatation, is a key medi - ator of these changes in endothelial function, inflammation  and coagulation.3-5)pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2013 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2013.21.3.130 ORIGINAL ARTICLE J Cardiovasc Ultrasound  2013;21(3):130-136 Acute Effect of Whole-Body Periodic  Acceleration on Brachial Flow-Mediated  Vasodilatation Assessed by a Novel   Semi-Automatic Vessel Chasing  UNEXEF18G System Bonpei Takase, MD1, Hidemi Hattori, PhD2, Yoshihiro Tanaka, MD2, Akimi Uehata, MD3,  Masayoshi Nagata, MD4, Masayuki Ishihara, PhD2 and Masatoshi Fujita, MD5 1Department of Intensive Care Medicine, 2Division of Biomedical Engineering, National Defense Medical College,  National Defense Medical College Research Institute, Saitama, Japan 3Self Defense Forces Central Hospital, Tokyo, Japan 4Iruma Heart Hospital, Saitama, Japan 5Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan Background:  Repeated application of whole-body periodic acceleration (WBPA) upregulates endothelial nitric oxide synthase  and improves brachial artery endothelial function (BAEF) as assessed by measurement of flow-mediated vasodilatation (FMD).",Non-OADS,/arxiv_data1/oa_pdf/e6/85/jcu-21-130.PMC3816163.pdf
"•	Received: April 6, 2013  •	Revised: July 31, 2013  •	Accepted: August 12, 2013    •	Address for Correspondence: Bonpei Takase, Department of Intensive Care Medicine, National Defense Medical College, National Defense Medical College    Research Institute, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan    T el: +81-4-2995-1211, Fax: +81-4-2991-1611, E-mail: bonpeit@ndmc.ac.jp •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/85/jcu-21-130.PMC3816163.pdf
"Cardiac enzyme pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2013 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2013.21.3.137 CASE REPORT J Cardiovasc Ultrasound  2013;21(3):137-139 A Case of Persistent Apical Ballooning  Complicated by Apical Thrombus   in Takotsubo Cardiomyopathy of Systemic  Lupus Erythematosus Patient In Kyoung Shim, MD, Bong-Joon Kim, MD, Hyunsu Kim, MD, Jae-Woo Lee, MD,   Tae-Joon Cha, MD and Jung Ho Heo, MD Division of Cardiology, Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea Takotsubo cardiomyopathy, which is also known as “transient apical ballooning”, is a cardiac syndrome associated with emotional  and physical stress that occurs in postmenopausal women.",Non-OADS,/arxiv_data1/oa_pdf/6e/82/jcu-21-137.PMC3816164.pdf
"•	Received: January 5, 2013  •	Revised: July 3, 2013  •	Accepted: August 12, 2013    •	Address for Correspondence: Jung Ho Heo, Division of Cardiology, Department of Internal Medicine, Kosin University Gospel Hospital, 262 Gamcheon-ro,   Seo-gu, Busan 602-702, Korea    T el: +82-51-990-6105, Fax: +82-51-990-3047, E-mail: duggymdc@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/82/jcu-21-137.PMC3816164.pdf
"The  RV was prominently dilated and revealed significantly de - creased contractility with a D-shaped left ventricle (LV) show -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2013 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2013.21.3.140 CASE REPORT J Cardiovasc Ultrasound  2013;21(3):140-144 Device Closure of a Large Atrial Septal  Defect in a Patient with Severe Pulmonary  Arterial Hypertension after 1 Year Use of  an Oral Endothelin Receptor Antagonist In Hyun Jung, MD, PhD1, Sang Yun Lee, MD, PhD2, Sook Jin Lee, MD, PhD1,  Joo Young Lee, RDCS1, Nam Jin Park, RDCS1, Dea Sung Ahn, MD1, Jae Hoon Jung, MD1,  Dong Hee Shin, MD1 and Dal Soo Lim, MD1 Departments of 1Internal Medicine, 2Pediatrics, Sejong General Hospital, Bucheon, Korea The presence of severe pulmonary arterial hypertension (PAH) in patients with atrial septal defect (ASD) is still thought to  preclude shunt closure, although there are several reports of good clinical outcomes after vasodilator therapy.",Non-OADS,/arxiv_data1/oa_pdf/1f/1b/jcu-21-140.PMC3816165.pdf
"•	Received: April 1, 2013  •	Revised: May 29, 2013  •	Accepted: August 12, 2013    •	Address for Correspondence: In Hyun Jung, Department of Internal Medicine, Sejong General Hospital, 28 Hohyeon-ro 489beon-gil, Sosa-gu, Bucheon 422-711,    Korea    T el: +82-32-340-1447, Fax: +82-32-340-1236, E-mail: drjih@naver.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/1b/jcu-21-140.PMC3816165.pdf
"The false chamber did not pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2013 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2013.21.3.145 CASE REPORT J Cardiovasc Ultrasound  2013;21(3):145-147 Left Atrial Wall Dissection after Mitral  Valve Replacement Kyung Woo Kim, MD, Jun Hyun Kim, MD, Se Hyeok Park, MD, Sang-Il Lee, MD,   Ji Yeon Kim, MD, PhD, Kyung-Tae Kim, MD, PhD, Won Joo Choe, MD, PhD,   Jang Su Park, MD, PhD and Jung Won Kim, MD, PhD Department of Anesthesiology and Pain Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea Left atrial dissection does occur, though rarely, after mitral valve surgery.",Non-OADS,/arxiv_data1/oa_pdf/05/90/jcu-21-145.PMC3816166.pdf
"•	Received: April 10, 2013  •	Revised: June 19, 2013  •	Accepted: August 12, 2013    •	Address for Correspondence: Jun Hyun Kim, Department of Anesthesiology and Pain Medicine, Inje University Ilsan Paik Hospital, 170 Juhwa-ro, Ilsanseo-gu,    Goyang 411-706, Korea    T el: +82-31-910-7067, Fax: +82-31-910-7184, E-mail: ishmael1@naver.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/90/jcu-21-145.PMC3816166.pdf
"pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2013 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2013.21.3.148 CASE REPORT J Cardiovasc Ultrasound  2013;21(3):148-151 Recurrent Syncope Episodes and Exercise  Intolerance in Hypertrophic  Cardiomyopathy Combined with  Atrioventricular Conduction Disturbance Kyun Hee Kim, MD, Dong Heon Yang, MD, Chang-Yeon Kim, MD, Nam Kyun Kim, MD,   Won Suk Choi, MD, Myung Hwan Bae, MD, Jang Hoon Lee, MD, Hun Sik Park, MD,  Yongkeun Cho, MD and Shung Chull Chae, MD Department of Cardiology, Kyungpook National University Hospital, Daegu, Korea A 30-year-old female patient with known hypertrophic cardiomyopathy (HCMP) was admitted for recurrent syncope episodes.",Non-OADS,/arxiv_data1/oa_pdf/c9/7a/jcu-21-148.PMC3816167.pdf
"•	Received: April 10, 2013  •	Revised: June 5, 2013  •	Accepted: August 12, 2013    •	Address for Correspondence: Dong Heon Yang, Department of Cardiology, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 700-721,   Korea    Tel: +82-53-420-5524, Fax: +82-53-424-6721, E-mail: ddhyang@knu.ac.kr •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/7a/jcu-21-148.PMC3816167.pdf
"1B-F and Supple -pISSN 1975-4612/ eISSN 2005-9655  Copyright © 2013 Korean Society of Echocardiography  www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2013.21.3.152 IMAGES IN CARDIOVASCULAR ULTRASOUND J Cardiovasc Ultrasound  2013;21(3):152-153 Free Floating Left Atrial Thrombus  Disappearing during Echocardiography Seung Pyo Hong, MD, Ji Yong Choi, MD and Kee Sik Kim, MD, PhD Department of Cardiology, Daegu Catholic University Medical Center, Daegu, Korea KEY WORDS:  Thrombus · Left atrium · Echocardiography .",Non-OADS,/arxiv_data1/oa_pdf/c1/50/jcu-21-152.PMC3816168.pdf
"•	Received: June 21, 2013  •	Revised: July 26, 2013  •	Accepted: August 12, 2013    •	Address for Correspondence: Seung Pyo Hong, Department of Cardiology, Daegu Catholic University Medical Center, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu    705-718, Korea    T el: +82-53-650-3015, Fax: +82-53-621-3166, E-mail: hongbanchang@gmail.com •	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)    which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Fig.",Non-OADS,/arxiv_data1/oa_pdf/c1/50/jcu-21-152.PMC3816168.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.419 The New Era of Journal o f Neurogastroenterology and Motility : What  S h o u l d  B e  P r e p a r e d  t o  B e  a  T o p  J o u r n a l  i n  t h e Category of Gastroenterology and Hepatology Sun Huh Department of Parasitology and Institute of Medical Education, College of Medicine, Hallym University, Chuncheon, Gangwon-do, Korea Received: September 22, 2013 Revised: None Accepted: September 25 , 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/1d/b8/jnm-19-419.PMC3816174.pdf
"Conflicts of interest: None.ORCID: http://orcid.org/0000-0002-8559-8640Congratulations on Becoming a Science  Citation Index Expanded Journal When I received an email from Dr. Nayoung Kim, the  Deputy Editor on September 14, 2013 that Journal of Neurogast- roenterology and Motility  (JNM) was selected as SCIE journal and  the citation and reference data would be included in the Web of  Science from volume 17, number 1, 2011, I was very delighted.",Non-OADS,/arxiv_data1/oa_pdf/1d/b8/jnm-19-419.PMC3816174.pdf
"Example can be seen from: http://jeehp.org./Scholarly Journal 10 Years After It can be estimated as followings: increased number of online  only journal, audio or video jo urnals, open access journal and  standards suggested by CrossRef; journal app as common tool;  increased needs of manuscript editing; promotion of journals from East Asia; and more common use of device-independent  viewer program such as PubReader.",Non-OADS,/arxiv_data1/oa_pdf/1d/b8/jnm-19-419.PMC3816174.pdf
Available from URL:  http://orcid.org/ (accessed 21 Sep 2013).,OADS,/arxiv_data1/oa_pdf/1d/b8/jnm-19-419.PMC3816174.pdf
Available from URL:  http://www.crossref.org/crossmark/ (accessed 21 Sep 2013).,OADS,/arxiv_data1/oa_pdf/1d/b8/jnm-19-419.PMC3816174.pdf
Available from URL:  http://www.crossref.org/fundref/ accessed 21 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/1d/b8/jnm-19-419.PMC3816174.pdf
Available from URL: http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/1d/b8/jnm-19-419.PMC3816174.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.422 Article: Esophageal motility in the supine and upright positions for liq uid and solid swallows through high-resolution  manometry Zhang X, Xiang X, Tu L, Xie X, Hou X  (J Neurogastroenterol Motil 2013;19:467-472)Use of Solid Boluses in High-resolution  Manometry Yu Tien Wang1* and Daniel Sifrim2 1Department of Gastroenterology and Hepatology, Singapore Genera l Hospital, Singapore; and2Barts and The London School of Medicine and  Dentistry, Queen Mary University of London, London, United King dom Received: August 22, 2013 Revised: None Accepted: September 10, 2 013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/86/af/jnm-19-422.PMC3816175.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.424 Development of Korean Rome III Questionnaire:  What Will We Do With Korean Rome III  Questionnaire?",Non-OADS,/arxiv_data1/oa_pdf/bf/59/jnm-19-424.PMC3816176.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.426 Ionic Conductance(s) in Response to  Post-junctional Potentials Sang Don Koh1 and Poong-Lyul Rhee2* 1Department of Physiology and Cell Biology, University of Nevada , School of Medicine, Reno, NV, USA; and2Division of Gastroenterology,  Department of Medicine, Sungkyunkwan University School of Medic ine, Samsung Medical Center, Seoul, Korea   The gastrointestinal motility is regulated by extrinsic and intrinsic neural regulation.",OADS,/arxiv_data1/oa_pdf/2e/f1/jnm-19-426.PMC3816177.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.433 Abdominal Bloating: Pathophysiology and  Treatment A Young Seo,1 Nayoung Kim1,2* and Dong Hyun Oh1 1Department of Internal Medicine, Seoul National University, Bun dang Hospital, Seongnam, Gyeonggi-do, Korea; and2Department of Internal  Medicine and Liver Research Institute, Seoul National Universit y College of Medicine, Seoul, Korea Abdominal bloating is a very common and troublesome symptom of all ages, but it has not been fully understood to date.",Non-OADS,/arxiv_data1/oa_pdf/2f/9d/jnm-19-433.PMC3816178.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.454 Received: May 4, 2013 Revised: July 28, 2013 Accepted: August 9, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/54/3d/jnm-19-454.PMC3816179.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.467 Received: April 1, 2013 Revised: July 1, 2013 Accepted: July 15, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/66/2b/jnm-19-467.PMC3816180.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.473 Received: February 9, 2013 Revised: June 10, 2013 Accepted: June 12, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/79/f2/jnm-19-473.PMC3816181.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.479 Received: June 8, 2013 Revised: August 13, 2013 Accepted: August 27, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/84/66/jnm-19-479.PMC3816182.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.485 Received: August 10, 2013 Revised: September 11, 2013 Accepted: S eptember 11, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/a3/df/jnm-19-485.PMC3816183.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.495 Received: January 28, 2013 Revised: June 24, 2013 Accepted: June 25, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/cd/44/jnm-19-495.PMC3816184.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.503 Received: May 9, 2013 Revised: July 23, 2013 Accepted: July 31, 2 013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/46/ff/jnm-19-503.PMC3816185.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.509 Received: June 5, 2013 Revised: June 25, 2013 Accepted: July 2, 2 013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/bf/fa/jnm-19-509.PMC3816186.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.516 Received: May 3, 2013 Revised: July 27, 2013 Accepted: July 30, 2 013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/47/8b/jnm-19-516.PMC3816187.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.521 Received: April 17, 2013 Revised: September 13, 2013 Accepted: Se ptember 15, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/3a/0b/jnm-19-521.PMC3816188.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.532 Technique of Functional and Motility Test: How  to Perform Biofeedback for Constipation and  Fecal Incontinence Hyo Jeong Lee, Kee Wook Jung and Seung-Jae Myung * Department of Gastroenterology, Asan Digestive Disease Research  Institute, Asan Medical Center, University of Ulsan College of  Medicine,  Seoul, Korea Biofeedback therapy is an instrument-based learning process ce ntered on operant conditioning.",Non-OADS,/arxiv_data1/oa_pdf/8e/8d/jnm-19-532.PMC3816189.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.538 Esophageal Dysmotility in Gillespie Syndrome Bruna Dell’Acqua Cassão, Daniel Tavares de Rezende, Luciana C Silva and Fernando A M Herbella* Department of Surgery, Escola Paulista de Medicina, Federal Uni versity of Sao Paulo, Sao Paulo, Brazil Received: August 23, 2013 Revised: September 27, 2013 Accepted: S eptember 28, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/8a/c5/jnm-19-538.PMC3816190.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.540 Delayed Dysphagia After Removal of Foreign  Bodies Near Upper Esophageal Sphincter Jung Ho Park Department of Internal Medicine, Sungkyunkwan University Colleg e of Medicine, Kangbuk Samsung Hospital, Seoul, Korea Received: September 10, 2013 Revised: September 17, 2013 Accepted : September 25, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/d9/85/jnm-19-540.PMC3816191.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.542 Significance of Persistent Nondysplasia Over  Multiple Endoscopic Surveillance in Risk  Stratification of Patients With Barrett's Esophagus (Gastroenterology 2013;145:548-553, e1) Received: September 14, 2013 Revised: September 23, 2013 Accepted : September 24, 2013 CC This is an Open Access article pdistributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/75/62/jnm-19-542.PMC3816192.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.544 Are Bloating and Abdominal Distention  Attributed to Gas Production and Visceral  Sensitivity in Irritable Bowel Syndrome?",Non-OADS,/arxiv_data1/oa_pdf/4b/53/jnm-19-544.PMC3816193.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.547 Role of Ultrastructural Alterations of Intercellular  Junction and Tight-junction  Proteins in Patients  With Gastroesophageal Reflux Disease TO THE EDITOR:  I read with great interest the study by Liu et  al1 regarding the significant correlation between presence of des- mosomal junction alterations and the severity of gastroesophageal reflux disease (GERD).",Non-OADS,/arxiv_data1/oa_pdf/80/ec/jnm-19-547.PMC3816194.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.549 Relevance of Position and Movement of the  Gastroesophageal Junction in Gastroesophageal  Reflux Disease TO THE EDITOR: Gastroesophageal reflux disease (GERD)  and its complications are increasingly recognized in many parts of Asia, largely due to an increasing prevalence of obesity.",Non-OADS,/arxiv_data1/oa_pdf/e1/94/jnm-19-549.PMC3816195.pdf
"4   October,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.550 Relevance of Position and Movement of the  Gastroesophageal Junction in Gastroesophageal  Reflux Disease:  Author’s Reply TO THE EDITOR: I appreciate the interest and comments1 on  our paper, which was published in the July 2013 issue of this journal.",Non-OADS,/arxiv_data1/oa_pdf/c3/61/jnm-19-550.PMC3816196.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)PHA-IL2 predicts bortezomib-induced neuropathy T Watanabe et al 7 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/36/83/bcj201347a.PMC3816208.pdf
"Mass spectrometric analysis of trypsin-digested size-fractionated proteins wasperformed as described elsewhere.31,32Peptides and proteins were identiﬁed with Mascot (Matrix Science, London, UK) and quantiﬁed with MSQuant (http://msquant.sourceforge.net) as described previously.32 Data and functional annotation analysis and correlation with gene ontology (GO) For deﬁned gene groups, we assigned GO terms, KEGG and Biocarta pathways, functional categories (COG_ontology, SP-PIR_keywords,UP_Seq_features), protein domains from interpro, PIR-superfamily and SMART databases using the DAVID bioinformatics resources 6.7, NIAID/ NIH.33Enrichment over the whole set of probed genes and heuristic multiple linkage clustering analysis was performed using the same toolsand Benjamini-Hochberg correction was applied to correct for multipletesting on the data set.",OADS,/arxiv_data1/oa_pdf/b7/ca/bcj201348a.PMC3816209.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)TEL-AML1 (ETV6-RUNX1) in B cells and leukaemia Y Linka et al 9 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/b7/ca/bcj201348a.PMC3816209.pdf
Hierarchical clustering wasperformed using Cluster 3.0 and visualized with Treeview v1.60 (http://rana.lbl.gov/EisenSoftware.htm).,OADS,/arxiv_data1/oa_pdf/82/89/bcj201349a.PMC3816210.pdf
Signiﬁcance analysis of microarrays (SAM) and prediction analysis of microarrays (PAM) were used to identify differentially expressed miRNAs between sample groups (http://www-stat.stanford.edu/Btibs/).,OADS,/arxiv_data1/oa_pdf/82/89/bcj201349a.PMC3816210.pdf
Protein levels were quantiﬁed on X-ray ﬁlms fromimmunoblots using ImageJ software (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/82/89/bcj201349a.PMC3816210.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)microRNAs and microRNA machinery in DLBCL S Caramuta et al 12 Blood Cancer Journal &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/82/89/bcj201349a.PMC3816210.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Lysosome-mediated cell death in CLL J-Y Yoon et al 9 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/10/21/bcj201350a.PMC3816211.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Letter to the Editor 2 Blood Cancer Journal &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/e2/28/bcj201351a.PMC3816212.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/Inhibiting RON kinase enhances HGF/MET signaling S Zhao et al 10 Oncogenesis (2013), 1 – 10 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/ee/36/oncsis201336a.PMC3816215.pdf
"Using a CpG Island Searcher web tool (http://www.cpgislands.com/), a CpG island was identiﬁed upstream (/C0250 bp) of the region encoding let-7e (Figure 2b).",OADS,/arxiv_data1/oa_pdf/94/88/oncsis201339a.PMC3816216.pdf
"EZH2 and CCND1 are potentially regulated by let-7e To further investigate the mechanisms of how let-7e impacts drug resistance, we used TargetScan (http://www.targetscan.org/)17andPicTar (http://pictar.mdc-berlin.de/)18to predict its target genes.",Non-OADS,/arxiv_data1/oa_pdf/94/88/oncsis201339a.PMC3816216.pdf
"5-aza-CdR treatment and quantitative methylation-speciﬁc PCR analysis Using the CpG Island Searcher web tool (http://www.cpgislands.com/), a CpG island was identiﬁed upstream ( /C0250 bp) of the region encoding let-7e.",OADS,/arxiv_data1/oa_pdf/94/88/oncsis201339a.PMC3816216.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/The role of let-7e in cisplatin-resistant ovarian cancer J Cai et al 8 Oncogenesis (2013), 1 – 8 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/94/88/oncsis201339a.PMC3816216.pdf
"( a) MacroH2A1-regulated genes were analyzed by DAVID bioinformatics resources (http://david.abcc.ncifcrf.gov), and ontological classiﬁcation of genes based on molecularfunction is presented as upregulated or downregulated gene groups.",OADS,/arxiv_data1/oa_pdf/d9/07/oncsis201340a.PMC3816217.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).Repressive role of macroH2A in Trpc3 and Trpc6 transcription J-M Kim et al 9 &2013 Macmillan Publishers Limited Oncogenesis (2013), 1 – 9",Non-OADS,/arxiv_data1/oa_pdf/d9/07/oncsis201340a.PMC3816217.pdf
"We checked these cell lines in the Tp53 mutation database at http://p53.fr/ for the presence of Tp53mutations, and found that a majority of the cancer cell lines that express high levels of PLAC1 indeed carry mutation in Tp53 (or, as in H929 cells, express high levels of MDM2,26leading to loss of Tp53 expression).",Non-OADS,/arxiv_data1/oa_pdf/18/db/oncsis201331a.PMC3816221.pdf
The recovered products weregel-purifed and cloned into the pPyCAG mammalian expression vector(http://www.cdb.riken.jp/pcs/protocol/vector/vector_top.html).,OADS,/arxiv_data1/oa_pdf/18/db/oncsis201331a.PMC3816221.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/Table 2.",Non-OADS,/arxiv_data1/oa_pdf/18/db/oncsis201331a.PMC3816221.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).ERbactivation impairs oxidative metabolism AG Manente et al 10 Oncogenesis (2013), 1 – 10 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/39/d0/oncsis201332a.PMC3816222.pdf
"Thedifferentially expressed probes were further investigated using the Ingenuity Pathways Analysis package (IPA; http://www.ingenuity.com) to identify the association of differentially expressed genes within the ‘cellgrowth and proliferation’, ‘tumor morphology’, ‘cellular development’, ‘celldeath and survival’, ‘cell movement’ and ‘cell morphology’ categories.Right-tailed Fisher’s exact test as implemented in the IPA software wasused to calculate a P-value for the probability of each network to be enriched by chance alone.",OADS,/arxiv_data1/oa_pdf/c2/ce/oncsis201333a.PMC3816223.pdf
The data discussed in thispublication have been deposited in NCBI’s Gene Expression Omnibusand are accessible through GEO Series accession number GSE41893 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41893).,OADS,/arxiv_data1/oa_pdf/c2/ce/oncsis201333a.PMC3816223.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/Orthotopic model of HNSCC R Masood et al 8 Oncogenesis (2013), 1 – 8 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/c2/ce/oncsis201333a.PMC3816223.pdf
"Elsevier, 2002, pp 507–529, http://dx.doi.org/10.1016/S0580-9517(02)31028-6.",Non-OADS,/arxiv_data1/oa_pdf/f5/54/oncsis201334a.PMC3816224.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).Centrosomal kinase Nek2 promotes metastasis TK Das et al 14 Oncogenesis (2013), 1 – 14 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/f5/54/oncsis201334a.PMC3816224.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).Genomic features of colon cancer cell lines D Ahmed et al 8 Oncogenesis (2013), 1 – 8 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/80/d6/oncsis201335a.PMC3816225.pdf
"Using a microarray database for A549 cells treated with TGF- b1 (http://www.ncbi.nlm.nih.gov/sites/GDSbrowser?acc= GDS3710), we found that 683 genes were potentially down- regulated by TGF- b1.",OADS,/arxiv_data1/oa_pdf/8f/ea/oncsis201337a.PMC3816226.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on the Oncogenesis website (http://www.nature.com/oncsis).Snail1 and SCARA5 in tumor cell migration Liuet al 10 Oncogenesis (2013), 1 – 10 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/8f/ea/oncsis201337a.PMC3816226.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/PIK3CA E545K induces mammary carcinomas DS Meyer et al 6 Oncogenesis (2013), 1 – 6 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/79/a3/oncsis201338a.PMC3816227.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003169).,Non-OADS,/arxiv_data1/oa_pdf/c2/aa/bmjopen-2013-003169.PMC3816230.pdf
http://www.terveysportti.fi/kotisivut/sivut.koti?p_sivusto=434 (accessed onJuly 2012) (in Finnish).,Non-OADS,/arxiv_data1/oa_pdf/c2/aa/bmjopen-2013-003169.PMC3816230.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003240).,Non-OADS,/arxiv_data1/oa_pdf/26/a4/bmjopen-2013-003240.PMC3816231.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/26/a4/bmjopen-2013-003240.PMC3816231.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003408).,Non-OADS,/arxiv_data1/oa_pdf/5e/e3/bmjopen-2013-003408.PMC3816232.pdf
"Geneva: WHO, 1999 (accessed 5 July 2010, at http://www.staff.ncl.ac.uk/ philip.home/who_dmg.pdf.)",Non-OADS,/arxiv_data1/oa_pdf/5e/e3/bmjopen-2013-003408.PMC3816232.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003418).,Non-OADS,/arxiv_data1/oa_pdf/a5/2b/bmjopen-2013-003418.PMC3816233.pdf
http://www.socialstyrelsen.se 17.,Non-OADS,/arxiv_data1/oa_pdf/a5/2b/bmjopen-2013-003418.PMC3816233.pdf
2010 [cited 25 February 2010]; http://www.scb.se 19.,Non-OADS,/arxiv_data1/oa_pdf/a5/2b/bmjopen-2013-003418.PMC3816233.pdf
2010 [cited 10 August 2010]; http://www.socialstyrelsen.se 20.,Non-OADS,/arxiv_data1/oa_pdf/a5/2b/bmjopen-2013-003418.PMC3816233.pdf
32. http://www.idf.org/diabetesatlas/5e/africa33.,Non-OADS,/arxiv_data1/oa_pdf/a5/2b/bmjopen-2013-003418.PMC3816233.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003559).,Non-OADS,/arxiv_data1/oa_pdf/4d/56/bmjopen-2013-003559.PMC3816234.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/56/bmjopen-2013-003559.PMC3816234.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003564).,Non-OADS,/arxiv_data1/oa_pdf/85/c1/bmjopen-2013-003564.PMC3816235.pdf
"We calculated statistics using the statistical computing language R (http://www.r-project.org, The R Foundation for Statistical Computing, Vienna,Austria).",OADS,/arxiv_data1/oa_pdf/85/c1/bmjopen-2013-003564.PMC3816235.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003605).,Non-OADS,/arxiv_data1/oa_pdf/ac/43/bmjopen-2013-003605.PMC3816237.pdf
Retrieved from The National Institute for Public Health and theEnvironment website: http://www.rivm.nl/dsresource?objectid=rivmp:61294&type=org&disposition=inline&ns_nc=1(accessed 28 Nov 2011).,OADS,/arxiv_data1/oa_pdf/ac/43/bmjopen-2013-003605.PMC3816237.pdf
ema.europa.eu (2012-001371-37) and http://www.clinicaltrials.gov (NCT01795248).,Non-OADS,/arxiv_data1/oa_pdf/e1/71/bmjopen-2013-003834.PMC3816238.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003603).,Non-OADS,/arxiv_data1/oa_pdf/03/54/bmjopen-2013-003603.PMC3816239.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003855).,Non-OADS,/arxiv_data1/oa_pdf/2a/f3/bmjopen-2013-003855.PMC3816240.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003871).,Non-OADS,/arxiv_data1/oa_pdf/d1/51/bmjopen-2013-003871.PMC3816241.pdf
http://www.idf.org/ position-statement-diabetic-foot 10.,Non-OADS,/arxiv_data1/oa_pdf/d1/51/bmjopen-2013-003871.PMC3816241.pdf
http://www.esri.ie/health_information/hipe 19.,Non-OADS,/arxiv_data1/oa_pdf/d1/51/bmjopen-2013-003871.PMC3816241.pdf
"Lyon, France: International Agency for Research on Cancer, 2010. http://globocan.iarc.fr (accessed 10 Oct 2012).",Non-OADS,/arxiv_data1/oa_pdf/bf/30/bmjopen-2013-003989.PMC3816242.pdf
http://www.hpa.gov.tw/BHPNet/English/Index.aspx (accessed 25 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/bf/30/bmjopen-2013-003989.PMC3816242.pdf
http://crs.cph.ntu.edu.tw/ main.php (accessed 21 Nov 2012).,OADS,/arxiv_data1/oa_pdf/bf/30/bmjopen-2013-003989.PMC3816242.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004009).,Non-OADS,/arxiv_data1/oa_pdf/1e/81/bmjopen-2013-004009.PMC3816243.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004034).,Non-OADS,/arxiv_data1/oa_pdf/e0/f6/bmjopen-2013-004034.PMC3816244.pdf
doi:10.1136/bmjopen-2013- 004049 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004049).,Non-OADS,/arxiv_data1/oa_pdf/25/7a/bmjopen-2013-004049.PMC3816245.pdf
Randomisation Eligible participants accepted into the programme willbe randomised based on an allocation sequence gener- ated by an independent person not involved in the study through a true randomisation process (http://www.random.org).,Non-OADS,/arxiv_data1/oa_pdf/25/7a/bmjopen-2013-004049.PMC3816245.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3126 | DOI: 10.1038/srep03126 7",Non-OADS,/arxiv_data1/oa_pdf/be/f0/srep03126.PMC3816284.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/19/5e/srep03132.PMC3816285.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3132 | DOI: 10.1038/srep03132 5",Non-OADS,/arxiv_data1/oa_pdf/19/5e/srep03132.PMC3816285.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d7/62/srep03124.PMC3816286.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3124 | DOI: 10.1038/srep03124 5",Non-OADS,/arxiv_data1/oa_pdf/d7/62/srep03124.PMC3816286.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3131 | DOI: 10.1038/srep03131 8",Non-OADS,/arxiv_data1/oa_pdf/70/61/srep03131.PMC3816287.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3087 | DOI: 10.1038/srep03087 8",Non-OADS,/arxiv_data1/oa_pdf/80/26/srep03087.PMC3816289.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/02/c5/srep03127.PMC3816290.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3127 | DOI: 10.1038/srep03127 8",Non-OADS,/arxiv_data1/oa_pdf/02/c5/srep03127.PMC3816290.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3128 | DOI: 10.1038/srep03128 6",Non-OADS,/arxiv_data1/oa_pdf/8b/6e/srep03128.PMC3816291.pdf
"A., Dyar, M. D. & Sklute, E. C. in 37th Annual Lunar and Planetary Science Conference 2 (League City, 2006), http://www.lpi.usra.edu/meetings/ lpsc2006/pdf/2009.pdf, (accessed 12 June 2013).",Non-OADS,/arxiv_data1/oa_pdf/37/cd/srep03122.PMC3816292.pdf
Global lightning pattern: http://earthobservatory.nasa.gov/IOTD/view.,Non-OADS,/arxiv_data1/oa_pdf/37/cd/srep03122.PMC3816292.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/37/cd/srep03122.PMC3816292.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3122 | DOI: 10.1038/srep03122 4",Non-OADS,/arxiv_data1/oa_pdf/37/cd/srep03122.PMC3816292.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e9/47/srep03130.PMC3816293.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3130 | DOI: 10.1038/srep03130 7",Non-OADS,/arxiv_data1/oa_pdf/e9/47/srep03130.PMC3816293.pdf
Available from http://www.geneious.com/).,Non-OADS,/arxiv_data1/oa_pdf/a1/f6/srep03035.PMC3816294.pdf
Mixing and convergence to stationary distributions were checked with Tracer v1.5 (http://tree.bio.ed.ac.uk/software/tracer/).,OADS,/arxiv_data1/oa_pdf/a1/f6/srep03035.PMC3816294.pdf
"DNA sequences have been deposited in GenBank (http://www.ncbi.nlm.nih.gov/), with accession numbers KF525706-KF525782.",Non-OADS,/arxiv_data1/oa_pdf/a1/f6/srep03035.PMC3816294.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a1/f6/srep03035.PMC3816294.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3035 | DOI: 10.1038/srep03035 8",Non-OADS,/arxiv_data1/oa_pdf/a1/f6/srep03035.PMC3816294.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Large cerebellar mass lesion: A rare intracranial manifestation of  blastomycosis Stephan A. Munich, Andrew K. Johnson, Sumeet K. Ahuja, Alexander Venizelos1, Richard W .",Non-OADS,/arxiv_data1/oa_pdf/36/92/SNI-4-141.PMC3816295.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/141/119882 Copyright: © 2013.,Non-OADS,/arxiv_data1/oa_pdf/36/92/SNI-4-141.PMC3816295.pdf
"Surgical Neurology International 2013, 4:141  http://www.surgicalneurologyint.com/content/4/1/141Osteomyelitis may occur in almost any bone, including  the vertebrae, pelvis, sacrum, skull, and long bones.",Non-OADS,/arxiv_data1/oa_pdf/36/92/SNI-4-141.PMC3816295.pdf
"Surgical Neurology International 2013, 4:141  http://www.surgicalneurologyint.com/content/4/1/141Like the symptoms of non‑CNS blastomycosis, those  of CNS disease are also nonspecific.",Non-OADS,/arxiv_data1/oa_pdf/36/92/SNI-4-141.PMC3816295.pdf
"Surgical Neurology International 2013, 4:141  http://www.surgicalneurologyint.com/content/4/1/141reported one case in which a patient had normal CT  findings, but diffuse leptomeningeal enhancement with  a basal ganglia lesion on MRI.",Non-OADS,/arxiv_data1/oa_pdf/36/92/SNI-4-141.PMC3816295.pdf
"Surgical Neurology International 2013, 4:141  http://www.surgicalneurologyint.com/content/4/1/14116.",Non-OADS,/arxiv_data1/oa_pdf/36/92/SNI-4-141.PMC3816295.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/3d/cwt085.PMC3816631.pdf
"Sumoylation in gene regulation, human disease, and therapeutic action Xiang-Jiao Yang1,2* and Cheng-Ming Chiang3-5* Addresses:1The Rosalind & Morris Goodman Cancer Research Center, McGill University, Montréal, Québec, H3A 1A3, Canada; 2Department of Medicine, McGill University, Montréal, Québec, H3A 1A3, Canada;3Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390-8807, USA;4Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390-8807, USA;5Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8807, USA * Corresponding authors: Xiang-Jiao Yang (xiang-jiao.yang@mcgill.ca) and Cheng-Ming Chiang (cheng-ming.chiang@utsouthwestern.edu) F1000Prime Reports 2013, 5:45 (doi:10.12703/P5-45) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/00/biolrep.05-45.PMC3816760.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/5/45 Abstract Similar to ubiquitination, sumoylation covalently attaches a small ubiquitin-like modifier (SUMO) protein (92 –97 amino acids) to the e-amino group of a lysine residue.",Non-OADS,/arxiv_data1/oa_pdf/3a/00/biolrep.05-45.PMC3816760.pdf
"Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2013, 5:45 http://f1000.com/prime/reports/b/5/45",Non-OADS,/arxiv_data1/oa_pdf/3a/00/biolrep.05-45.PMC3816760.pdf
"Page 3 of 9 (page number not for citation purposes)F1000Prime Reports 2013, 5:45 http://f1000.com/prime/reports/b/5/45",Non-OADS,/arxiv_data1/oa_pdf/3a/00/biolrep.05-45.PMC3816760.pdf
"Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2013, 5:45 http://f1000.com/prime/reports/b/5/45",Non-OADS,/arxiv_data1/oa_pdf/3a/00/biolrep.05-45.PMC3816760.pdf
"Page 5 of 9 (page number not for citation purposes)F1000Prime Reports 2013, 5:45 http://f1000.com/prime/reports/b/5/45",Non-OADS,/arxiv_data1/oa_pdf/3a/00/biolrep.05-45.PMC3816760.pdf
"Acknowledgments Our work was supported by research grants from theCanadian funding agencies NSERC, CIHR, and CFI (to Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2013, 5:45 http://f1000.com/prime/reports/b/5/45",Non-OADS,/arxiv_data1/oa_pdf/3a/00/biolrep.05-45.PMC3816760.pdf
"Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2013, 5:45 http://f1000.com/prime/reports/b/5/45",Non-OADS,/arxiv_data1/oa_pdf/3a/00/biolrep.05-45.PMC3816760.pdf
"Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2013, 5:45 http://f1000.com/prime/reports/b/5/45",Non-OADS,/arxiv_data1/oa_pdf/3a/00/biolrep.05-45.PMC3816760.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2013, 5:45 http://f1000.com/prime/reports/b/5/45",Non-OADS,/arxiv_data1/oa_pdf/3a/00/biolrep.05-45.PMC3816760.pdf
"RNA modularity for synthetic biology Wade Grabow 1 * and Luc Jaeger 2 * Addresses: 1 Department of Chemistry and Biochemistry, Seattle Pacific University, 3307 Third Avenue West, Seattle, WA 98119, USA; 2 Department of Chemistry and Biochemistry, Bio-Molecular Science and Engineering Program, University of California, Santa Barbara, CA 93106-9510, USA * Corresponding authors: Wade Grabow (grabow@spu.edu); Luc Jaeger (jaeger@chem.ucsb.edu) F1000Prime Reports 2013, 5:46 (doi:10.12703/P5-46) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/fd/biolrep-05-46.PMC3816761.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/5/46 Abstract RNA molecules are highly modular components that can be used in a variety of contexts for building new metabolic, regulatory and genetic circuits in cells.",Non-OADS,/arxiv_data1/oa_pdf/82/fd/biolrep-05-46.PMC3816761.pdf
"Page 2 of 10 (page number not for citation purposes) F1000Prime Reports 2013, 5:46 http://f1000.com/prime/reports/b/5/46",Non-OADS,/arxiv_data1/oa_pdf/82/fd/biolrep-05-46.PMC3816761.pdf
"The impor-tant contributions that long-range interactions make in riboswitches (with respect to functional activity) are Page 3 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:46 http://f1000.com/prime/reports/b/5/46",Non-OADS,/arxiv_data1/oa_pdf/82/fd/biolrep-05-46.PMC3816761.pdf
"Page 4 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:46 http://f1000.com/prime/reports/b/5/46",Non-OADS,/arxiv_data1/oa_pdf/82/fd/biolrep-05-46.PMC3816761.pdf
"Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:46 http://f1000.com/prime/reports/b/5/46",Non-OADS,/arxiv_data1/oa_pdf/82/fd/biolrep-05-46.PMC3816761.pdf
"Page 6 of 10 (page number not for citation purposes) F1000Prime Reports 2013, 5:46 http://f1000.com/prime/reports/b/5/46",Non-OADS,/arxiv_data1/oa_pdf/82/fd/biolrep-05-46.PMC3816761.pdf
"Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:46 http://f1000.com/prime/reports/b/5/46",Non-OADS,/arxiv_data1/oa_pdf/82/fd/biolrep-05-46.PMC3816761.pdf
"Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:46 http://f1000.com/prime/reports/b/5/46",Non-OADS,/arxiv_data1/oa_pdf/82/fd/biolrep-05-46.PMC3816761.pdf
"Busi F, Cayrol B, Lavelle C, LeDerout J, Piétrement O, Le Cam E, Geinguenaud F, Lacoste J, Régnier P, Arluison V: Auto-assembly as Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:46 http://f1000.com/prime/reports/b/5/46",Non-OADS,/arxiv_data1/oa_pdf/82/fd/biolrep-05-46.PMC3816761.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:46 http://f1000.com/prime/reports/b/5/46",Non-OADS,/arxiv_data1/oa_pdf/82/fd/biolrep-05-46.PMC3816761.pdf
"Control of gene expression by CRISPR-Cas systems David Bikard* and Luciano A. Marraffini* Address: Laboratory of Bacteriology, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA * Corresponding authors: David Bikard (dbikard@rockefeller.edu) and Luciano A. Marraffini (marraffini@rockefeller.edu) F1000Prime Reports 2013, 5:47 (doi:10.12703/P5-47) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/74/biolrep-05-47.PMC3816762.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/5/47 Abstract Clustered regularly interspaced short palindromic repeats (CRISPR) loci and their associated cas (CRISPR-associated) genes provide adaptive immunity against viruses (phages) and other mobile genetic elements in bacteria and archaea.,Non-OADS,/arxiv_data1/oa_pdf/87/74/biolrep-05-47.PMC3816762.pdf
"Page 2 of 8 (page number not for citation purposes) F1000Prime Reports 2013, 5:47 http://f1000.com/prime/reports/b/5/47",Non-OADS,/arxiv_data1/oa_pdf/87/74/biolrep-05-47.PMC3816762.pdf
"Instead, they hypothesized Page 3 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:47 http://f1000.com/prime/reports/b/5/47",Non-OADS,/arxiv_data1/oa_pdf/87/74/biolrep-05-47.PMC3816762.pdf
"Page 4 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:47 http://f1000.com/prime/reports/b/5/47",Non-OADS,/arxiv_data1/oa_pdf/87/74/biolrep-05-47.PMC3816762.pdf
"Thebinding of dCas9 to the promoter region of a reporter gene blocks transcription initiation (Figure 3a), while Page 5 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:47 http://f1000.com/prime/reports/b/5/47",Non-OADS,/arxiv_data1/oa_pdf/87/74/biolrep-05-47.PMC3816762.pdf
"Page 6 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:47 http://f1000.com/prime/reports/b/5/47",Non-OADS,/arxiv_data1/oa_pdf/87/74/biolrep-05-47.PMC3816762.pdf
"Wiedenheft B, van Duijn E, Bultema JB, Bultema J, Waghmare SP, Waghmare S, Zhou K, Barendregt A, Westphal W, Heck AJR, Heck A, Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:47 http://f1000.com/prime/reports/b/5/47",Non-OADS,/arxiv_data1/oa_pdf/87/74/biolrep-05-47.PMC3816762.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:47 http://f1000.com/prime/reports/b/5/47",Non-OADS,/arxiv_data1/oa_pdf/87/74/biolrep-05-47.PMC3816762.pdf
"New developments in the anti-neoplastic drug management of ovarian cancer Maurie Markman Address: Cancer Treatment Centers of America, Eastern Regional Medical Center, 1331 East Wyoming Avenue, Philadelphia, PA 19124, USA Email: maurie.markman@ctca-hope.com F1000Prime Reports 2013, 5:48 (doi:10.12703/P5-48) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/f1/medrep-05-48.PMC3816763.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/5/48 Abstract Over the past several years, there have been a number of relevant evidence-based randomized trials that have the potential to change the standard management paradigm in the malignancy of ovariancancer and (most importantly) enhance clinically relevant outcomes.",Non-OADS,/arxiv_data1/oa_pdf/51/f1/medrep-05-48.PMC3816763.pdf
"Page 2 of 4 (page number not for citation purposes)F1000Prime Reports 2013, 5:48 http://f1000.com/prime/reports/m/5/48",Non-OADS,/arxiv_data1/oa_pdf/51/f1/medrep-05-48.PMC3816763.pdf
"Pujade-Lauraine E, Wagner U, Aavall-Lundqvist E, Gebski V, Heywood M, Vasey PA, Volgger B, Vergote I, Pignata S, Ferrero A, Sehouli J, Lortholary A, Kristensen G, Jackisch C, Joly F, Brown C, Le Fur N, Du Bois A: Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for Page 3 of 4 (page number not for citation purposes)F1000Prime Reports 2013, 5:48 http://f1000.com/prime/reports/m/5/48",Non-OADS,/arxiv_data1/oa_pdf/51/f1/medrep-05-48.PMC3816763.pdf
"Page 4 of 4 (page number not for citation purposes)F1000Prime Reports 2013, 5:48 http://f1000.com/prime/reports/m/5/48",Non-OADS,/arxiv_data1/oa_pdf/51/f1/medrep-05-48.PMC3816763.pdf
"Reanimating the paralyzed face Kofi Boahene Address: Department of Otolaryngology Head and Neck Surgery, Johns Hopkins Institute of Medicine, 601 N. Caroline Street, Baltimore, MD 21287, USA Email: dboahen1@jhmi.edu F1000Prime Reports 2013, 5:49 (doi:10.12703/P5-49) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/53/medrep-05-49.PMC3816764.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/5/49 Abstract Facial animation is an essential part of human communication and one of the main means of expressing emotions, indexing our physiologic state and providing nonverbal cues.",Non-OADS,/arxiv_data1/oa_pdf/9c/53/medrep-05-49.PMC3816764.pdf
"Page 2 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:49 http://f1000.com/prime/reports/m/5/49",Non-OADS,/arxiv_data1/oa_pdf/9c/53/medrep-05-49.PMC3816764.pdf
"Page 3 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:49 http://f1000.com/prime/reports/m/5/49",Non-OADS,/arxiv_data1/oa_pdf/9c/53/medrep-05-49.PMC3816764.pdf
"Page 4 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:49 http://f1000.com/prime/reports/m/5/49",Non-OADS,/arxiv_data1/oa_pdf/9c/53/medrep-05-49.PMC3816764.pdf
"Page 5 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:49 http://f1000.com/prime/reports/m/5/49",Non-OADS,/arxiv_data1/oa_pdf/9c/53/medrep-05-49.PMC3816764.pdf
"Page 6 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:49 http://f1000.com/prime/reports/m/5/49",Non-OADS,/arxiv_data1/oa_pdf/9c/53/medrep-05-49.PMC3816764.pdf
"Page 7 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:49 http://f1000.com/prime/reports/m/5/49",Non-OADS,/arxiv_data1/oa_pdf/9c/53/medrep-05-49.PMC3816764.pdf
"Page 8 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:49 http://f1000.com/prime/reports/m/5/49",Non-OADS,/arxiv_data1/oa_pdf/9c/53/medrep-05-49.PMC3816764.pdf
"Page 9 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:49 http://f1000.com/prime/reports/m/5/49",Non-OADS,/arxiv_data1/oa_pdf/9c/53/medrep-05-49.PMC3816764.pdf
"Page 10 of 10 (page number not for citation purposes)F1000Prime Reports 2013, 5:49 http://f1000.com/prime/reports/m/5/49",Non-OADS,/arxiv_data1/oa_pdf/9c/53/medrep-05-49.PMC3816764.pdf
"Vivek Chhaya and Richard Pollok* Address: Department of Gastroenterology, St George ’s Hospital University NHS Trust, Blackshaw Road, London SW17 0QT * Corresponding author: Richard Pollok (richard.pollok@nhs.net) F1000Prime Reports 2013, 5:50 (doi:10.12703/P5-50) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/07/medrep-05-50.PMC3816845.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/5/50 Abstract Ulcerative colitis and Crohn ’s disease together are known as inflammatory bowel disease (IBD).,Non-OADS,/arxiv_data1/oa_pdf/3a/07/medrep-05-50.PMC3816845.pdf
"Perianal complications are a frequent mani- festation of Crohn ’s disease and result in significant Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2013, 5:50 http://f1000.com/prime/reports/m/5/50",Non-OADS,/arxiv_data1/oa_pdf/3a/07/medrep-05-50.PMC3816845.pdf
"This coincides with theincreasing use of immunomodulator therapy, mainly thiopurines, in both Crohn ’s disease and ulcerative Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2013, 5:50 http://f1000.com/prime/reports/m/5/50",Non-OADS,/arxiv_data1/oa_pdf/3a/07/medrep-05-50.PMC3816845.pdf
"In conclusion, thiopurines have a definite role in the management of ulcerative colitis and Crohn ’s disease Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2013, 5:50 http://f1000.com/prime/reports/m/5/50",Non-OADS,/arxiv_data1/oa_pdf/3a/07/medrep-05-50.PMC3816845.pdf
"Page 5 of 7 (page number not for citation purposes)F1000Prime Reports 2013, 5:50 http://f1000.com/prime/reports/m/5/50",Non-OADS,/arxiv_data1/oa_pdf/3a/07/medrep-05-50.PMC3816845.pdf
"Surgical rates and medical management in a population-based Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2013, 5:50 http://f1000.com/prime/reports/m/5/50",Non-OADS,/arxiv_data1/oa_pdf/3a/07/medrep-05-50.PMC3816845.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2013, 5:50 http://f1000.com/prime/reports/m/5/50",Non-OADS,/arxiv_data1/oa_pdf/3a/07/medrep-05-50.PMC3816845.pdf
DOI: 10.2337/dc12-1615This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1615/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e9/3c/3495.PMC3816848.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e9/3c/3495.PMC3816848.pdf
Available fromhttp://www.aemmedi.i t/algoritmi_en_ 2013.,Non-OADS,/arxiv_data1/oa_pdf/de/21/e192.PMC3816849.pdf
"NCT00234832, www.clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0027/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/d1/6a/3746.PMC3816850.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d1/6a/3746.PMC3816850.pdf
"no.ISRCTN35739639, www.isrctn.org.This article contains Supplementary Data online at http://care.diabetesjour nals.org/lookup/suppl/ doi:10.2337/dc13-0955/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/48/68/3803.PMC3816851.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/49/dd/3671.PMC3816852.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d4/c1/3425.PMC3816853.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/95/f0/3620.PMC3816854.pdf
"NCT00623610, clinicaltrials.org.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0128/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/72/e2/3483.PMC3816855.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/72/e2/3483.PMC3816855.pdf
"NCT0476658, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0256/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/d5/7c/3793.PMC3816856.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d5/7c/3793.PMC3816856.pdf
Received 21 December 2012 and accepted 17 May 2013.DOI: 10.2337/dc12-2675 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2675/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/98/70/3510.PMC3816858.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/98/70/3510.PMC3816858.pdf
Available from https://www.icsi.org/guidelines__more/catalog_ guidelines_and_more/catalog_guidelines/ catalog_endocrine_gu idelines/diabetes/.,Non-OADS,/arxiv_data1/oa_pdf/98/70/3510.PMC3816858.pdf
Received 7 February 2013 and accepted 8 June 2013.DOI: 10.2337/dc13-0323This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0323/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/34/ea/3460.PMC3816860.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/34/ea/3460.PMC3816860.pdf
Received 29 December 2012 and accepted 18 June 2013.DOI: 10.2337/dc12-2710This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2710/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/16/ad/3726.PMC3816861.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/16/ad/3726.PMC3816861.pdf
"NCT00956566, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0102/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/2e/d5/3786.PMC3816862.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/2e/d5/3786.PMC3816862.pdf
Post hoc power analysis was calculated with G*Power 3.1.7 (http://www.psycho.uni-duesseldorf.de/abteilungen/aap/gpower3).,OADS,/arxiv_data1/oa_pdf/2e/d5/3786.PMC3816862.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/2d/bd/3772.PMC3816863.pdf
"NCT00681850, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1853/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/f8/a0/3388.PMC3816864.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f8/a0/3388.PMC3816864.pdf
Available from http://www.idf.org/diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/f8/a0/3388.PMC3816864.pdf
"Brussels, International Diabetes Federation.Available from http://archive.diabetesatlas.org.",Non-OADS,/arxiv_data1/oa_pdf/f8/a0/3388.PMC3816864.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/2d/62/3535.PMC3816866.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/dd/de/3779.PMC3816867.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/6f/66/3382.PMC3816868.pdf
Available fromhttp://www.who.int/features/fact ﬁles/ obesity/facts/en/.,Non-OADS,/arxiv_data1/oa_pdf/6f/66/3382.PMC3816868.pdf
Available from http://www.idf.org/sites/default/ ﬁles/ Diabetes-in-Childhood-and-Adolescence-Guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/66/3382.PMC3816868.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/b4/9d/3405.PMC3816869.pdf
"Corresponding author: Takashi Wada, twada@m-kanazawa.jp.Received 5 February 2013 and accepted 28 May 2013.DOI: 10.2337/dc13-0298This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0298/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/23/0e/3655.PMC3816871.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/23/0e/3655.PMC3816871.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/06/a0/3678.PMC3816872.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/39/d7/3469.PMC3816873.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4a/d5/3613.PMC3816874.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/9c/72/3543.PMC3816875.pdf
"Corresponding author: Marius Trøseid, troseid@hotmail.com.Received 22 February 2013 and accepted 30 April 2013.DOI: 10.2337/dc13-0451This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0451/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/3f/aa/3627.PMC3816876.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3f/aa/3627.PMC3816876.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/84/31/3766.PMC3816877.pdf
Available from http://www.idf.org/ diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/84/31/3766.PMC3816877.pdf
"Corresponding author: Gilberto Velho, gilberto.velho@inserm.fr.Received 21 March 2013 and accepted 7 May 2013.DOI: 10.2337/dc13-0683This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0683/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/73/f3/3639.PMC3816878.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/73/f3/3639.PMC3816878.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/71/09/3684.PMC3816879.pdf
"Corresponding author: Gang Hu, gang.hu@pbrc.edu.Received 21 February 2013 and accepted 19 June 2013.DOI: 10.2337/dc13-0437This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0437/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/ed/dd/3591.PMC3816880.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ed/dd/3591.PMC3816880.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8c/71/3706.PMC3816881.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/3843.PMC3816882.pdf
Available from http://innovation.cm s.gov/initiatives/ fqhcs/.,OADS,/arxiv_data1/oa_pdf/c5/0d/3843.PMC3816882.pdf
Available from http://dhhs.nv.gov/HealthCare/Docs/MedicalHomes/ Outcomes%20of% 20Implementing% 20Medical%20Home%20Interventions%20by%20the%20PCPCC%20-%20Nov% 202010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/3843.PMC3816882.pdf
Available from http://www.managedcaremag.com/archives/1008/ 1008.medicalhome.html.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/3843.PMC3816882.pdf
http://www.pcpcc.org/guide/practices-spotlight.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/3843.PMC3816882.pdf
Available from http://nhsc.hrsa.gov/ loanrepayment/index.html.,Non-OADS,/arxiv_data1/oa_pdf/c5/0d/3843.PMC3816882.pdf
"Corresponding author: Masaru Sakurai, m-sakura@kanazawa-med.ac.jp.Received 19 November 2012 and accepted 17 May 2013.DOI: 10.2337/dc12-2412This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2412/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/4b/82/3759.PMC3816883.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4b/82/3759.PMC3816883.pdf
"Corresponding author: Kari Anne Sveen, k.a.sveen@medisin.uio.no.Received 2 April 2013 and accepted 13 June 2013.DOI: 10.2337/dc13-0788This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0788/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/df/a2/3712.PMC3816884.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/df/a2/3712.PMC3816884.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/82/9a/3498.PMC3816885.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f5/76/3691.PMC3816886.pdf
"NCT00945165, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2620/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/29/59/3448.PMC3816888.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/29/59/3448.PMC3816888.pdf
"Corresponding author: Kamlesh Khunti, kk22@leicester.ac.uk.Received 8 February 2013 and accepted 9 May 2013.DOI: 10.2337/dc13-0331This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0331/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/f1/d3/3411.PMC3816889.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f1/d3/3411.PMC3816889.pdf
"Corresponding author: Krishnarajah Nirantharakumar, k.nirantharakumar@warwick.ac.uk.Received 22 February 2013 and accepted 5 June 2013.DOI: 10.2337/dc13-0452 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0452/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/57/1c/3566.PMC3816890.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/57/1c/3566.PMC3816890.pdf
http://www.yhpho.org.uk/default.aspx?,Non-OADS,/arxiv_data1/oa_pdf/57/1c/3566.PMC3816890.pdf
Available fro m http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/57/1c/3566.PMC3816890.pdf
Available from http://www.diabetes .nhs.uk/document.,Non-OADS,/arxiv_data1/oa_pdf/57/1c/3566.PMC3816890.pdf
Available from http://www.hscic.gov.uk/media/9748/Amended-AHRQ-CCS-ICD-10-lookup-table-Oct12/xls/ CCS_ICD10_lookup_ta ble_Oct12.xlsx.,Non-OADS,/arxiv_data1/oa_pdf/57/1c/3566.PMC3816890.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8f/ac/3739.PMC3816891.pdf
The data then were compounded into 60-s epochs for use with the currenta c t i v i t yc u tp o i n t s .T h ed a t aw e r ep r o -cessed using an adaptation of the SAS code developed by the National Cancer Institute for use with National Healthand Nutrition Examination Survey data (available at: http://riskfactor.cancer.gov/ tools/nhanes_pam).,OADS,/arxiv_data1/oa_pdf/8f/ac/3739.PMC3816891.pdf
Available from http://www.health.gov/paguidelines/ pdf/paguide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/ac/3739.PMC3816891.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/93/8d/3476.PMC3816892.pdf
"is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.Table 1—Patient noti ﬁcation events resulting from multipatient use of insulin pens in U.S. health care settings, 2011 –2013 SettingPersons notiﬁed (n)Time period during which insulin pens might have been used for more than one patient Source Primary care clinica,b2,345 2006 –2011 http://www.deancare.com/about- dean/news/2011/important- patient-safety-noti ﬁcation/ Hospitala57 2001 –2011 Wisconsin Division of Public Health, unpublished data Hospital 716 2010 –2012 http://www.buffalonews.com/ apps/pbcs.dll/article?AID=/20130111/CITYANDREGION/130119728/1002 Hospital 1,915 2009 –2013 http://www.cbsnews.com/8301- 204_162-57565678/second-n.y-hospital-warns-of-hiv-infection- risk-from-insulin-pens/ Hospital 205 2010 –2013 http://www.wbtv.com/story/ 21546682/salisbury-va-insulin Hospital NA 2007 –2013 http://www.recordonlin.com/apps/ pbcs.dll/article?AID=/20130521/NEWS/ 130529929 aInsulin demonstration pens were reused.bNotiﬁcation also included patients that were potentially exposed to reused ﬁnger-stick devices.",Non-OADS,/arxiv_data1/oa_pdf/ba/09/e188.PMC3816894.pdf
Availablefrom http://www.cdc.gov/injectionsafety/clinical-reminders/i nsulin-pens.html.,Non-OADS,/arxiv_data1/oa_pdf/ba/09/e188.PMC3816894.pdf
Availableat: http://www.oneandonlycampaign.org/ content/insulin-pen-safety.,Non-OADS,/arxiv_data1/oa_pdf/ba/09/e188.PMC3816894.pdf
Available from http://www.cms.gov/Medicare/Provider-Enrollment-and-Certi ﬁcation/ SurveyCerti ﬁcationGenInfo/downloads/ Survey-and-Cert-Letter-12-30.pdf.,OADS,/arxiv_data1/oa_pdf/ba/09/e188.PMC3816894.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/6d/84/3599.PMC3816896.pdf
DOI: 10.2337/dc13-0450This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0450/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6f/e6/3718.PMC3816897.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/6f/e6/3718.PMC3816897.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4b/d0/3454.PMC3816898.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/dd/62/3815.PMC3816899.pdf
Availablefrom http://ahc-path-aperio11.ad.u ﬂ.edu.,Non-OADS,/arxiv_data1/oa_pdf/dd/62/3815.PMC3816899.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/78/93/3646.PMC3816900.pdf
DOI: 10.2337/dc13-0446 This article contains Supplementary Data online at http://care.diabetesjour nals.org/lookup/suppl/ doi:10.2337/dc13-0446/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ab/f6/3526.PMC3816901.pdf
Received 3 April 2013 and accepted 18 June 2013.DOI: 10.2337/dc13-0800This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0800/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/41/57/3732.PMC3816902.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/41/57/3732.PMC3816902.pdf
"Corresponding author: Tina Costacou, costacout@edc.pitt.edu.Received 14 November 2012 and accepted 17 May 2013.DOI: 10.2337/dc12-2378This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2378/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/a7/d9/3503.PMC3816903.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a7/d9/3503.PMC3816903.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/19/36/3585.PMC3816904.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/41/40/3663.PMC3816905.pdf
DOI: 10.2337/dc13-0260 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0260/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e0/6b/3754.PMC3816906.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e0/6b/3754.PMC3816906.pdf
DOI: 10.2337/dc13-0705This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0705/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ed/b1/3818.PMC3816907.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ed/b1/3818.PMC3816907.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/18/66/3698.PMC3816908.pdf
Availablefrom http://www.iasp-p ain.org/AM/Template .cfm?Section=Technical_Corner&Template=/ CM/ContentDisplay.cfm&ContentID=2188.Accessed 10 February 2013 38.,Non-OADS,/arxiv_data1/oa_pdf/18/66/3698.PMC3816908.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0018/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/51/42/3442.PMC3816909.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/51/42/3442.PMC3816909.pdf
"NCT01378117, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0277/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/10/ca/3430.PMC3816910.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/10/ca/3430.PMC3816910.pdf
Received 20 December 2012 and accepted 6 June 2013.DOI: 10.2337/dc12-2643This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2643/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/8a/c5/3573.PMC3816911.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8a/c5/3573.PMC3816911.pdf
Received 1 November 2012 and accepted 12 May 2013.DOI: 10.2337/dc12-2251This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2251/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/41/f4/3418.PMC3816912.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/41/f4/3418.PMC3816912.pdf
"Corresponding author: Chandra L. Jackson, cjackson@hsph.harvard.edu.Received 1 April 2013 and accepted 3 June 2013.DOI: 10.2337/dc13-0777This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0777/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/30/3b/3557.PMC3816913.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/30/3b/3557.PMC3816913.pdf
Available from http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5708a8.htm.,OADS,/arxiv_data1/oa_pdf/30/3b/3557.PMC3816913.pdf
Available from http://www.cdc.gov/nchs/nhis.htm.,OADS,/arxiv_data1/oa_pdf/30/3b/3557.PMC3816913.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/29/bc/3489.PMC3816914.pdf
"Corresponding author: John B. Buse, jbuse@med.unc.edu.Received 31 January 2013 and accepted 17 May 2013.DOI: 10.2337/dc13-0263 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0263/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/08/03/3517.PMC3816915.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/08/03/3517.PMC3816915.pdf
The study protocol was registered in the European Network ofCentres for Pharmacoepidemiology andPharmacovigilance (ENCePP) electronic register of studies (http://www.encepp .eu/encepp/viewResource.htm?id=2334).,Non-OADS,/arxiv_data1/oa_pdf/08/03/3517.PMC3816915.pdf
Available from http://www.inovalon .com/howwehelp/pages/more2-registry- database.aspx.,OADS,/arxiv_data1/oa_pdf/08/03/3517.PMC3816915.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d1/50/3821.PMC3816916.pdf
"Geneva, World Health Organization.Available from http://www.who.int/ nutrition/publications/guidelines/sodium_ intake_printversion.pdf.",Non-OADS,/arxiv_data1/oa_pdf/d1/50/3821.PMC3816916.pdf
"NCT01159600, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2673/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/d9/4c/3396.PMC3816918.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d9/4c/3396.PMC3816918.pdf
Available fromhttp://www.forxiga.eu/sites/default/ ﬁles/ Forxiga%20Summary%20of%20Product% 20Characteristics_SmPC_.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d9/4c/3396.PMC3816918.pdf
"Corresponding author: Dariush Mozaffarian, dmozaffa@hsph.harvard.edu.Received 16 April 2013 and accepted 22 June 2013.DOI: 10.2337/dc13-0894This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0894/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/76/e5/3578.PMC3816920.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/76/e5/3578.PMC3816920.pdf
Available from http://www.fda.gov/food/resourcesforyou/consumers/ucm110591.,Non-OADS,/arxiv_data1/oa_pdf/76/e5/3578.PMC3816920.pdf
Available from http://www.epa.gov/iris/subst/0073.htm.,OADS,/arxiv_data1/oa_pdf/76/e5/3578.PMC3816920.pdf
Available from http://www.fda.gov/ohrms/dockets/ac/02/ brieﬁng/3872_advisory%207.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/e5/3578.PMC3816920.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c8/ad/3607.PMC3816921.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/21/28/3652.PMC3816922.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/73/dc/3812.PMC3816923.pdf
Received 20 December 2012 and accepted 24 May 2013.DOI: 10.2337/dc12-2653This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2653/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/83/04/3549.PMC3816924.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/83/04/3549.PMC3816924.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0d/f9/3436.PMC3816925.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/45/btt-7-231.PMC3816975.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/ee/45/btt-7-231.PMC3816975.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ee/45/btt-7-231.PMC3816975.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/9a/ccide-5-077.PMC3816985.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dentistry 2013:5 77–80Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  77OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCIDE.S5335 9effect of lip position and gingival display  on smile and esthetics as perceived by  college students with different educational  backgrounds Khalid h Zawawi1 ghadah a Malki2 Mohammad s al-Zahrani3 Yaser M alkhiary4 1Department of Preventive Dental  science, Faculty of Dentistry, King  abdulaziz University, 2Consultant  Pediatric Dentist, north Jeddah  Dental specialty Center, 3Department  of Oral Basic and Clinical sciences,   Faculty of Dentistry, 4Department of  Oral and Maxillofacial rehabilitation,   Faculty of Dentistry, King abdulaziz  University, Jeddah, saudi arabia Correspondence: Khalid h Zawawi   Department of Preventive Dental  science, Faculty of Dentistry, King  abdulaziz University, PO Box 80209,  Jeddah 21589, saudi arabia   Tel +966 2640 2000   Fax +966 2640 3316   email kzawawi@kau.edu.s aAim:  The aim of this study was to evaluate the influence of education on the perception of female  college students on the effect of lip position and gingival display upon smiling and esthetics.",Non-OADS,/arxiv_data1/oa_pdf/93/9a/ccide-5-077.PMC3816985.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/93/9a/ccide-5-077.PMC3816985.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/93/9a/ccide-5-077.PMC3816985.pdf
"Molecular Vision  2013; 19:2124-2134 <http://www.molvis.org/molvis/v 19/2124 > Received 4 September 2012 | Accepted 29 October 2013 | Published 30 October 2013© 2013 Molecular Vision 2124Preliminary identification of differentially expressed tear proteins  in keratoconus Sivaraman A. Balasubramanian,1,2,3 Valerie C. Wasinger,4 David C. Pye,1,5 Mark D. P. Willcox1 1School of Optometry and Vision Science, The University of New South Wales, Sydney, Australia; 2School of Medicine, Deakin  University, Waurn Ponds, Victoria, Australia; 3Centre for Eye Research Australia, University of Melbourne, Royal Victorian  Eye and Ear Hospital, Melbourne, Victoria, Australia; 4Bioanalytical Mass Spectrometry Facility, Mark Wainwright Analytical  Centre, The University of New South Wales, Sydney, Australia; 5Centre for Eye Health, The University of New South Wales,  Sydney, Australia Purpose:  To examine the proteins differentially expressed in the tear film of people with keratoconus and normal  subjects.",Non-OADS,/arxiv_data1/oa_pdf/89/04/mv-v19-2124.PMC3816990.pdf
"Molecular Vision  2013; 19:2124-2134 <http://www.molvis.org/molvis/v 19/2124 > © 2013 Molecular Vision  2125First introduced by Horvath and coworkers in 1994, MF10  uses the established principles of electrophoresis to move  charged molecules in a solution [ 15].",Non-OADS,/arxiv_data1/oa_pdf/89/04/mv-v19-2124.PMC3816990.pdf
"Molecular Vision  2013; 19:2124-2134 <http://www.molvis.org/molvis/v 19/2124 > © 2013 Molecular Vision  2126membranes were washed twice with ultrapure water (H2O)  and then twice with 1X Tris-ε-aminocaproic acid (EACA)/ urea buffer (90 mM Tris (hydroxymethyl) aminomethane,  10 mM EACA, 2 M urea).",Non-OADS,/arxiv_data1/oa_pdf/89/04/mv-v19-2124.PMC3816990.pdf
Molecular Vision  2013; 19:2124-2134 <http://www.molvis.org/molvis/v 19/2124 > © 2013 Molecular Vision  2127a vacuum centrifuge and frozen at −20 °C until further use.,Non-OADS,/arxiv_data1/oa_pdf/89/04/mv-v19-2124.PMC3816990.pdf
Molecular Vision  2013; 19:2124-2134 <http://www.molvis.org/molvis/v 19/2124 > © 2013 Molecular Vision  2128a micro C18 precolumn (500 µm × 2 mm) with 0.05% (v/v)  heptafluorobutyric acid (HFBA) 20  µl/min.,Non-OADS,/arxiv_data1/oa_pdf/89/04/mv-v19-2124.PMC3816990.pdf
Molecular Vision  2013; 19:2124-2134 <http://www.molvis.org/molvis/v 19/2124 > © 2013 Molecular Vision  2129Tear protein profile:  Pooled C (36 µl) and KC group (72 µl)  tear samples had equal total protein amounts before protein  fractionation.,OADS,/arxiv_data1/oa_pdf/89/04/mv-v19-2124.PMC3816990.pdf
"Molecular Vision  2013; 19:2124-2134 <http://www.molvis.org/molvis/v 19/2124 > © 2013 Molecular Vision  2130patients with KC reported previously [ 9,31].",Non-OADS,/arxiv_data1/oa_pdf/89/04/mv-v19-2124.PMC3816990.pdf
Molecular Vision  2013; 19:2124-2134 <http://www.molvis.org/molvis/v 19/2124 > © 2013 Molecular Vision  2131film.,Non-OADS,/arxiv_data1/oa_pdf/89/04/mv-v19-2124.PMC3816990.pdf
Molecular Vision  2013; 19:2124-2134 <http://www.molvis.org/molvis/v 19/2124 > © 2013 Molecular Vision  2132occurred in the tear film before collection and addition of  trypsin for MS analysis.,Non-OADS,/arxiv_data1/oa_pdf/89/04/mv-v19-2124.PMC3816990.pdf
Molecular Vision  2013; 19:2124-2134 <http://www.molvis.org/molvis/v 19/2124 > © 2013 Molecular Vision  2133investigating tear proteases and protease inhibitors are vital  to understand the course of the disease and formulate new  therapeutic interventions.,Non-OADS,/arxiv_data1/oa_pdf/89/04/mv-v19-2124.PMC3816990.pdf
Molecular Vision  2013; 19:2124-2134 <http://www.molvis.org/molvis/v 19/2124 > © 2013 Molecular Vision  213417.,Non-OADS,/arxiv_data1/oa_pdf/89/04/mv-v19-2124.PMC3816990.pdf
"Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > Received 30 May 2013 | Accepted 29 October 2013 | Published 1 November 2013© 2013 Molecular Vision 2135An ophthalmic solution of a peroxisome proliferator-activated  receptor gamma agonist prevents corneal inflammation in a rat  alkali burn model Masaaki Uchiyama,1,2 Akira Shimizu,2 Yukinari Masuda,2 Shinya Nagasaka,2 Yuh Fukuda,2 Hiroshi  Takahashi1 1Department of Ophthalmology, Nippon Medical School, Tokyo, Japan; 2Department of Analytic Human Pathology, Nippon  Medical School, Tokyo, Japan Purpose:  We clarified the effects of an ophthalmic solution of a peroxisome proliferator-activated receptor gamma  (PPARγ) agonist on corneal inflammation and wound healing after alkali burn injury in rats.",Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
"Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2136Thiazolidinediones are mainly used as insulin-sensitizing  drugs for patients with type 2 diabetes mellitus, but have  been shown to have a potential role in attenuating vascular  fibrosis and inhibiting inflammatory responses [ 16,17].",Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2137tissue sections.,Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2138 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
"Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2139cells/HPF, p=0.024) and macrophages (PPARγ group:  32.2±5.3 cells/HPF; vehicle group: 48.6±8.8 cells/HPF,  p=0.049) peaked in the injured corneas in both groups  (Figure 3E; Figure 4E).",Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
"Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2140center of the cornea by day 7 (Figure 3C,D, Figure 4C,D).",Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2141The mRNA levels of IL-8 and MCP-1 gradually decreased  by day 14.,Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2142PPARγ and the vehicle groups (Figure 8F).,Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2143 Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2144 Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2145with the ophthalmic solution of the PPARγ agonist.,Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
"Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2146corneal cells, the blood-aqueous barrier is compromised,  and necrotic debris is released into the aqueous humor [ 24].",Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2147elements from the injured vessels and necrotic tissue.,Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2148was reduced by treatment with an ophthalmic solution of a  PPARγ agonist from the early phase after alkali injury.,Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  2149transition-like phenotypic changes of retinal pigment epithe - lium induced by TGF-β are prevented by PPAR-γ agonists.,Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
Molecular Vision  2013; 19:2135-2150 <http://www.molvis.org/molvis/v 19/2135 > © 2013 Molecular Vision  215035.,Non-OADS,/arxiv_data1/oa_pdf/ed/ac/mv-v19-2135.PMC3816991.pdf
"In this study, we extend the clinical phenotypes observed  in each family and show that they have the same disorder, Molecular Vision  2013; 19:2165-2172 <http://www.molvis.org/molvis/v 19/2165 > Received 6 September 2013 | Accepted 29 October 2013 | Published 1 November 2013© 2013 Molecular Vision 2165A new recessively inherited disorder composed of foveal  hypoplasia, optic nerve decussation defects and anterior segment  dysgenesis maps to chromosome 16q23.3-24.1 Musallam Al-Araimi,1 Bishwanath Pal,1 James A. Poulter,1 Maria M. van Genderen,2 Ian Carr,3 Tomas  Cudrnak,4 Lawrence Brown,5 Eamonn Sheridan,6, 7 Moin D. Mohamed,1 John Bradbury,4 Manir Ali,1 Chris F.  Inglehearn,1 Carmel Toomes1 (The first two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/5b/df/mv-v19-2165.PMC3816992.pdf
"Molecular Vision  2013; 19:2165-2172 <http://www.molvis.org/molvis/v 19/2165 > © 2013 Molecular Vision  2166which we have termed foveal hypoplasia, optic nerve decus- sation defects and anterior segment dysgenesis (FHONDA  syndrome).",Non-OADS,/arxiv_data1/oa_pdf/5b/df/mv-v19-2165.PMC3816992.pdf
"Molecular Vision  2013; 19:2165-2172 <http://www.molvis.org/molvis/v 19/2165 > © 2013 Molecular Vision  2167METHODS Patients:  Ethical approval was obtained from the Leeds East  Teaching Hospitals Trust Research Ethics Committee, and  informed consent was obtained for all subjects.",Non-OADS,/arxiv_data1/oa_pdf/5b/df/mv-v19-2165.PMC3816992.pdf
Molecular Vision  2013; 19:2165-2172 <http://www.molvis.org/molvis/v 19/2165 > © 2013 Molecular Vision  2168RESULTS The presence of foveal hypoplasia in the absence of well- recognized syndromes such as albinism and aniridia is rare.,Non-OADS,/arxiv_data1/oa_pdf/5b/df/mv-v19-2165.PMC3816992.pdf
Molecular Vision  2013; 19:2165-2172 <http://www.molvis.org/molvis/v 19/2165 > © 2013 Molecular Vision  2169Table  2. c linical  findings  in fHonda paTienTs.,Non-OADS,/arxiv_data1/oa_pdf/5b/df/mv-v19-2165.PMC3816992.pdf
"Molecular Vision  2013; 19:2165-2172 <http://www.molvis.org/molvis/v 19/2165 > © 2013 Molecular Vision  2170DISCUSSION In this study, we defined a new disorder called FHONDA  syndrome comprising foveal hypoplasia, optic nerve decus - sation defects and anterior segment abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/5b/df/mv-v19-2165.PMC3816992.pdf
"Molecular Vision  2013; 19:2165-2172 <http://www.molvis.org/molvis/v 19/2165 > © 2013 Molecular Vision  2171influence the development of these structures, but only those  involved in the melanogenesis pathway have been shown to  impact the development of both.",Non-OADS,/arxiv_data1/oa_pdf/5b/df/mv-v19-2165.PMC3816992.pdf
"Molecular Vision  2013; 19:2165-2172 <http://www.molvis.org/molvis/v 19/2165 > © 2013 Molecular Vision  2172Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/5b/df/mv-v19-2165.PMC3816992.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinicoEconomics and Outcomes Research 2013:5 555–564ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  555ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S4786 7Cost-effectiveness of modified-release prednisone  in the treatment of moderate to severe rheumatoid  arthritis with morning stiffness based on directly  elicited public preference values William Dunlop1 itrat iqbal1 ifty Khan2 Mario Ouwens3 louise heron4 1Mundipharma international   limited, Cambridge, 2University  College london, london, United  Kingdom; 3Mapi hEOR, houten,    The netherlands; 4adelphi Values,    Macclesfield, Cheshire,    United Kingdom Correspondence: William Dunlop   Mundipharma international limited,   Unit 194, Cambridge science Park,   Milton Road, Cambridge CB4 0aB,   United Kingdom   Tel +44 012 2342 4444   Fax +44 1223 426626   Email will.dunlop@mundipharma.co.u kBackground:  Assessing the cost-effectiveness of treatments in rheumatoid arthritis (RA) is  of growing importance due to the chronic nature of the disease, rising treatment costs, and  budget-constrained health care systems.",Non-OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
"Available from: http://www.aarda.org/pdf/cbad.pd f. Accessed  July 27, 2013.",OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
Available from: http://publications.nice.org.uk/ rheumatoid-arthritis-cg7 9.,Non-OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
"Available from: http://www.nao.org.uk/wp-content/ uploads/2009/07/0809823.pd f. Accessed July 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
Available from: http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
"Available from: http://www.nras.org.uk/about_rheumatoid_arthritis/ living_with_rheumatoid_arthritis /default.asp x. Accessed July 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
"EuroQol Group http://www.euroqol.org/about-eq-5d/eq-5d-nomencla - ture.htm l. Accessed 15, August 2013.",Non-OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
"Available  from: http://www.medicinescomplete.com/mc/bnf/current/213856.ht m.  Accessed July 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
Available from: http://www.pssru.ac.uk /.,Non-OADS,/arxiv_data1/oa_pdf/9c/df/ceor-5-555.PMC3816994.pdf
"CD44 Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > Received 3 July 2013 | Accepted 29 October 2013 | Published 1 November 2013© 2013 Molecular Vision 2151sCD44 overexpression increases intraocular pressure and aqueous  outflow resistance Michael Giovingo,1 Michael Nolan,1 Ryan McCarty,1 Iok-Hou Pang,2,3,4 Abbot F. Clark,3,4 Rachel M. Beverley,1  Steven Schwartz,1 W. Daniel Stamer,5 Loyal Walker,1 Algis Grybauskas,1 Kevin Skuran,1 Paulius V .",Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  2152splice variants containing variable exons are designated  CD44v.,Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  2153The sCD44 32-kDa ectodomain fragment of CD44 is  released by proteolytic cleavage [ 7].,Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
"Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  2154antibody was monoclonal BU52 antibody (Ancell, Bayport,  MN), and a proprietary γ-secretase inhibitor was supplied by  Alcon Research.",Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  2155lysates than in the media.,Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
"Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  2156at 44 days, and remained significantly higher than control  eyes.",Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  2157point.,Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
"Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  2158to that of DMEM, eventually finishing at a negative-20%  baseline flow rate.",Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
"Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  2159To examine changes in cell cytoskeletal response to  sCD44 in cell culture, the percent of F-actin that exhibited  CLAN-like characteristics was analyzed in individual cells.",OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  216071.9 normal actin vertices and 39.8 CLAN-like vertices  (range of 12–62) per cell count.,Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
"Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  2161Lipid raft profiles:  CD44 is present in detergent-resistant,  cholesterol-containing lipid rafts.",Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  2162intracytoplasmic domain that acts as a transcription factor to  cause further synthesis of CD44 receptor [ 17].,Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
"Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  2163Smolyak R, Hasan F, Barnett EM, Samples JR, Knepper PA.  Aqueous humor sCD44 concentration and visual field loss in  primary open-angle glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
Molecular Vision  2013; 19:2151-2164 <http://www.molvis.org/molvis/v 19/2151 > © 2013 Molecular Vision  216429.,Non-OADS,/arxiv_data1/oa_pdf/61/9f/mv-v19-2151.PMC3816995.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/63/fa/cia-8-1055.PMC3817003.pdf
Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1055–1061Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1055RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4746 2Age-related reduction of cerebral ischemic  preconditioning: myth or reality?,Non-OADS,/arxiv_data1/oa_pdf/63/fa/cia-8-1055.PMC3817003.pdf
Available from: http://www.cdc.gov/nchs/data/ad/ad359.pdf .,OADS,/arxiv_data1/oa_pdf/63/fa/cia-8-1055.PMC3817003.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/63/fa/cia-8-1055.PMC3817003.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/fa/cia-8-1055.PMC3817003.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/86/cia-8-1471.PMC3817007.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1471–1482Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1471RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S3673 9Pain management in patients with dementia wilco P Achterberg1 Marjoleine JC Pieper2 Annelore H van Dalen-Kok1 Margot wM de waal1 Bettina S Husebo3 Stefan Lautenbacher4 Miriam Kunz4 erik JA Scherder5 Anne Corbett6 1Department of Public Health and  Primary Care, Leiden University  Medical Center, Leiden, 2Department  of General Practice and elderly Care  Medicine, vU University Medical  Center Amsterdam, Amsterdam,   The Netherlands; 3Department of  Global Public Health and Primary  Care, University of Bergen, Bergen,   Norway; 4Physiological Psychology,   Otto Friedrich University Bamberg,   Bamberg, Germany; 5Department  of Clinical Neuropsychology, vU  University Amsterdam, Amsterdam,   The Netherlands; 6wolfson Centre for  Age-Related Diseases, King’s College  London, London, UK Correspondence: wilco P Achterberg   Department of Public Health and Primary  Care, Leiden University Medical Center,  Post zone v0-P, PO Box 9600,   2300 RC Leiden, The Netherlands   Tel +31 71 526 8412   email w.p.achterberg@lumc.n lAbstract:  There are an estimated 35 million people with dementia across the world, of whom  50% experience regular pain.",Non-OADS,/arxiv_data1/oa_pdf/d6/86/cia-8-1471.PMC3817007.pdf
"Available from: http://apps.who.int/ iris/ bitstream/10665/75263/1/9789241564458_eng.pd f. Accessed  September 19, 2013.",OADS,/arxiv_data1/oa_pdf/d6/86/cia-8-1471.PMC3817007.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d6/86/cia-8-1471.PMC3817007.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/86/cia-8-1471.PMC3817007.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/2d/clep-5-429.PMC3817011.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2013:5 429–437Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  429Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S4971 3Methods and rationale used in a matched cohort  study of the incidence of new primary cancers  following prostate cancer Deirdre P Cronin-Fenton1 sussie antonsen1 Karynsa Cetin2 John acquavella2 andre Daniels3 Timothy l lash1,4 1Department of Clinical Epidemiology,   aarhus University hospital, aarhus,   Denmark; 2Center for Observational  research, amgen incorporated,   Thousand Oaks, C a, Usa; 3global  regulatory affairs and safety, amgen  incorporated, Thousand Oaks, C a,   Usa; 4Department of Epidemiology,   rollins school of Public health, Emory  University, atlanta, ga, Usa Correspondence: Deirdre P Cronin-Fenton   Department of Clinical Epidemiology,   aarhus University hospital,   Olof Palmes allè 43-45,   8200 aarhus n, Denmark   Tel +45 8716 8209   Fax +45 8716 7215   Email dc@dce.au.d kObjectives:  We describe several methodological issues that were addressed in conducting a  Danish population-based matched cohort study comparing rates of new primary cancers (NPCs)  in men with and without prostate cancer (PC).",Non-OADS,/arxiv_data1/oa_pdf/df/2d/clep-5-429.PMC3817011.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/df/2d/clep-5-429.PMC3817011.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/copd-8-523.PMC3817018.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 523–532International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  523OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5263 7Changes in the airway lumen and surrounding  parenchyma in chronic obstructive pulmonary  disease Kazuyoshi Kurashima1 T oshiko hoshi2 Y otaro Takaku1 T etsu Kanauchi2 Keitaro nakamoto1 Miyuki Ueda2 noboru Takayanagi1 Thomas V Colby4 Yutaka sugita1 Y oshinori Kawabata3 1Department of respiratory  Medicine, 2Department of radiology,   3Department of Pathology, saitama  Cardiovascular and respiratory  Center, Kumagaya City, saitama, Japan;   4Department of laboratory Medicine  and Pathology, Mayo Clinic, scottsdale,   aZ, Usa Correspondence: Kazuyoshi Kurashima   Department of respiratory Medicine,  saitama Cardiovascular and respiratory  Center, Itai 1696, Kumagaya City,   saitama, Japan   Tel +814 8536 9900   Fax +814 8536 9920   email kurashima.kazuyoshi@pref.saitama.",Non-OADS,/arxiv_data1/oa_pdf/1e/d4/copd-8-523.PMC3817018.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1e/d4/copd-8-523.PMC3817018.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/copd-8-523.PMC3817018.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/1e/d4/copd-8-523.PMC3817018.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1d/42/dddt-7-1315.PMC3817019.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1315–1322Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1315Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5248 5Molecularly targeted drugs for metastatic  colorectal cancer Ying-dong Cheng Hua Yang Guo-qing Chen Zhi-cao Zhang Department of General Surgery,   Xinqiao Hospital, Third Military  Medical University, Chongqing,   People’s Republic of China Correspondence: Hua Yang   Department of General Surgery,  Xinqiao Hospital, Third Military Medical  University, Xinqiao Street, Chongqing  400037, People’s Republic of China   Tel +86 23 6875 5705   email hwbyang@yahoo.co mAbstract:  The survival rate of patients with metastatic colorectal cancer (mCRC) has  significantly improved with applications of molecularly targeted drugs, such as bevacizumab,  and led to a substantial improvement in the overall survival rate.",Non-OADS,/arxiv_data1/oa_pdf/1d/42/dddt-7-1315.PMC3817019.pdf
"Available from: http://globocan.iarc.fr/factsheets/cancers/ colorectal.as p. Accessed August 15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/1d/42/dddt-7-1315.PMC3817019.pdf
"Available from: http://www.cancer.gov/ cancertopics/druginfo/fda-bevacizuma b. Accessed August 15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/1d/42/dddt-7-1315.PMC3817019.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1d/42/dddt-7-1315.PMC3817019.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1d/42/dddt-7-1315.PMC3817019.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/3f/ijgm-6-833.PMC3817020.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2013:6 833–838International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  833Case serIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S52718Mucormycosis in two community hospitals   and the role of infectious disease consultation:   a case series Yue Dai1 James W Walker1 ruba a Halloush2 Faisal a Khasawneh3 1Department of Internal Medicine,   T exas T ech University Health sciences  Center, 2amarillo Pathology Group,   3section of Infectious Diseases,   Department of Internal Medicine,   T exas T ech University Health sciences  Center, amarillo, TX, Usa Correspondence: Faisal a Khasawneh   section of Infectious Diseases,  Department of Internal Medicine, Texas  Tech University Health sciences Center,  1400 south Coulter street, amarillo, TX  79106, Usa   Tel +1 806 354 5480   Fax +1 806 354 5765   email faisal.khasawneh@ttuhsc.ed uBackground:  Mucorales are ubiquitous filamentous fungi that can cause a devastating, inva - sive infection.",Non-OADS,/arxiv_data1/oa_pdf/26/3f/ijgm-6-833.PMC3817020.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/26/3f/ijgm-6-833.PMC3817020.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/3f/ijgm-6-833.PMC3817020.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/54/35/ijn-8-4103.PMC3817021.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4103–4114International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4103OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5362 2Inhibition of a/human/hubei/3/2005 (h3N2)  influenza virus infection by silver nanoparticles   in vitro and in vivo Dongxi Xiang1 Yang Zheng2 Wei Duan1 Xiujing li3 Jianjian Yin3 sarah shigdar1 Michael liam O’connor1 Manju Marappan1 Xiaojuan Zhao4 Yingqiu Miao3 Bin Xiang5 conglong Zheng3 1School of Medicine, Deakin University,   Waurn Ponds, Victoria, australia;   2Department of Pharmacology, Osaka  University, Osaka, Japan; 3Department  of Biology, Medical College, Dalian  University, Liaoning, People’s Republic of  china; 4Department of Gynaecology and  Obstetrics, Qingdao central hospital,   shandong, People’s republic of china;   5Department of Oral Medicine and Medical  research center, Medical college, Dalian  University, Liaoning, People’s Republic of  china correspondence: Dongxi Xiang   School of Medicine, Deakin University,  Waurn Ponds, Victoria 3217, australia   Tel +614 5256 5738   email dxiang@deakin.edu.a u    conglong Zheng   Department of Biology, Medical College,  Dalian University, 10 Xue Fu St,   Dalian 116622, liaoning,   People’s republic of china   Tel +86 411 8740 2353   Fax +86 411 8740 2050   email zhengconglong@dlu.edu.c nAbstract:  Silver nanoparticles (AgNPs) have attracted much attention as antimicrobial agents  and have demonstrated efficient inhibitory activity against various viruses, including human  immunodeficiency virus, hepatitis B virus, and Tacaribe virus.",Non-OADS,/arxiv_data1/oa_pdf/54/35/ijn-8-4103.PMC3817021.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/54/35/ijn-8-4103.PMC3817021.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/35/ijn-8-4103.PMC3817021.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/be/ijn-8-4115.PMC3817022.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4115–4130International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4115OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5006 1Induction of apoptosis in cancer cells by NiZn  ferrite nanoparticles through mitochondrial  cytochrome c release Mothanna sadiq al-Qubaisi1 abdullah rasedee1,2 Moayad husein Flaifel3 sahrim hj ahmad3 samer hussein-al-ali1 Mohd Zobir hussein4 Zulkarnain Zainal4 Fatah h alhassan4 Yun h Taufiq-Yap4 eltayeb eM eid5 Ismail adam arbab1 Bandar a al-asbahi3 Thomas J Webster6,7 Mohamed ezzat el  Zowalaty1,8,9 1Institute of Bioscience, 2Faculty of  Veterinary Medicine, Universiti Putra  Malaysia, 3Faculty of science and  T echnology, Universiti Kebangsaan  Malaysia, 4Faculty of science, Universiti  Putra Malaysia, selangor, Malaysia;  5college of Pharmacy, Qassim University,  Buraidah, saudi arabia; 6Department of  chemical engineering and Program in  Bioengineering, Northeastern University,  Boston, M a, Usa; 7center of excellence  for advanced Materials research, King  abdulaziz University, Jeddah, saudi arabia;  8Faculty of Pharmacy, Zagazig University,  Zagazig, egypt;  9Faculty of Public health  and Tropical Medicine, Jazan University,  Jazan, saudi arabia correspondence: abdullah rasedee   Faculty of Veterinary Medicine, Universiti  Putra Malaysia, 43400 UPM serdang,  selangor, Malaysia   Tel +60 389 463 455   Fax +60 389 461 971   email rasedee@vet.upm.edu.m yAbstract:  The long-term objective of the present study was to determine the ability of NiZn  ferrite nanoparticles to kill cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/f7/be/ijn-8-4115.PMC3817022.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f7/be/ijn-8-4115.PMC3817022.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/be/ijn-8-4115.PMC3817022.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/6e/ijn-8-4077.PMC3817023.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4077–4089International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4077OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5168 4Biodistribution of newly synthesized Phea-based  polymer-coated sPION in sprague Dawley rats   as magnetic resonance contrast agent Junsung Park1,2,* Wonkyung cho1,2,* hee Jun Park1,2 Kwang-ho cha1,2 Dae-chul ha2,5 Y oun-Woong choi5 ha-Y oung lee3 sun-hang cho5 sung-Joo hwang1,4 1Yonsei Institute of Pharmaceutical  sciences, Y onsei University, Incheon,   republic of Korea; 2college of  Pharmacy, chungnam National  University, Daejeon, republic of  Korea; 3Biomaterials laboratory,   Korea research Institutes of chemical  Technology, Daejeon, republic of  Korea; 4college of Pharmacy, Y onsei  University, Incheon, republic of Korea;   5Korea United Pharm Inc, seoul,   republic of Korea *These authors contributed equally   to this work correspondence: sung-Joo hwang   college of Pharmacy, Yonsei University,  162-1, songdo-dong, Yeonsu-gu, Incheon,  406-840, republic of Korea   Tel +82 32 749 4518   Fax +82 32 749 4105   email sjh11@yonsei.ac.k rObjectives:  The purpose of this study was to observe the pharmacokinetic behavior of newly  synthesized biocompatible polymers based on polyhydroxyethylaspartamide (PHEA) to be used  to coat an iron oxide core to make superparamagnetic iron oxide nanoparticles (SPION).",Non-OADS,/arxiv_data1/oa_pdf/a1/6e/ijn-8-4077.PMC3817023.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a1/6e/ijn-8-4077.PMC3817023.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/6e/ijn-8-4077.PMC3817023.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/cb/67/ijn-8-4091.PMC3817027.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4091–4102International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4091OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S47413linear polyethylenimine produced by partial   acid hydrolysis of poly(2-ethyl-2-oxazoline)   for DNa and sirNa delivery in vitro Julio c Fernandes1 Xingping Qiu2 Françoise M Winnik2,5 Mohamed Benderdour1 Xiaoling Zhang3,4 Kerong Dai3,4 Qin shi1 1Orthopaedics research laboratory,   research centre, sacré-coeur  hospital, 2Faculty of Pharmacy  and chemistry, University of  Montreal, Montreal, Quebec,   canada; 3Orthopaedic cellular and  Molecular Biology laboratories,   Institute of health sciences, chinese  academy of sciences, 4Department  of Orthopaedics, Ninth People’s  hospital, shanghai Jiao T ong University  school of Medicine, shanghai,   People’s republic of china; 5WPI  International center for Materials  Nanoarchitectonics, National Institute  for Materials science, Ibaraki, Tsukuba,   Japan correspondence: Qin shi   Orthopaedics research laboratory,   research centre, sacré-coeur   hospital, University of Montreal,   5400 gouin Blvd West, Montreal,   Quebec, canada h4J 1c5   Tel +51 4338 2222 extn 3043   Fax +51 4338 2694   email qin.shi@umontreal.c aAbstract:  Polyethylenimines (PEIs) are the most efficient synthetic vectors for gene delivery  available to date.",Non-OADS,/arxiv_data1/oa_pdf/cb/67/ijn-8-4091.PMC3817027.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cb/67/ijn-8-4091.PMC3817027.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/67/ijn-8-4091.PMC3817027.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/01/ijn-8-4147.PMC3817028.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4147–4155International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4147OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S517563-aminopropyl functionalized magnesium  phyllosilicate as an organoclay based drug carrier  for improving the bioavailability of flurbiprofen liang Yang1 soo-Kyung choi2 hyun-Jae shin2 hyo-Kyung han1 1college of Pharmacy, Dongguk  University-seoul, siksa-dong, Ilsan- Donggu, goyang, gyunggi-do, Korea;   2Department of chemical and  Biochemical engineering, chosun  University, gwangju, Korea correspondence: hyo-Kyung han   college of Pharmacy, Dongguk  University-seoul, siksa-dong, Ilsan- Donggu, goyang, gyunggi-do,   410-820, Korea   Tel +82 31 961 5217   Fax +82 31 961 5206   email hkhan@dongguk.ed uAbstract:  This study aimed to develop an oral delivery system using clay-based organic– inorganic hybrid materials to improve the bioavailability of the drug, flurbiprofen, which is  poorly soluble in water.",Non-OADS,/arxiv_data1/oa_pdf/65/01/ijn-8-4147.PMC3817028.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/65/01/ijn-8-4147.PMC3817028.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/01/ijn-8-4147.PMC3817028.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/f3/ijn-8-4157.PMC3817029.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4157–4168International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4157OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5273 1glutaraldehyde cross-linking of amniotic  membranes affects their nanofibrous structures  and limbal epithelial cell culture characteristics Jui-Yang lai1–3 David hui-Kang Ma4,5 1Institute of Biochemical and  Biomedical engineering, 2Biomedical  engineering research center,   3Molecular Medicine research center,   chang gung University, Taoyuan,   Taiwan; 4limbal stem cell laboratory,   Department of Ophthalmology, chang  gung Memorial hospital, Taoyuan,   Taiwan; 5Department of chinese  Medicine, chang gung University,   Taoyuan, Taiwan correspondence: Jui-Yang lai   Institute of Biochemical and Biomedical  engineering, chang gung University,   259, Wen-hwa 1st road, Kwei-shan,  Taoyuan, Taiwan 33302   Tel +886 3 211 8800 ext 3598   Fax +886 3 211 8668   email jylai@mail.cgu.edu.t wAbstract:  Given that the cells can sense nanometer dimensions, the chemical cross-linking- mediated alteration in fibrillar structure of collagenous tissue scaffolds is critical to determining  their cell culture performances.",Non-OADS,/arxiv_data1/oa_pdf/01/f3/ijn-8-4157.PMC3817029.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/01/f3/ijn-8-4157.PMC3817029.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/f3/ijn-8-4157.PMC3817029.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/74/5b/ijn-8-4169.PMC3817030.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4169–4181International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4169OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5055 7Preparation and characterization of tetrandrine- phospholipid complex loaded lipid nanocapsules  as potential oral carriers Yi-qing Zhao li-ping Wang chao Ma Kun Zhao Ying liu Nian-ping Feng school of Pharmacy, shanghai  University of Traditional chinese  Medicine, shanghai, People’s republic  of china correspondence: Ying liu   Department of Pharmaceutics, school   of Pharmacy, shanghai University   of Traditional chinese Medicine,   1200 cailun road, Zhangjiang hi-Tech   Park, Pudong New District, shanghai   201203, People’s republic of china   Tel +86 21 5132 2210   Fax +86 21 5132 2198   email debbyly@163.co m    Nian-ping Feng   Department of Pharmaceutics, school  of Pharmacy, shanghai University of  Traditional chinese Medicine,   1200 cailun road, Zhangjiang hi-T ech  Park, Pudong New District, shanghai  201203, People’s republic of china   Tel +86 21 5132 2198   Fax +86 21 5132 2198   email npfeng@hotmail.co mBackground:  Tetrandrine is an active constituent that is extracted from the root tuber of the  Chinese herb Stephania tetrandra  S. Moore.",Non-OADS,/arxiv_data1/oa_pdf/74/5b/ijn-8-4169.PMC3817030.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/74/5b/ijn-8-4169.PMC3817030.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/5b/ijn-8-4169.PMC3817030.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/92/ndt-9-1671.PMC3817031.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1671–1672Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1671Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5338 8sodium valproate-induced enuresis in a pediatric  bipolar patient Wentao Cheng1,* Xiaoling Lin2,* Dali Lu1 1Department of pediatric and  Geriatric psychiatry, Fuzhou  Neuropsychiatric Hospital, Fuzhou,   Fujian, people’s republic of China;   2school of Nursing of Central south  University, Changsha, Hunan, people’s  republic of China *These authors contributed equally to  this work Correspondence: Dali Lu   Department of pediatric and Geriatric  psychiatry, Fuzhou Neuropsychiatric  Hospital, Nan erhuan road 451#, Fuzhou,  Fujian, people’s republic of China   Tel +86 185 591 966 59   email childpsy2012@163.co mAbstract:  Sodium valproate (SV) is effective and well tolerated for the treatment of epilepsy  and mood disorders.",Non-OADS,/arxiv_data1/oa_pdf/8c/92/ndt-9-1671.PMC3817031.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/8c/92/ndt-9-1671.PMC3817031.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/92/ndt-9-1671.PMC3817031.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/ec/opth-7-2107.PMC3817032.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2107–2111Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2107Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5351 8The association of human leukocyte antigen B27  with anterior uveitis in patients from the western  region of saudi arabia: a retrospective study ahmed M Bawazeer1,2 heba ismail Joharjy1 1Uveitis services, Department   of Ophthalmology, King abdulaziz  University, 2Magrabi eye and ear   hospital, Jeddah, saudi arabia Correspondence: ahmed M Bawazeer   Faculty of Medicine, King abdulaziz  University, PO Box 5095, Jeddah 21422,   saudi arabia   Tel +966 5903 30312   Fax +966 1264 08330   email drbawazeer@yahoo.co mBackground:  The association of human leukocyte antigen B27 (HLA-B27) with anterior  uveitis is well known.",Non-OADS,/arxiv_data1/oa_pdf/d1/ec/opth-7-2107.PMC3817032.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d1/ec/opth-7-2107.PMC3817032.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/ec/opth-7-2107.PMC3817032.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/54/opth-7-2123.PMC3817033.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2013:7 2123–2126Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2123Case seRIesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5247 5Efficacy of reduced-fluence photodynamic therapy  for serous retinal pigment epithelial detachment  with choroidal hyperpermeability asako shibata Yasuhiro Ohkuma Takaaki Hayashi Hiroshi Tsuneoka Department of Ophthalmology,    The Jikei University school of   Medicine, T okyo, Japan Correspondence: asako shibata   Department of Ophthalmology, The  Jikei University school of Medicine,  3-25-8 Nishi-shimbashi, Minato-ku,   Tokyo 105-8461, Japan   Tel +81 3 3433 1111 (ext 3581)   Fax +81 3 3433 1936   email asako9o3@hotmail.co.j pBackground:  Very few reports have addressed methods of treatment for idiopathic serous (IS)  pigment epithelial detachment (PED).",Non-OADS,/arxiv_data1/oa_pdf/09/54/opth-7-2123.PMC3817033.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/09/54/opth-7-2123.PMC3817033.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/54/opth-7-2123.PMC3817033.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/63/opth-7-2127.PMC3817054.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2127–2130Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2127Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5302 4Bilateral macular injury from a green laser pointer ali Dirani1,2 elias Chelala2 ali Fadlallah1,2 rafic antonios1 George Cherfan1 1Beirut eye specialist Hospital,   2Faculty of Medicine, saint-Joseph  University, Beirut, Lebanon Correspondence: ali Fadlallah   Faculty of Medicine, saint-Joseph  University, pO Box 116-5311,   Beirut, Lebanon   tel +961 7 138 8893   email f adlallah2000@hotmail.co mAbstract:  We report the case of a 13-year-old boy who had a bilateral macular injury after  playing with a green laser pointer for a duration of 1 minute.",Non-OADS,/arxiv_data1/oa_pdf/72/63/opth-7-2127.PMC3817054.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/72/63/opth-7-2127.PMC3817054.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/63/opth-7-2127.PMC3817054.pdf
"Available from: http://www.fda.gov/ForConsumers/ConsumerUpdates/ ucm166649.ht m. Accessed September 22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/72/63/opth-7-2127.PMC3817054.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/3f/opth-7-2131.PMC3817055.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2131–2135Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2131Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S4135 8Preservative toxicity in glaucoma medication:  clinical evaluation of benzalkonium chloride-free  0.5% timolol eye drops Lauren M Rosin1 Nicholas P Bell1,2 1Ruiz Department of Ophthalmology  and visual Science, The University of  T exas Medical School at Houston,   2Robert Cizik eye Clinic, Houston,   TX, USA Correspondence: Nicholas P Bell   Robert Cizik eye Clinic, 6400 Fannin St,  Suite 1800, Houston, TX 77030, USA   Tel +1 713 559 5261   Fax +1 713 795 0768   email nbell@cizikeye.or gAbstract:  Timolol (generic name) is a frequently used medication for the control of glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/83/3f/opth-7-2131.PMC3817055.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/83/3f/opth-7-2131.PMC3817055.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/3f/opth-7-2131.PMC3817055.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/05/opth-7-2137.PMC3817060.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2137–2141Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2137Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5451 1topical rebamipide improves lid wiper  epitheliopathy Hirotaka Itakura1,2 tomoyuki Kashima2 Mariko Itakura1 Hideo akiyama2 shoji Kishi2 1Department of Ophthalmology,   Maebashi red Cross Hospital,   2Department of Ophthalmology,   Gunma University, school of Medicine,   Maebashi, Japan Correspondence: Hirotaka Itakura   Maebashi red Cross Hospital,  3-21-36 asahi-cho, Maebashi,   Gunma 371-0014, Japan   tel +812 7224 4585   Fax +812 7243 3380   email itakura@gunma-u.ac.j pAbstract:  Administration of topical rebamipide increases the mucin level of tear film and  improves the ocular surface in short break-up time type of dry eye.",Non-OADS,/arxiv_data1/oa_pdf/2f/05/opth-7-2137.PMC3817060.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/2f/05/opth-7-2137.PMC3817060.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/05/opth-7-2137.PMC3817060.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/90/opth-7-2143.PMC3817061.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2143–2146Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2143Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5324 3Intravitreal anti-VeGF injection for the treatment   of progressive juxtapapillary retinal capillary   hemangioma: a case report and mini review   of the literature elias Chelala ali Dirani ali Fadlallah saint-Joseph University, Faculty   of Medicine, Beirut, Lebanon Correspondence: ali Fadlallah   saint-Joseph University, Faculty of   Medicine, Damascus road, Bp 17-5208   Mar Mikhaël, Beirut 1104-2020, Lebanon   tel +961 1 7138 8893   email fadlallah2000@hotmail.co mAbstract:  We report a case of a patient known to have a von Hippel–Lindau disease with docu - mented progressive juxtapapillary retinal capillary hemangioma (JRCH) with well-preserved  visual acuity (V A) and visual field (VF).",Non-OADS,/arxiv_data1/oa_pdf/a8/90/opth-7-2143.PMC3817061.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a8/90/opth-7-2143.PMC3817061.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/90/opth-7-2143.PMC3817061.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/76/opth-7-2153.PMC3817064.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2153–2158Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2153Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5118 0Bilateral corneal ulceration in ocular   graft-versus-host disease William stevenson Hasanain shikari Ujwala s saboo Francisco amparo reza Dana Cornea service, Massachusetts eye  and ear infirmary, Boston, M a, Usa Correspondence: reza Dana   Cornea service, Massachusetts eye   and Ear Infirmary, 243 Charles Street,   Boston, MA 02114, USA   Tel +1 617 573 4439   Fax +1 617 573 4300   email reza_dana@meei.harvard.ed uPurpose:  To report on corneal ulceration in ocular graft-versus-host disease (GVHD).",Non-OADS,/arxiv_data1/oa_pdf/95/76/opth-7-2153.PMC3817064.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/95/76/opth-7-2153.PMC3817064.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/76/opth-7-2153.PMC3817064.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/21/opth-7-2159.PMC3817065.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2159–2164Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2159Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5277 1Comparisons of amplitude   of pseudoaccommodation with aspheric   yellow, spheric yellow, and spheric clear   monofocal intraocular lenses T omo nishi Futoshi Taketani T etsuo Ueda nahoko Ogata Department of Ophthalmology,    nara Medical University,    Kashihara City, nara, Japan Correspondence: Tomo nishi   Department of Ophthalmology,   nara Medical University, 840 Kashihara   City, nara, 634-8522, Japan   email tomon@naramed-u.ac.j pPurpose:  To determine the amplitude of pseudoaccommodation and higher-order aberrations  with three types of implanted monofocal intraocular lenses (IOLs): aspheric yellow (IQ); spheric  yellow (NT); and spheric clear (AT).",Non-OADS,/arxiv_data1/oa_pdf/65/21/opth-7-2159.PMC3817065.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/65/21/opth-7-2159.PMC3817065.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/21/opth-7-2159.PMC3817065.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/e3/prbm-6-117.PMC3817076.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPsychology Research and Behavior Management 2013:6 117–123Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  117ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PRBM.S5371 3assessing leadership decision-making styles:   psychometric properties of the leadership   Judgement indicator Palmira Faraci1 Michael lock2 Robert Wheeler2 1Faculty of human and social sciences,   University of enna “Kore”, enna,   italy; 2Formula 4 leadership limited,   nottingham, UK correspondence: Palmira Faraci   Faculty of human and social sciences,  University of enna “Kore”, cittadella  Universitaria, enna 94100, italy   email palmira.faraci@unikore.i tAbstract:  This study aimed to validate the Italian version of the Leadership Judgement Indicator,  an unconventional instrument devoted to measurement of leaders’ judgments and preferred styles,  ie, directive, consultative, consensual, or delegative, when dealing with a range of decision- making scenarios.",Non-OADS,/arxiv_data1/oa_pdf/62/e3/prbm-6-117.PMC3817076.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/62/e3/prbm-6-117.PMC3817076.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/62/e3/prbm-6-117.PMC3817076.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4f/3d/ott-6-1539.PMC3817086.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1539–1543OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1539ShO rT repO rTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S5280 5Low expression of mixed lineage kinase   domain-like protein is associated with poor   prognosis in ovarian cancer patients Ling he1 Kuan peng2 Yizhi Liu1 Jing Xiong1 Fu-fan Zhu1 1Department of Gynecology and  Obstetrics, The Second Xiangya  hospital of Central South University,   2Institute of Biomedical engineering,   School of Info- physics and Geomatics  engineering, Central South University,   Changsha, people’s republic of China Correspondence: Fu-fan Zhu   Department of Gynecology and  Obstetrics, The Second Xiangya hospital   of Central South University, Changsha,  410078, people’s republic of China   Tel +86 139 7492 7947   Fax +86 731 8838 8788   email fufanzhu@gmail.co mBackground:  Mixed lineage kinase domain-like protein (MLKL) was initially identified as  a key receptor interacting protein 3 downstream component of tumor-necrosis-factor-induced  necrosis.",Non-OADS,/arxiv_data1/oa_pdf/4f/3d/ott-6-1539.PMC3817086.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4f/3d/ott-6-1539.PMC3817086.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/3d/ott-6-1539.PMC3817086.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/20/ott-6-1545.PMC3817087.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1545–1552OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1545Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3254 5New and emerging treatment options   for biliary tract cancer Marcus S Noel Aram F Hezel James P wilmot Cancer Center,   University of Rochester, Rochester,   NY, USA Correspondence: Aram F Hezel   University of Rochester Medical Center,   James P wilmot Cancer Center,   601 elmwood Avenue, Box 704,   Rochester, NY 14642, USA   Tel +1 585 275 9319   Fax +1 585 276 0350   email aram_hezel@urmc.rochester.ed uAbstract:  Biliary tract cancer (BTC) is a group of relatively rare tumors with a poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/0a/20/ott-6-1545.PMC3817087.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0a/20/ott-6-1545.PMC3817087.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/20/ott-6-1545.PMC3817087.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/31/cia-8-1461.PMC3817103.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1461–1465Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1461OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4748 5Apolipoprotein e ε4 is superior   to apolipoprotein e ε2 in predicting   cognitive scores over 30 months Paul regal Balakrishnan nair eileen hetherington geriatric Medicine and gerontology,   University of newcastle,    Callaghan, nsW, Australia Correspondence: Paul regal   Wyong hospital, PO Box 4200, lake   haven, Wyong, nsW, Australia   Tel +61 04 4867 5993   Fax +61 24 394 8098   email pregal@nsccahs.health.nsw.gov.a uBackground:  The purpose of this study was to compare apolipoprotein E ε4 (Apo E ε4)  and apolipoprotein E ε2 (Apo E ε2) as predictors of cognitive and functional trajectories over  30 months.",Non-OADS,/arxiv_data1/oa_pdf/c3/31/cia-8-1461.PMC3817103.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c3/31/cia-8-1461.PMC3817103.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/31/cia-8-1461.PMC3817103.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/fb/opth-7-2147.PMC3817136.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2147–2152Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2147Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5032 1Orbital cellulitis following silicone-sponge   scleral buckles arie Y nemet Joseph r Ferencz Ori segal amit Meshi Department of Ophthalmology, Meir  Medical Center, Kfar saba, israel Correspondence: arie Y nemet   Department of Ophthalmology,   Meir Medical Center, 59 Tsharnihovski  street, Kfar saba 44299, israel   Tel +972 52 838 6855   Fax +972 9747 2427   email nemet.arik@gmail.co mBackground:  Acute or chronic infection of the scleral explant is rare.",Non-OADS,/arxiv_data1/oa_pdf/76/fb/opth-7-2147.PMC3817136.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/76/fb/opth-7-2147.PMC3817136.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/fb/opth-7-2147.PMC3817136.pdf
"http://www.landesbioscience.com/journals/ nucleus/article/25342/   Reference Bai B, et al.",OADS,/arxiv_data1/oa_pdf/c2/96/rna-10-1231.PMC3817141.pdf
"Nucleus 2013; 4:315-25; PMid:23782956;  http://dx.doi.org/10.4161/nucl.25342 RNAs fold into intricate structures that are  determined by specific base pairing interac - tions encoded within their primary sequences, and similar to proteins, folding into specific confirmations is essential for RNAs to func - tion properly.",Non-OADS,/arxiv_data1/oa_pdf/c2/96/rna-10-1231.PMC3817141.pdf
"http://www.landesbioscience.com/journals/10/article/24301/ Reference Vandivier L, et al.",OADS,/arxiv_data1/oa_pdf/c2/96/rna-10-1231.PMC3817141.pdf
Plant Signal Behav 2013; 8:e24301;  PMid:23603972; http://dx.doi.org/10.4161/psb.24301,OADS,/arxiv_data1/oa_pdf/c2/96/rna-10-1231.PMC3817141.pdf
"the molecular mecha- nisms governing tumor dormancy described  in this work may provide promising targets  for early prevention of cancer and could lead to novel treatments to convert the malignant tumor phenotype into an asymptomatic dor - mant state.http://www.landesbioscience.com/journals/transcription/article/25558/   Reference Almog N, et al.",Non-OADS,/arxiv_data1/oa_pdf/c2/96/rna-10-1231.PMC3817141.pdf
"transcr 2013; 4:177-91; PMid:23863200;  http://dx.doi.org/10.4161/trns.25558 Exogenous ribonucleases are known to inhibit  tumor growth via apoptosis induction in  tumor cells, and can therefore be considered  as potential anticancer drugs for clinical appli-cation.",Non-OADS,/arxiv_data1/oa_pdf/c2/96/rna-10-1231.PMC3817141.pdf
"http://www.landesbioscience.com/journals/ cc/article/25164/ Reference Mironova NL, et al.",OADS,/arxiv_data1/oa_pdf/c2/96/rna-10-1231.PMC3817141.pdf
Cell Cycle 2013; 12:2120-31;  PMid:23759588; http://dx.doi.org/10.4161/cc.25164,OADS,/arxiv_data1/oa_pdf/c2/96/rna-10-1231.PMC3817141.pdf
"www.landesbioscience.com RNA Biology 1233RNA Biology 10:8, 1233–1239; August 2013; © 2013 Landes Bioscience PoiNt-of-View PoiNt-of-View Keywords:  Drosophila melanogaster ,  piRNA biogenesis, germline, epigenetics,  paramutation, transposable elements, argonaute proteins Submitted: 06/08/2013Accepted: 07/15/2013http://dx.doi.org/10.4161/rna.25756 *Correspondence to: Stéphane Ronsseray,   Email: stephane.ronsseray@upmc.fr;  Christophe Antoniewski; Email: christophe.antoniewski@upmc.frPiwi-interacting RNAs (piRNAs)  ensure transposable element silenc - ing in Drosophila , thereby preserving  genome integrity across generations.",Non-OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
Silence 2012; 3:4; PMID:22647250; http://dx.doi.org/10.1186/1758-907X-3-4 26.,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
RNA 2012; 18:42- 52; PMID:22096018; http://dx.doi.org/10.1261/ rna.029769.11110.,OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
Dev Cell 2013; 24:502-16;  PMID:23434410; http://dx.doi.org/10.1016/j.dev - cel.2013.01.023 12.,OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
"Cell 2009; 138:1137-49; PMID:19732946; http://dx.doi.org/10.1016/j.cell.2009.07.014 14. de Vanssay A, Bougé AL, Boivin A, Hermant C,  Teysset L, Delmarre V, et al.",OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
Nature 2012; 490:112-5; PMID:22922650;  http://dx.doi.org/10.1038/nature11416 15.,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
PLoS Genet 2007; 3:1633-43; PMID:17941712; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
Science 2008; 322:1387-92; PMID:19039138; http://dx.doi.org/10.1126/science.1165171 18.,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
Curr Opin Genet Dev 2013; 23:44- 52; PMID:23317515; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
Cell  2012; 151:871-84; PMID:23141543; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
Nature 2012; 491:284-7; PMID:23064230; http://dx.doi.org/10.1038/nature11509 4.,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
Science 2007; 315:1587-90;  PMID:17322028; http://dx.doi.org/10.1126/sci - ence.1140494 6.,OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
Cell 2007; 128:1089-103;  PMID:17346786; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
Nature  2009; 461:1296-9; PMID:19812547; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
Proc Natl Acad Sci USA  2011; 108:18760-5; PMID:22065765; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/e1/rna-10-1233.PMC3817142.pdf
"Do not distribute.RNA Biology 10:8, 1248–1254; August 2013; © 2013 Landes Bioscience Poi Nt-of-View 1248  RNA Biology  V olume 10 i ssue 8PoiNt-of-View Keywords:  mRNA-cognate protein  complementarity, stereochemical   hypothesis, polar requirement,  knowledge-based statistical potentials, origin of the genetic code Submitted: 07/08/2013Revised: 07/29/2013Accepted: 07/31/2013http://dx.doi.org/10.4161/rna.25977 *Correspondence to: Bojan Zagrovic;   Email: bojan.zagrovic@univie.ac.atDespite more than 50 years of effort,  the origin of the genetic code  remains enigmatic.",Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Nature 1961; 190:576-81; PMID:20446365; http://dx.doi.org/10.1038/190576a0 3.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
J Biophys Biochem Cytol 1955; 1:59-68; PMID:14381428; http://dx.doi.org/10.1083/jcb.1.1.59 4.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Nature 1953; 171:737-8; PMID:13054692; http://dx.doi.org/10.1038/171737a0 5.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
IUBMB Life 2009; 61:99-111; PMID:19117371; http://dx.doi.org/10.1002/iub.146 6.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Nucleic Acids Res 2012; 40(Database issue):D180-6; PMID:22086949; http://dx.doi.org/10.1093/nar/gkr1007 7.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Mol Cell 2012; 46:674-90; PMID:22681889; http://dx.doi.org/10.1016/j.molcel.2012.05.021 8.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Cell 2012; 149:1393-406; PMID:22658674; http://dx.doi.org/10.1016/j.cell.2012.04.031 9.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Nat Rev Genet 2011; 13:77-83; PMID:22251872; http://dx.doi.org/10.1038/nrg3141 10.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
J Theor Biol 1993; 163:373-92; PMID:8246508; http://dx.doi.org/10.1006/jtbi.1993.1126 11.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
J Theor Biol 1994; 167:373-9; PMID:8207952; http://dx.doi.org/10.1006/jtbi.1994.1076 12.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Front Biosci 2004; 9:2521-6; PMID:15353304; http://dx.doi.org/10.2741/1413 14.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
J Am Chem Soc 2008; 130:9507-13; PMID:18576621; http://dx.doi.org/10.1021/ja801994z 15.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Protein Expr Purif 2010; 72:262-6; PMID:20363330; http://dx.doi.org/10.1016/j.pep.2010.03.028 16.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Nucleic Acids Res 2012; 40:8874-82; PMID:22844092; http://dx.doi.org/10.1093/nar/gks679are subsequently degraded.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Cold Spring Harb Perspect Biol 2012; 4:a003681; PMID:20610545; http://dx.doi.org/10.1101/cshperspect.a003681 38.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Annu Rev Microbiol 2009; 63:27-44; PMID:19385727; http://dx.doi.org/10.1146/annurev.micro.091208.073514 39.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
RNA Biol 2013; 10:481-9; PMID:23422316; http://dx.doi.org/10.4161/rna.23838 41.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Science 2009; 324:1729-32; PMID:19460965; http://dx.doi.org/10.1126/science.1172046 42.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Cell 2012; 149:1188-91; PMID:22682242; http://dx.doi.org/10.1016/j.cell.2012.05.02227.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Nucleic Acids Res 2007; 35:1039-47; PMID:17259221; http://dx.doi.org/10.1093/nar/gkl1103 28.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
RNA 2009; 15:189-99; PMID:19144906; http://dx.doi.org/10.1261/rna.1270809 29.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
BMC Bioinformatics 2011; 12:348; PMID:21851628; http://dx.doi.org/10.1186/1471-2105-12-348 31.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
J Mol Evol 1976; 9:59-72; PMID:1018332; http://dx.doi.org/10.1007/BF01796123 32.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Bioessays 2005; 27:416-25; PMID:15770677; http://dx.doi.org/10.1002/bies.20208 34.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
J Mol Evol 2001; 53:394-401; PMID:11675599; http://dx.doi.org/10.1007/s002390010229 35.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
J Mol Evol 1991; 33:412-7; PMID:1960738; http://dx.doi.org/10.1007/BF0210313217.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Nucleic Acids Res 2013; In press: http://dx.doi.org/10.1093/nar/gkt618; PMID:23868089 18.,OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Naturwissenschaften 1973; 60:447-59; PMID:4588588; http://dx.doi.org/10.1007/BF00592854 19.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
J Mol Evol 2008; 66:519-28; PMID:18443736; http://dx.doi.org/10.1007/s00239-008-9073-9 20.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
J Mol Evol 1998; 47:109-17; PMID:9664701; http://dx.doi.org/10.1007/PL00006357 24.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
J Mol Evol 2009; 69:406-29; PMID:19795157; http://dx.doi.org/10.1007/s00239-009-9270-1 25.,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
Macromolecules 1985; 18:534-52; http://dx.doi.org/10.1021/ma00145a039,Non-OADS,/arxiv_data1/oa_pdf/03/3a/rna-10-1248.PMC3817144.pdf
"The emergence of the nuclear envelope during evolutionary his - tory separated the genetic material that is transcribed into mes - senger RNA (mRNA) from that of the cytoplasmic translational  *Correspondence to: Ervin Fodor, Email: ervin.fodor@path.ox.ac.uk Submitted: 05/03/2013; Revised: 06/06/2013; Accepted: 06/10/2013http://dx.doi.org/10.4161/rna.25356The flow of genetic information from sites of transcription  within the nucleus to the cytoplasmic translational machinery of eukaryotic cells is obstructed by a physical blockade, the  nuclear double membrane, which must be overcome in  order to adhere to the central dogma of molecular biology, DNA makes r NA makes protein.",Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Genes Dev 2004; 18:2845-60; PMID:15574591;  http://dx.doi.org/10.1101/gad.1256904 2.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nat Rev Genet 2013; 14:275-87;  PMID:23478349; http://dx.doi.org/10.1038/nrg3434 4.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nat Rev Mol Cell Biol 2007; 8:761- 73; PMID:17786152; http://dx.doi.org/10.1038/ nrm2255 5.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Biochim Biophys Acta 2012;  1819:391-400; PMID:22306664; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Annu Rev Biochem  2011; 80:613-43; PMID:21495847; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nat Rev Mol Cell Biol 2010; 11:490-501; PMID:20571586; http://dx.doi.org/10.1038/ nrm29288.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Trends Biochem Sci 2003; 28:419-24; PMID:12932730; http://dx.doi.org/10.1016/S0968- 0004(03)00142-7 9.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nature 2005; 433:26-7; PMID:15635396; http://dx.doi.org/10.1038/433026a 10.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Vaccine 2006; 24:6651-5; PMID:16806605;  http://dx.doi.org/10.1016/j.vaccine.2006.05.066 12.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Rev Med Virol 2006; 16:329-45;  PMID:16933365; http://dx.doi.org/10.1002/rmv.512 13.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nat Med 2001; 7:1306- 12; PMID:11726970; http://dx.doi.org/10.1038/ nm1201-1306 15.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Science 2012; 337:199-204;  PMID:22745253; http://dx.doi.org/10.1126/sci- ence.122221316.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Virol  2013; 87:2455-62; PMID:23236060; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Emerg Microbes Infec 2012; 1:e42; http://dx.doi.org/10.1038/emi.2012.38 18.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Virol 2009; 83:8021- 31; PMID:19494001; http://dx.doi.org/10.1128/ JVI.00826-09 19.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
PLoS Pathog 2012; 8:e1002998; PMID:23133386;  http://dx.doi.org/10.1371/journal.ppat.1002998 20.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
RNA Biol 2011; 8:207- 15; PMID:21358279; http://dx.doi.org/10.4161/ rna.8.2.14513 21.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Curr Opin Struct Biol  2010; 20:104-13; PMID:20061134; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nature  1976; 263:211-4; PMID:822353; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Genes Dev 2011; 25:1770-82;  PMID:21896654; http://dx.doi.org/10.1101/ gad.17268411 59.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Virol 2000; 74:418- 27; PMID:10590131; http://dx.doi.org/10.1128/ JVI.74.1.418-427.2000 64.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Science  2012; 335:1643-6; PMID:22461616; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Cell Sci 2009; 122:1933-7; PMID:19494120;  http://dx.doi.org/10.1242/jcs.041236 67.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nature 2011;  475:333-41; PMID:21776079; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nat Cell Biol 2010; 12:543-52;  PMID:20453848; http://dx.doi.org/10.1038/ncb2056 69.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nat Rev Mol Cell Biol  2011; 12:377-84; PMID:21602906; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Biochim Biophys Acta 2012; 1819:507-13;  PMID:22178508; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nucleic Acids Res 2012; 40:4562-73;  PMID:22307388; http://dx.doi.org/10.1093/nar/gks059 73.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Wiley Interdiscip Rev RNA 2011; 2:79-91; PMID:21956970; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nat  Struct Mol Biol 2008; 15:500-6; PMID:18454157;  http://dx.doi.org/10.1038/nsmb.1421 43.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nature  2009; 458:909-13; PMID:19194458; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Cell 2006; 127:1389-400;  PMID:17190602; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Cell 2002; 108:523- 31; PMID:11909523; http://dx.doi.org/10.1016/ S0092-8674(02)00627-X 48.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Curr Opin Cell Biol 2003; 15:326-31;  PMID:12787775; http://dx.doi.org/10.1016/S0955- 0674(03)00048-6 49.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nature  2000; 407:401-5; PMID:11014198; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Curr Opin Struct Biol  2008; 18:112-9; PMID:18164611; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Gen Virol 2012; 93:113- 8; PMID:21918006; http://dx.doi.org/10.1099/vir.0.035485-0 53.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Gen Virol 2010; 91:2331-40; PMID:20519456; http://dx.doi.org/10.1099/ vir.0.022004-0 54.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nucleic Acids Res  2007; 35:4573-82; PMID:17488845; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Cell Rep 2013;  3:23-9; PMID:23333274; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
FEBS Lett  2013; 587:1206-14; PMID:23499938; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Vaccine  2012; 30:7353-8; PMID:22652398; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
PLoS Pathog  2012; 8:e1003019; PMID:23236273; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nucleic Acids  Res 1980; 8:3575-89; PMID:7433101; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Proc Natl Acad Sci  USA 1979; 76:3790-4; PMID:291039; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nucleic Acids Res 1981; 9:2727-40; PMID:6169001;  http://dx.doi.org/10.1093/nar/9.12.2727 30.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Virology 1981; 112:729-37; PMID:7257188;  http://dx.doi.org/10.1016/0042-6822(81)90317-2 31.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Proc Natl Acad Sci USA  1981; 78:4170-4; PMID:6945577; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Cell 1980; 21:475-85; PMID:7407920; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Science  2010; 327:284-6; PMID:20075242; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Virus Res  2011; 162:12-8; PMID:22027189; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Mol Biol 2010; 395:1-10;  PMID:19852969; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Wiley Interdiscip Rev RNA 2011; 2:277- 98; PMID:21957010; http://dx.doi.org/10.1002/wrna.52 39.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Virol 2005; 79:5812-8; PMID:15827195; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Virology  1996; 226:430-5; PMID:8955065; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Virol 2011; 85:8569-81; PMID:21715506;  http://dx.doi.org/10.1128/JVI.00496-11 107.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Proteomics 2008; 8:2077-88; PMID:18491320;  http://dx.doi.org/10.1002/pmic.200700508 108.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Virol 2002; 76:12877-89; PMID:12438613; http://dx.doi.org/10.1128/ JVI.76.24.12877-12889.2002 111.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Mol Cell Biol 2006; 26:1631- 43; PMID:16478985; http://dx.doi.org/10.1128/ MCB.26.5.1631-1643.2006 112.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Front Biosci 2008; 13:2939-49;  PMID:17981767; http://dx.doi.org/10.2741/2899 113.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Mol Cell 2012; 46:674-90;  PMID:22681889; http://dx.doi.org/10.1016/j.mol- cel.2012.05.021 114.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Proteomics 2012; 75:3478- 94; PMID:22575267; http://dx.doi.org/10.1016/j.jprot.2012.04.030 115.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Trends Cell Biol  2010; 20:380-90; PMID:20444605; http://dx.doi.org/10.1016/j.tcb.2010.03.00689.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
EMBO  J 1997; 16:7500-10; PMID:9405378; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Trends Cell Biol  2007; 17:193-201; PMID:17317185; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Virol 2001; 75:408- 19; PMID:11119609; http://dx.doi.org/10.1128/ JVI.75.1.408-419.2001 92.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Virology  2001; 282:215-20; PMID:11289803; http://dx.doi.org/10.1006/viro.2001.0833 93.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Virus Res 2001; 77:31-42;  PMID:11451485; http://dx.doi.org/10.1016/S0168- 1702(01)00263-5 94.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Curr Biol 1998;  8:305-14; PMID:9512417; http://dx.doi.org/10.1016/ S0960-9822(98)70130-7 95.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
EMBO J 2002; 21:6216- 24; PMID:12426393; http://dx.doi.org/10.1093/ emboj/cdf620 97.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Mol Cell 1998;  1:359-69; PMID:9660920; http://dx.doi.org/10.1016/ S1097-2765(00)80036-2 98.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Science  2004; 303:95-8; PMID:14631048; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Genes Dev 2003; 17:3011- 6; PMID:14681208; http://dx.doi.org/10.1101/gad.1158803 100.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Vaccine 2009; 27:6312-6; PMID:19840666; http://dx.doi.org/10.1016/j.vac- cine.2009.01.015 101.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Proc Natl Acad Sci USA 2007; 104:1853- 8; PMID:17267598; http://dx.doi.org/10.1073/ pnas.0610977104 102.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Virol 2002; 76:1206- 12; PMID:11773396; http://dx.doi.org/10.1128/ JVI.76.3.1206-1212.200274.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Traffic 2007;  8:1-11; PMID:17132145; http://dx.doi.org/10.1111/ j.1600-0854.2006.00507.x 75.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nucleic Acids Res  2008; 36:4913-28; PMID:18653528; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Cell 2009; 139:1243- 54; PMID:20064371; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nature 2008; 454:890-3; PMID:18615016; http://dx.doi.org/10.1038/nature07151 78.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Nature 2010; 463:818-22; PMID:20081832;  http://dx.doi.org/10.1038/nature08760 79.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Cell 2009; 139:1255-67; PMID:20064372;  http://dx.doi.org/10.1016/j.cell.2009.12.018 80.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Cell  Host Microbe 2010; 7:427-39; PMID:20542247;  http://dx.doi.org/10.1016/j.chom.2010.05.008 81.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Gen Virol  2010; 91:1290-301; PMID:20071484; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Cell Biol 2002; 159:579- 88; PMID:12438415; http://dx.doi.org/10.1083/ jcb.200207128 83.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
RNA 2003; 9:881- 91; PMID:12810921; http://dx.doi.org/10.1261/ rna.5420503 84.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
J Gen Virol  2011; 92:1627-34; PMID:21402597; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Mol Cell 2003; 11:837-43;  PMID:12667464; http://dx.doi.org/10.1016/S1097- 2765(03)00089-3 86.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
Cell 2013; 153:112-25; PMID:23477864;  http://dx.doi.org/10.1016/j.cell.2013.02.027 88.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
RNA 2000; 6:136-58; PMID:10668806; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/66/rna-10-1274.PMC3817148.pdf
"www.landesbioscience.com RNA Biology 1291RNA Biology 10:8, 1291–1298; August 2013; © 2013 Landes BioscienceBRief CommuNiCA tioN *Correspondence to: Niels H Gehring; Email: ngehring@uni-koeln.de Submitted: 11/22/2012; Revised: 07/19/2013; Accepted: 07/22/2013http://dx.doi.org/10.4161/rna.25827Introduction The process of gene expression in eukaryotic cells is organized as  a series of events, which are all performed by large multi-protein machineries.",Non-OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
"Following this observation, we noticed that a sec - ond MAGOH gene is present in the human genome (NCBI: NM_018048; UniProt: Q96A72), referred to as “MAGOHB” (HUGO nomenclature database; http://www.genenames.org/), as well as two MAGOH pseudogenes (referred to as MAGOH2 and MAGOH3P; HUGO nomenclature database).",OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Nature  2002; 416:499-506; PMID:11932736; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Proc Natl Acad Sci USA  2012; 109:21313-8; PMID:23236153; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Nat Struct Mol Biol  2012; 19:983-90; PMID:22961380; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Cell Rep 2012; 2:454-61; PMID:22959432; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Cell 2012; 151:750-64; PMID:23084401;  http://dx.doi.org/10.1016/j.cell.2012.10.007,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Nucleic Acids Res 2005; 33:5965-77;  PMID:16254077; http://dx.doi.org/10.1093/nar/ gki905 25.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
EMBO J  2001; 20:1785-96; PMID:11285241; http://dx.doi.org/10.1093/emboj/20.7.1785 26.,Non-OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Epigenetics Chromatin 2009; 2:5;  PMID:19348672; http://dx.doi.org/10.1186/1756- 8935-2-5 27.,Non-OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Mol Cell 2003; 11:939-49;  PMID:12718880; http://dx.doi.org/10.1016/S1097- 2765(03)00142-4 28.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Cell 2006; 126:713- 25; PMID:16923391; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Science 2006; 313:1968- 72; PMID:16931718; http://dx.doi.org/10.1126/sci- ence.1131981 17.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Nat Neurosci  2010; 13:551-8; PMID:20364144; http://dx.doi.org/10.1038/nn.2527 18.,Non-OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Eur J Hum Genet 2012; 20:754-61; PMID:22317977;  http://dx.doi.org/10.1038/ejhg.2012.6 20.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Syst Biol 2003; 52:696-704; PMID:14530136;  http://dx.doi.org/10.1080/10635150390235520 21.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
PLoS Biol  2009; 7:e1000120; PMID:19478851; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Nat Struct Mol Biol  2012; 19:1124-31; PMID:23085716; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
EMBO J  2001; 20:4987-97; PMID:11532962; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Science  2001; 293:1836-9; PMID:11546874; http://dx.doi.org/10.1126/science.1062786 10.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Cell 2008; 133:303-13; PMID:18423201;  http://dx.doi.org/10.1016/j.cell.2008.02.031 11.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Cell 2010; 143:238- 50; PMID:20946982; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Cell  2010; 143:251-62; PMID:20946983; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Proc Natl Acad Sci USA 2013; 110:5903- 8; PMID:23530232; http://dx.doi.org/10.1073/ pnas.1218732110 14.,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
Nat Struct Mol Biol 2005; 12:861-9; PMID:16170325; http://dx.doi.org/10.1038/ nsmb990,OADS,/arxiv_data1/oa_pdf/81/8e/rna-10-1291.PMC3817150.pdf
"www.landesbioscience.com RNA Biology 1299RNA Biology 10:8, 1299–1306; August 2013; © 2013 Landes BioscienceTechNic AL PAPeR *Correspondence to: Claudio De Virgilio; Email: Claudio.DeVirgilio@unifr.ch Submitted: 04/30/2013; Revised: 06/06/2013; Accepted: 06/10/2013http://dx.doi.org/10.4161/rna.25355Introduction mRNA turnover is a key factor in the regulation of eukaryotic  gene expression, which, in parallel to transcriptional activa - tion/repression, allows cells to rapidly adjust their levels of spe - cific transcripts in response to environmental stress conditions.",Non-OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Proc Natl Acad Sci USA 2002; 99:5860- 5; PMID:11972065; http://dx.doi.org/10.1073/ pnas.092538799 2.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
FEMS Yeast Res 2006; 6:160-70;  PMID:16487339; http://dx.doi.org/10.1111/j.1567- 1364.2006.00032.x 3.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Mol Cell 2010; 38:345-55;  PMID:20471941; http://dx.doi.org/10.1016/j.mol- cel.2010.02.039 6.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Mol Cell Biol 1987; 7:1602- 11; PMID:3299050; http://dx.doi.org/10.1128/ MCB.7.5.1602 7.,Non-OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Methods Enzymol 2008; 448:267-84; PMID:19111181; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Cell  1998; 95:717-28; PMID:9845373; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Mol Cell Biol 1999; 19:5393-404;  PMID:10409730; http://dx.doi.org/10.1152/ ajpgi.00315.2009 11.,Non-OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Nucleic Acids Res  1988; 16:7917-29; PMID:3047675; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Yeast 2008; 25:85-92; PMID:17914747; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Mol  Syst Biol 2011; 7:458; PMID:21206491; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Mol Biol Cell 2011; 22:2787-95; PMID:21680716;  http://dx.doi.org/10.1091/mbc.E11-01-0028 15.,Non-OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
J Mol  Biol 2013; In press; PMID:23467123; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Genome Res  2012; 22:1350-9; PMID:22466169; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
RNA Biol 2011; 8:14-7; PMID:21289492;  http://dx.doi.org/10.4161/rna.8.1.1348318.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Cell  Rep 2013; 3:16-22; PMID:23273919; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Cell Cycle 2004; 3:462-8; PMID:15300954; http://dx.doi.org/10.4161/cc.3.4.791 20.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Genetics  2009; 183:413-22; PMID:19652178; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Cell 2012; 148:958-72; PMID:22385961; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Nucleic Acids Res  2000; 28:E108; PMID:11121495; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Yeast 1994; 10:1793-808; PMID:7747518; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Mol Cell  2007; 26:663-74; PMID:17560372; http://dx.doi.org/10.1016/j.molcel.2007.04.020 25.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Mol Microbiol 2008; 69:277-85; PMID:18513215; http://dx.doi.org/10.1111/j.1365- 2958.2008.06292.x,Non-OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Nucleic Acids Res 2011; 39:1501- 9; PMID:20959291; http://dx.doi.org/10.1093/nar/ gkq920 34.,Non-OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
RNA 2008; 14:1328- 36; PMID:18469165; http://dx.doi.org/10.1261/ rna.955508 35.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Methods Enzymol 1991; 194:169-82;  PMID:2005785; http://dx.doi.org/10.1016/0076- 6879(91)94014-430.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
RNA 2007; 13:982-97; PMID:17586758;  http://dx.doi.org/10.1261/rna.569407 31.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Mol Cell 2003; 12:1607-13;  PMID:14690612; http://dx.doi.org/10.1016/S1097- 2765(03)00485-4 32.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
EMBO J 2005; 24:4271- 8; PMID:16308562; http://dx.doi.org/10.1038/ sj.emboj.760088926.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Cell 2011; 147:1484-97; PMID:22196726; http://dx.doi.org/10.1016/j.cell.2011.11.051 27.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Cell 2011; 147:1473-83; PMID:22196725; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
Genome Biol 2005; 6:R86;  PMID:16207357; http://dx.doi.org/10.1186/gb-2005- 6-10-r86 29.,OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
BMC  Genomics 2009; 10:391; PMID:19698117; http://dx.doi.org/10.1186/1471-2164-10-391,Non-OADS,/arxiv_data1/oa_pdf/df/cd/rna-10-1299.PMC3817151.pdf
"www.landesbioscience.com RNA Biology 1333RNA Biology 10:8, 1333–1344; August 2013; © 2013 Landes BioscienceReseAR ch p ApeR *Correspondence to: Michael E Buckland; Email: michael.buckland@sydney.edu.au; Catherine M Suter; Email: c.suter@victorchang.edu.au Submitted: 05/12/13; Accepted: 06/05/13http://dx.doi.org/10.4161/rna.25281Introduction Gliomas are the most common and deadly of adult primary  brain tumors.",Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Nat Biotechnol 2011;  29:341-5; PMID:21423189; http://dx.doi.org/10.1038/ nbt.1807 4.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Nat Rev Immunol 2009;  9:581-93; PMID:19498381; http://dx.doi.org/10.1038/ nri2567 5.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Prog Neurobiol 2010; 91:140-51; PMID:20117166;  http://dx.doi.org/10.1016/j.pneurobio.2010.01.007 6.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Genes  Dev 2012; 26:1287-99; PMID:22713869; http://dx.doi.org/10.1101/gad.192351.112 7.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Cell Mol Life  Sci 2011; 68:2667-88; PMID:21560073; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Gynecol Oncol 2008; 110:13- 21; PMID:18589210; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Int J Cancer  2005; 113:752-60; PMID:15499615; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Cancer Res  2007; 67:7458-66; PMID:17671216; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Immunol Res 2006; 36:247- 54; PMID:17337785; http://dx.doi.org/10.1385/ IR:36:1:247 15.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Nat Cell  Biol 2008; 10:1470-6; PMID:19011622; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Neuro Oncol 2012; 14:689-700;  PMID:22492962; http://dx.doi.org/10.1093/neuonc/ nos074 18.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Cell 2009; 136:215-33; PMID:19167326;  http://dx.doi.org/10.1016/j.cell.2009.01.002 19.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Hum Mol Genet 2006; 15(Spec No 1):R17-29; PMID:16651366;  http://dx.doi.org/10.1093/hmg/ddl046 20.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
PLoS One 2008;  3:e3694; PMID:19002258; http://dx.doi.org/10.1371/ journal.pone.0003694,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Nucleic Acids Res 2010; 38:5141- 51; PMID:20385573; http://dx.doi.org/10.1093/nar/ gkq229 47.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
"Mol Biol Rep 2012; 39:903-9;  PMID:21567196; http://dx.doi.org/10.1007/s11033- 011-0815-1 48. van Zon A, Mossink MH, Scheper RJ, Sonneveld P, Wiemer EA.",OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Cell Mol Life  Sci 2003; 60:1828-37; PMID:14523546; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Int  J Cancer 2001; 94:377-82; PMID:11745417; http://dx.doi.org/10.1002/ijc.1486 50.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Hum Mol Genet  2012; 21(R1):R125-34; PMID:22872698; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
PLoS  One 2010; 5:e13415; PMID:20976232; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Proteomics  2010; 10:1265-9; PMID:20077414; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
PLoS Comput Biol 2009; 5:e1000386;  PMID:19461883; http://dx.doi.org/10.1371/journal.pcbi.1000386 55.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Nat Genet 2006; 38:500-1;  PMID:16642009; http://dx.doi.org/10.1038/ng0506-500 56.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Stat Appl Genet Mol Biol 2004; 3:e3; PMID:16646809; http://dx.doi.org/10.2202/1544- 6115.102735.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Proc Natl Acad Sci USA 2010; 107:6328- 33; PMID:20304794; http://dx.doi.org/10.1073/ pnas.0914843107 36.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Cancer Sci 2010; 101:2087- 92; PMID:20624164; http://dx.doi.org/10.1111/j.1349- 7006.2010.01650.x 37.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Blood 2012; 119:756-66; PMID:22031862;  http://dx.doi.org/10.1182/blood-2011-02-338004 38.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Cardiovasc Res 2012; 93:633- 44; PMID:22258631; http://dx.doi.org/10.1093/cvr/cvs007 39.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Mol Cancer 2012; 11:37; PMID:22682234; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Mol Cell 2010; 37:620-32;  PMID:20227367; http://dx.doi.org/10.1016/j.mol- cel.2010.02.018 41.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
FASEB J 2012;  26:420-9; PMID:21965597; http://dx.doi.org/10.1096/ fj.11-186817 42.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Nat Rev Cancer 2007; 7:519-30; PMID:17585332;  http://dx.doi.org/10.1038/nrc2171 43.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
J Cell Biol  2012; 196:395-406; PMID:22351925; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Proc Natl Acad Sci USA 2012; 109:E2110- 6; PMID:22753494; http://dx.doi.org/10.1073/ pnas.1209414109 45.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Nat Neurosci 2012; 15:827-35; PMID:22610069; http://dx.doi.org/10.1038/nn.311321.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Nat Cell Biol 2007; 9:654-9;  PMID:17486113; http://dx.doi.org/10.1038/ncb1596 22.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Nucleic Acids Res 2012; 40(Database  issue):D1241-4; PMID:21989406; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Cell  2007; 129:1401-14; PMID:17604727; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Oncogene 2007; 26:2799- 803; PMID:17072344; http://dx.doi.org/10.1038/ sj.onc.1210083 27.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
BMC Genomics 2012; 13:357; PMID:22849433; http://dx.doi.org/10.1186/1471- 2164-13-357 28.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
PLoS One 2010; 5:e13515; PMID:20976003;  http://dx.doi.org/10.1371/journal.pone.0013515 29.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Nat Rev Cancer 2002; 2:521-8;  PMID:12094238; http://dx.doi.org/10.1038/nrc842 30.,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Genome Res 2005; 15:1073- 8; PMID:16024818; http://dx.doi.org/10.1101/ gr.3688905 33.,OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
Nat Cell Biol 2009; 11:1268-71;  PMID:19749744; http://dx.doi.org/10.1038/ncb1972,Non-OADS,/arxiv_data1/oa_pdf/16/ee/rna-10-1333.PMC3817155.pdf
"www.landesbioscience.com RNA Biology 1345RNA Biology 10:8, 1345–1355; August 2013; © 2013 Landes BioscienceReseAR ch p ApeR *Correspondence to: Sarah F Newbury; Email: s.newbury@bsms.ac.uk Submitted: 12/13/2012; Revised: 06/10/2013; Accepted: 06/10/2013http://dx.doi.org/10.4161/rna.25354Introduction A key aspect in the regulation of eukaryotic gene expression is the  cytoplasmic control of mRNA stability.",Non-OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
BMC Genomics 2005; 6:75;  PMID:15907206; http://dx.doi.org/10.1186/1471- 2164-6-75 2.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
J Biomed Biotechnol 2009; 2009:634520; PMID:19672455; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Nat Rev Mol Cell  Biol 2007; 8:113-26; PMID:17245413; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Biochem Soc Trans 2006; 34:30-4; PMID:16246172;  http://dx.doi.org/10.1042/BST0340030 6.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Blood  2001; 98:2389-95; PMID:11588035; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
J Biol Chem 2008; 283:11689-99; PMID:18256032; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
RNA 2004; 10:59- 65; PMID:14681585; http://dx.doi.org/10.1261/rna.2195504 10.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Nat Struct Mol Biol  2004; 11:121-7; PMID:14749774; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Biochim Biophys Acta 2013; 1829:590- 603; PMID:23517755; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
RNA 2005; 11:459-69; PMID:15703439;  http://dx.doi.org/10.1261/rna.7231505 14.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Biochem Soc Trans 2010; 38:242-51; PMID:20074068; http://dx.doi.org/10.1042/ BST0380242 15.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Biochem J 2008; 416:327-35; PMID:18652574;  http://dx.doi.org/10.1042/BJ20071720 16.,Non-OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
J Cell Sci 2008; 121:2463- 72; PMID:18611963; http://dx.doi.org/10.1242/ jcs.024976 17.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Mol Cell 2011; 41:600-8; PMID:21362555;  http://dx.doi.org/10.1016/j.molcel.2011.02.004 18.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Nat Struct Mol Biol 2012; 19:1324-31; PMID:23142987; http://dx.doi.org/10.1038/ nsmb.2413 20.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Biol Cell 2008; 100:687-701; PMID:18547166;  http://dx.doi.org/10.1042/BC20080049 21.,Non-OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Biostatistics 2003; 4:249-64;  PMID:12925520; http://dx.doi.org/10.1093/biostatis- tics/4.2.24923.,Non-OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Bioinformatics 2002; 18:1585-92;  PMID:12490442; http://dx.doi.org/10.1093/bioinfor-matics/18.12.1585 24.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
J Am Stat Assoc 2004; 99:909-17; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
PLoS One 2012; 7:e52521;  PMID:23300696; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
PLoS Genet 2012; 8:e1002901;  PMID:22956911; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Wiley Interdiscip Rev RNA 2012; 3:593-600;  PMID:22461385; http://dx.doi.org/10.1002/ wrna.1114 30.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Nature 2013; 497:244- 8; PMID:23594738; http://dx.doi.org/10.1038/nature12119 31.,Non-OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
RNA  2010; 16:1032-9; PMID:20348442; http://dx.doi.org/10.1261/rna.1851510 32.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Dev Cell 2011; 20:388-96; PMID:21397849; http://dx.doi.org/10.1016/j.devcel.2011.02.008 33.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Biochem Soc Trans 2012; 40:891-5; PMID:22817754; http://dx.doi.org/10.1042/BST20120035 34.,Non-OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Biochem Soc Trans  2010; 38:1137-43; PMID:20659018; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Proc Natl Acad Sci USA 2004; 101:159-64; PMID:14684833; http://dx.doi.org/10.1073/ pnas.0307205101 46.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
J Biol Chem  2010; 285:37811-22; PMID:20858900; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
J Biol Chem 2009; 284:5523- 32; PMID:19114712; http://dx.doi.org/10.1074/jbc.M807440200 43.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Nucleic Acids Res 2012; 40(Database issue):D706-14; PMID:22127867; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Genetics 2005; 169:2087- 100; PMID:15695365; http://dx.doi.org/10.1534/ genetics.104.03459535.,Non-OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Nucleic Acids Res 2011; 39(Database issue):D152-7;  PMID:21037258; http://dx.doi.org/10.1093/nar/ gkq1027 36.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Mol Biol Cell 2011; 22:748-58; PMID:21233283;  http://dx.doi.org/10.1091/mbc.E10-11-0898 37.,Non-OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
PLoS Genet 2011; 7:e1002273;  PMID:21931566; http://dx.doi.org/10.1371/journal.pgen.1002273 38.,Non-OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Genome Res  2012; 22:1350-9; PMID:22466169; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
Biochem Biophys Res Commun  2013; 431:321-5; PMID:23291172; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/41/rna-10-1345.PMC3817156.pdf
"www.landesbioscience.com RNA Biology 1379RNA Biology 10:8, 1379–1395; August 2013; © 2013 Landes BioscienceReseAR ch p ApeR *Correspondence to: R Keith Slotkin; Email: Slotkin.2@OSU.edu Submitted: 05/08/2013; Revised: 06/10/2013; Accepted: 06/25/2013http://dx.doi.org/10.4161/rna.25555Introduction Gene regulation occurs in plants and animals through the  microRNA pathway, which is dependent upon the ability of an Argonaute  family protein to bind small RNAs and guide  the regulation of target mRNA transcripts (reviewed in ref.",Non-OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Nat Rev Genet 2004; 5:522-31;  PMID:15211354; http://dx.doi.org/10.1038/nrg1379 2.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Curr Biol 2002; 12:1484-95; PMID:12225663;  http://dx.doi.org/10.1016/S0960-9822(02)01017-5 3.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Genes Dev 2004; 18:1187- 97; PMID:15131082; http://dx.doi.org/10.1101/ gad.1201404 4.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Proc Natl Acad Sci USA 2005; 102:11928-33;  PMID:16081530; http://dx.doi.org/10.1073/ pnas.0505461102 5.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Science 2008; 320:1185-90; PMID:18483398; http://dx.doi.org/10.1126/sci- ence.1159151 6.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Mol Cell 2004; 16:69-79; PMID:15469823;  http://dx.doi.org/10.1016/j.molcel.2004.09.028 7.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Curr Biol 2006; 16:933- 8; PMID:16682355; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Development  2006; 133:2973-81; PMID:16818444; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Genome Biol 2005; 6:R90; PMID:16277745; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
EMBO  J 2007; 26:1691-701; PMID:17332757; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Plant Cell 2010; 22:321-34; PMID:20173091; http://dx.doi.org/10.1105/ tpc.109.072199 14.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
PLoS Genet 2012; 8:e1002474;  PMID:22346759; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
PLoS One 2012; 7:e43785;  PMID:22937095; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
PLoS Genet  2010; 6:e1001175; PMID:21060865; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Nature 2010; 467:1128-32; PMID:20953170;  http://dx.doi.org/10.1038/nature0946523.,Non-OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Trends Genet  2012; 28:616-23; PMID:23040327; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Nat Genet 1999; 22:94-7; PMID:10319870;  http://dx.doi.org/10.1038/8803 26.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Cell 2013; 153:193-205; PMID:23540698; http://dx.doi.org/10.1016/j.cell.2013.02.033 27.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Science 2002; 297:1871-3; PMID:12077425;  http://dx.doi.org/10.1126/science.1074950 28.,Non-OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Proc Natl Acad Sci USA 1996; 93:12406- 11; PMID:8901594; http://dx.doi.org/10.1073/ pnas.93.22.12406 30.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Nature 2001;  411:212-4; PMID:11346800; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Plant Physiol 2013; 162:116-31; PMID:23542151;  http://dx.doi.org/10.1104/pp.113.216481 32.,Non-OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Plant J 2011; 67:292-304;  PMID:21457371; http://dx.doi.org/10.1111/j.1365- 313X.2011.04594.x,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Proc Natl Acad Sci USA  2008; 105:14958-63; PMID:18815367; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Bioinformatics  2008; 24:2252-3; PMID:18713789; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Nucleic Acids Res 2005; 33(Web  Server issue):W701-4; PMID:15980567; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Nucleic  Acids Res 2007; 35:e60; PMID:17405769; http://dx.doi.org/10.1093/nar/gkm112 53.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Nucleic Acids Res 2013; 41(Database  issue):D377-86; PMID:23193289; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
International Journal of Plant Biology  2010; 1:e13; http://dx.doi.org/10.4081/pb.2010.e1342.,Non-OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
J Cell Biol 2000; 151:1257-68; PMID:11121440;  http://dx.doi.org/10.1083/jcb.151.6.1257 43.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Nucleic Acids Res  2010; 38:750-63; PMID:19933264; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
J Cell Sci 2011; 124:293- 7; PMID:21242308; http://dx.doi.org/10.1242/ jcs.072140 45.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Nat Biotechnol 2007; 25:473-7;  PMID:17351617; http://dx.doi.org/10.1038/nbt129134.,Non-OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Nucleic Acids Res 2011; 39(Web  Server issue):W155-9; PMID:21622958; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Front Biosci 2012; 17:1329-44; PMID:22201807;  http://dx.doi.org/10.2741/3990 37.,Non-OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Nat Rev Genet 2008; 9:397- 405; PMID:18368054; http://dx.doi.org/10.1038/ nrg2337 38.,Non-OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Plant Cell  2012; 24:415-27; PMID:22345490; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Plant J 2003; 33:413-23;  PMID:12535353; http://dx.doi.org/10.1046/j.1365- 313X.2003.01644.x 40.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Plant Cell 2006; 18:3355-69; PMID:17189346;  http://dx.doi.org/10.1105/tpc.106.044420 41.,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
Plant J 2008; 56:517-30; PMID:18643965;  http://dx.doi.org/10.1111/j.1365-313X.2008.03623.x,OADS,/arxiv_data1/oa_pdf/68/c7/rna-10-1379.PMC3817159.pdf
"www.landesbioscience.com RNA Biology 1407RNA Biology 10:8, 1407–1414; August 2013; © 2013 Landes BioscienceReseAR ch p ApeR Correspondence to: Juan Mata; Email: jm593@cam.ac.uk Submitted: 05/28/2013; Revised: 07/02/2013; Accepted: 07/15/2013http://dx.doi.org/10.4161/rna.25758Introduction Most eukaryotic mRNAs carry a non-encoded tail of adenosine  residues at their 3' end [poly(A) tail].",Non-OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
"For all analyses, S. pombe  annotations and sequences  available from GeneDB (http://old.genedb.org/), now PomBase (http://www.pombase.org/), on May 9, 2011 were used.",OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Nat Struct Mol Biol 2012; 19:845- 52; PMID:22820990; http://dx.doi.org/10.1038/ nsmb.2345 26.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Nucleic Acids Res 2013; 41:e65;  PMID:23295673; http://dx.doi.org/10.1093/nar/ gks1249 28.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Genome Res  2012; 22:1173-83; PMID:22454233; http://dx.doi.org/10.1101/gr.132563.111 29.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Science 2011; 332:930-6; PMID:21511999; http://dx.doi.org/10.1126/sci- ence.1203357 30.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Nat  Struct Mol Biol 2010; 17:251-7; PMID:20118936;  http://dx.doi.org/10.1038/nsmb.1741 31.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Nat Genet 2008; 40:977-86;  PMID:18641648; http://dx.doi.org/10.1038/ng.196 32.,Non-OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Mol Cell 2011; 43:853-66; PMID:21925375;  http://dx.doi.org/10.1016/j.molcel.2011.08.017 34.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Genome  Biol 2009; 10:R25; PMID:19261174; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Nat Struct Mol Biol 2009; 16:616- 23; PMID:19430462; http://dx.doi.org/10.1038/ nsmb.1601 17.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
EMBO J 1998; 17:3066-77; PMID:9606189; http://dx.doi.org/10.1093/emboj/17.11.3066 18.,Non-OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Mol Biol Cell 2011; 22:66- 77; PMID:21148298; http://dx.doi.org/10.1091/mbc.E10-05-0448 19.,Non-OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Nat Genet 2002; 32:143-7; PMID:12161753; http://dx.doi.org/10.1038/ng951 20.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Mol Cell 2007; 26:145-55; PMID:17434133; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Cell 2012; 151:671-83; PMID:23101633;  http://dx.doi.org/10.1016/j.cell.2012.09.019 22.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Cell 2010; 143:1018- 29; PMID:21145465; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
RNA 2011; 17:761- 72; PMID:21343387; http://dx.doi.org/10.1261/ rna.2581711 24.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Genes Dev 2007; 21:1833-56; PMID:17671086;  http://dx.doi.org/10.1101/gad.1566807References 1.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Cell Mol Life Sci 2008;  65:1099-122; PMID:18158581; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Genes Dev 2011; 25:1770-82;  PMID:21896654; http://dx.doi.org/10.1101/ gad.17268411 3.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Nucleic Acids Res 2005; 33:201-12; PMID:15647503;  http://dx.doi.org/10.1093/nar/gki158 5.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Science 2008; 320:1643-7; PMID:18566288;  http://dx.doi.org/10.1126/science.1155390 6.,Non-OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Proc Natl Acad Sci USA 2009; 106:7028- 33; PMID:19372383; http://dx.doi.org/10.1073/ pnas.0900028106 7.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Nature 2011; 469:97-101; PMID:21085120; http://dx.doi.org/10.1038/nature09616 8.,Non-OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Cell 2009; 138:673-84; PMID:19703394; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
RNA 2012; 18:2105-17; PMID:23097429; http://dx.doi.org/10.1261/ rna.035899.112 10.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Proc Natl Acad Sci USA  2002; 99:6152-6; PMID:11972056; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Science 2009; 324:218-23; PMID:19213877;  http://dx.doi.org/10.1126/science.1168978 12.,Non-OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
Nature 2008; 453:1239-43; PMID:18488015;  http://dx.doi.org/10.1038/nature07002,Non-OADS,/arxiv_data1/oa_pdf/cf/95/rna-10-1407.PMC3817161.pdf
"Thisreview provides a summary of recent studies of functionaldiversity of AMF and their roles in natural ecosystems.Mini-review Mycobiology 2013 September, 41(3): 121-125 http://dx.doi.org/10.5941/MYCO.2013.41.3.121pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: eomah@knue.ac.kr Received  September 10, 2013 Accepted  September 11, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/7a/mb-41-121.PMC3817225.pdf
"Thedissecting microscope (SMZ645; Nikon, Tokyo, Japan) wasçs çsResearch Article Mycobiology 2013 September, 41(3): 126-130 http://dx.doi.org/10.5941/MYCO.2013.41.3.126 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr Received  April 11, 2013 Revised  June 9, 2013 Accepted  June 22, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/10/mb-41-126.PMC3817226.pdf
"For the currentstudy, we selected 23 of these specimens belonging to theResearch Article Mycobiology 2013 September, 41(3): 131-138 http://dx.doi.org/10.5941/MYCO.2013.41.3.131 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: hansk75@forest.go.kr (S.-K. Han) sung97330@gmail.com (G.-H.",Non-OADS,/arxiv_data1/oa_pdf/68/f6/mb-41-131.PMC3817227.pdf
"Amanita vaginata , which comprises several varieties and formae (Index Fungorum, http://www.indexfungorum.org/ Names/Names.asp), belongs to a group of Amanita  species w i t h  c o l o r s  r a n g i n g  f r o m  w h i t e  t o  g r a y  t o  b r o w n - c a p p e d[27].",Non-OADS,/arxiv_data1/oa_pdf/68/f6/mb-41-131.PMC3817227.pdf
"The previously reported species (i.e., A. alboflavescens , A. farinosa , A. fulva , A. melleiceps , and A. rubrovolvata ) were clearly consistent with those of previous taxonomicaldescriptions (detailed descriptions of each species are availableat http://www.amanitaceae.org/), and phylogeneticallygrouped with the deposited sequences in GenBank (Figs.",Non-OADS,/arxiv_data1/oa_pdf/68/f6/mb-41-131.PMC3817227.pdf
"anomala,  i t  w a s  r e c e n t l y  g r a n t e d “ qualified presumption of safety (QPS)” status by the EuropeanResearch Article Mycobiology 2013 September, 41(3): 139-144 http://dx.doi.org/10.5941/MYCO.2013.41.3.139 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: bhahn@kfri.re.kr Received  June 4, 2013 Revised  September 12, 2013 Accepted  September 12, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/5e/mb-41-139.PMC3817228.pdf
"A. fumigatus AF293 (WT) [10], ∆flbA4 (pyrG1 , ∆flbA4::pyrG+), andResearch Article Mycobiology 2013 September, 41(3): 145-148 http://dx.doi.org/10.5941/MYCO.2013.41.3.145 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: shinks@dju.kr Received  May 29, 2013 Revised  August 24, 2013 Accepted  August 26, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/8c/mb-41-145.PMC3817229.pdf
"Many papers havereported on commercial α-glucosidase inhibitors such asResearch Article Mycobiology 2013 September, 41(3): 149-154 http://dx.doi.org/10.5941/MYCO.2013.41.3.149 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: biotech8@pcu.ac.kr Received  June 12, 2013 Revised  June 25, 2013 Accepted  July 18, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/92/mb-41-149.PMC3817230.pdf
"Amplification was performed on a TakaraJP/TP600 PCR machine (Takara Bio Inc., Otsu, Japan).One initial cycle of 5 min at 94 oC was followed by 30 cycles of the following steps: 30 sec at 94oC, 39 sec at 57oCResearch Note Mycobiology 2013 September, 41(3): 155-158 http://dx.doi.org/10.5941/MYCO.2013.41.3.155 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr Received  April 25, 2013 Revised  June 10, 2013 Accepted  August 26, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/89/mb-41-155.PMC3817231.pdf
"The strains studied in thisexperiment were obtained from the Culture Collection ofResearch Note Mycobiology 2013 September, 41(3): 159-163 http://dx.doi.org/10.5941/MYCO.2013.41.3.159 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: rohyeon@gnu.ac.kr Received  May 20, 2013 Revised  June 10, 2013 Accepted  June 24, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/48/mb-41-159.PMC3817232.pdf
"BS061, which was maintained on Mueller hinton (MH) agar plate, was transferred into a500 mL Erlenmeyer flasks containing 200 mL MH broth.Research Note Mycobiology 2013 September, 41(3): 164-166 http://dx.doi.org/10.5941/MYCO.2013.41.3.164pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: bsyun@jbnu.ac.kr Received  August 12, 2013 Accepted  August 27, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/a7/mb-41-164.PMC3817233.pdf
"When the isolated fungi wereResearch Note Mycobiology 2013 September, 41(3): 167-169 http://dx.doi.org/10.5941/MYCO.2013.41.3.167 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: kwak@gnu.ac.kr Received  July 28, 2013 Revised  August 25, 2013 Accepted  September 3, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/72/mb-41-167.PMC3817234.pdf
"List of fungal species from soybeans and their isolation frequencies Scientific nameRepresentative strains Incidence on mejubIsolation frequency from sodium hypochlorite untreated soybeanscIsolation frequency from sodium hypochlorite-treated  soybeansc Strain numberSequence numberaNumber of factoriesd DRBC DG18 MEANumber of factoriesd DRBC DG18 MEA Mycobiology 2013 September, 41(3): 00-00 http://dx.doi.org/10.5941/MYCO.2013.41.3.00 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: selpest@knu.ac.kr Received   Revised   Accepted   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/d5/mb-41-170.PMC3817235.pdf
"5: 163-167, October, 2013http://dx.doi.org/10.4110/in.2013.13.5.163 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 163Received on August 14, 2013.",Non-OADS,/arxiv_data1/oa_pdf/71/1c/in-13-163.PMC3817296.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/1c/in-13-163.PMC3817296.pdf
"5: 168-176, October, 2013http://dx.doi.org/10.4110/in.2013.13.5.168 pISSN 1598-2629  eISSN 2092-6685 168REVIEW ARTICLE Received on August 21, 2013.",Non-OADS,/arxiv_data1/oa_pdf/fe/46/in-13-168.PMC3817297.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/46/in-13-168.PMC3817297.pdf
Updated July 2013.  http://www.who.int/mediacentre/factsheets/fs164/en/.,Non-OADS,/arxiv_data1/oa_pdf/fe/46/in-13-168.PMC3817297.pdf
in press : http://ini.sagepub.com/content/  early/2013/09/13/1753425913503385.,Non-OADS,/arxiv_data1/oa_pdf/fe/46/in-13-168.PMC3817297.pdf
"5: 177-183, October, 2013http://dx.doi.org/10.4110/in.2013.13.5.177 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 177Received on August 29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/34/84/in-13-177.PMC3817298.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/84/in-13-177.PMC3817298.pdf
In press: http://dx.doi.org/10.1016/j.copbio.,OADS,/arxiv_data1/oa_pdf/34/84/in-13-177.PMC3817298.pdf
In press : http://dx.doi.org/10.1016/j.ejpb.2013.07.,OADS,/arxiv_data1/oa_pdf/34/84/in-13-177.PMC3817298.pdf
In press : http://dx.doi.org/10.1016/j.addr.,OADS,/arxiv_data1/oa_pdf/34/84/in-13-177.PMC3817298.pdf
"5: 184-193, October, 2013http://dx.doi.org/10.4110/in.2013.13.5.184 pISSN 1598-2629    eISSN 2092-6685 184REVIEW ARTICLE Received on September 11, 2013.",Non-OADS,/arxiv_data1/oa_pdf/bc/fa/in-13-184.PMC3817299.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/fa/in-13-184.PMC3817299.pdf
In press: http://dx.doi.org/10.1016/j.it.,OADS,/arxiv_data1/oa_pdf/bc/fa/in-13-184.PMC3817299.pdf
"5: 194-198, October, 2013http://dx.doi.org/10.4110/in.2013.13.5.194 pISSN 1598-2629    eISSN 2092-6685 194REVIEW ARTICLE Received on September 16, 2013.",Non-OADS,/arxiv_data1/oa_pdf/4a/9c/in-13-194.PMC3817300.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/9c/in-13-194.PMC3817300.pdf
"5: 199-204, October, 2013http://dx.doi.org/10.4110/in.2013.13.5.199 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 199Received on August 21, 2013.",Non-OADS,/arxiv_data1/oa_pdf/88/53/in-13-199.PMC3817301.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/53/in-13-199.PMC3817301.pdf
"5: 205-212, October, 2013http://dx.doi.org/10.4110/in.2013.13.5.205 pISSN 1598-2629    eISSN 2092-6685 205Received on September 12, 2013.",OADS,/arxiv_data1/oa_pdf/16/52/in-13-205.PMC3817302.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/52/in-13-205.PMC3817302.pdf
"5: 213-217, October, 2013http://dx.doi.org/10.4110/in.2013.13.5.213 pISSN 1598-2629    eISSN 2092-6685BRIEF COMMUNICATION 213Received on September 3, 2013.",Non-OADS,/arxiv_data1/oa_pdf/3f/6a/in-13-213.PMC3817303.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/6a/in-13-213.PMC3817303.pdf
"5: 218-221, October, 2013http://dx.doi.org/10.4110/in.2013.13.5.218 pISSN 1598-2629    eISSN 2092-6685BRIEF COMMUNICATION 218Received on September 11, 2013.",Non-OADS,/arxiv_data1/oa_pdf/75/80/in-13-218.PMC3817304.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/80/in-13-218.PMC3817304.pdf
"5: 222-226, October, 2013http://dx.doi.org/10.4110/in.2013.13.5.222 pISSN 1598-2629    eISSN 2092-6685 222CASE REPORT Received on September 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d4/8f/in-13-222.PMC3817305.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/8f/in-13-222.PMC3817305.pdf
"Samples were collected during five consecutive trials at the Surgery Branch, National Cancer Institute (Dudley et al, 2010; Rosenberg et al , 2011; Uccellini et al , 2012; http://www.clinicaltrials.gov/ ct2/show/NCT00513604?term=07C0176&rank=1), codified as: TNMA, T200, T1200, TYT, and TCD8 (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/fb/1c/bjc2013557a.PMC3817317.pdf
"Detailed study protocol information are available elsewhere (http://www.clinicaltrials.gov/ct2/show/ NCT00513604?term=07C0176&rank=1), (Dudley et al , 2010; Rosenberg et al, 2011).",Non-OADS,/arxiv_data1/oa_pdf/fb/1c/bjc2013557a.PMC3817317.pdf
Primers were designed using the Primer3 software (http://www.frodo.wi.mit.edu/).,OADS,/arxiv_data1/oa_pdf/fb/1c/bjc2013557a.PMC3817317.pdf
"Single subject CXCR3 rs2280964 genotypes (HapMap and 1000 Genome Projects, CEU populations) were downloaded from ensembl (http://www.useast.ensembl.org/index.html).",OADS,/arxiv_data1/oa_pdf/fb/1c/bjc2013557a.PMC3817317.pdf
"Interest- ingly, we found four men (one CR, two PR, and one NR) carrying the G allele (electopherograms in Supplementary Figure S1).Although rs2280964 is annotated as bi-allelic (C/T) polymorphism in the dbSNP database (http://www.ncbi.nlm.nih.gov/snp/ ?term=2280964), HapMap project and genome-wide association studies (both array based) might miss the identification of tri-allelic variants (Ellinghaus et al, 2009).",OADS,/arxiv_data1/oa_pdf/fb/1c/bjc2013557a.PMC3817317.pdf
(http://www.1000genomes.org/faq/ are-all-genotype-calls-current-release-vcf-files-bi-allelic).,OADS,/arxiv_data1/oa_pdf/fb/1c/bjc2013557a.PMC3817317.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CXCR3/CCR5 pathways in adoptive therapy BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.557 2423,Non-OADS,/arxiv_data1/oa_pdf/fb/1c/bjc2013557a.PMC3817317.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Prognostic value of ABO blood group in NPC 2466 www.bjcancer.com | DOI:10.1038/bjc.2013.559,Non-OADS,/arxiv_data1/oa_pdf/d9/ee/bjc2013559a.PMC3817319.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER HCC develop after interferon based therapy 2488 www.bjcancer.com | DOI:10.1038/bjc.2013.564,Non-OADS,/arxiv_data1/oa_pdf/5c/98/bjc2013564a.PMC3817320.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CX3CR1 early expression in pancreatic cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.565 2433,Non-OADS,/arxiv_data1/oa_pdf/06/7c/bjc2013565a.PMC3817321.pdf
"Phase III trials of perhaps the most advanced of the CDK inhibitors, dinaciclib (a pyrazolo[1,5- a]pyrimidine pan-CDK1/2/5/9 inhibitorwith PSA ¼91 Å 2,( NþO)¼8, MW ¼368 and Log P¼1.38), has been initiated in patients with refractory chronic lymphocytic leukaemia comparing efficacy against ofatumumab (NCT 01580228; http://clinicaltrials.gov/); however, no data on ABC transporter substrate specificity has been reported (Parry et al, 2010).",Non-OADS,/arxiv_data1/oa_pdf/eb/fb/bjc2013584a.PMC3817326.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CDK inhibitors and drug efflux BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.584 2367,Non-OADS,/arxiv_data1/oa_pdf/eb/fb/bjc2013584a.PMC3817326.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Change in breast density with AI therapy BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.587 2339,Non-OADS,/arxiv_data1/oa_pdf/51/9f/bjc2013587a.PMC3817329.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Sigma-2 ligands as tumour-targeted drug delivery agents BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.593 2377,Non-OADS,/arxiv_data1/oa_pdf/bf/ce/bjc2013593a.PMC3817331.pdf
National Comprehensive Cancer Network (2012) NCCN Clinical Practice Guidelines in Oncology Soft Tissue Sarcoma (Version 3.2012).Accessed February 2013; http://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/15/bjc2013594a.PMC3817332.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Dovitinib for GISTs after failure of imatinib and sunitinib BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.594 2315,Non-OADS,/arxiv_data1/oa_pdf/56/15/bjc2013594a.PMC3817332.pdf
"Mutational analysis by TP53 sequencing in two patients identified the missense mutations c.817C 4A (exon 8, with resulting p.R273S) in one and c.613T 4G (exon 6, causing p.Y205D) in the other, both associated with loss of p53 transcriptional activity (International Agency for Research in Cancer, TP53 Database, http://p53.iarc.fr).",Non-OADS,/arxiv_data1/oa_pdf/ab/2c/bjc2013601a.PMC3817336.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER p53 and cell cycle independent autophagy dysregulation 2444 www.bjcancer.com | DOI:10.1038/bjc.2013.601,Non-OADS,/arxiv_data1/oa_pdf/ab/2c/bjc2013601a.PMC3817336.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc) APPENDIX DeCoDe PET group collaborators: All collaborators of the DeCoDe PET group have contributed to data acquisition and approved the final paper after cri tical revision.,Non-OADS,/arxiv_data1/oa_pdf/93/fc/bjc2013608a.PMC3817339.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Predictive biomarkers in TEAM BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.609 2461,Non-OADS,/arxiv_data1/oa_pdf/15/57/bjc2013609a.PMC3817340.pdf
Database search utilised the Mascot (http://www.matrixscience.com) and Protein Prospector (http://prospector.ucsf.edu) websites.,OADS,/arxiv_data1/oa_pdf/f8/31/bjc2013613a.PMC3817341.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)DPYD copy number aberrations in triple-negative breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.621 2355,Non-OADS,/arxiv_data1/oa_pdf/30/5d/bjc2013621a.PMC3817342.pdf
Statistical analysis of the TLDA cards and qRT–PCR data were conducted using statistical computing environment R (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/37/7a/bjc2013623a.PMC3817343.pdf
"For the analysis of the TLDA cards, significant miRNA differential expression between groups was classified utilising empirical Bayes moderated t-statistics with the limma package (http://www.bioconductor.org/).",OADS,/arxiv_data1/oa_pdf/37/7a/bjc2013623a.PMC3817343.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)miRNA-based lung cancer diagnosis BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.623 2411,Non-OADS,/arxiv_data1/oa_pdf/37/7a/bjc2013623a.PMC3817343.pdf
"Your Guide to Lowering Your Blood Pressure: DASH Eating Plan, 2009. http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf.",Non-OADS,/arxiv_data1/oa_pdf/00/c1/nutd201332a.PMC3817346.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/DASH diet and CVD risk change in youth with diabetes TL Barnes et al 4 Nutrition & Diabetes (2013) 1 – 4 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/00/c1/nutd201332a.PMC3817346.pdf
A complete listing of ADNI investigators can be found at: http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_   Acknowledgement_List.pdf.,OADS,/arxiv_data1/oa_pdf/bb/6e/psp201354a.PMC3817374.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)Study highlights WhAT IS The CURReNT KNOWleDge ON The TOPIC?",Non-OADS,/arxiv_data1/oa_pdf/bb/6e/psp201354a.PMC3817374.pdf
<http://www.fda.gov/Drugs/DrugSafety/ucm239821.htm#sa> (2011).,Non-OADS,/arxiv_data1/oa_pdf/b3/9b/psp201355a.PMC3817375.pdf
<http://www.gpo.gov/fdsys/pkg/BILLS-112s3187enr/ pdf/BILLS-112s3187enr.pdf> (2012).,Non-OADS,/arxiv_data1/oa_pdf/b3/9b/psp201355a.PMC3817375.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/b3/9b/psp201355a.PMC3817375.pdf
The chap- ter in the ggplot2 book 1 corresponding to qplot()  is avail- able on the book’s web page: http://ggplot2.org/book/.,Non-OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
"A useful companion is the online help pages for ggplot2 (http://docs.ggplot2.org/current), which contains  a series of illustrative examples under each help page.",Non-OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
"For illustration, suppose we want to map SEX to color (“colour” is used in the example code here following Hadley Wickham’s ggplot web page (http://had.co.nz/ggplot2) and his book, but “color” works as a substitute for “colour.”); to do  this, use aes()to define the mapping: ggplot(Data, aes(x, y,  colour = SEX )) This reveals a few more properties of aesthetics in ggplot2 : • Aesthetics fall into two general groups: positional and  non-positional.",OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
"A list of values for the primary aes- thetics is given in Appendix B of the ggplot2 book, 1 found at  http://ggplot2.org/book/appendices.pdf.",Non-OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
A  complete list of available arguments and definitions of theme elements can be found in the online help pages (http://docs.ggplot2.org/current/theme.html).,OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
• Hadley Wickham’s web page for ggplot2 http://had.co.nz/ggplot2 • ggplot2 help documentation http://docs.ggplot2.org/current/ • ggplot2 book “ggplot2: Elegant Graphics for Data Anal- ysis” by Hadley Wickham http://amzn.com/0387981403(all codes are available from the author’s website) • Cookbook for common graphics by Winston Chang 10 http://wiki.stdout.org/rcookbook/Graphs/ • ggplot2 (0.9.0) transition guide8 http://cloud.github.com/downloads/hadley/ggplots2/ guide-col.pdf • ggplot2 mailing list http://groups.google.com/group/ggplot2 • stackoverflow http://stackoverflow.com/tags/ggplot2 • ggplot2 Wiki https://github.com/hadley/ggplot2/wikiFigure 8  Multiple plots (row × column) in one page using grid.arrange ( gridExtra package).,Non-OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
CPT: Pharmacometrics & Systems Pharmacology Application of ggplot2 to Pharmacometric Graphics Ito and Murphy16 •  lattice to ggplot2 conversion http://learnr.wordpress.com/?s=lattice CoNCluSIoN ggplot2 combines the advantages of both base and lattice   graphics and is able to create “publication-ready” plots.,OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
"Note that ggplot2 has been rapidly evolving over the past several  years; therefore, refer to the most current help files (http://docs.ggplot2.org/current/) as the canonical reference.Conflict of Interest.",Non-OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
<http://www.R-project.org/>.,Non-OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
<http://docs.ggplot2.org/current/guide_legend.html>7.,Non-OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
(2013) <http://CRAN.R-project.org/package=ggthemes> 8.,Non-OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
<http://cloud.github.com/downloads/hadley/ggplot2/guide-col.pdf>9.,Non-OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/f3/68/psp201356a.PMC3817376.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/9a/f4/psp201358a.PMC3817378.pdf
The HPO database was downloaded from http://www.human-phenotype-onto-logy.org/contao/index.php/downloads.html in August 2012.,OADS,/arxiv_data1/oa_pdf/ba/da/msb201350.PMC3817400.pdf
To viewa copy of this licence visit http://creativecommons.org/ licenses/by-nc-sa/3.0/.Phylogenetic mapping of disease-pathway proteins Y Tabach et al &2013 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2013 17,Non-OADS,/arxiv_data1/oa_pdf/ba/da/msb201350.PMC3817400.pdf
File formats and accessibility The model is freely available as part of the openCOBRA Project(http://opencobra.sourceforge.net).,OADS,/arxiv_data1/oa_pdf/44/0f/msb201352.PMC3817402.pdf
To viewa copy of this licence visit http://creativecommons.org/ licenses/by-nc-sa/3.0/.Extending and reﬁning growth phenotype prediction EJ O’Brien et al &2013 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2013 13,Non-OADS,/arxiv_data1/oa_pdf/44/0f/msb201352.PMC3817402.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/be/bf/srep03138.PMC3817431.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3138 | DOI: 10.1038/srep03138 6",Non-OADS,/arxiv_data1/oa_pdf/be/bf/srep03138.PMC3817431.pdf
"After re-selection by whole-cell ELISA, the selected monoclonal DNA phages were sequenced at Invitrogen, Guangzhou, China.Multiple sequence alignments and the identification of small peptide motifs were performed using CLUSTALX 2.0.10 (EMBL-EBI, http://www.ebi.ac.uk/Tools/ clustalw2).",OADS,/arxiv_data1/oa_pdf/03/2f/srep03134.PMC3817438.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/03/2f/srep03134.PMC3817438.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3134 | DOI: 10.1038/srep03134 9",Non-OADS,/arxiv_data1/oa_pdf/03/2f/srep03134.PMC3817438.pdf
"ChanTest, Stably Transfected Cell Line - Product Data Sheet hTRPM8-CHO, http://www.chantest.com/media/cms/pdf/data_CT6193.pdf., Date of Access April 1 2013.",Non-OADS,/arxiv_data1/oa_pdf/99/b9/srep03139.PMC3817439.pdf
